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SUMMARY 
First isolated in Australia in the 1970s, Salmonella II Sofia is currently the most 
prevalent Salmonella serovar isolated from Australian poultry flocks, accounting for at 
least half of the Salmonella strains isolated annually from chickens and chicken products 
in Australia. Despite its high frequency in chickens, S. II Sofia is rarely associated with 
animals or human salmonellosis as this serovar is avirulent in nature. The reason for the 
persistence of S. II Sofia (belonging to the Salmonella subspecies group II, which is 
more commonly associated with cold-blooded animals) in chickens but its avirulence is 
unknown as very few studies have been conducted on the epidemiology and 
pathogenicity of this strain. This study details the various experimental methods utilised 
to characterise the genetic relatedness of Australian S. II Sofia isolates and to 
investigate the molecular mechanisms involved in S. II Sofia pathogenesis.  
 
The first part of this study was to investigate the epidemiology of S. II Sofia isolates 
using 2 molecular fingerprinting methods: PFGE (XbaI and SpeI) and Rep-PCR (using 
REP1 element). The previous problem of DNAse activity from S. II Sofia strains causing 
DNA degradation was solved by modifying the lysis solution used to treat the bacterial 
plugs (addition of SDS and increasing sarkosyl and proteinase K concentration),allowing 
S. II Sofia to be subtyped using PFGE. A total of 84 Australian S. II Sofia isolates from 
various states in Australia were subtyped using these 2 fingerprinting methods – 
resulting in generation of 8 XbaI, 6 SpeI and 5 REP1 pattern subtypes although no 
correlation could be found between any of the fingerprint typing methods. Assessment of 
the individual typing methods with the Simpson’s Index of Diversity showed low index 
values (less than 0.5), indicating the poor discriminatory ability of the methods. However, 
the combination of the typing methods was able to improve the discrimination of the 
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isolates, further dividing them into 16 subtypes and raising the index value to 0.721. The 
Australian S. II Sofia isolates were found to show limited genetic diversity and probably 
share a clonal relationship. A majority of the S. II Sofia isolates were not geographically 
restricted with the predominant pattern subtype spread out among the isolates from 
various states – however, the analysis of more isolates is still required before any firm 
conclusions could be drawn. 
 
The second focus of this study was to examine the distribution and variation of the 
SPI-associated virulence genes within S. II Sofia. Southern hybridisation detecting the 
SPI1 to SPI5 regions showed that while differences were observed between the 
Typhimurium and Sofia serovars, all the S. II Sofia isolates tested shared the same SPI 
pattern. Based on RFLP and sequencing analysis, most of the differences observed in 
SPI1 to SPI5 of S. II Sofia could be attributed to a loss or gain of restriction cleavage 
sites within these regions. Most of the SPI genes were predicted to encode proteins 
sharing 87% to 99% similarity with corresponding SPI proteins from S. Typhimurium LT2 
(reference strain). However, a number of genes in SPI1 (orgB, prgI, sptP, sipD and invJ), 
SPI2 (ssaP, ssaI and ssaE), SPI3 (misL, marT and slsA) and SPI5 (ORF) were found to 
have accumulated mutations that could have affected gene transcription and/or protein 
translation – these genes have been shown to be involved in different aspects of the 
virulence process. Further, the deletion of avrA (from SPI1), sugR-rhuM (from SPI3) and 
sopB-pipA (from SPI5) and the insertion of an identical 1.2 kB transposase in SPI1 and 
SPI3 were observed. The effects of these mutations, insertions and deletions probably 
contributed to the reduced pathogenicity in S. II Sofia and thus, avirulence of this serovar 
is not the result of a single genetic change but rather a series of alterations to a large 
number of its virulence-associated genes.  
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Plasmid-mediated virulence was also assessed in S. II Sofia isolates. Isolation and 
analysis of plasmids from S. II Sofia isolates showed the presence a large plasmid along 
with several smaller plasmids (~ 1 to 100 kB in size). Southern hybridisation with 2 DNA 
probes (spvRABCD and traYALE) derived from the virulence plasmid of S. Typhimurium 
failed to detect the presence of both these regions in S. II Sofia isolates, indicating either 
the total absence of the virulence plasmid or the presence of a virulence plasmid 
containing major deletions. Clones constructed with the missing spv operon using 2 
different cloning vectors (high-copy pCR®2.1 and low-copy pWSK29) were inserted into 
S. II Sofia Bt6 and the adherence, invasion (INT407 and CEF-DF1 cells) and intracellular 
survival (J774 macrophages) of the mutant strain was evaluated in vitro. The presence 
of spvRABCD was shown to have no effect on intracellular survival and replication in 
murine macrophages. Although the cloning of spv with pCR®2.1 was observed to 
significantly increase invasiveness of S. II Sofia in INT407 cells, but it was not capable of 
restoring the invasive ability of S. II Sofia to the level of S. Typhimurium 82/6915. On the 
other hand, the uneven adherence and invasion ability of the other mutant strains 
appeared to be linked to the presence of pWSK29 and this observation is further 
supported by RT-PCR analysis of the clones – indicating that perhaps pWSK29 is not a 
suitable vector for this study.       
 
The assessment of the pathogenic potential of Australian S. II Sofia isolates was 
done based on the epidemiology and molecular data obtained in this study. Wild-type S. 
II Sofia isolates are unlikely to regain full pathogenicity because of the numerous 
mutations in many important virulence genes: even the chance acquisition of a virulence 
factor (e.g. spvRABCD) is not sufficient to completely restore S. II Sofia virulence. 
Therefore, S. II Sofia should not be considered similar to other Salmonella spp. when 
monitoring Salmonellae in food samples. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Salmonella spp. 
Salmonella spp. is one of the most widespread disease-causing organisms 
isolated from animals and humans worldwide. First isolated from infected pigs in 1885, 
the bacterium was described by Theobald Smith and Damon Elder Salmon in the 1886 
paper Investigations on Swine Plague, published in the Second Annual Report of Bureau 
of Animal Industry (Enerson, 2007). However, it was the French bacteriologist, Joseph 
Léon Marcel Ligniéres who, in 1900, made the suggestion of adopting the name 
Salmonella (in honour of D.E. Salmon) to encompass this whole genus, as we know it 
today (Enerson, 2007). 
 
1.1.1 Nomenclature 
The issue of taxonomy of Salmonella spp. is complex and has been the subject of 
debate for some time now (Brenner et al., 2000; Euzéby, 1999; Ezaki et al., 2000a; 
Ezaki et al., 2000b; Grimont et al., 2000; Le Minor and Popoff, 1987; Tindall et al., 2005). 
The nomenclature used by the CDC and WHO is chosen as the nomenclature for this 
thesis. According to this system, Salmonella spp. is divided into 3 species – S. enterica, 
which contains six subspecies (I: enterica, II: salamae, IIIa: arizonae, IIIb: diarizonae, IV: 
houtenae and VI: indica), S. bongori, formerly known as subspecies V (Brenner et al., 
2000) and S. subterranea (Shelobolina et al., 2004). To simplify matters, the name of 
Salmonella spp. will be written as outlined: e.g. Salmonella Typhimurium (S. 
Typhimurium) and Salmonella II Sofia (S. II Sofia), instead of the full designation, 
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Salmonella enterica subspecies enterica serovar Typhimurium and Salmonella enterica 
subspecies salamae serovar Sofia, respectively.  
 
1.1.2 Morphology 
Salmonella spp. are non-spore forming rod shaped bacteria belonging to the family 
Enterobacteriaceae. They are Gram negative due to the higher lipid content and thinner 
bacterial cell wall and most are motile with peritrichous flagella (Chapin, 2007; Grimont 
et al., 2000).  Like all enterobacteria, Salmonella spp. is able to ferment glucose and 
other sugars (producing gas), can grow in the presence and absence of oxygen, reduce 
nitrate to nitrite and are oxidase negative and catalase positive (Ewing, 1986; Farmer III 
et al., 2007). Most Salmonella spp. are also able to utilise citrate as a carbon source, 
produce hydrogen sulphide from inorganic sulphur, decarboxylate ornithine and lysine 
(Ewing, 1986; Farmer III et al., 2007; Grimont et al., 2000). In addition, most Salmonella 
strains cannot produce indole and beta-galactosidase, deaminate tryptophan and 
phenylalanine, hydrolyse urea or utilise malonate (Ewing, 1986; Farmer III et al., 2007; 
Grimont et al., 2000). It is these properties that allow Salmonella spp. to be 
biochemically identified and the serovars differentiated from one another (see Section 
1.2.1). 
 
1.2 Typing of Salmonella spp. 
1.2.1 Biotyping 
Salmonella spp. can be differentiated based on their biochemical reactions via 
biotyping. For example, the test for utilisation of sodium malonate can differentiate 
subspecies I (negative) from subspecies II (positive) (Ewing, 1986). Biotyping have been 
used to study Salmonella isolates in several instances (Crichton and Old, 1990; 
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Millemann et al., 1995; Old et al., 1999). However, the choice of tests for biotyping has 
often been empirical (Grimont et al., 2000). This typing method is also not discriminatory 
enough to separate strains within the same subspecies or serovar. 
 
1.2.2 Serotyping 
Salmonella isolates are serotyped based on the antigenic properties of 3 surface 
structures from the lipopolysaccharide (LPS) layer of the cell wall – the O (somatic), H 
(flagellar) and Vi (capsular) anitgens (Ewing, 1986; Nataro et al., 2007). Salmonella 
serotyping has been invaluable in epidemiological investigations of disease outbreaks 
(Ethelberg et al., 2004; Uesugi et al., 2007). Since salmonella serotyping is done 
worldwide, this has assisted in the surveillance and identification of international 
outbreaks (Nataro et al., 2007). However, full serotype determination is beyond the 
expertise of many routine laboratories, limiting this method to larger reference 
laboratories (Nataro et al., 2007). 
 
1.2.3 Phage Typing 
This typing method is based on the susceptibility or resistance of Salmonella spp. 
to a set of lysogenic and temperate bacteriophages. Phage typing has become a useful 
tool in epidemiological investigations – detecting and following salmonellosis outbreaks, 
tracing the source of infections and future disease control and prevention strategies 
(Ethelberg et al., 2004; Gudmundsdottir et al., 2003; Matsumoto et al., 2006; McNeil et 
al., 1999; Stafford et al., 2002; Usera et al., 1998; Ward et al., 2005). Due to the stability 
of the phage type (in most cases), this method is also employed in the long-term 
surveillance of the spread of a particular Salmonella spp. serotype within a single or 
different host populations (Maré et al., 2000; Nastasi and Mammina, 2000; Pang et al., 
2005; Rabatsky-Ehr et al., 2004; Rabsch et al., 2002; Rabsch et al., 2007; Sullivan et al., 
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1998; Uesegi et al., 2007). Although salmonella phage typing is sensitive, cheap, rapid 
and requires no specialised equipment, smaller laboratories may encounter problems in 
maintaining expertise in this method (Demczuk et al., 2003; Grimont et al., 2000). This 
would generally limit phage typing of strains to larger reference laboratories.  
 
1.2.4 Plasmid Profile Typing 
A majority of Salmonella strains carry plasmids between 2 to 150 kB in size and 
the frequency, size and distribution of plasmids vary from serovar to serovar (Olsen, 
2000). It is this variation that forms the basis of this typing method. Plasmid profiling has 
been employed to investigate the clonality of Salmonella strains (Bakeri et al., 2003; 
Liebisch and Schwarz, 1996; Malorny et al., 2001; Mare et al., 2001; Ridley et al., 1998), 
elucidate routes of transmission of Salmonella spp. (Langvad et al., 2006; Nayak et al., 
2004) and in epidemiological surveillance (Holmberg et al., 1984; Liebana et al., 2001; 
Nastasi and Mammina, 2000; Pang et al., 2005; Tsen et al., 2000; Tsen and Lin, 2001). 
However, this method does have its disadvantages. Salmonella strains without plasmids 
cannot be typed using this method. Moreover, plasmid typing alone is not discriminatory 
enough to analyse the strains (Baquar et al., 1994; Mare et al., 2001; Millemann et al., 
1995).  Therefore, plasmid typing and its restriction analysis is usually performed 
together with other typing methods. 
 
1.2.5 Restriction Fragment Length Polymorphism (RFLP) 
RFLP analysis involves all techniques that utilise probes to investigate the 
polymorphic nature within DNA regions of bacterial isolates (Olive and Bean, 1999; 
Olsen, 2000). This method is carried out by digesting chromosomal DNA, transferring 
the fragments on to hybridisation membranes and probing said membranes with specific 
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probes. RFLP is based on the observation that the locations of various restriction 
enzymes (RE) sites differ from serovar to serovar, resulting in DNA band patterns that 
differ between unlike strains (Olive and Bean, 1999). Two examples of this method are 
ribotyping and IS200 typing. 
 
1.2.5.1 Ribotyping 
Ribotyping utilises DNA probes derived from the 16S and 23S rRNA genes (Olive 
and Bean, 1999; Olsen, 2000). This typing method has been widely used to study the 
relationships within and between Salmonella serovars (Baquar et al., 1994; Gruner et al., 
1994; Millemann et al., 1995; Old et al., 1999; 2000). Ribotyping usually results in a 
small number of bands, which makes data interpretation simple. However, this also 
lowers the discriminatory ability of the method to differentiate between closely related 
strains (Liebisch and Schwarz, 1996; Millemann et al., 1995; Thong et al., 1995; Usera 
et al., 1998). It is for this reason that ribotyping is not commonly used to investigate 
disease outbreaks (Olsen, 2000). 
 
1.2.5.2 IS200 Typing 
Lam and Roth (Lam and Roth, 1983) discovered a 708 bp insertion sequence in S. 
Typhimurium LT2, which they identified as IS200. This insertion sequence (IS) element 
appears to be found in a majority of the Salmonella strains examined and is absent from 
other enterobacteria, making it a good candidate for use in Salmonella spp. typing (Lam 
and Roth, 1983). In some cases, IS200 typing alone is discriminatory enough to 
distinguish between strains. Threlfall and his colleagues (Threlfall et al., 1993) 
discovered that it was possible to differentiate between drug-sensitive and drug-resistant 
Salmonella serovar Typhi of Vi-phage types E1 and M1 based on their IS200 profiles. 
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IS200 typing has since been applied to the typing of a wide variety of Salmonella 
serovars (Baquar et al., 1994; Millemann et al., 1995; Old et al., 1999; 2000). 
 
1.2.6 Pulsed-Field Gel Electrophoresis (PFGE) 
This particular typing method is often considered the “gold standard” of molecular 
typing methods. Whole bacterial cells are embedded in agarose plugs and treated with a 
detergent-lysis solution to break down cell walls and proteins (Olive and Bean, 1999; 
Olsen, 2000).  The treated plugs containing whole bacterial DNA are then digested with 
a rare cutting restriction enzyme (e.g. XbaI) before being subjected to pulsed field 
electrophoresis. This allows large fragments of DNA, ranging from 10 to 800 kB, to be 
separated for analysis (Olive and Bean, 1999).  
 
PFGE is very widely used in the study of Salmonella spp. due to its accuracy and 
reproducibility. It has become an invaluable tool in the study of genetic relatedness 
(Bakeri et al., 2003, Bessa et al., 2007; Old et al., 1999; Olsen et al., 1994), in 
investigation of outbreaks (Ethelberg et al., 2004; Murase et al., 1995; Matsumoto et al., 
2006; Usera et al., 1998; Ward et al., 2005) and in epidemiological surveillance of 
Salmonella isolates (Cardinale et al., 2005; Langvad et al., 2006; Pang et al., 2005; Seo 
et al., 2006; Tsen et al., 2000; Tsen and Lin, 2001; Uesugi et al., 2007). PFGE typing 
has been proven on numerous occasions to be highly discriminatory and superior 
compared to other molecular typing methods like RAPD (Seo et al., 2006; Tsen et al., 
2000), ribotyping and IS200 typing (Baquar et al., 1994, Liebisch and Schwarz, 1996; 
Lindqvist et al., 2002; Nayak et al., 2004; Ridley et al., 1998), multilocus sequence typing 
(Fakhr et al., 2005) and plasmid profiling (Foley et al., 2006; Ridley et al., 1998).  
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With the advent of computerised gel scanning and analysis software, it has 
become feasible to create reference databases of PFGE patterns for all disease-causing 
organisms like Salmonella spp. (Olive and Bean, 1999). This has allowed the 
comparison of any new strain isolated from an outbreak to the strains available in the 
database, enabling phylogenetic identification of said strain (Olive and Bean, 1999). An 
example of one such database is PulseNet. Established in 1996 and maintained by the 
CDC, PulseNet has utilised PFGE analysis to rapidly identify incidents of food-borne 
illness in the United States (Hunter et al., 2005). However, PFGE method is time-
consuming and labour-intensive, usually taking 2 -3 days to complete (Olive and Bean, 
1999; Olsen, 2000). This can reduce and limit the number of strains that can be 
processed by a laboratory. There is a great need to develop alternative, shorter PFGE 
protocols, like the one devised by Gautom (Gautom, 1997).  
  
1.2.7 PCR-Based Typing 
1.2.7.1 Salmonella-specific PCR  
This typing method utilises gene-specific primers to amplify and examine variation 
between strains. Target sequences that have been used include the IS200 element 
(Millemann et al., 2000) and the fljB gene (Kardos et al., 2007). Using a set of 6 primers, 
Alvarez and his coworkers (Alvarez et al., 2004) developed a multiplex PCR assay to 
detect and type Salmonella serotypes, which is both sensitive and reproducible. This 
PCR typing method has the advantage in that it is specific to Salmonella spp. and will 
not detect any other bacterial isolates (thereby giving false positive results). 
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1.2.7.2 Rapid Amplified Polymorphic DNA (RAPD) 
RAPD assay (also known as arbitrary primed PCR) is based on the use of short 
random PCR primers (between 9-10 bases in length) to subtype Salmonella isolates 
(Olive and Bean, 1999). The number and location of random primer sites within the 
bacterial genome differ from strain to strain and thus, amplification of the primers at low 
annealing temperatures will result in DNA band patterns characteristic of the particular 
strain (Olive and Bean, 1999). RAPD typing has been successfully used to investigate 
Salmonella isolates in several studies (Chansiripornchai et al., 2000; Hilton et al., 1996; 
Hudson et al., 2001; Kerouanton et al., 1996; Lin et al., 1996; Löfström et al., 2006; 
Malorny et al., 2001; Millemann et al., 1996; Millemann et al., 2000). However, 
reproducibility and standardisation of this method has been reported to be problematic 
(Olive and Bean, 1999; Olsen, 2000; Seo et al., 2006; Tsen et al., 2000). 
 
1.2.7.3 Repetitive PCR (Rep-PCR) 
Short, interspersed repetitive DNA sequences are found throughout the genome of 
all organisms (Lupski and Weinstock, 1992; Versalovic et al., 1991, Versalovic et al., 
1994). They are conserved and the number and distribution of repeat DNA elements 
present in the bacterial genome differs in different species, strains and serovars (Olsen, 
2000). Using specific primers and PCR to detect and amplify these short sequences, a 
set of band patterns can be obtained for analysis and this forms the basis for this typing 
method. Examples of such repeat sequences are BOX element (Koeuth et al., 1995; 
Martin et al., 1992; Versalovic et al., 1991; Versalovic et al., 1994), the enterobacterial 
repetitive intergenic consensus (ERIC) sequence (Hulton et al., 1991; Versalovic et al., 
1991; Versalovic et al., 1994) and the repetitive extragenic palindrome (REP) element 
(Gilson et al., 1984; 1990; Stern et al., 1984; Versalovic et al., 1991; 1994).  
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First discovered in the Gram positive bacterium Streptococcus pneumoniae, BOX 
element is composed of 3 subunits – boxA, box B and boxC (Martin et al, 1992; 
Versalovic et al., 1994). Koeuth and his colleagues (Koeuth et al., 1995) discovered that 
out of the 3 subunits, only boxA appears to be conserved among diverse bacteria and 
sequences similar to boxB and boxC were only found in S. pneumoniae. The ERIC 
sequence is 126 bp in length and consists of a central core inverted repeat located in 
extragenic regions of the bacterial genome (Hulton et al., 1991; Lupski and Weinstock, 
1992; Versalovic et al., 1991; Versalovic et al., 1994). REP elements are 38 bp 
palindrome units, which contain 6 degenerate sites and a 5 bp variable loop able to form 
stem-loop structures (Gilson et al., 1984; Lupski and Weinstock, 1992; Stern et al., 1984; 
Versalovic et al., 1991; Versalovic et al., 1994).  
 
Rep- PCR is fast becoming one of the most frequently used DNA typing method to 
investigate strains of Salmonella (Beyer et al., 1998; Foley et al., 2006; Johnson et al., 
2001; Maré et al., 2001; Millemann et al., 2000; Mills-Robertson et al., 2003; Rasschaert 
et al., 2005; Saxena et al., 2002; Weigel et al., 2004; Woo and Lee, 2006). This typing 
method is economical and simple to carry out, which allows a large number of samples 
to be processed at once (Olive and Bean, 1999). However, there have been problems 
regarding the reproducibility and discriminatory ability of this method (Bessa et al., 2007; 
Burr et al., 1998; Gebreyes et al., 2006; Kerouanton et al., 1996; Millemann et al., 1996). 
 
1.2.7.4 Amplified Fragment Length Polymorphism (AFLP) 
First developed in the 1990s, AFLP is based on the selective PCR amplification of 
DNA fragments generated from restriction enzyme digestion (Vos et al, 1995). The 
typing method is carried out in 3 steps – digestion of genomic DNA and ligation to 
adapters containing restriction sites followed by PCR amplification with selective primers 
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and gel analysis of the amplified products (Olive and Bean, 1999; Vos et al., 1995). 
AFLP has been successfully applied to subtype Salmonella isolates in several studies 
(Aarts et al., 1998; Gebreyes et al., 2006; Lan et al., 2007; Ross and Heuzenroeder, 
2005b; Torpdahl and Ahrens, 2004). Although AFLP typing is reproducible and has a 
high discriminatory ability, the setup cost for equipment and expertise is high (Olive and 
Bean, 1999). 
 
1.2.8 Other Typing Methods 
Other typing methods that have been used to investigate and study Salmonella 
strains include the use of antibiotic resistance genes as epidemiological markers (Bessa 
et al., 2007; Cardinale et al., 2005; Foley et al., 2006; Malorny et al., 2001; Matsumoto et 
al., 2006; Nayak et al., 2004; Rabatsky-Ehr et al., 2004; Ward et al., 2005), multilocus 
sequence typing, which analyses the DNA sequences of a series of housekeeping, 
ribosomal and/or virulent genes (Foley et al., 2006, Kotetishvili et al., 2002), multilocus 
variable-number tandem repeats analysis, which makes use of short sequence repeat 
motifs as a target to type isolates (Lindstedt et al., 2004; Lindsedt, 2005) and multiple 
amplification of phage typing locus, which detects presence/absence of a range of 
bacteriophage in the genome (Ross and Heuzenroeder, 2005a; 2008; Ross et al., 2008). 
 
1.3 Pathogenicity of Salmonella spp. 
Non-typhoidal Salmonella spp. have the ability to cause infection in 2 ways – 
gastroenteritis and systemic infection (Jones and Falkow, 1996; Marcus et al., 2000; Ohl 
and Miller, 2001). Salmonella pathogenesis begins with the ingestion or uptake of the 
bacteria into the host. After encountering and surviving the acidic pH environment of the 
stomach (Foster and Hall, 1990; Garcia-del-Portillo et al., 1993a; Giannella et al., 1972), 
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the bacteria migrate to the intestines, where it attaches and invades the intestinal 
epithelial cells (Ohl and Miller, 2001). In Salmonella spp. associated with gastroenteritis, 
the adhesion and invasion of the intestinal cells results in a series of inflammatory and 
secretory responses in the host, causing disease (Hansen-Wester and Hensel, 2001; 
Ohl and Miller, 2001).   
 
On the other hand, Salmonella serotypes that cause systemic disease establish 
infection through their ability to survive and replicate in phagocytic macrophage cells 
(Ohl and Miller, 2001). After invading M cells of the Peyer’s patches in the intestine 
(Jones et al., 1994), the bacteria migrate to the local mesenteric lymph nodes and then 
to the spleen and liver via phagocytic cells, resulting in the spread of the disease 
(Hansen-Wester and Hensel, 2001; Jones and Falkow, 1996; Marcus et al., 2000; Ohl 
and Miller, 2001). In order for Salmonella spp. to initiate both gastroenteritis and 
systemic infection, a wide variety of virulence determinants are required. These 
virulence factors and their complex interactions with one another are outlined in detail 
below. 
 
1.3.1 Salmonella Pathogenicity Island (SPI) 
A pathogenicity island is a genetic element that occurs as a distinct and separate 
unit in the bacterial chromosome (Hentschel and Hacker, 2001; Hensel, 2004). All 
pathogenicity islands share a few common features: (a) they are not found in a closely 
related, nonpathogenic reference species or strain, (b) they often encompass large DNA 
regions (10-200 kB) and contains genes that often confer virulence to a bacteria, (c) they 
have a GC content lower than the rest of the bacterial genome (d) they are inserted into 
tRNA sites, (e) they are often flanked by short sequences (direct repeats), and (f) they 
CHAPTER 1 
 15
are usually associated with elements like inverted repeats, transposases, integrases, IS 
elements and origin of replications (Hacker and Kaper, 2000; Hensel, 2004; Hentschel 
and Hacker, 2001; Marcus et al., 2000; van Asten and van Dijk, 2005).  First described 
in pathogenic E. coli (Hacker et al., 1983; Low et al., 1984), pathogenicity islands are 
now found in a wide variety of bacterial pathogens, including Salmonella spp. 
 
1.3.1.1 SPI1 
Galán and Curtiss III (Galán and Curtiss III, 1989) were the first to identify a 
genetic locus called inv that gives S. Typhimurium its ability to invade tissue culture 
cells. The inv locus discovered is located on the pathogenicity island termed SPI1 (see 
Figure 1.1A). SPI1 is a 40 kB region in the Salmonella genome, located at centisome 63 
and flanked by the fhlA and mutS genes (Mills et al., 1995). It is thought that SPI1 is 
acquired very early on in the evolution of Salmonella spp. – at the divergence of 
Salmonella and Escherichia spp. from a common ancestor (Bäumler, 1997; Boyd et al., 
1996; Galán, 1999; Li et al., 1995). In order for Salmonella spp. to cause disease, the 
presence of an intact and functional SPI1 is required. Ginnocchio and her coworkers 
(Ginnocchio et al., 1997) have found that environmental isolates of Salmonella carrying 
naturally occurring deletions in the SPI1 region lack the ability to invade mammalian 
cells. SPI1 contains genes that encode a type III secretion (TTS) system that gives 
Salmonella isolates the ability to colonise and invade intestinal epithelial cells and 
transport virulent effector proteins from the bacteria into the host cell cytosol (Galán, 
1999; Hansen-Wester and Hensel, 2001; Hensel, 2004; Marcus et al., 2000; Ohl and 
Miller, 2001).  
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Figure 1.1 Genetic organisation of Salmonella pathogenicity island (SPI), SPI1 and SPI2 (Amavisit et al., 2003
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1.3.1.1.1 SPI1-Associated TTS Apparatus 
Several genes in SPI1 (see Figure 1.1) encode for structural components that form 
a supramolecular structure called the needle complex, which spans both the outer and 
inner membranes of the bacteria (Kubori et al., 1998). Using electron microscopy, Kubori 
and his colleagues (Kubori et al., 1998) have shown that this needle apparatus is multi-
ringed with a cylindrical base that is anchored to both the inner and outer membranes 
and a slender, hollow, needle-like barrel projecting outward from the outer membrane. 
For the proper assembly of a functional needle complex, a variety of genes are required 
– prg, org, spa and inv operons have been shown to be involved in the formation of the 
needle complex (Eichelberg et al., 1994; Kaniga et al., 1994; Kimbrough and Miller, 
2000; Klein et al., 2000; Kubori et al., 1998; Kubori et al., 2000; Sukhan et al., 2001; 
Watson et al., 1998).   
 
The entire prg operon (prgHIJK) is required for the assembly of a functional needle 
apparatus (Kimbrough and Miller, 2000). The proteins prgH, prgK and invG have been 
identified as components of the base of the needle structure and prgI and prgJ as part of 
the external needle substructure (Kimbrough and Miller, 2000; Kubori et al., 1998; Kubori 
et al., 2000; Sukhan et al., 2001; Sukhan et al., 2003). The length of the needle structure 
is controlled by another TTS associated protein invJ, whose secretion is stimulated by 
contact with cultured epithelial cells and thus, is required for cell invasion (Chen et al., 
1996; Collazo et al., 1995; Kubori et al., 2000, Sukhan et al., 2001; Zierler and Galán, 
1995). A loss of function of the invJ gene has resulted in the formation of abnormally 
long needle structures and the complete absence of TTS system (Kubori et al., 2000, 
Sukhan et al., 2001).  
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Kubori and his coworkers (Kubori et al., 2000) have reported that mutations in 
either invA or invC have resulted in the complete absence of the needle substructure, 
highlighting the importance of these genes in the full assembly of the needle complex. It 
has been observed that the InvC protein shared significant sequence similarity with the 
F0F1 ATPase family of proteins, leading to the suggestion that the translocation of 
effector proteins via the TTS apparatus may be driven by ATPase activity of this gene 
(Eichelberg et al., 1994). On the other hand, Salmonella strains carrying mutations in 
invI were unable to secrete the protein PrgI and lacked needle substructures, dismissing 
the initial theory that InvI is a chaperone of invJ since its mutation did not lead to a 
similar phenotype observed in invJ mutation (Collazo et al., 1995; Sukhan et al., 2001). 
While not involved in the needle complex assembly, invH increases the efficiency of the 
process (Kubori et al., 1998; Kubori et al., 2000; Sukhan et al., 2001) and a mutation in 
the gene not only reduces the number of needle complexes observed (Sukhan et al., 
2001) it also appears to hinder the normal secretion of several proteins including prgH, 
prgK, prgI, invG and sipC (Sukhan et al., 2001; Watson et al., 1998). 
 
Another operon found to be involved with the TTS apparatus is the orgABC. 
Originally identified as a single operon (orgA) during a screening of oxygen-regulated 
genes required for invasion (Jones and Falkow, 1994), Klein and her colleagues (Klein 
et al., 2000), reported an error in the published DNA sequence, splitting this region into 2 
ORFs – orgA and orgB along with the identification of another ORF overlapping the orgB 
gene (orgC). The proteins orgA and orgB have been demonstrated to be required for 
invasion and secretion (e.g. protein prgI) while orgC does not appear to be essential for 
the invasive phenotype (Klein et al., 2000; Sukhan et al., 2001). The spa locus 
(spaOPQR) has also been shown to be part of the TTS apparatus and is essential for 
host invasion and secretion of proteins like InvJ, SipB and SipC (Collazo and Galán, 
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1996). Further evidence of this has been demonstrated by Sukhan and his coworkers 
(Sukhan et al., 2001) through electron microscopy and biochemical analysis of needle 
complexes from spa mutants. 
 
1.3.1.1.2 SPI-Associated Effector Proteins 
After assembly of the TTS system, Salmonella strains are able to transport a range 
of substrate proteins (encoded by genes within and outside of SPI1) into the host cells to 
initiate invasion (Cherayil et al., 2000; Collazo and Galán, 1997b; Fu and Galán, 1998b; 
Galyov et al.¸1997; Hardt and Galán, 1997; Wood et al., 1996). An example of 
translocated effectors encoded by SPI1 are the Sip proteins, encoded by the genes 
sipABCD. First characterised by Kaniga and his coworkers (Kaniga et al., 1995a; 
1995b), these proteins share high sequence homology to the Ipa proteins, which are 
required by Shigella spp. for invasion.  Although SipD is not internalised into the host 
cells, it does interact with SipB and SipC and is involved in the translocation process of 
effector proteins (Collazo and Galán, 1997b; Darwin and Miller, 1999b). It has been 
suggested that SipD, along with the proteins sipB and SipC form a translocation complex 
that delivers effector proteins into the host cells (Cherayil et al., 2000; Darwin and Miller, 
1999b; Zhang et al., 2003).  
 
SipB and SipC in particular appear to have dual roles in acting as translocases and 
as effectors proteins (Darwin and Miller, 1999b; Hayward et al., 2000; Hayward and 
Koronakis, 1999; Zhang et al., 2003). SipB is able to induce cell cytotoxicity and 
apoptosis via a mechanism dependent on the proapoptotic protease caspase-1 (Hersh 
et al., 1999; van der Velden et al., 2003). The ability of SipC to form dimers and 
multimers to elicit actin nucleation and condensation (“bundling”) allows Salmonella spp. 
to rearrange host cytoskeletal structure, contributing to bacterial invasion (Chang et al., 
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2007; Hayward and Koronakis, 1999). SipC-mediated actin polymerisation is 
demonstrated to be enhanced by sipA, which binds directly to actin, reducing its critical 
concentration and inhibiting depolymerisation of its filaments, thereby inducing 
membrane ruffling and bacterial internalisation (Lilic et al., 2003; McGhie et al., 2001; 
Zhou et al., 1999). In addition, Brawn and her colleagues (Brawn et al., 2007) have 
recently found that during infection, sipA cooperates with the SPI2 effector sifA to 
modulate phagosome maturation and intracellular replication.   
  
Another substrate protein translocated by the TTS system in a Sip-dependent 
manner is the tyrosine phosphatase protein SptP (Fu and Galán, 1998b; Kaniga et al., 
1996). SptP functions by disrupting the actin cytoskeleton of the cell, possibly by 
targeting filament proteins like vimentin, which has been shown to be recruited to the 
Salmonella-induced membrane ruffling process (Fu and Galán, 1998b; Murli et al., 
2001). Although not required for bacterial internalisation (Chen et al., 1996; Kaniga et al., 
1996), SptP is still needed for virulence in vivo, since sptP mutants lack the ability to 
colonise the spleens of orally infected mice (Kaniga et al., 1996). Hardt and Galán (Hardt 
and Galán, 1997) identified a novel Salmonella protein, AvrA which is encoded by the 
avrA gene and translocated by the SPI1 TTS system. Secretion of AvrA is not 
dependent on sipA, sipB or sipC but requires sipD for translocation and strains carrying 
mutations in invG, invJ and spaO are unable to secrete this protein (Hardt and Galán, 
1997). It has been shown that AvrA inhibits activation of the proinflammatory anti-
apoptotic NF-κB transcription factor, initiating and enhancing cell apoptosis (Collier-
Hyams et al., 2002; Ye et al., 2007).  
 
The TTS system also translocates effector proteins that are encoded by the genes 
located outside of the SPI1 region. These include proteins like sopA (Wood et al., 2000), 
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sopB/sigD (Galyov et al.¸1997; Hong and Miller, 1998), sopD (Jones et al., 1998), sopE 
(Wood et al., 1996) and sopE2 (Stender et al., 2000). It has been demonstrated that 
these proteins interact and cooperate with one another to cause a range of responses in 
the host such as cytoskeleton rearrangements, membrane ruffling, leading to bacterial 
internalisation and invasion (Bakowski et al., 2007; Mirold et al., 2001; Raffatellu et 
al.,2005; Zhou et al., 2001), fluid accumulation and intestinal inflammation (Jones et al., 
1998; Zhang et al.¸2002), stimulation of Rho family of GTPases and disruption of 
intestinal epithelial tight junctions and function (Boyle et al., 2006; Zhou et al., 2001).    
 
1.3.1.1.3 SPI1-Associated Accessory/Chaperone Proteins 
SPI1 of Salmonella spp. also contains genes that encode a group of proteins that 
functions as accessory or cognate chaperones of effector proteins. The type III secretion 
chaperones share a few common features like being small acidic proteins (15–20 kDa) 
with a putative alpha-helical structure in the C-terminal portion and a signal portion in the 
N-termini region of the corresponding effector protein (Cornelis and van Gijsegem, 2000; 
Galán and Wolf-Watz, 2006; Parsot et al., 2003; Wattiau et al., 1996). Chaperone 
proteins perform a wide range of functions, from prevention of protein degradation, 
premature interactions, maintenance of optimal conformation for export to conferring 
TTSS-pathway specificity to effector proteins (Collazo and Galán, 1997a; Galán and 
Wolf-Watz, 2006; Lee and Galán, 2004; Parsot et al., 2003; Stebbins and Galán, 2001). 
One example would be the protein invB, part of the inv genetic locus in SPI1 (Eichelberg 
et al., 1994). InvB has been shown to act as a chaperone for range of substrate proteins, 
including sipA (Bronstein et al., 2000), sopA (Ehrbar et al., 2004; Higashide and Zhou, 
2006), sopE (Ehrbar et al., 2003; Lee and Galán, 2003) and sopE2 (Ehrbar et al., 2003).  
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Fu and Galán (Fu and Galán, 1998a) identified and characterised the 13 kDa 
protein sicP as a specific chaperone for SptP. Expression levels of SptP was observed 
to be drastically reduced in sicP mutant strains and although the sptP expression itself 
was not hindered, there was an increased in SptP degradation (Fu and Galán, 1998a). 
sicA encodes a  protein that functions as a putative chaperone for the TTS-associated 
Sip proteins (Kaniga et al., 1995b; Tucker and Galán, 2000). SicA functions by binding to 
both SipB and sipC, thereby partitioning and stabilising the proteins and degradation of 
both these proteins have been observed in sicA mutants (Tucker and Galán, 2000). 
Tucker and Galán (Tucker and Galán, 2000) also show that SicA has an indirect 
influence on the expression of SopE, which is also a TTS system effector protein. In 
addition, the chaperone SicA also acts in concert with transcriptional regulator InvF to 
activate the expression of several Salmonella virulence genes (see Section 1.3.1.1.4) 
(Darwin and Miller, 2000).  
 
The iagB gene, located within SPI1 region, is predicted to encode a 160 amino 
acids polypeptide that shares sequence homology to the ipgF (a glycosidase) from the 
virulence plasmid of Shigella flexneri (Miras et al., 1995). Due to this similarity, it has 
been suggested that this protein has peptidoglycan hydrolysing activity and is involved in 
the passage of the needle complex through the bacterial peptidoglycan layer (Sukhan, 
2000) However, a later study has shown that it is not involved in the TTS-associated 
apparatus since a mutation in this gene does not seem to have any effect on the 
secretion of invG and Prg proteins or on the structure of the needle complex (Sukhan et 
al., 2000). Its precise function has not been elucidated yet. In addition to identifying sipD 
and sipA genes, Kaniga and his colleagues (Kaniga et al., 1995a) also found an ORF 
immediately downstream from sipA, predicted to encode a 9 kDa protein homologous to 
the acyl carrier proteins. As such proteins are involved in the biosynthesis of lipids 
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(Kaniga et al., 1995a), it has been suggested that that this protein (IacP) could be 
involved in the modification of effectors before translocation (Collazo and Galán, 1997a; 
Kaniga et al., 1995a). However, the actual function and nature of this gene has yet to be 
elucidated.  
 
1.3.1.1.4 SPI1-Associated Regulators 
Salmonella spp. is able to detect environmental stimuli in its surroundings and 
activate/repress virulence-associated genes accordingly. SPI1 genes are optimally 
expressed under the following conditions: temperature of 37°C, low or limited oxygen, 
high osmolarity, neutral to slightly basic pH and during late log to stationary phase of 
bacterial growth (Bajaj et al., 1996; Ernst et al., 1990; Jones and Falkow, 1994; Lee and 
Falkow, 1990; Tartera and Metcalf, 1993). The expression of all the SPI1-associated 
genes is controlled by a series of transcriptional activators and regulators, which are 
detailed below. For example, although not essential for assembly of the needle complex 
(Sukhan et al., 2001), SPI1 TTS system protein InvE controls translocation process by 
regulating and interacting with the SipB-SipC-SicA protein complex (Kubori and Galán, 
2002).   
 
The hilA gene encodes a novel transcriptional regulator whose polypeptide 
sequence shares significant homology with the ompR/toxR family of transcriptional 
activators (Bajaj et al., 1995; Lee and Falkow, 1992). Epithelial cell invasion, apoptosis 
of macrophages and long term colonisation of chicken caeca have been demonstrated 
to be dependent on hilA expression (Bajaj et al., 1995; Bohez et al., 2006; Monack et al., 
1996). The hilA gene is considered a central regulator of SPI1, binding to promoters and 
activating TTS-associated genes like prg/org and inv/spa operons (Ahmer et al., 1999; 
Bajaj et al., 1995; Lee and Falkow, 1992; Lostroh and Lee, 2001). Following activation of 
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inv/spa, a small amount of transcriptional read-through from this operon continues 
through to the sic/sip genes (Darwin and Miller, 1999a; Eichelberg and Galán, 1999; 
Ellermeier and Slauch, 2007; Lostroh and Lee, 2001). However, optimal expression of 
sic/sip operon is dependent on invF, a homolog of the AraC family of proteins and part 
the inv genetic locus of SPI1 (Darwin and Miller, 1999a; Eichelberg and Galán, 1999; 
Kaniga et al., 1994). InvF and its putative chaperone protein, SicA (along with HilA) is 
responsible for activating and controlling the expression of TTS-associated proteins 
encoded within and outside of SPI1 (Darwin and Miller, 1999a; Darwin and Miller, 2000; 
Darwin and Miller, 2001a; Eichelberg and Galán, 1999).  
 
     A variety of environmental and regulatory factors affect hilA expression, which 
in turn affects the invasion phenotype of Salmonella strains. An upstream repressing 
sequence (URS) has been mapped and identified in the hilA promoter region and it has 
been hypothesised that an unidentified repressor protein binds to this sequence to stop 
hilA expression under conditions unfavourable for bacterial invasion (Schechter et al., 
1999).  Schechter and her coworkers (Schechter et al., 1999) also identified 2 SPI1-
associated genes, hilC and hilD, that can counteract repression of hilA. The proteins of 
HilC and HilD are similar to the members of AraC/XylS family of transcriptional 
regulators and have been demonstrated to derepress hilA expression by binding directly 
to the URS in the hilA promoter region (Schechter et al., 1999; Schechter and Lee, 
2001). While a mutation in hilC only modestly affected bacterial invasion, it has been 
shown that the presence of a functional hilD is essential for the expression of hilA, 
highlighting the minor and major role these genes play in SPI1 regulation (Akbar et al., 
2003; Boddicker et al., 2003; Ellermeier et al., 2005; Lucas and Lee, 2001; Schechter et 
al., 1999).  
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Expression of hilA is also controlled by RtsA, another member of the AraC/XylS 
family of proteins (Ellermeier and Slauch, 2003). Although not encoded within SPI1, rtsA 
is able to increase hilA expression (independent of both hilC and hilD) and induce the 
expression of hilC, hilD and invF genes (Ellermeier and Slauch, 2003). Ellermeier and 
his colleagues (Ellermeier et al., 2005) recently showed that HilC, hilD and RtsA can 
each individually activate hilA and that these 3 proteins can act together in a feed-
forward loop that controls the expression of hilA and thus, the SPI1 TTS system. It has 
also been demonstrated that the HilC and HilD proteins are capable of activating the 
regulator invF and in turn, a subset of SPI1 genes, independently of hilA (Akbar et al., 
2003).  
 
In addition to regulators encoded within the island itself, SPI1 TTS system is also 
regulated by a series of global regulators, which are not found in the SPI1 region. One 
such regulatory system is the two-component EnvZ/OmpR, which affects the expression 
of hilC, possibly in a hilD-mediated manner (Ellermeier et al., 2005; Lucas and Lee, 
2001). A response regulator, SirA and its corresponding sensor kinase, BarA regulates 
SPI expression by interacting with hilA (in the presence of hilD) in response to unknown 
environmental conditions (Ahmer et al., 1999; Altier et al., 2000b; Ellermeier et al., 2005; 
Ellermeier and Slauch, 2007). The PhoP/PhoQ regulatory system has been determined 
to be required for virulence in vivo (Miller et al., 1989). It has an opposing regulatory 
function in SPI1 - shown to repress prg operon and hilA expression and also able to 
induce the orgBC operon (Aguirre et al., 2006; Behlau and Miller, 1993; Pegues et al., 
1995).  
 
Ellermeier and Slauch (Ellermeier and Slauch, 2007) have recently shown that a 
ferric uptake regulator (Fur), a major iron regulator in Salmonella, is able to mediate hilA 
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transcription (and SPI expression) in a hilD-dependent manner. The hilE protein is 
another transcriptional regulator that is capable of negatively regulating hilA (Baxter et 
al., 2003; Ellermeier and Slauch, 2007). Baxter and his colleagues (Baxter et al., 2003) 
characterised the Salmonella-specific hilE and found that the presence of this gene 
super-represses expression of hilA through its interaction with hilD. Examples of other 
genes that affect SPI1 gene expression by regulating hilA transcription include fis 
(Wilson et al., 2001), csrAB (Altier et al., 2000a; Altier et al., 2000b), phoB, fadD and fliZ 
(Lucas et al., 2000), hha (Fahlen et al., 2001), lon (Takaya et al., 2002; 2005), ams and 
pag (Fahlen et al., 2000). In conclusion, SPI1 expression is a complex series of 
interactions between different genes in response to the host environment, allowing 
Salmonella spp. to initiate invasion and bacterial internalisation. 
 
1.3.1.2 SPI2 
The SPI2 locus is another 40 kB pathogenicity island that encodes a second TTS 
system in Salmonella spp. (Hensel et al., 1995; Ochman et al., 1996; Shea et al., 1996). 
This virulence element is located between centisome 30.5 and 31 and inserted adjacent 
to the valV tRNA gene (Hensel et al., 1997a; Shea et al., 1996). The SPI2 region is 
composed of 2 segments – a larger 25.3 kB portion containing more than 30 genes 
required for virulence of SPI2 and a 14.5 kB portion harbouring a cluster of 5 ttr genes 
(involved in anaerobic tetrathionate reduction) and 7 ORFs of unknown function (Hensel 
et al., 1999a; 1999b). Hensel and his coworkers (Hensel et al., 1999b) have shown that 
the 14.5 kB portion of the SPI2 region does not contribute as significantly to systemic 
infection in mice compared to the larger 25.3 kB portion. The mosaic structure of SPI2 
suggests that each portion may have been the result of distinct and separate horizontal 
transfer events (Hensel et al., 1999b).  
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Although SPI2 is conserved among and specific to Salmonella spp., it is not 
present in all of the Salmonella subspecies groups (Hensel et al., 1997a; 1997b; 
Ochman and Groisman, 1996; Shea et al., 1996). Hybridisation studies have 
demonstrated that while SPI1 is found in all Salmonella spp., the larger 25.3 kB segment 
of SPI2 is absent from S. bongori, suggesting that SPI2 was probably acquired by 
Salmonella enterica after its divergence from S. bongori (Hensel et al., 1997a; 1997b; 
Hensel et al., 1999b; Ochman and Groisman, 1996).  While SPI1 is necessary for 
bacterial invasion and internalisation, SPI2 is required for establishment of systemic 
infection and intracellular replication (Cirillo et al., 1998; Hensel et al., 1998; Hensel et 
al., 1999b; Ochman et al., 1996; Ohl and Miller, 2001; Paesold et al., 2002). DNA 
sequence analysis of the SPI2 region resulted in the identification of about 42 ORFs 
(see Figure 1.1), encoding components of a TTS apparatus (ssa), effector proteins and 
their cognate chaperones (sse and ssc) and regulatory proteins (ssr) (Hensel et al., 
1997a; Hensel, 2000; Shea et al., 1996).   
 
1.3.1.2.1 Intracellular Replication Mechanism of Salmonella spp. 
Upon bacterial invasion, Salmonella bacterium is enclosed within unique 
membrane-bound vesicles known as Salmonella-containing vacuoles (SCV) (Finlay et 
al., 1988; Richter-Dahlfors et al., 1997; Salcedo et al., 2001).  The SCVs then migrate to 
a perinuclear position close to the Golgi apparatus, where the SCV undergoes 
maturation via selective interaction with different components from the endocytic 
pathway of the host cell (Garcia-del Portillo et al., 1993; Garcia-del Portillo and Finlay, 
1995; Méresse et al., 1999; Rathman et al., 1997; Salcedo and Holden, 2003; Steele-
Mortimer et al.¸1999; Stein et al., 1996). The formation of endosomes containing 
lysosomal glycoproteins (lgp) occurs at the final maturation step of the SCV (Garcia-del 
Portillo et al., 1993b). The presence of Salmonella isolate induces the formation of lgp-
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tubules (Sif formation) that interconnect with the SCVs, resulting in eventual intracellular 
replication (Garcia-del Portillo et al., 1993b; Garcia-del Portillo and Finlay, 1995; Stein et 
al., 1996). The maturation, maintenance and precise positioning of the SCV is 
dependent on the SPI2 TTS system and its effector proteins, which are outlined in detail 
below.  
 
1.3.1.2.2 SPI2-Associated TTS Apparatus 
The TTS system encoded by SPI2 is structurally and functionally different from that 
of SPI1 – components from SPI2 are not able to compensate for mutations in 
components of SPI1 within the same bacterium (Chakravortty et al., 2005; Hensel et al., 
1997b; Marcus et al., 2000). A majority of the ssa genes show significant homology to 
the lcr/ysc genes from Yersinia spp. and only ssaL, ssaM and ssaP seem to be specific 
to Salmonella spp. (Hensel et al., 1997b). Mutations in any of these genes have been 
shown to affect the secretion of SPI1-encoded protein SipC (Hensel et al., 1997b), 
hinder the ability of Salmonella spp. to accumulate in spleen cells (Shea et al., 1999), 
restricts movement of the SCVs (Ramsden et al., 2007), prevents the formation of the 
SPI2 needle appendages and stop the secretion and translocation of SPI2 effector 
proteins (Chakravortty et al., 2005; Coombes et al., 2004; Klein and Jones, 2001; 
Nikolaus et al., 2001; Yu et al., 2004). 
 
Using resolution field emission scanning and TEM, Chakravortty and his coworkers 
(Chakravortty et al., 2005) have shown that the SPI2 needle appendages are cylindrical 
structures with an irregular surface appearance, indicating the distribution of secreted 
proteins on the surface of these structures. The ssaV, ssaC and ssaH genes have been 
shown to be essential in the formation of the needle structures as the appendages were 
absent in Salmonella strains carrying these mutations (Chakravortty et al., 2005). The 
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SsaC protein is predicted to form the outer membrane ring of the SPI2 TTS system while 
ssaV and ssaT are predicted to be part of the TTS apparatus in the inner membrane of 
the bacteria (Freeman et al., 2002). A functional TTS apparatus also requires the 
presence of intact ssaL, ssaR, ssaM, ssaG and ssaI genes as such Salmonella mutant 
strains are unable to replicate intracellularly and are defective in their translocation and 
secretion process (Chakravortty et al., 2005; Coombes et al., 2004; Yu et al., 2004).  
 
Coombes and his colleagues (Coombes et al., 2004) demonstrated that SsaL is 
only required for the secretion and translocation of SPI2-encoded effectors and a 
mutation in ssaL has no effect on the secretion of SPI2 effectors encoded outside of this 
pathogenicity island. Another TTS component, SsaM has been shown to interact with 
ssaB/SpiC and it was proposed that these 2 proteins form a complex able to distinguish 
between translocators and effector proteins and thus, control their ordered secretion 
through the SPI2 TTS system (Yu et al., 2004). Analysis of the combination of an aroC 
and ssaV mutation in S. Typhi Ty2 and S. Typhimurium reveal the potential of utilising 
TTS system mutants for the development of live vaccines in humans (Hindle et al., 
2002). However, the precise function of a number of the ssa genes in SPI2 have yet to 
be elucidated and more work on this region needs to be carried out. 
 
Several studies on the SPI2-encoded proteins SseBCD show that they are 
localised primarily to the cell membrane of Salmonella spp. (Beuzón et al., 1999; 
Chakravortty et al., 2005; Klein and Jones, 2001; Nikolaus et al., 2001). These proteins 
share weak but significant homology to the Esp proteins from enteropathogenic E. coli 
(EPEC) and their mutants were severely attenuated in virulence and intramacrophage 
replication (Hensel et al., 1998).  Chakravortty and his coworkers (Chakravortty et al., 
2005) have reported that the irregular appearance of the needle structures is due to the 
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distribution of SseC and SseD on its surface. On the other hand, SseB loosely 
associates with the needle appendage and a mutation in sseB results in formation of 
appendages lacking its irregular form (Chakravortty et al., 2005). Nikolaus and his 
colleagues (Nikolaus et al., 2001) have determined that sseB, sseC and sseD interact 
with each other after secretion to form a complex for the translocation of effector 
proteins. It has also been shown that sseC is not essential for the secretion of sseD and 
vice versa (Chakravortty et al., 2005; Nikolaus et al., 2001). Although not required for the 
formation of the needle appendages, sseB is needed for the assembly of SseCD 
translocon (Chakravortty et al., 2005; Nikolaus et al., 2001).  
 
1.3.1.2.3 SPI2-Associated Effector Proteins  
The protein ssaB/SpiC was the first SPI2-encoded effector protein to be identified 
(Uchiya et al., 1999). It has been reported that ssaB does not show sequence homology 
to any known proteins and is translocated via the SPI2 TTS system into the macrophage 
cytosol (Hansen-Wester and Hensel, 2001; Uchiya et al.¸1999). SsaB is able to interfere 
with normal intracellular trafficking and inhibit the fusion of phagosome-lysosome 
vesicles (Uchiya et al., 1999). Freeman and his coworkers (Freeman et al., 2002) have 
also shown that SsaB is required for the secretion and translocation of the components 
SseB and SseC to the bacterial surface. In addition, ssaB interacts with ssaM to control 
the secretion process of translocators and effectors (Yu et al., 2004).  
 
Located downstream of the sseBCD cluster (see Figure 1.1), sseF and sseG have 
been identified as genes encoding SPI2 effector proteins (Hansen-Wester et al., 2002; 
Kuhle and Hensel, 2002). Both these genes are not required for the assembly of the 
needle appendages and their mutations have been shown to only modestly affect 
salmonella virulence (Chakravortty et al.¸2005; Hensel et al., 1998).  Like ssaB, SseF 
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and SseG are proteins specific to Salmonella spp. and require a functional SPI2 TTS 
system for secretion (Hensel et al., 1998; Kuhle and Hensel, 2002). Work conducted by 
2 different research groups (Guy et al., 2000; Kuhle and Hensel, 2002) have indicated 
that SseF and SseG contribute to Salmonella-induced aggregation of host endosomal 
compartments. Guy and his colleagues (Guy et al., 2000) also show that in addition to 
SseFG; SsaB, SsaJ, SsaL, SsaM, SsaV, and SsaP is needed for formation of lgp-
tubules (see Section 1.3.1.2.1). SseG is characterised as a Golgi-targeting protein while 
SseF affects the distribution of the motor protein dynein (required for the formation of 
perinuclear microcolonies of Salmonella spp. in host cells) to the SCV (Abrahams et al., 
2006; Salcedo and Holden, 2003). Both these proteins are thought to form a complex 
that interacts with the host cells either by connecting the SCVs to the Golgi network 
and/or by modulating the recruitment of microtubule motor proteins kinesin and dynein, 
which in turn controls the vacuole membrane dynamics (Abrahams et al., 2006; Deiwick 
et al., 2006; Ramsden et al., 2007).  
 
Another SPI2 effector protein that is involved in the association of SCV with the 
Golgi network is SifA (Brumell et al., 2001; Deiwick et al., 2006; Stein et al., 1996). 
Although not encoded by SPI2, SifA is involved in lgp-tubule formation, recruitment of 
kinesin and maintenance of SCV and is thereby required for intracellular survival and 
replication and systemic infection (Beuzón et al., 2000; Boucrot et al., 2005; Brumell et 
al., 2001; Brumell et al., 2002; Stein et al., 1996). The precise intracellular positioning of 
the SCV in the host cell is the result of the concerted effort between 3 SPI2 effectors – 
SseF, SseG and SifA (Deiwick et al., 2006; Salcedo and Holden, 2003). SifB, which 
shares a conserved N-terminal domain with SifA, is localised to the SCV in infected cells 
and its trafficking away from the SCV along Sifs requires SifA (Freeman et al., 2003; 
Miao and Miller, 2000). However, SifB is not involved in Salmonella virulence as its 
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mutants are not attenuated in their intracellular replication (Freeman et al., 2003; Ruiz-
Albert et al., 2002).  
 
On the other hand, SseJ is required for intracellular replication of Salmonella spp. 
and it has been suggested that the combined actions of SseJ and SifA regulate the 
vacuole dynamics in infected host cells (Freeman et al., 2003; Ohlson et al., 2005; Miao 
and Miller, 2000; Ruiz-Albert et al., 2002). More recently, Ohlson and his colleagues 
(Ohlson et al., 2005) have demonstrated that SseJ is an enzyme with deacylase activity 
that is important for salmonella pathogenesis. SspH2 has been identified as a SPI2 
translocated effector protein that contains leucine-rich repeats and shares the same 
conserved amino terminal as SifA, SifB and SseJ (Miao et al., 1999; Miao and Miller, 
2000). The transcription and translocation of SspH2 is specific to SPI2 (requires 
SseBCD translocon) and sspH2 mutants lack the ability to cause lethal infection in 
calves (Miao et al., 1999; Nikolaus et al., 2001). Brumell and his coworkers (Brumell et 
al., 2003) described SopD2, a novel SPI2-associated TTS effector required for mouse 
virulence, that targets late endocytic compartments in host cells. Examples of other non 
SPI2-encoded proteins that affect salmonella virulence through the SPI2 TTS system 
include SseI (Miao and Miller, 2000; Miao et al., 2003), SseK1 and SseK2 (Kujat-Choy et 
al., 2004) and SseL (Coombes et al., 2007).  
 
1.3.1.2.4 SPI2-Associated Chaperones 
Based on sequence analysis, SPI2 region has been predicted to contain genes 
encoding proteins that function as chaperones (Hensel et al., 1998). Coombes and his 
colleagues (Coombes et al.¸2003) have reported that a SPI2-encoded protein, SseA, is 
required for intracellular survival and replication in macrophage and epithelial cells. The 
virulence defect in the sseA mutant show a phenotype similar to that of a SPI2 TTS 
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apparatus mutant and it was shown that such mutants are attenuated due to their 
inability to translocate effector proteins via the SPI2 TTS system (Coombes et al., 2003). 
Two different research groups (Ruiz-Albert et al., 2003; Zurawski and Stein, 2003) 
separately demonstrate that SseA functions as a chaperone for the translocon 
components SseB and SseD and absence of sseA leads to the failure in the assembly of 
a proper SPI2 translocon complex. The presence of a C-terminal SseB and SseD 
domain is required for SseA binding and the N-terminus of this protein has been shown 
to be essential for export of SseB to cell surface (Zurawski and Stein, 2004). SPI2 also 
encodes the chaperone genes sscA and sscB (see Figure 1.1) – sscA mutants have 
been shown to be unable to secrete SseC while SscB acts as a chaperone for SseF by 
modulating its secretion, function and stability (Dai and Zhou, 2004; Hensel et al., 1998; 
Nikolaus et al., 2001).  
 
1.3.1.2.5 SPI2-Associated Regulators 
SPI2 gene expression appears to be induced when Salmonella spp. are located 
intracellularly in infected host cells (Deiwick et al., 1999; Valdivia and Falkow, 1997). It 
has been proposed that detection of these intracellular environmental conditions by the 
bacteria leads to activation/repression of SPI2 genes. Analysis of the SPI2 region by 
Deiwick and his coworkers (Deiwick et al., 1999) have shown that conditions that 
activate SPI1 gene expression (see Section 1.3.1.1.4) are not able to induce expression 
of SPI2 genes and vice versa. This particular observation has led to suggestions that the 
TTS systems of SPI1 and SPI2 are inversely regulated – both these regions response to 
different environmental signals and therefore are not likely to be induced simultaneously 
(Deiwick et al., 1999). Deprivation of divalent cations like Mg2+ and phosphate starvation, 
which probably mirrors the conditions encountered by intracellular Salmonella isolates, 
have been identified as signals that induce SPI2 gene expression (Deiwick et al., 1999).  
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An acidic pH environment inside the SCVs appears to be another physiological 
stimulus essential for SPI2 mediated expression. A low pH (pH 5.0) has been implicated 
in a wide variety of SPI2-associated functions: macrophage-induction of SPI2 genes 
(Cirillo et al., 1998), secretion of the translocon components SseBCD (Coombes et al., 
2004; Nikolaus et al., 2001), functional assembly of SPI2 TTS system (Rappl et al., 
2003), increasing expression levels of SsaC and oligomerisation of its subunits (Rappl et 
al., 2003) and secretion of  formation of needle appendages (Chakravortty et al., 2005). 
The 2 component regulon encoded in SPI2, SsrAB (See Figure 1.1) (Deiwick et al., 
1999; Ochman et al., 1996) is observed to be stimulated by an acidic pH condition (Lee 
et al., 2000; Miao et al., 2002).  
 
SsrA is a putative sensor kinase and SsrB has been identified as a transcriptional 
activator that shares sequence homology with proteins like UvrY of E. coil and SirA of 
S.Typhimurium (Deiwick et al., 1999; Ochman et al., 1996). Together, both these 
proteins are upregulated intracellularly although studies on their expression in response 
to different environmental signals have yielded mixed results (Deiwick et al., 1999; Lee 
et al., 2000; Miao et al., 2002; Worley et al., 2000). Deiwick and his colleagues (Deiwick 
et al., 1999) reported that induction of SPI2 gene expression is modulated by SsrAB and 
PhoPQ under Mg2+ and phosphate limited conditions. This conclusion was contradicted 
by 2 research groups (Lee et al., 2000; Miao et al., 2002) which presented data 
indicating that transcription of SsrAB is independent of Mg2+ concentration and PhoPQ 
regulator.  
 
However, SsrAB is essential for salmonella pathogenesis as they have been 
shown to regulate the expression of proteins encoded within and outside of the SPI2 
region (Chakravortty et al., 2005; Cirillo et al., 1998; Coombes et al., 2004; Coombes et 
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al., 2007; Deiwick et al., 1999; Hensel et al., 1998; Julio et al., 2000; Kujat-Choy et al., 
2004; Miao et al.¸2002; Worley et al., 2000). Transcription of SsrA and SsrB is 
uncoupled and overexpression of ssrB in the absence of SsrA is sufficient to activate 
SPI2 gene expression (Feng et al., 2003; 2004; Walthers et al., 2007). SsrA has been 
recently shown to promote reproductive tract (but not intestinal) colonisation of chickens 
by S. Enteritidis (Bohez et al., 2008). SsrB is autoregulated and appears to have a dual 
function - activation of SPI2-associated genes by binding to their promoters and to 
counteract gene silencing by the H-NS protein (Feng et al., 2003; 2004; Walthers et al., 
2007).      
 
It has been suggested that SPI2 expression is positively modulated by PhoP/PhoQ 
through the regulation of the SPI2-encoded SsrA-SsrB regulon, further supporting the 
theory that SPI1and SPI2 are inversely regulated since SPI1 is repressed by 
PhoP/PhoQ (Behlau and Miller, 1993; Bijlsma et al., 2005; Deiwick et al., 1999; 
Garmendia et al., 2003; Pegues et al., 1995; Worley et al., 2000). Furthermore, it has 
been demonstrated that the in vitro accumulation of the SPI2 translocated effectors 
SseK1 and SseK2 required intact ssrB and phoP/phoQ genes (Kujat-Choy et al., 2004). 
However, other investigators have reported that the transcription and expression of SPI2 
genes does not require PhoP/PhoQ regulation (Kim and Falkow, 2004; Lee et al., 2000; 
Miao et al., 2002). These contradictory observations and findings highlight the need for 
more extensive research to be carried out on this regulator to elucidate its exact role in 
SPI2 gene expression and regulation.   
 
Another 2-component global regulator, OmpR/EnvZ, has been shown to regulate 
expression of SPI2 via SsrAB (Feng et al., 2003; 2004; Garmendia et al., 2003; Kim and 
Falkow, 2004; Lee et al., 2000; Worley et al., 2000). Upon entry into the macrophages, 
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OmpR binds directly to ssrA promoter region, activating its transcription (Feng et al., 
2003; Lee et al., 2000) and an overlap of binding sites at the ssrA and ssrB regions have 
been shown to occur between SsrB and OmpR (Feng et al., 2003; 2004). OmpR 
activation of SsrAB requires the presence of its cognate sensor kinase EnvZ (involved in 
the phosphorylation of OmpR and thereby converting it into its active form, OmpR-P) 
and mutations in envZ have resulted in the elimination of SPI2 promoter activity and 
gene expression (Feng et al., 2003; 2004; Kim and Falkow, 2004). The transcription 
factor protein SlyA has been shown to contribute to Salmonella virulence by affecting 
expression of SPI2 genes like ssrA-ssrB (Feng et al., 2004; Linehan et al., 2005). 
Examples of other proteins that are involved in regulation of SPI2 genes include the 
nucleoid-associated protein H-NS (Walthers et al., 2007), Hha and YdgT (Coombes et 
al., 2005; Silphaduang et al.¸2007) and Fis (Kelly et al., 2004; Lim et al., 2006).  
          
1.3.1.3 SPI3 
Blanc-Potard and Groisman (Blanc-Potard and Groisman, 1997) identified the 
presence of a 17 kB DNA region at the selC tRNA locus in S. Typhimurium, which is also 
the insertional site of pathogenicity islands in E. coli (Blum et al., 1994, McDaniel et al., 
1997). This pathogenicity island termed SPI3 is specific to Salmonella spp., with a G+C 
content of 47.5% and found to contain 10 ORFs organised in 6 transcriptional units (see 
Figure 1.2) (Blanc-Potard and Groisman, 1997; Blanc-Potard et al., 1999). One such 
transcriptional unit is the mgtCB operon, which is essential for salmonella virulence and 
required for intramacrophage survival and growth in low Mg2+ conditions (Blanc-Potard 
and Groisman, 1997). Southern hybridisation experiments have revealed that while the 
right end of SPI3 (including slsA and mgtBC) is present in all Salmonella subspecies, the 
central region (including rmbA, fidL, and marT) is only found in Salmonella subspecies I, 
II and V (S. bongori) and is surrounded by remnants of insertion sequences 
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Figure 1.2 Genetic organisation of SPI3 (Amavisit et al., 2003), SPI4 (schematic drawn based on Gerlach et al., 2007) and SPI5 
(Amavisit et al., 2003) 
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(Blanc- Potard et al., 1999). Such a mosaic structure indicates that this island appeared 
to have evolved in a mutlistep process (Blanc-Potard et al., 1999).  
 
The misL gene encodes a 955 amino acid polypeptide that shares sequence 
homology with the immunoglobin A1 protease family of autotransported proteins (Blanc-
Potard et al., 1999). The C-terminus of this protein also shares similarity with the C-
terminal region of the AIDA-I protein from enteropathogenic E. coli and VirG from 
Shigella flexneri, which have been shown to be involved in diffuse adherence to HeLa 
cells (Benz and Schmidt, 1992) and cell-to-cell spreading (Goldberg et al., 1993), 
respectively (Blanc-Potard et al., 1999). This would suggest that MisL protein functions 
as an autotransporter in some host-pathogen virulence capacity. Although it has been 
reported that misL is not essential for virulence (Blanc-Potard et al., 1999), screening of 
transposon mutants for attenuation in animal models by Morgan and his colleagues 
(Morgan et al., 2004) have revealed a misL mutant is defective in its ability to colonise 
chicks. It was discovered that MisL functions as a surface adhesin, able to bind to 
extracellular matrix protein fibronectin and is required for the long-term intestinal 
colonisation in mice (Dorsey et al., 2005). The MarT protein shares sequence similarity 
with 2 different proteins – the homology of its N-terminal region to the ToxR protein from 
Vibrio cholerae, a transmembrane regulatory protein required for the synthesis of 
cholera toxin; and of its central region with the putative DNA binding domain of CadC, a 
transcriptional activator of E. coli K-12 (Blanc-Potard et al., 1999). The regulatory 
function of MarT was recently confirmed from work carried out by Tükel and his 
colleagues (Tükel et al., 2007) which identified MarT as a transcriptional activator of the 
misL promoter. 
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As stated earlier, mgtCB operon is required for salmonella virulence (Blanc-Potard 
and Groisman, 1997). The mgtC gene, which encodes a 22.5 kDa hydrophobic protein, 
is cotranscribed with mgtB and has been shown to be essential for lethal infection in 
mice and long-term intramacrophage survival (Blanc-Potard and Groisman, 1997; 
Snavely et al., 1991). While MgtC shows no similarity to any other known protein 
sequence, the 102 kDa MgtB protein contains 10 transmembrane domains and shares 
significant homology with the eukaryotic Ca2+ -type ATPase, a part of the cation 
transporter family of proteins (Smith and Maguire, 1993; Snavely et al., 1991). In 
contrast to other Ca2+ -type ATPases, which mediates efflux of cations, MgtB is involved 
in the influx of cations (like Mg2+) into the cell (Snavely et al., 1991).  Mutation of mgtB 
caused only a mild defect in virulence (Blanc-Potard and Groisman, 1997) and its role 
during salmonella infection is still unclear (Blanc-Potard and Groisman, 1997; Moncrief 
and Maguire, 1998; Smith et al., 1998).  
 
Initially thought to contribute to Mg2+ transport (due to the defect in growth of mgtC 
mutants in Mg2+ limited conditions) (Blanc-Potard-Groisman, 1997; Lawley et al., 2006; 
Snavely et al., 1991; Soncini et al., 1996), studies have revealed that MgtC is not a Mg2+ 
transporter, is not produced or unstable in the presence of MgtB and does not mediate 
the transport of any other cations like H+, Ca2+ and Ni2+ (Alix and Blanc-Potard, 2007; 
Günkel et al., 2006; Moncrief and Maguire, 1998; Smith et al., 1998). Recent work 
conducted by Günkel and his colleagues (Günkel et al., 2006) have lead to suggestions 
that MgtC may be involved in the modulation of cellular ion homeostasis and thus, 
membrane potential through the activation of the host cell Na+ K+ -ATPase. The exact 
function of MgtC in pathogenesis is still as yet unknown.  In a genome-wide screening of 
genes from Salmonella spp. required for long-term systemic infection in mice, Lawley 
and his coworkers (Lawley et al.¸2006) were able to identify cigR, rhuM, rmbA and fidL  
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(along with mgtC and marT) as SPI3 genes that could potentially be involved in the 
systemic disease process. This observation supports the work done by Morgan and his 
colleagues (Morgan et al., 2004) on the identification of host-specific colonisation 
factors: the SPI3 gene rmbA is required for colonisation of calves while slsA is needed 
for colonisation in both calves and chicks. However, more research needs to be carried 
out on this pathogenicity island in order to elucidate the roles played by these genes.  
 
Magnesium concentration levels have been shown to control the expression of 
PhoP regulon and in turn, the transcriptional of PhoP-regulated genes, which includes 
the mgtCB operon (Soncini et al., 1996). MgtC is only expressed in wild-type Salmonella 
strains in low Mg2+ conditions and phoP mutant strains are unable to induce the 
expression of mgtC, indicating that the SPI-3 carried gene mgtC is regulated by 
magnesium levels and PhoP/PhoQ (Soncini et al., 1996). This is further confirmed by 
other investigators (Moncrief and Maguire, 1998; Smith et al., 1998): the increase in 
transcription levels of mgtCB operon is influenced by Mg2+ deprivation and invasion of 
epithelial cells by Salmonella spp. And unlike SPI2 genes, mgtCB does not require a low 
pH for activation and expression (Moncrief and Maguire, 1998; Smith et al., 1998). 
Currently, the induction and regulation of the other SPI3 genes are still not known. 
           
1.3.1.4 SPI4 
SPI4 is a 27 kB pathogenicity island located at centisome 92 and flanked by the 
ssb and soxSR loci (Wong et al., 1998). This island has a mosaic structure, is found to 
be conserved among the most common serovars of S. enterica and is likely to carry 
genes encoding a Type I Secretion System (T1SS) (Marcus et al., 2000; Wong et al., 
1998). A previously identified locus shown to be required for intramacrophage survival 
(Bäumler et al., 1994) was also mapped to the SPI4 region, leading to suggestions that 
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SPI4 may be needed for intramacrophage survival (Wong et al., 1998).  Initially 
predicted to contain 18 ORFs (Wong et al., 1998), an improved analysis on the genome 
sequence of S. Typhimurium have reorganised the operons into 6 ORFs, renamed 
siiABCDEF (see Figure 1.2)  (McCelland et al., 2004; Morgan et al., 2004). SPI4 mutants 
have been shown to be defective in the intestinal colonization of calves (Morgan et al., 
2004) and attenuated in long-term persistence in mice (Lawley et al., 2006). 
Furthermore, work conducted on SPI4 region have revealed: it is not required for 
invasion and persistence in epithelial and macrophage cells, causes gastrointestinal 
inflammation but not systemic infection in mice, does not contribute to enteropathogenic 
responses, needed for adhesion to epithelial cells and has no effect on the expression 
and secretion of SPI1 effector proteins (Gerlach et al., 2007b; Morgan et al., 2004).  
 
Detailed sequence and functional analysis have determined that SPI4 encodes a 
very large novel secreted protein (SiiE), components of a T1SS (SiiDCF) and 2 other 
putative secreted proteins (SiiAB) (Gerlach et al., 2007b; Morgan et al., 2004; 2007). 
Sequence analysis indicate that all six genes form an operon and are most probably 
cotranscribed together as a large mRNA (Gerlach et al., 2007a; 2007b; Morgan et al., 
2004; 2007). SiiE is a highly repetitive ~600 kDa non-fimbrial adhesin protein that 
mediates contact-dependent adhesion of Salmonella to epithelial cell surfaces (Gerlach 
et al., 2007b; Morgan et al., 2007). This protein is secreted through a cognate T1SS 
complex, composed of the proteins SiiCDF, which is predicted to be a putative outer 
membrane component, a putative fusion protein spanning the inner and outer 
membranes and a ATP-binding cassette component, respectively (Gerlach et al., 2007b; 
Morgan et al., 2007). In addition, Morgan and his coworkers (Morgan et al., 2007) have 
confirmed that the intestinal colonisation of cattle is influenced by the genes siiE and 
siiF. On the other hand, siiA and siiB show no homology to any known DNA or protein 
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sequences (Morgan et al., 2004). Both SiiA and SiiB are not secreted into the culture 
medium and are not part of the T1SS, leading to the hypothesis that these 2 proteins 
may have a regulatory or chaperone function (Gerlach et al., 2007b).    
 
The discovery of insertions within the SPI4 region during a screening of random 
lacZY fusions for regulation by sirA and hilA dependence indicated a possible link 
between the regulation of SPI1 and SPI4 genes (Ahmer et al., 1999). Expression of SiiE 
has been shown to be regulated by HilA, a central regulator of SPI1 genes (Ahmer et al., 
1999; Bajaj et al., 1995; Morgan et al., 2007). This finding is further confirmed through a 
recent study carried out by Gerlach and his colleagues (Gerlach et al., 2007a) whose 
data demonstrate that expression of SPI4 genes is coregulated with SPI1 invasion 
genes by the global regulator SirA and that both SirA and HilA is essential for the 
secretion of SiiE and SPI4-mediated adhesion. The fact that SPI4 gene expression is 
controlled by HilA, which is regulated by SirA (Ahmer et al., 1999), also indicates that 
SPI4 genes are activated under SPI1-inducing conditions – highest activity level was 
detected when grown at pH 7.4 and during late log/early stationary phase of growth 
(Gerlach et al., 2007a). Other than HilA and SirA, the various other regulatory proteins 
(InvF, PhoPQ, OmpR/EnvZ, SlyA, SsrB, RpoS and RpoE) have little to no effect on the 
expression of SPI4 genes (Gerlach et al., 2007a).   
    
1.3.1.5 SPI5 
SPI5 is a 7.6 kB Salmonella-specific DNA region found in serovars like Dublin and 
Typhimurium (Hong and Miller, 1998; Wood et al., 1998). SPI5 is located at centisome 
25 and flanked by serT on one end and copS/copR on the other (Hong and Miller, 1998; 
Wood et al., 1998). Sequence analysis revealed that this region contains 6 novel genes 
– pipD, orfX, sopB/sigD, pipC/sigE, pipB and pipA (see Figure 1.2) (Wood et al., 1998). 
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SPI5-encoded genes have been shown to be involved in intestinal secretory and 
inflammation responses (but not systemic infection) and mutations in these genes have 
resulted in attenuation and reduced virulence (Norris et al., 1998; Pfeifer et al., 1999; 
Wood et al., 1998).  
 
The SPI5-encoded protein, SopB/SigD shares sequence homology with IpgD of 
Shigella spp. and is essential for salmonella enteropathogenicity (Galyov et al., 1997; 
Hong and Miller, 1998; Norris et al., 1998). SopB is an inositol phosphate phosphatase 
whose enzyme activity mediates chloride secretion in infected epithelial cells; leading to 
fluid influx, neutrophil accumulation in the gut and intestinal inflammation; all of which 
cause diarrhoea (Galyov et al., 1997; Norris et al., 1998). SopB has been shown to be 
translocated into the host cytosol in a Sip-dependent pathway, indicating that the SPI1 
TTS system is responsible for its delivery into host cells (Galyov et al., 1997; Hong and 
Miller, 1998; Zhang et al., 2002). In addition, the transcriptional organisation of 
sopB/sigD-pipC/sigE suggests that these 2 genes are likely to form an operon and it has 
been demonstrated that pipC functions as a chaperone for sopB and is able to interact 
with itself and SopB (Darwin et al., 2001b; Wood et al., 1998).  
 
On the other hand, PipB is translocated by the SPI2 TTS system to both the SCVs 
and Sifs but is not involved in the formation and maintenance of either of these 
structures (Knodler et al., 2002). Southern hybridisation studies show that while the left 
segment of SPI5 (including sopB) is found in all Salmonella spp. (Mirold et al., 2001), the 
left segment (including pipB and pipA) was much less conserved; indicating the mosaic 
structure and acquisition of SPI5 by horizontal gene transfer (Knodler et al., 2002). 
Insertional mutations in pipB are attenuated in the bovine ligated ileal loop model (Wood 
et al., 1998) and chicks (Morgan et al.¸2004). However, their attenuation in the murine 
CHAPTER 1 
 44
model have yielded mixed results with some investigators reporting full virulence of 
mutants (Wood et al., 1998) and others a reduction in virulence (Pfeifer et al. 1999). 
Knodler and his colleagues (Knodler et al., 2002) have shown the possibility that the 
reduction in virulence for the pipB mutant could have resulted from polar effects on the 
pipA gene. This observation would mean that pipBA is likely to be cotranscribed and that 
it is PipA (and not PipB) that contributes to the development of systemic infection and 
virulence (Knodler et al., 2002). However, the exact function of PipB and PipA is 
currently still unknown. 
 
    SPI5 encoded effector proteins are able to interact with other virulence effectors 
to perform a range of virulence-associated functions. SopB has been shown to interact 
with SPI1 translocated effectors like SipA, SopA, SopD, SopE and SopE2 to induce host 
cell invasion (Mirold et al.¸2001; Raffatellu et al., 2005) and enteropathogenicity (Jones 
et al., 1998; Zhang et al., 2002), to disrupt tight junction structure and function (Boyle et 
al., 2006) and mediate actin cytoskeletal rearrangements (Zhou et al., 2001). SipB along 
with SipB2 associate with the detergent-resistant microdomains (DRM) present on the 
membranes of SCVs and Sifs, leading to suggestions that the interaction between DRMs 
and effectors modulate Salmonella-induced signal transduction events in host cells 
(Knodler et al., 2003).  
 
As SPI5 effectors are translocated by different TTS systems, it is reasonable to 
assume that the effectors are regulated by the same conditions that control the particular 
TTS system. As SopB is translocated by the SPI1 TTS system, it has been shown to be 
expressed upon bacterial invasion and during late log/early stationary phase and is 
dependent on the global regulator SirA (Hong and Miller, 1998; Papezova et al., 2007; 
Pfeifer et al., 1999). In contrast, PipB is induced intracellularly, during stationary phase 
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of bacterial growth and is regulated by SsrAB of SPI2 (Knodler et al., 2002; Papezova et 
al., 2007; Pfeifer et al., 1999).   
 
 
1.3.1.6 Other SPIs 
Salmonella Chromosomal Island (SCI) or SPI6 is a 59 kB region located adjacent 
to the aspV tRNA gene and contains the saf fimbrial operon, pagN, which encodes an 
invasin and other genes encoding proteins sharing homology with virulence-associated 
proteins from other Gram negative bacteria (Folkesson et al., 2002; Hensel, 2004; 
Parkhill et al., 2001). SPI6 is present in all S. enterica subspecies I but only portions of 
this region was detected in isolates of subspecies IIIb and IV (Folkesson et al., 2002; 
Hensel, 2004). SPI7 is a very large genetic locus (134 kB in size) inserted adjacent to 
tRNA pheU (Hansen-Wester and Hensel, 2002; Pickard et al., 2003; Parkhill et al., 
2001). This pathogenicity island appears to be specific to serovars Typhi, Dublin and 
Paratyphi C and encodes virulence factors like the ViaB proteins, necessary for the 
synthesis and export of the Vi polysaccharide antigen; and SopE (Hansen-Wester and 
Hensel, 2002; Hensel, 2004; Pickard et al., 2003). Examples of other SPIs include the S. 
Typhi-specific SPI8, SPI9 and SPI10 – 6.8, 16.3 and 32.8 kB genetic regions, 
respectively (Hensel, 2004; Parkhill et al., 2001).  
    
1.3.2 Virulence Plasmids 
Although a majority of the Salmonella spp. carry plasmid(s), not all of these 
plasmids confer a virulence phenotype to the strain (Boyd and Hartl, 1998). Such 
virulence plasmids have a low-copy number, vary in size (50 to 95 kB) (Akiba et al., 
1999; Barrow et al., 1987b; Chu et al., 1999; Haneda et al., 2001) and appear to be 
limited to S. enterica subspecies I serovars like Typhimurium, Enteritidis, Dublin, 
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Choleraesius, Gallinarum, Pullorum and Abortusovis (Barrow and Lovell, 1988; Barrow 
et al., 1987a; 1987b; Guiney et al., 1994; Montenegro et al., 1991; Popoff et al., 1984; 
Rotger and Casadesús, 1999; Rychlik et al., 2006; Woodward et al., 1989). Virulence 
plasmids have been shown to be involved in the expression of salmonella virulence 
(Akiba et al., 1999; Barrow et al., 1987b; 1988; Danbara et al., 1992; Gulig and Curtiss 
III, 1987; Gulig and Doyle, 1993; Guilloteau et al., 1996; Jones et al., 1982; Fierer et al., 
1992 Kawahara et al., 1988; Pardon et al., 1986; Uzzau et al., 2000; Wallis et al., 1995). 
 
All virulence plasmid-containing Salmonella spp. share a highly conserved 8 kB 
operon encompassing 5 genes, designated spvRABCD (Guiney et al., 1994; Gulig et al., 
1993; Rychlik et al.¸2006). It has been demonstrated that this operon encodes the major 
virulence phenotype of the plasmid as the presence of this 8 kB region is sufficient to 
restore wild-type virulence to plasmid-cured strains in the murine model (Guiney et al., 
1994; Gulig et al., 1992; Krause et al., 1991; Williamson et al., 1988). While SpvABCD 
show no significant homology with any known proteins, the 33 kDa SpvR protein shares 
sequence similarity with the MetR/LysR family of bacterial transcriptional activators 
(Caldwell and Gulig, 1991; Gulig et al., 1992; Gulig et al., 1993). SpvR is able to activate 
its own expression and the expression of SpvABCD by binding to a promoter region 
upstream of spvA (Coynault et al., 1992; Grob and Guiney, 1996; Krause et al., 1992; 
Krause et al.¸1995).  SpvR is required for pathogenesis as spvR mutants are attenuated 
and unable to proliferate in macrophages (Gulig et al.¸1992; Krause et al., 1995; Libby et 
al., 1997; 2000). This is probably due to the fact loss of function in spvR results in the 
nonactivation of the downstream spvABCD.  
 
Insertional mutations in the individual genes (spvA, spvB, spvC and spvD) have 
resulted in reduction of virulence and attenuation (Gulig et al., 1992).  Localisation 
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studies by El-Gedaily and his coworkers (El-Gedaily et al., 1997) have shown that SpvA 
was present in the outer membrane, SpvB in the cytoplasm and inner membrane, SpvC 
in the cytoplasm and SpvD is not only secreted into the supernatant but also associated 
with the cytoplasm and membranes. SpvB has been identified as a mono (ADP-ribosyl) 
transferase that mediates virulence functions like actin degradation and apoptotic cell 
death and whose translocation is independent of any TTS system (Gotoh et al., 2003; 
Kurita et al., 2003; Otto et al., 2000; Tezcan-Merdol et al., 2005). By examining a series 
of spv mutations and cloned spv sequences, Matsui and his colleagues (Matsui et al., 
2001) have shown that spvBC was sufficient to replace the spv operon, as well as the 
entire virulence plasmid, of S. Typhimurium for causing systemic disease in mice after 
subcutaneous, but not oral inoculation.  
 
It has been suggested that SpvC is required for the functional activity of SpvB and 
also interacts with spvD for its function, since an overexpression of SpvC can 
compensate for the absence of spvD (Matsui et al., 2001). This observation seems to be 
supported by the work carried out by Valone and his coworkers (Valone et al., 1993) 
who show that a mutation in spvC resulted in loss of expression of all the Spv proteins. 
Furthermore, it has been demonstrated that none of the Spv proteins were expressed in 
a spvA mutant and that a spvB mutant only expressed SpvA, indicating that the spv 
genes interact with one another and may be transcribed as an operon (Valone et al., 
1993).  
 
Regulation of spv gene expression is dependent on a number of conditions: genes 
are induced intracellularly (Fierer et al., 1993; Rhen et al., 1993; Wilson et al., 1997), 
during stationary growth phase (Coynault et al., 1992; El-Gedaily et al.¸1997; Krause et 
al., 1992; Spink et al., 1994; Valone et al., 1993; Wilson et al., 1997; Wilson and Gulig, 
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1998), in nutrient limited condition like glucose starvation and low pH (Valone et 
al.¸1993) and in low iron concentrations (Gotoh et al., 2003; Spink et al., 1994; Valone et 
al.¸1993). Valone and his colleagues (Valone et al., 1993) also show that when S. Dublin 
was grown to late log phase in the absence of glucose, application of heat shock 
treatment strongly induced expression of SpvA. SpvR is a positive regulator of spvABCD 
operon and of its own expression (Coynault et al., 1992; Gulig et al., 1993; Krause et al., 
1992; Spink et al., 1994). In addition, SpvA appear to regulate SpvR expression, 
providing a negative feedback mechanism for this gene (Heiskanen et al., 1994; Spink et 
al., 1994).   
  
The rpoS or katF gene, which encodes the alternative sigma factor RpoS, 
regulates the stationary phase expression of a wide variety of genes, including the spv 
operon (Chen et al., 1995; Fang et al.¸1992; Heiskanen et al., 1994; Kowarz et al., 1994; 
Nickerson and Curtiss III, 1997; Norel et al., 1992; Wilson et al.¸1997). RpoS mediates 
expression of spvRABCD by controlling the transcription of spvR, and rpoS/katF mutants 
have been shown to be less virulent and more susceptible to a range of environmental 
stresses like nutrient limitation, DNA damage, oxidative and acid stress (Fang et al., 
1992; Kowarz et al., 1994; Nickerson and Curtiss III, 1997; Wilson et al.¸1997). The 
PhoP/PhoQ regulatory system also controls rpoS/katF (and thereby spv expression) via 
the stabilisation of RpoS in low Mg2+ concentrations (Tu et al.¸2006). Other proteins that 
have been found to regulate spv expression include polynucleotide phosphorylase 
(PNPase), integration host factor (IHF) and leucine-responsive regulatory protein (Lrp) 
(Marshall et al.¸1999; Ygberg et al., 2006). 
 
The spv genes are responsible for promoting intracellular survival and replication 
in the host (i.e. macrophage cytopathology, leading to cell detachment and apoptosis), 
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thereby leading to development of systemic infection (Guiney et al., 1994; Gulig et al., 
1998; Libby et al., 1997; 2000; Paesold et al., 2002). However, this observation has 
been contradicted by other investigators who have found no correlation between spv 
gene expression and intracellular survival (Gulig and Curtiss III, 1987; Guilloteau et al., 
1996; Rhen et al., 1993; Riikonen et al., 1992; Wilson et al., 1997). Therefore, spv 
function in salmonella pathogenesis appears to be more complex than initially thought 
and requires further study. 
    
Friedrich and his colleagues (Friedrich et al., 1993) analysed a 13.9 kB segment of 
the 90 kB virulence plasmid from S. Typhimurium and reported a 7 kB region containing 
the pef operon, which encodes components of a fimbriae/pili structure (see Section 
1.3.3), and rck, which mediates serum resistance in Salmonella spp. Rck is a 17 kDa 
OMP that shares homology with virulence-associated proteins like PagC from 
Salmonella spp. and Ail from Yersinia enterocolitica (Heffernan et al., 1992a). Rck 
confers high level resistance to the bactericidal activity of human serum by interfering 
with the polymerisation of tubular membrane attack complexes on the bacterial surface 
(Hackett et al., 1987; Heffernan et al., 1992a; 1992b). Rck has also been shown to be 
important in cell adhesion/invasion (Heffernan et al., 1994). Examples of other plasmid-
encoded loci conferring serum resistance include the traT and rsk genes (Rhen and 
Sukupolvi, 1988; Vandenbosch et al., 1989a; 1989b).  
 
1.3.3 Bacterial Fimbriae 
Bacterial fimbriae are defined as thin, filamentous appendages localised on the cell 
surface that mediate the attachment of bacteria to host cells (Anon, 1998). To date, 13 
fimbrial operons have been identified in the Salmonella genome: agf (csf), fim, bcf, lpf, 
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pef, saf, stb, std, stc, stf, sti and stj (Bäumler and Heffron, 1995; Clegg et al., 1987; 
Clouthier et al., 1993; Collinson et al., 1996; Doran et al., 1993; Folkesson et al., 1999; 
Friedrich et al., 1993; McCelland et al., 2001; Müller et al., 1991; Townsend et al., 2001). 
Genetic analysis have shown that a series of horizontal transfer and deletion events 
have resulted in the highly variable distribution pattern of fimbrial operons observed 
among the Salmonella serovars (Bäumler et al., 1997; Folkesson et al., 1999). 
Salmonella spp. fimbrial genes have been implicated in virulence in vitro and in vivo 
(Althouse et al., 2003; Bäumler et al., 1996a; 1996b; Boddicker et al., 2002; Cogan et 
al., 2004; De Buck et al., 2004; Dibb-Fuller et al., 1999; Forest et al., 2007; Guo et al., 
2007; Humphries et al., 2003; Ledeboer et al., 2006; van der Velden et al., 1998; 
Weening et al., 2005). Furthermore, several studies have shown that a large number of 
fimbrial operons often act in concert to elicit various virulence-associated functions 
(Ledeboer et al., 2006; van der Velden et al., 1998; Weening et al., 2005).   
       
1.3.4 Toxins 
Salmonella spp. is capable of producing both endotxins and exotoxins (van Asten 
and van Dijk, 2005). The lipopolysaccharide (LPS) endotoxin is a major component of 
the outer membrane of many enterobacteria, including Salmonella spp. (Hitchcock et al., 
1986; Raetz and Whitfield, 2002). Structural analysis of LPS has revealed that it is 
composed of 3 regions: the core polysaccharide, the O-specific (somatic) antigen 
polysaccharide side chain and the hydrophobic lipid A (Hitchcock et al., 1986; Raetz and 
Whitfield, 2002; Todar et al.¸ 2002). Although the core and Lipid A region is conserved 
among the Salmonella genus, great variation exist with the O-antigen chain, forming the 
basis for the Kaufmann-White serotyping scheme (Fierer and Guiney, 2001; Todar, 
2002). LPS forms a layer around the bacterial cell and functions as a permeability 
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barrier, selectively allowing and excluding substances (Todar, 2002). This enables the 
Salmonella bacterium to protect itself against the environment (e.g. acid and bile salts in 
the gastrointestinal tract) and substances (e.g. lysozyme and antimicrobial) found inside 
the host cell (Fierer and Guiney, 2001; Todar, 2002). Since it is a surface structure, LPS 
also mediates host-pathogen interaction, making it important in the virulence process 
(Todar, 2002).    
 
Lipid A is the active portion of LPS and its interaction with the Toll-like receptors 
during infection activates the host innate immune system and results in the production of 
substances necesssary for inflammatory responses, which at high levels, leads to the 
development of sepsis and septic shock (Ernst et al., 2001; Khan et al., 1998; Morrison 
and Ryan, 1987; Raetz, 1993; Raetz and Whitfield, 2002; Todar, 2002). Biosynthesis 
and assembly of this molecule involves a number of genes, including lpx, pag and pmr 
(Ernst et al., 2001; Raetz and Whitfield, 2002). Formation of the core region involves the 
waa operon (Raetz and Whitfield, 2002; Yethon et al., 1998). The rfb and wzz locus is 
reponsible for the synthesis and assembly of monosaccharide units into the O-antigen 
chain and controlling the length of the polysaccharide chain, respectively (Batchelor et 
al., 1992; Fierer and Guiney, 2001). Mutations in any of genetic loci above have led to a 
loss in virulence and/or reduction in complement resistance (Craven, 1994; Licht et 
al.¸1996; Mintz and Deibel, 1983; Murray et al., 2003; 2005; 2006; Nevola et al., 1985; 
1987; Shaio and Rowland, 1985; Yethon et al., 2000). Although Salmonella spp. are 
able to secrete exotoxins – cytotoxins and enterotoxins, not much is known about its 
exact role and function in pathogenesis (van Asten and van Dijk, 2005).  
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1.4 Variation in Salmonella Pathogenicity 
Although a majority of Salmonella strains are pathogenic to humans and animals, 
their virulence appears to vary from serovar to serovar. Salmonella serotypes usually 
cause gastroenteritis, with a few (e.g. S. Typhi and S. Typhimurium) able to cause 
enteric fever and serovars like Dublin and Pullorum more likely to cause bacteraemia to 
target animals (Fierer and Guiney, 2001; Wallis, 2006). Salmonella spp. also have a 
wide host range: from the ubiquitous serovars like Typhimurium and Enteritidis, to host-
restricted (e.g. S. Dublin and S. Choleraesuis, both capable of causing infection in cattle, 
pigs and humans) and host-specific ones (e.g. S. Typhi and S. Pullorum, which are fully 
adapted to humans and chickens, respectively) (Fierer and Guiney, 2001; Wallis, 2006). 
As pathogenicity of a serotype is determined by various virulence genes, this diversity 
can be attributed to genetic variation or polymorphisms in virulence genes. 
 
Since infection is initiated by contact between the host and pathogen, it has been 
suggested that surface structures such as LPS and fimbriae can contribute to the 
pathogenic diversity of a strain (Fierer and Guiney, 2001; Wallis, 2006). Salmonella 
serotypes differ structurally in the monosaccharide units that make up the O-antigen 
chain of the LPS and this is due to the highly polymorphic nature of the rfb region, which 
encodes genes responsible for the biosynthesis of the polysaccharide chain (Fierer and 
Guiney, 2001; Liu et al., 1991; Verma et al., 1988; Wang et al., 1992; 2002). Genetic 
variation is also observed with the fimbrial operons of Salmonella spp. While the agf and 
fim fimbrial cluster is found in all Salmonella serotypes, some have been shown to be 
present in only a small number of serovars (e.g. pef and sef, whose presence correlate 
with serotypes frequently isolated from common domesticated animals) and others 
appear to be serovar-specific e.g. the S. Typhi fimbrial operon tcf (Bäumler et al., 1997; 
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Folkesson et al., 1999; Porwollik et al., 2002). Both LPS and fimbriae are located on the 
bacterial surface and therefore, subjected to selection pressure from the host immune 
system, leading to the development of genetic variation (Fierer and Guiney, 2001).  
 
Salmonella pathogenicity is affected by large chromosomal islands, termed SPIs 
that confer virulence to a serotype. SPIs are the result of a single or a series of 
horizontal gene transfer events and mediated by mobile genetic elements such as 
integrons, tranposons, IS elements and origin of replications (Gal-Mor and Finlay, 2006; 
Hacker and Kaper, 2000; Hensel, 2004; Hentschel and Hacker, 2001; Marcus et al., 
2000). Once inside the bacteria, the SPI regions might undergo genetic modifications 
(insertion and deletion events, mutations, etc), generating the pathogenic diversity 
observed in Salmonella spp. Environmental isolates of Salmonella with naturally 
occurring deletions in the SPI1 region are unable to invade mammalian cells 
(Ginnocchio et al., 1997). S. bongori, a commensal usually found in cold-blooded 
animals, rarely causes infections in humans and this can be attributed to the absence of 
SPI2-TTSS and effector genes from its genome, which renders the serovar unable to 
cause systemic infection (Boyd et al., 1996; Hansen-Wester et al., 2004; Ochman and 
Groisman, 1996; Porwollik et al., 2002).  
 
Analysis and comparison across the entire SPI1 to SPI5 region of various 
Salmonella serotypes have revealed that a range of insertions and deletions were found 
in the strains (Amavisit et al., 2003; Porwollik et al., 2002). While SPI2 and SPI4 appear 
to be relatively conserved, great variation is observed with SPI1, SPI3 and SPI5 – a 
number of genes appear to be absent or divergent amongst the different Salmonella 
subspecies (Amavisit et al., 2003; Porwollik et al., 2002). It has been reported that only 
Salmonella subspecies I contain the full complement of genes of all 5 SPIs and that the 
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variation seen in the SPIs is conserved within a serovar (Amavisit et al., 2003; Porwollik 
et al., 2002). This finding could explain why the subspecies I strains are more able to 
effectively cause infections in a wide range of hosts (especially warm-blooded animals) 
in comparison to the other Salmonella subspecies.  
 
Insertion and deletion of various genes is mediated by mobile elements like 
transposons and IS elements (Dobrindt et al., 2004; Steinert et al., 2000). While a 
transposon contains both functional genes and transposase, the IS element is a small 
DNA fragment that encode only the transposase gene (Dobrindt et al., 2004; Steinert et 
al., 2000). These “jumping genes” are capable of changing chromosomal location, 
inserting or excising genes as they “jump”. By inserting itself into the sequence of 
virulence genes, the IS element can inactivate the gene by causing a frameshift, which 
disrupts gene transcription (Steinert et al., 2000). IS elements have also been 
associated with the rfb region in several Salmonella serovars, showing that the presence 
of such mobile genes can indicate genetic polymorphisms in a specific region (Wang et 
al., 2002). Changes in the genetic sequence such as base insertion, deletion or 
substitution can also seriously affect expression of virulence-associated genes (Anon, 
2008). Such mutations can result in the creation of a stop codon, truncating the protein 
(nonsense mutation) or translation of a different amino acid (misense mutation), which 
may alter function of the protein (Anon, 2008).  
 
The virulence plasmid of Salmonella spp. is sometimes referred to as a serovar-
specific plasmid (Rotger and Casadesús, 1999). They are usually found in S. enterica 
subspecies I strains showing host adaptation, implying a possible correlation between 
the presence of the plasmid and host-specific virulence (Guiney et al., 1994; Rotger and 
Casadesús, 1999; Woodward et al., 1989). Ahmer and his colleagues (Ahmer et al., 
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1999) have determined that the 90 kB virulence plasmid of S. Typhimurium is self-
transmissible, allowing for the possibility of new salmonella virulence gene combinations. 
While the virulence-associated spv operon is located within the virulence plasmid of 
Salmonella subspeices I, this region is encoded on the chromosome in subspecies II, 
IIIa and IV (Boyd and Hartl, 1998). It is possible that the presence of spv operon on the 
chormosome either confers a selective advantage to these subspecies or causes a 
disadvantage by affecting virulence, in comparison to S. enterica subspecies I (Boyd and 
Hartl, 1998). A single point mutation leading to the substitution of amino acid glycine for 
aspartic acid in Rck, another virulence plasmid protein has been shown to reduce the 
Rck-mediated serum resistance property of Salmonella isolates (Cirillo et al., 1996). 
Overall, although virulence plasmid are particularly associated with host adapted 
serovars and may contribute to pathogenic diversity of Salmonella spp., more research 
needs to be done in order to gain further knowledge regarding the association between 
the two factors. 
 
1.5 Nontyphoidal Salmonella spp. Associated with 
Human Hosts 
1.5.1 Source 
Transmission of Salmonella spp. occurs either via the ingestion of substances 
contaminated by faeces from human or animal sources or directly from an infected 
person or animal (Bell and Kyriakides, 2002; Stevenson and Hughes, 1988). The most 
common way for people to acquire salmonellosis is through the consumption of 
contaminated food. This usually happens when there is insufficient cooking of raw foods, 
improper storage of food items and cross-contamination of cooked foods from contact 
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with surface and utensils used for raw food products (Humphrey, 2000; 2006; Stevenson 
and Hughes, 1988; Wagner, 2007). High protein foods like meat (e.g. beef, pork, poultry 
and seafood), eggs and milk are more likely to become Salmonella-contaminated 
(Stevenson and Hughes, 1988; Wagner, 2007). Salmonella infection can also be 
acquired through contact with an infected animal, e.g. turtle-associated salmonellosis in 
the United States (CDC, 2007b).  
 
1.5.2 Disease Symptoms and Treatment 
After an incubation period of 6-72 hours (depending on the host and dosage), 
infected patients generally manifest symptoms like diarrhoea, abdominal pain and 
cramping, nausea, vomiting and fever (Bell and Kyriakides, 2002; Hohmann, 2001; 
Humphrey, 2000; Nataro et al., 2007; Stevenson and Hughes, 1988). This is the most 
common form of salmonellosis – development of gastroenteritis. Occasionally, 
salmonella infection can occur in the bloodstream, leading to bacteraemia, whose onset 
results in prolonged spiking fever, malaise, chills, chest and abdominal pains and 
anorexia (Bell and Kyriakides, 2002; Stevenson and Hughes, 1988). Focal infection of 
certain tissues (brain, heart valves, etc) can also occur, with local inflammation and 
abscesses, leading to conditions such as pneumonia, meningitis, endocarditis and 
osteoarthritis (Bell and Kyriakides, 2002; Stevenson and Hughes, 1988).  
 
Treatment for gastroenteritis usually involves lots of rest, rehydration and 
electrolyte replacement (Bell and Kyriakides, 2002; Stevenson and Hughes, 1988). Upon 
recovery, a patient may excrete Salmonella for a period of time – anywhere from the 
normal (up to 3 months) to the chronic carrier status (persistent shedding of Salmonella, 
making the individual a great risk to food safety and public health) (Bell and Kyriakides, 
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2002). Antibiotic treatment is only applied in cases of severe gastroenteritis or for 
bacteraemia and in focal infections (Bell and Kyriakides, 2002; Hohmann, 2001; 
Stevenson and Hughes, 1988). However, the issue of treatment of salmonella infection 
with antibiotic therapy is becoming fairly controversial as use of antibiotics can prolong 
excretion time of Salmonella spp. and due to the emerging problem of antibiotic-resistant 
Salmonella strains (Bell and Kyriakides, 2002; Hohmann, 2001; Stevenson and Hughes, 
1988). 
 
1.5.3 Epidemiology 
Young children, the elderly and patients with chronic illnesses or 
immunocompromised systems are particularly susceptible to salmonellosis (Bell and 
Kyriakides, 2002). Infective dose of Salmonella batcterium required to overcome host 
defenses and cause disease varies, usually about 106 to 108 CFU is needed (Humphrey, 
2000; 2006). It has been reported that lower numbers of S. enterica may be capable of 
causing outbreaks, especially in cases involving foods with a high fat content (Bell and 
Kyriakides, 2002; Humphrey, 2000; 2006; Jay et al., 2003). In the United States (USA) 
alone, an estimated 1.4 million cases of salmonellosis is thought to occur annually, of 
which about 200 000 cases are reported to the CDC (Lynch et al., 2002; Voetsch et al., 
2004). Salmonella infection accounts for ~30% (about 400 yearly) of deaths resulting 
from foodborne illnesses in USA and the most commonly isolated serovars are 
Typhimurium and Enteritidis (CDC, 2007a; Mead et al., 1999).  
 
Incidence of salmonella infections in the United Kingdom (which have 
salmonellosis patterns typical of much of the rest of Western Europe) have increased 
from about 10 000 in 1981 to 33 000 cases in 1997; with the serovars Enteritidis, 
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followed by Typhimurium and Virchow being identified as the most frequent causative 
agent of illnesses (Humphrey, 2006). On the other hand, Australian salmonellosis cases 
have been reported to be largely caused by serotypes Typhimurium (PT9, 135 and 170), 
followed by Saintpaul and Virchow (Miller et al., 2005; Murray, 1994; Yohannes et al., 
2004). Approximately 7000-8000 cases of salmonella infections (about 30-35% of all 
Australian foodborne illnesses) are reported in Australia annually, and it is estimated to 
cost as much as 1.2 billion dollars for disease control and treatment (Dalton et al., 2004; 
Miller et al., 2005; OzFoodNet Working Group, 2003; 2004; 2005; 2006). Such economic 
losses highlight the importance of improved surveillance and intervention to prevent 
Salmonella spp. infections and outbreaks.  
 
1.6 Salmonella spp. Associated with Domesticated 
Animal Hosts 
1.6.1 Salmonella spp. in Cattle and Sheep 
Salmonellosis affects cattle worldwide and is most commonly associated with the 
serovars Dublin and Typhimurium (Murray, 1994; Stevenson and Hughes, 1988; Wallis, 
2006). S. Typhimurium is considered a broad-range host and hence, is frequently 
isolated from both cattle and humans. While S. Dublin is capable of causing serious 
disease in humans, it is a host adapted serovar – it commonly causes gastroenteritis 
and/or septicaemia in cattle but is rarely isolated from humans (Murray, 1994; Stevenson 
and Hughes, 1988; Wallis, 2006). Cattle are useful as a model for studying salmonella 
enteropathogenesis: they are a natural target species for Salmonella bacteria and its 
virulence mechanisms are similar to that in humans (Wallis and Galyov, 2000; Zhang et 
al., 2003). Several studies conducted on the virulence factors involved in the intestinal 
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colonisation and inflammation (Jones et al., 1998; Libby et al., 1997; Morgan et al., 
2004; 2007; Wallis et al., 1995; Wallis, 2006; Watson et al., 1998; Zhang et al., 2002), 
and development of systemic disease (Libby et al., 1997; Wallis et al., 1995; Wallis, 
2006) in cattle have allowed researchers to gain a better understanding of salmonella 
pathogenesis in animals and humans.  
 
Ovine salmonellosis has been associated with Salmonella serovars Typhumurium, 
Dublin and Abortusovis (Murray, 1994; Pardon et al., 1988; Uzzau et al., 2001). Serovar 
Abortusovis is highly specific to sheep, known to cause spontaneous abortions through a 
mechanism that is not yet fully understood (Pardon et al., 1988; Rubino et al., 1993; 
Uzzau et al., 2001). It has been reported that S. Abortusovis is able to invade ovine 
intestinal mucosa in a SPI1-dependent manner but does not cause enteritis, leading to 
the suggestion of the serovar being involved in dissemination and persistence at 
systemic disease sites (Uzzau et al., 2001). In addition, mutations in the virulence 
factors of this serovar have shown a reduced virulence in the mouse model (Rubino et 
al., 1993; Uzzau et al., 2000).  
 
1.6.2 Salmonella spp. in Pigs 
The Salmonella serovars most commonly associated with porcine salmonellosis 
include the ubiquitous S. Typhimurium and the host-restricted S. Choleraesius (Murray, 
1994; Stevenson and Hughes, 1988; Wallis, 2006).  Salmonella spp. infections in pigs 
usually results in either enteritis, caused by S. Typhimurium or septicaemia, typically 
caused by S. Choleraesuis (Wallis, 2006; Watson et al., 2000). S. Typhimurium is able 
to induce enteritis through adherence and invasion of intestinal epithelial cells (Althouse 
et al., 2003; Boyen et al., 2006b; Isaacson and Kinsel, 1992) and it has been shown that 
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the tonsil and lung tissue appear to be important sites for bacterial invasion and 
dissemination in pigs (Fedorka-Cray et al., 1995; Wood et al., 1989). In contrast, 
septicaemia appears to be related to the ablilty of S. Choleraesuis to cause systemic 
infection (Danbara et al., 1992; Watson et al., 2000). A variety of virulence genes within 
Salmonella spp. have been determined to be important for virulence in pigs (Althouse et 
al., 2003; Boyen et al., 2006a; 2006b; Brumme et al., 2007; Carnell et al., 2007; Danbara 
et al., 1992; Huang et al., 2007; Kawahara et al., 1988; Ku et al., 2005; Lichtensteiger 
and Vimr, 2003; Uthe et al.¸ 2007). 
  
1.6.3 Salmonella spp. in Horses 
Horses of all ages can be affected by salmonellosis and serovars known to cause 
infection in horses include Typhimurium, Bovismorbificans, Newport and Abortusequi 
(Akiba et al., 1999; Stevenson and Hughes, 1988). Knowledge on the virulence 
mechanisms involved in equine salmonellosis is restricted by the limited number of 
studies investigating these virulence factors in relation to infections in horses. However, 
Akiba and his colleagues (Akiba et al., 1999) have reported the presence of a single 95 
kB plasmid in S. Abortusequi strains, which contain spv genes and confers virulence to 
this serovar in mice.  
 
1.6.4 Salmonella spp. in Cats and Dogs 
Although Salmonella spp. can be isolated from the faeces of dogs and cats, clinical 
salmonellosis is rare in both these animals (Stevenson and Hughes, 1988). However, 
there have been reports that domestic pets can acts as a reservoir for Salmonella 
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strains, facilitating its transmission to humans and other animals, resulting in disease 
(Cherry et al., 2004; Sato et al., 2000; Van Immerseel et al., 2004; Willard et al., 1987).  
 
 
1.6.5 Salmonella spp. in Poultry 
Salmonella infections occurring in poultry worldwide have mainly been associated 
with the serotypes Typhimurium, Enteritidis, Gallinarum and Pullorum (Murray, 1994; 
Stevenson and Hughes, 1988; Wallis, 2006). Although subspecies II Sofia is the most 
prevalent serotype amongst Australian poultry, it is avirulent in both chickens and 
humans and this situation appears to be unique in Australia (see Section 1.7) 
(Harrington et al., 1991; Heuzenroder et al., 2001; Murray, 1994). The ubiquitous S. 
Typhimurium is able to invade and colonise intestinal tissue and can cause severe 
systemic infection in young chicks (Barrow et al., 1987a; 1994; Henderson et al., 1999; 
Kaiser et al., 2000; Wallis, 2006). While S. Enteritidis (another broad host range serovar) 
shares the same pathogenic mechanisms as serovar Typhimurium (Kaiser et al., 2000; 
Wallis, 2006); this serovar has also been shown to be very efficient in the colonisation of 
reproductive organs of chickens, which may explain the frequent contamination of eggs 
by S. Enteritidis (Mizumoto et al., 2005; Okamura et al., 2001; Saeed et al.¸2006). On 
the other hand, serotypes Gallinarum and Pullorum are avian-specific and most 
commonly associated with the ability to produce systemic disease in poultry (Barrow et 
al., 1994; Buchholz and Fairbrother, 1992; Henderson et al., 1999; Kaiser et al., 2000; 
Roy et al., 2001; Stevenson and Hughes, 1988; Wallis, 2006). 
 
It has been shown that the genes within SPI1 and SPI2 are involved in both 
gastrointestinal colonisation and systemic infection of serovars Typhimurium and 
Enteritidis in chickens (Bohez et al., 2006; Jones et al.¸2007; Porter and Curtiss III, 
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1997; Turner et al., 1998). On the other hand, both S. Gallinarum and S. Pullorum 
require SPI2 for virulence and persistence in chickens and SPI1 appears to contribute 
to, but is not essential for virulence or survival in the host (Jones et al., 2001; Wigley et 
al., 2002). In addition, other virulence factors have also been reported to be important for 
Salmonella virulence in poultry – virulence plasmid (Bakshi et al., 2003; Barrow et al., 
1987b; 1988), fimbriae (Cogan et al.¸2004; De Buck et al., 2004; Lee et al., 1996) and 
LPS (Caroll et al., 2004; Craven, 1994; Turner et al., 1998; Zhao et al., 2002).  
 
1.7 Salmonella Serovar II Sofia 
Salmonella II Sofia, which belongs to the S. enterica subspecies II, was first 
isolated in Australia in the 1970s, where its isolation incidence has continued to increase 
over the past 3 decades (Harrington et al., 1991; Heuzenroder et al., 2001). The S. II 
Sofia situation in Australia is unique for a number of reasons: it is the predominant 
serovar isolated from Australian chickens (see Table 1.1) – around 50 to 60% of 
Salmonella chicken isolates belong to this group (Heuzenroder et al., 2001). There has 
been no reported spread to other domesticated animal hosts nor has there been a 
parallel increase in the isolation of S. II Sofia from humans (Harrington et al., 1991). This 
high frequency of S. II Sofia in chickens and the very low incidence in humans (<0.2-
0.3% of total Salmonella isolates) does not appear to be prevalent elsewhere, although 
S. II Sofia has been reported in Israel (Harrington et al., 1991; Murray, 1994; Ross et al., 
2003). S. II Sofia is not widely as researched compared to other Salmonella serotypes: 
from its identification in the 1970s until the present day, only a handful of articles have 
been published, detailing studies conducted on this strain (Harrington et al., 1991; 
Heuzenroder et al., 2001; Rickard, 1998; Ross et al., 2003). The epidemiological study 
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Table 1.1 Distribution of Salmonella serovars isolated from chickens in Australia from 1987-1992 and 1997-1999. 
 
Serovar Year Percentage (%) Reference 
II Sofia 35.7 
Typhimurium 19.9 
Anatum 4.6 
Infantis 3.5 
Singapore 
1987-1992 
2.2 
Murray, 1994 
II Sofia 55.5 
Typhimurium 16.9 
4, 12:d:- 3.7 
Kiambu 3.0 
Virchow 3.0 
Singapore 1.8 
Ohio 
1997-1999 
1.1 
Heuzenroeder et al., 2001 
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carried out by Harrington and her colleagues (Harrington et al., 1991) have shown 
significant differences exist between the Australian and Israeli S. II Sofia strains.  
 
Harrington and her coworkers (Harrington et al., 1991) also suggested that the 
Israeli chicken strains appear to be more pathogenic to humans compared to the 
Australian chicken strains, but were unable to detect the presence of any potential 
virulence factors (e.g. pili or outer membrane proteins) to support this observation. It is 
possible that these Israeli strains may have acquired virulence genes but have been 
unable to maintain them in the genome for long. A more likely explaination would be that 
the S. II Sofia is avirulent and masking the presence of the “real” pathogen, which would 
be present in lower numbers due to the low infective dose. Using fluorescent AFLP, 
Ross and his colleagues (Ross et al., 2003) have shown that while S. II Sofia is 
genetically variable, clonal groupings persist over time and no dominant clone could be 
found in the Australian isolates that would explain its persistence and isolation from 
poultry. 
 
Despite widespread colonisation of Australian poultry, S. II Sofia is avirulent and 
does not cause disease in either humans or poultry (Harrington et al., 1991; 
Heuzenroder et al., 2001). The efficient colonisation of a warm-blooded host like the 
chicken is puzzling as S. enterica subspecies II strains are usually associated with cold-
blooded animals such as reptiles (Heuzenroeder et al.¸2001). This colonisation property 
has led to the idea that S. II Sofia can act as a competitive exclusion agent, capable of 
excluding more pathogenic Salmonella variants from the intestinal tract (Heuzenroeder 
et al., 2001). However, studies conducted by Heuzenroeder and his coworkers 
(Heuzenroeder et al., 2001) have found no evidence that S. II Sofia is able to exclude or 
reduce numbers of pathogenic S. Typhimurium.  
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Very little is known or understood about pathogenicity of S. II Sofia at a molecular 
level. It has been shown that while S. II Sofia is able to adhere and invade cultured 
epithelial cells, the strain is unable to survive intracellularly (Rickard, 1998). However, 
Rickard (Rickard, 1998) did show that a dosage of 107 bacteria was sufficient to cause 
systemic infection, leading to mortality (at levels comparable to that of pathogenic S. 
Typhimurium 82/6915) in 70-95% of the chicken embyros. This finding indicates that S. II 
Sofia infection is only able to cause systemic disease in hosts with immature or 
immunocompromised systems (Rickard, 1998).  DNA sequence analysis have revealed 
that S. II Sofia is incomplete within the inv region of SPI1 (lacking invH as well as 
adjacent genes in the inv operon) and also missing the plasmid borne spv and pef genes 
(Heuzenroeder et al., 2001). As these genes have been shown to be required for 
Salmonella pathogenesis (Bäumler et al., 1996a; Darwin and Miller, 1999b; Fierer et al., 
1992; Galán and Curtiss III, 1989; Guiney et al., 1994; Gulig et al., 1992; Kubori et al., 
1998; Kubori et al., 2000; Sukhan et al., 2001; Watson et al., 1998), their absence could 
explain the avirulent nature of S. II Sofia. However, more research into this area needs 
to be done before any conclusions can be made. 
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1.8 Aims 
This research project was designed to study the molecular pathogenesis of the Australian 
isolates of Salmonella serovar II Sofia and has 3 main objectives: 
1) To investigate the genetic relationship between S. II Sofia isolates from various locations 
around Australia using molecular typing methods. 
 
2) To examine the genetic variation and distribution of Salmonella pathogenicity islands (SPI1 
to SPI5) and virulence plasmid in S. II Sofia in comparison to S. Typhimurium 82/6915. 
 
3) To assess the pathogenic potential of S. II Sofia isolates in Australian poultry.
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 General Procedures 
All chemicals used were of analytical and molecular reagent grade. Solutions were 
prepared in deionised water (dH2O) delivered from a Millipore Milli-Q® water system, unless 
otherwise specified. Solutions were dispensed using Finnpipette micropipettes (Pathtech Pty 
Ltd., Australia) with the following volume ranges: 200 µL to 1 mL, 20 µL to 200 µL, 5 µL to 50 
µL, 0.5 µL to 10 µL and 0.1 µL to 2 µL.  
 
Glassware was washed using Pyroneg detergent, rinsed in tap water, with a final rinse in 
dH2O. All glassware, micropipette tips, plasticware, media and solutions used for bacterial, DNA 
and molecular work was sterilised by autoclaving at 121°C for 20 min,  unless stated otherwise. 
General chemicals and equipment used throughout this study is listed in Appendix I. 
 
2.2 Bacteriological Methods 
 
2.2.1 Media and Antibiotics 
2.2.1.1 Antibiotics 
Ampicillin and Kanamycin were dissolved in sterile dH2O at a concentration of 100 mg/mL 
and 50 mg/mL, respectively. Gentamicin sulfate was prepared by dissolving the antibiotic in 
sterile dH2O to a concentration of 400 mg/mL. All antibiotic stock solutions were sterilised by 
filtration through a 0.2 µm membrane filter and stored at -20°C. 
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2.2.1.2 Luria Bertani Agar (LBA) 
Tryptone (1.0% w/v), yeast extract (0.5% w/v), NaCl (0.5% w/v) and bacteriological agar 
(1.0% w/v) was dissolved in dH2O and autoclaved under standard conditions. After cooling to 
50°C, the agar was poured into Petri dishes and allowed to set. LBA plates were stored at 4°C.  
 
2.2.1.3 LBA Containing Ampicillin 
LBA was prepared as stated above. After cooling agar to 50°C, ampicillin was added to a 
final concentration of 100 µg/mL before pouring into Petri dishes. Plates were stored at 4°C. 
 
2.2.1.4 Luria Bertani Broth (LBB) 
Tryptone (1.0% w/v), yeast extract (0.5% w/v) and NaCl (0.5% w/v) was dissolved in dH2O 
and autoclaved under standard conditions.  
 
2.2.1.5 LBB Containing Ampicillin 
LB broth was prepared as stated above. Before use, ampicillin was added at a final 
concentration of 100 µg/mL. 
 
2.2.1.6 Malonate Broth 
The following ingredients: (NH4)2SO4 (0.2% w/v), K2HPO4 (0.06% w/v), KH2PO4 (0.04% 
w/v), NaCl (0.2% w/v), sodium malonate (0.3% w/v), DL-phenylalanine (0.2% w/v), yeast extract 
(0.1% w/v) and NaCl (0.5% w/v) were dissolved in dH2O by heating. Media was filtered before 
the addition of bromothymol blue (0.0025% w/v) and autoclaved at 115°C for 20 min.   
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2.2.1.7 N Minimal Medium 
The following ingredients: KCl (5 mM), (NH4)2SO4 (7.5 mM), K2SO4 (0.5 mM), KH2PO4 (1 
mM), 0.1 mM Tris-HCl (pH 7.4), MgCl2 (10mM) were dissolved in dH2O and autoclaved under 
standard conditions. After cooling to room temperature, the required amount of filter-sterilised 
glucose (0.2% w/v) was added to the solution. 
 
2.2.1.8 ONPG Broth 
 This broth was made up of 2 components: ONPG solution and peptone water. ONPG
 (6% w/v) was dissolved in Na2HPO4 (0.01 M) at pH 7.5, filter and stored wrapped in foil 
at 4°C. Bacteriological peptone (0.1% w/v) and NaCl (0.5% w/v) was dissolved in dH2O, 
adjusted to pH 7.2 and autoclaved. ONPG solution was aseptically added to the peptone water 
at a ratio of 1:3 before use.  
 
2.2.1.9 SOC Broth 
The following ingredients: tryptone (2.0% w/v), yeast extract (0.5% w/v), NaCl (0.05% 
w/v), KCl (5 mM), MgSO4 (10 mM), MgCl2 (10 mM) and glucose (20 mM) were dissolved in 
dH2O, adjusted to pH 7.0 with NaOH and autoclaved under standard conditions. After the 
addition of glucose, the broth was filter-sterilised and stored at room temperature in aliquots. 
 
2.2.1.10 X-gal Agar 
Using LBA plates supplemented with the appropriate antibiotics, 40 µL of both 24 mg/mL 
IPTG and 40 mg/mL X-gal was spread evenly onto the surface of the agar just before use. 
These plates were incubated wrapped in foil as X-gal is light sensitive. 
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2.2.1.11 XLD Agar 
XLD agar was prepared by mixing XLD agar powder (5.3 % w/v) with dH2O and heating 
the mixture in a microwave oven until completely dissolved. Agar mixture was allowed to cool to 
50°C before pouring into Petri dishes. Before use, XLD plates are dried at 37°C for 30 min. 
 
2.2.2 Bacterial Isolates  
2.2.2.1 Bacterial Strains Used 
The majority of S. II Sofia isolates used in this study were supplied by Inghams 
Enterprises Pty Ltd and are listed in Table 2.1. The S. II Sofia strains were isolated from chicken 
flocks from different states around Australia. Other Salmonella spp. used in this study are listed 
in Table 2.2.  The Escherichia coli strain DH5α was utilised as a host for pCR2.1 and pWSK29 
(see Section 2.3.8.4 and 2.3.8.5). Salmonella constructs were first passaged into S. 
Typhimurium LT2 9121 (to stabilise constructs and for restriction modification) before being 
inserted into S. II Sofia Bt6 (refer to Section 2.3.8.4 and 2.3.8.5). 
   
2.2.2.2 Bacterial Culture Conditions 
All bacteria were grown on LBA or in LBB and incubated aerobically at 37°C overnight 
(16-18 h), unless specified otherwise. Cultures grown in LBB were placed on a rotary shaker for 
appropriate periods. All bacterial analysis was carried out on culture no older than 8 passages. 
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Table 2.1     Salmonella II Sofia isolates used in this study. 
 
Strain Identification Location/Origin Source 
Bt1-3, 6, 8, 13-16 and 
18 
Victoria Biotechnology Laboratory, 
RMIT University, Melbourne, 
VIC 
FSAW 3451-3455 Victoria Dr. Alvin Lee, Food Science 
Australia, Werribee, VIC 
826V, 838V, 842V, 
846V, 847V, 856V, 
858V, 9VCA, 10VCA, 
985VCA, 987VCA, 
992VCA, 620MSC, 
627MSC, 629SMC, 
630MSC, 632MSC, 
633MSC, 637MSC  
Victoria Inghams Enterprises Pty 
Ltd., Springwood, QLD 
539NC, 561NC, 566NC, 
568NC, 537NCA, 
538NCA, 541NCA, 
554NCA, 561NCA, 
566NCA, 567NCA, 
569NCA, 768XTA  
New South Wales Inghams Enterprises Pty 
Ltd., Springwood, QLD 
786CL, 963Q, 965Q, 
985Q, 986Q, 988Q, 
336QC, 339QC, 
348QC, 360QC, 
362QC, 365QC, 
366QC, 403QCA, 
404QCA 
Queensland Inghams Enterprises Pty 
Ltd., Springwood, QLD 
565SC, 636SC, 642SC, 
644SC, 671SC, 
655SCA, 656SCA, 
659SCA, 664SCA, 
665SCA, 671SCA  
South Australia Inghams Enterprises Pty 
Ltd., Springwood, QLD 
146TC, 147TC, 148TC, 
150TC, 140TCA, 
146TCA, 147TCA, 
148TCA, 150TCA 
Tasmania Inghams Enterprises Pty 
Ltd., Springwood, QLD 
131 Unknown Biotechnology Laboratory, 
RMIT University, Melbourne, 
VIC 
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Table 2.2     Other Salmonella spp. isolates used in this study. 
 
Isolate 
Serotype 
Strain 
Identification 
Location/ 
Origin 
Source 
Agona FSAW 3416, 
3463 
- Dr. Alvin Lee, Food Science 
Australia, Werribee, VIC 
Cholaerasius Braenderup 
H9812 (ATCC 
BAA664) 
- Libby Grabsch, Department of 
Microbiology, Austin Health, VIC 
Enteritidis 446302 - Biotechnology Laboratory, RMIT 
University, Melbourne, VIC 
Hadar P12 - Biotechnology Laboratory, RMIT 
University, Melbourne, VIC 
Heidelberg - - Biotechnology Laboratory, RMIT 
University, Melbourne, VIC 
Infantis 999S South 
Australia 
Inghams Enterprises Pty Ltd., 
Springwood, QLD 
Kiambu 343W, 345W West 
Australia 
Inghams Enterprises Pty Ltd., 
Springwood, QLD 
Ohio 213N New South 
Wales 
Inghams Enterprises Pty Ltd., 
Springwood, QLD 
82/6915 - 
LT2 9121 - 
ATCC14028 - 
9 - 
Biotechnology Laboratory, RMIT 
University, Melbourne, VIC 
Typhimurium 
SL1344 - Professor Dick Strugnell, 
Melbourne University, VIC 
845V Victoria Inghams Enterprises Pty Ltd., 
Springwood, QLD 
Virchow 
370QC Queensland Inghams Enterprises Pty Ltd., 
Springwood, QLD 
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2.2.2.3 Storage of Stock Cultures 
Overnight bacterial cultures were mixed with sterile 100% glycerol at a ratio of 1:1, placed 
into cyrovials and stored frozen at -70°C. Bacterial stocks were reconstituted by scraping the 
surface of frozen culture with a heated loop and streaking onto a LBA plate followed by 
overnight incubation at 37°C. 
 
2.2.2.4 Estimation of Bacterial Cell Concentration 
Salmonella cell culture densities were estimated by measuring absorbance (A600) at 600 
nm and calculating CFU. The suspension solution (without any bacterial cells) was used as a 
blank for absorbance readings. Concentrations were confirmed by serial dilutions of bacteria 
and plating onto LBA plates. 
 
2.2.3 Bacterial Profiles 
Biochemical testing was carried out to confirm the identity of S. II Sofia isolates used in 
this study. The appropriate bacteria were used as negative/positive controls throughout the 
testing. All strains were streaked onto XLD agar and incubated overnight at 37°C. Biochemical 
tests for malonate and ONPG were performed as described in Cowan and Steel’s Manual for 
Identification of Medical Bacteria (Shaw and Clarke, 1955; Lowe, 1962). The results are listed in 
Appendix II and confirm that all the bacteria received were S. II Sofia isolates. The bacterial 
isolates were also confirmed as Salmonella spp. and serogrouped with mono- and polyvalent 
Salmonella agglutinating sera, according to the manufacturer’s instruction. The results are listed 
in Appendix II.  
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2.3 DNA Methods 
2.3.1 Buffers and Reagents 
2.3.1.1 Anti-DIG Antibody Solution 
Anti-DIG antibody (1:5000 Dilution) in 1% blocking solution. 
 
2.3.1.2 Blocking Reagent Stock Solution 
Blocking reagent (10% w/v) was dissolved in 1x maleic acid buffer (pH 7.5) and heated at 
low heat for 15 min with constant stirring. Once completely dissolved, the mixture was 
autoclaved and stored at 4°C. 
 
2.3.1.3 1% Blocking Solution  
10% Blocking reagent stock solution diluted with 1x maleic acid buffer (pH 7.5). 
 
2.3.1.4 Chloroform/Isoamyl Alcohol (24:1) 
Chloroform was mixed with isoamyl alcohol at a ration of 24:1. 
 
2.3.1.5 CTAB Solution 
NaCl (0.7 M) and CTAB (10% w/v) was mixed in sterile dH2O with constant heating and 
stirring until completely dissolved. 
 
2.3.1.6 Detection Buffer (pH 9.5) 
100 mM Tris-HCl and 100 mM NaCl dissolved in dH2O and adjusted to pH 9.5 with 20 M 
NaOH. 
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2.3.1.7 Denaturation Solution 
NaOH (0.5 M) and NaCl (1.5 M) dissolved in dH2O. 
 
2.3.1.8 Depurination Solution  
HCl (0.25 M) diluted in dH2O. 
 
2.3.1.9 70 % Ethanol 
Ethanol (100% v/v) diluted in sterile dH2O. 
 
2.3.1.10 E buffer (pH 7.9) 
Tris-acetate (40 mM) and EDTA (2 mM) was dissolved in dH2O, adjusted to pH 7.9 with 
glacial acetic acid and autoclaved. 
 
2.3.1.11 0.5 M EDTA 
EDTA (0.5 M) was dissolved in dH2O, adjusted to the appropriate pH with NaOH and 
autoclaved. 
 
2.3.1.12 ESP Solution (PFGE Lysis Buffer) 
EDTA (0.5 M, pH 9), sarkosyl (1% w/v) and proteinase K (100 µg/mL) dissolved in sterile 
dH2O and stored at -20°C. 
 
2.3.1.13 Frozen Storage Buffer (FSB)  
MnCl2.4H2O   45 mM 
CaCl2.2H2O   10 mM 
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KCl    100 mM 
Hexamminecobalt chloride 3 mM 
Potassium acetate  10 mM 
Glycerol   10% v/v 
All ingredients were dissolved in sterile dH2O, adjusted to pH 6.4, filter sterilise and stored 
at 4°C. 
 
2.3.1.14 HEPES Running Buffer 
HEPES-NaOH (16 mM), sodium acetate (16 mM) and 0.8 mM EDTA (pH 7.5) was 
dissolved in dH2O and autoclaved. 
 
2.3.1.15 IPTG Stock Solution 
IPTG (24 mg/mL) was dissolved in sterile dH2O, filter sterilised and stored at -20°C. 
 
2.3.1.16 λDNA (PstI and HindIII) marker 
λDNA   20 µg 
RE buffer  1× 
PstI   100U 
sterile dH2O  variable 
All ingredients were mixed and incubated overnight at 37°C. A volume of 40 µL of sterile 
dH2O and 20 µL of 11× loading dye was added into the mixture before being stored at -20°C in 
aliquots. This was used as a molecular weight marker at a final concentration of 100 ng/µL 
(Appendix IV). 
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2.3.1.17 11x Loading Buffer 
Ficol-400 (10% v/v), Orange G dye (0.5% w/v), SDS (1% w/v), glycerol (50% w/v), 50 mM 
Tris-HCl (pH 8.0) and EDTA (10 mM) were dissolved in sterile dH2O and stored at room 
temperature. 
 
2.3.1.18 Lysis Solution (Plasmid Extraction) 
Tris-base (50 mM) was dissolved in dH2O, adjusted to pH 12.6 and autoclaved. SDS (3% 
w/v) was added to the solution. 
 
2.3.1.19 10× Maleic Acid Buffer Stock solution  
Maleic acid (1 M) and NaCl (1.5 M) dissolved in dH2O, adjusted to pH 7.5 with NaOH. This 
was diluted to 1× and autoclaved before use. 
 
2.3.1.20 Maleic Acid Wash Buffer 
Tween® 20 (0.3% w/v) in 1× maleic acid buffer. 
 
2.3.1.21 Neutralisation Solution 
Tris-HCl (0.5 M, pH 7.5) and NaCl (3 M) dissolved in dH2O. 
 
2.3.1.22 1× PBS  
To obtain a final concentration of 1×, one PBS tablet was dissolved in 100 mL dH2O and 
autoclaved. 
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2.3.1.23 Phenol/Chloroform/Isoamyl Alcohol (25:24:1) 
Phenol and Chloroform/Isoamyl alcohol was mixed at a ration of 1:1 in a sterile bottle or 
plastic tube (wrapped in aluminium foil to keep out light) and stored at 4°C. 
 
2.3.1.24 PIV Buffer 
Tris-base (10 mM) and NaCl (1 M) dissolved in deionised H2O, adjusted to pH 8.0, and 
autoclaved. 
 
2.3.1.25 Proteinase K Stock Solution 
Proteinase K (20 mg/mL) was dissolved in sterile dH2O in a sterile microcentrifuge tube 
and stored at -20°C. 
 
2.3.1.26 RNase Stock Solution (DNase-free) 
Bovine pancreatic RNase (10 mg/mL) was dissolved in sterile dH2O and boiled for 5 min 
to denature any contaminating DNAses. The stock solution was then stored at  
-20°C. 
 
2.3.1.27 Standard Hybridisation Buffer (Pre-hybridisation Buffer) 
5× SSC, sarkosyl (0.1% w/v), SDS (0.02% w/v) and blocking solution (1% w/v) were 
diluted in sterile dH2O and stored at -20°C. 
 
2.3.1.28 3M Sodium Acetate (pH 4.6) 
 Sodium acetate (3 M) was dissolved in dH2O, adjusted to pH 4.6 with glacial acetic acid 
and autoclaved. 
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2.3.1.29 5 M NaCl 
NaCl (5 M) was prepared with dH2O and autoclaved. 
 
2.3.1.30 20X SSC 
NaCl (3 M) and sodium citrate (0.3 M) dissolved in dH2O, adjusted to pH 7.0 and 
autoclaved. 
 
2.3.1.31 2X SSC Wash Buffer 
SSC (2X) and 0.1% SDS diluted in sterile dH2O. 
 
2.3.1.32 0.1X SSC Wash Buffer 
SSC (0.1X) and 0.1% SDS diluted in sterile dH2O. 
 
2.3.1.33 Solution I 
Glucose   50 mM 
Tris-HCl   25 mM 
EDTA    10 mM 
All ingredients were dissolved in dH2O, autoclaved and stored at 4°C. 
 
 
2.3.1.34 Solution II 
NaOH (0.2 M) and SDS (1% w/v) dissolved in sterile dH2O. This solution is prepared fresh 
before every use. 
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2.3.1.35 Solution III 
Potassium acetate (5 M), 11.5 mL of glacial acetic acid were dissolved in 28.5 mL of 
dH2O, autoclaved and stored at 4°C. 
 
2.3.1.36 Substrate Solution 
NBT/BCIP substrate solution (200 µL) diluted in 10 mL of detection buffer. 
 
2.3.1.37 50× TAE Buffer  
Tris-base (24.2% w/v), glacial acetic acid (5.17% w/v) and EDTA (1.86% w/v) were 
dissolved in deionised water. This was diluted to 1X before use. 
 
2.3.1.38 5× TBE Buffer  
Tris-base (0.445 M), boric Acid (0.445 M) and EDTA (12.5 mM, pH 8.0), dissolved in H2O 
and autoclaved. This was diluted to 0.5× before use. 
 
2.3.1.39 TE buffer 
Tris-base (10 mM) and EDTA (1 mM) was dissolved in water.   The pH was adjusted as 
required with HCl and solution was then autoclaved. 
 
2.3.1.40 X-gal Stock Solution 
X-gal (40 mg/mL) was dissolved in DMF and stored at –20°C. 
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2.3.2 DNA Isolation Techniques 
2.3.2.1 Chromosomal DNA Extraction 
Bacterial chromosomal DNA was isolated using the CTAB method as described in Current 
Protocols In Molecular Biology (Volume 1) (Reichardt and Rogers, 1994). Cultures were grown 
overnight in 5 to 10 mL LBB at 37°C. Bacterial cells were obtained by centrifugation at 4000 × g 
for 10 min. Cell pellets were resuspended in 565 µL of TE (pH 8.0) in a sterile microcentrifuge 
tube. Lysis of cells was achieved by the addition of SDS and proteinase K to a final 
concentration of 0.5% and 100 µg/mL, respectively. Tubes were mixed by inversion and 
incubated at 37°C for 1h.  100 µL of 5 M NaCl and 80 µL of CTAB was added and after mixing 
thoroughly, the tubes were incubated at 65°C for 15 min.   
 
An approximately equal volume of chloroform/isoamyl alcohol was added and the mixture 
was centrifuged. The aqueous phase was recovered and extracted with an equal volume of 
phenol/chloroform/isoamyl alcohol (PCI). In both cases, phase separation was achieved by 
centrifugation at 10 000 × g for 10 min. DNA was precipitated by the addition of 0.6 volumes of 
isopropanol. Precipitated DNA was collected by centrifugation at 10 000 × g for 10 min. DNA 
pellets were washed in 70% ethanol before being resuspended in 20-50 µL of TE or sterile 
dH2O.  All isolated chromosomal DNA was stored frozen at -20°C. 
 
2.3.2.2 Plasmid Miniprep 
Plasmid miniprep was performed using the method described by Sambrook and Russell 
(Sambrook and Russell, 2001). Cultures were grown overnight in 3 mL LBB at 37°C. Bacterial 
cells were obtained by centrifuging 1.5 mL of the overnight culture at 4000 × g for 10 min. Cells 
were washed with 500 µL of sterile 1× PBS and after centrifugation, the cell pellets were 
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resuspended in 100 µL of ice-cold Solution I. To this, 200 µL of ice-cold Solution II was added 
and after mixing the tubes by inversion, the mixture was incubated on ice for 5 min. A 150 µL 
volume of Solution III was added and the samples were mixed by inversion and incubated on 
ice for another 5 min.  
 
Cell debris and proteins were pelleted by centrifugation at 16 100 × g for 5 min at room 
temperature. The supernatant was removed and extracted with an equal volume of PCI. Phase 
separation after the addition of PCI was achieved by centrifugation as stated above Plasmid 
DNA was precipitated by the addition of 2 volumes of 100 % ethanol and 0.1 volumes of sodium 
acetate (pH 4.6). The samples were mixed, incubated at room temperature for 2 min and then 
centrifuged as stated above. DNA pellets were rinsed with 1 mL of 70% ethanol, air dried for 5-
10 min and resuspended in 20-50 µL of sterile dH2O. All plasmid DNA isolated were stored at -
20°C. 
 
2.3.2.3 Plasmid Midiprep 
To obtain larger amounts of DNA from larger volumes of culture, plasmid midiprep was 
carried out according to the miniprep method described above with the following scaled-up 
volumes: 
   Cultures   10 mL LBB  
Sterile 1× PBS   1 mL 
Solution I   200 µL 
Solution II    400 µL 
Solution III    350 µL 
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Cell debris and proteins were pelleted by centrifugation at 16 100 × g for 10 min at room 
temperature. The supernatant (600 µL) was removed and extracted with an equal volume of 
PCI. Phase separation was achieved by centrifugation as stated above. Plasmid DNA was 
precipitated by the addition of an equal volume of isopropanol and 0.1 volumes of sodium 
acetate (pH4.6). The samples were mixed, incubated at room temperature for 2 min and then 
centrifuged as stated above. DNA pellets were rinsed with 1 mL of 70% ethanol, air dried for 5-
10 min and resuspended in 20-50 µL of sterile dH2O. All plasmid DNA isolated were stored at -
20°C. 
 
2.3.2.4 Plasmid Extraction (Kado and Liu Method) 
Isolation of large plasmids was carried out as described by Kado and Liu (Kado and Liu, 
1981) with some modifications. Cultures were grown overnight at 37°C in 10 mL LBB. A 5 mL 
volume of culture was centrifuged at 4000 × g for 10 min and the pellet was resuspended in 200 
µL of E buffer. Lysis of cells was achieved by the addition of 400 µL of lysis solution and 
incubation at 60°C for 1hr. Sample was then extracted with 900 µL of PCI and cell debris and 
proteins were pelleted by centrifugation at 16 100 × g for 6 min. The aqueous phase was 
recovered and PCI extraction was repeated until no protein precipitate occurred at the phase 
interface. A 500 µL volume of chloroform was added and the sample was centrifuged as stated 
above. The upper aqueous phase containing the plasmid DNA was collected and stored at -
20°C. 
 
2.3.2.5 Purification of DNA from Agarose Gel 
Purification of DNA from agarose gel was performed with the Geneclean kit by following 
the manual provided by the manufacturer. Briefly, the desired DNA band was excised from the 
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gel and weighed. Three gel volumes of sodium iodide was added to the gel slice and the 
mixture was incubated at 55°C until the agarose was melted. An appropriate amount of 
Glassmilk suspension was mixed with the sample and allowed to stand at room temperature for 
5-15 min, with frequent agitation. The Glassmilk was centrifuged at 16 100 × g for 30s and the 
supernatant was discarded. The Glassmilk was washed twice with New Wash solution provided 
in the kit and recovered by centrifugation at 16100 × g for 30s. Glassmilk pellet was then dried 
at 55°C for 10 min. DNA was eluted from Glassmilk by resuspending pellet with 10-50 µL of 
sterile dH2O and collecting the dH2O after centrifugation at 16 100 × g for 1 min. All purified 
DNA samples were stored frozen at -20°C. 
 
2.3.2.6 Estimation of DNA Concentration 
Concentration of isolated DNA was determined using a spectrophotometer to measure 
absorbance at 260 and 280 nm. The DNA concentration was calculated by using the ratio of 1 
O.D. to 50 µg/mL of dsDNA and taking the dilution factor into account. Alternatively, amount of 
DNA was measured by running the sample on an agarose gel and comparing band intensity 
with the intensity of DNA marker.  
 
2.3.3 PCR 
2.3.3.1 Design of Primers 
Primers were designed with the Clone Manager 7 software using the normal criteria for 
primer design. When RE sites were incorporated, an additional 4 bp were added to the 5’-end of 
the primer sequence to allow the binding of the RE. 
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2.3.3.2 General PCR Amplification 
PCR was carried out according to the protocol below, unless specified otherwise: 
  10× PCR buffer   1× 
  25 mM MgCl2    2.5 mM 
  dNTP mix    200 µM 
  Forward primer   0.25 µM 
  Reverse primer   0.25 µM 
  DNA template    100 ng 
  Taq polymerase   0.25U 
  Sterile dH2O    to a total volume of 25 µL 
 
The reaction mixture was subjected to the following cycling conditions, unless stated 
otherwise: 1 cycle of 95°C for 5 min followed by 35 cycles of 94°C for 45 s, annealing 
temperature for 1 min and 72°C for 1 min, with a final extension time of 72°C for 10 min. All 
PCR products were stored at either 4°C (short term) or -20°C (long term). 
      
2.3.3.3 General Expand Amplification 
PCR was carried out according to the protocol below, unless specified otherwise: 
  10× Expand Buffer 3   1× 
  dNTP mix    350 µM 
  Forward primer   0.4 µM 
  Reverse primer   0.4 µM 
  DNA template    200-400 ng 
  Taq polymerase   0.25U 
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  Sterile dH2O    to a total volume of 50 µL 
 
The reaction mixture was subjected to the following cycling conditions (Amavisit et al., 
2003):   
   92°C     3 min 
   92°C     10s 
   Annealing Temperature  30 s  
   68°C     Variable  
   92°C     10 s 
   Annealing Temperature  30 s  
   68°C     Variable (+ 10 s per cycle) 
   68°C    7 min 
All PCR products were stored at either 4°C (short term) or -20°C (long term). 
 
2.3.3.4 DNA Sequencing Reactions 
DNA sequencing was carried out according to the protocol below: 
  Sequencing mix   2 µL 
  5× Dilution buffer   3 µL 
  Forward primer (3 µM)  1 µL 
  Reverse primer (3 µM)  1 µL 
  Purified DNA template  100-1000 ng 
  Sterile dH2O    to a total volume of 20 µL 
 
The reaction mixture was subjected to the following cycling conditions: 1 cycle of 96°C for 
1 min followed by 25 cycles of 96°C for 10 s, 50°C for 5 s and 60°C for 4 min. 
10× 
20× 
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Dye-labeled DNA was precipitated by the addition of 0.1 volumes of sodium acetate (pH 
4.6) and 2.5 volumes of 100% ethanol. Tubes were vortexed, allowed to stand at room 
temperature for 10 min. and centrifuged at 16100× g for 20 min. After discarding the 
supernatant, pellets were rinsed twice with 250 µL of 70% ethanol and air dried before being 
sent for sequencing analysis at the Micromon facility at Monash University, Melbourne, 
Australia. 
 
2.3.4 Agarose Gel Electrophoresis 
2.3.4.1 Agarose Gel Preparation 
Agarose gels for electrophoresis of DNA samples were prepared by boiling required 
amount of agarose in 1× TAE (50 mL for minigels, 100 mL for midigels and 300 mL for 
maxigels) until fully dissolved. After cooling to 50°C, the mixture was poured into a casting tray 
and allowed to set.  
 
2.3.4.2 Sample Preparation 
Prior to running the gel, a 1/10 volume of 11× loading dye was added to the sample.   
 
2.3.4.3 Electrophoresis 
Samples were mixed with dye and loaded into wells of the gel. Electrophoresis was 
carried out using the power supply units at the required voltage and appropriate time periods. 
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2.3.4.4 Staining of Agarose Gels 
All DNA gels were stained after electrophoresis in a 1 mg/mL ethidium bromide solution 
for about 5-10 min and detained by washing in running tap water. 
 
2.3.4.5 Visualisation of DNA 
DNA gels were? visualized with the UV transilluminator and photographed using Gel-Doc 
System. 
 
2.3.5 Restriction Enzyme (RE) Digestion 
All RE digestions were carried out with the following reagents, unless specified otherwise: 
  10× RE buffer   1× 
  BSA    100 ng/µL 
  DNA    Variable 
  Sterile dH2O   Variable 
  RE (10-12U/µL)  5-10U 
 
The digest reaction was incubated for 2-16 h at 37°C and stored at -20°C. 
 
2.3.6 Pulsed-Field Gel Electrophoresis (PFGE) 
2.3.6.1 Conventional PFGE  
2.3.6.1.1 Preparation of bacterial plugs 
PFGE protocol used in this study was adapted from the method of Smith and Cantor 
(Smith and Cantor, 1987). One colony from LBA was inoculated into 5 mL LBB and incubated 
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with shaking at 37°C for about 3 h. Cells were harvested by centrifugation at 4000 × g for 10 
min and washed in 1 mL of TE (pH8.0). Cells were centrifuged again and resuspended in 400 
µL of PIV buffer on ice. The suspension was mixed with an equal amount of 2% low melting 
point agarose (dissolved in PIV) and pipetted into? perspex moulds. Plugs were allowed to set 
at 4°C for 20 min before being placed in 2 mL of ESP solution and incubated overnight at 50°C. 
After overnight lysis, plugs were incubated in PMSF-TE solution (made fresh before very use) 
for 2 h at 37°C. Plugs were then placed in 2-3 mL of TE and incubated for 1 h with gentle 
shaking at room temperature. This is followed by 3 additional washes in TE of 20 min each. All 
plugs were stored in TE buffer at 4°C for up to 6 months. 
 
2.3.6.1.2 Restriction digests of plugs and PFGE 
A 1 mm portion of DNA plug was cut and placed in 100 µL of RE solution, containing the 
appropriate RE (30U of XbaI or 20U of SpeI), 1× RE buffer, BSA (100 ng/µL) and sterile dH2O. 
DNA was digested 6 h at 37°C. Following RE digestion, the DNA plugs were inserted into the 
wells of 1.2% agarose midigel (dissolved in 0.5× TBE) and sealed with molten agarose.  The gel 
was placed in the electrophoretic chamber with 2.5 L of 0.5× TBE buffer and subjected to 
electrophoresis (Bio-rad CHEF DR II system), with PFGE λ ladder as a reference marker (see 
Appendix III). The electrophoretic conditions for XbaI digestion: initial switch time of 2.2 s, final 
switch time of 54.1 s and run time of 22 h (Gautom, 1997). The electrophoretic conditions for 
SpeI digestion: pulse ramped time of 4 to 40 s for duration of 24 h (Tsen et al., 2001). Both 
PFGE conditions were performed at 14°C and a constant voltage of 6.0 V/cm. PFGE gel was 
stained and visualized as outlined in Section 2.3.4.5. 
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2.3.6.2 Formaldehyde Treatment of Cells 
Inactivation of possible DNase activity in S. II Sofia isolates was performed as described 
by Gibson and colleagues (Gibson et al., 1994) with some minor modifications. After harvesting 
the cells, cell pellets were resuspended in 100 µL of formaldehyde and incubated on ice for 1 h. 
Cell suspension was then centrifuged and washed 3 times with PBS to remove excess 
formaldehyde. Formalin-treated cells were then processed according to the PFGE protocol 
stated above. 
 
2.3.6.3 Modifications to PFGE Running Buffer 
Two methods involving alterations to the running buffer to prevent DNA degradation in 
PFGE was tested and in both cases, PFGE plugs were prepared as outlined above. Addition of 
100 µM thiourea to 0.5× TBE buffer was carried out according to method of Leisegang and 
Tschäpe (Leisegang and Tschäpe, 2002). Replacement of 0.5× TBE with HEPES as a running 
buffer was performed as described by Koort and colleagues (Koort et al., 2002).    
 
2.3.7 DNA-DNA Hybridisation 
2.3.7.1 Probe Synthesis, Labelling and Estimation 
All DNA probes were synthesized from S. Typhimurium SL1344 by general or expand 
PCR (genes used as probes are outlined in the methods section of the relevant chapters). DNA 
was labeled using the random primed method according to the manufacturer’s protocol. Briefly, 
3 µg of DNA was diluted to 15 µL with sterile dH2O, heat-denatured at 100°C for 10 min and 
quickly chilled on ice. Hexanucleotide mix (2 µL), DIG labeling mix (2 µL) and Klenow enzyme 
(1 µL) was added and the reaction was incubated overnight at 37°C. Labeling reaction was 
terminated by the addition of 2 µL of EDTA. 
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Yield of DIG-labeled DNA was estimated with a spot test using DIG-labeled controls. The 
DIG-labeled control DNA was diluted to 1 ng/ µL. From this stock, five 10-fold serial dilutions 
were prepared, creating a set of standards ranging from 1 ng/ µL to 0.1 pg/ µL. Using the table 
from the manufacturer’s manual, the expected yield of labeled probes was obtained. The 
experimental probe was then diluted to approximately 1 ng/ µL and from this stock, a series of 
dilutions were made. 
 
Labeled controls and experimental probe dilutions were spotted parallel to one another on 
a piece of nylon membrane. The DNA was fixed to the membrane by cross-linking with UV light 
for 5 min. Membrane was then washed briefly in washing buffer before being incubated in 1% 
blocking solution, followed by anti-DIG antibody solution for 30 min each. The membrane was 
washed twice for 15 min each with washing buffer at room temperature (to remove any unbound 
antibody). The membrane was equilibrated in detection buffer for 2 min and then incubated in 
NBT/BCIP substrate in the dark to develop the colour. Substrate reaction was stopped by 
washing the membrane with sterile dH2O. Spot intensities of the control and experimental 
dilutions were compared to determine probe concentration. 
 
2.3.7.2 Southern Blot Procedure 
About 15-20 µg of DNA was digested with 10U of the appropriate REs and subjected to 
electrophoresis in a 1% midigel for 2 hrs at 70V. Following electrophoresis, the gel was 
depurinated in 0.25 M HCl for 10 min and then rinsed in water (to make fragments larger than 
10 kb easier to transfer into the membrane). The gel was incubated in denaturation solution 
twice for 15 min each, followed by two 15 min washes in neutralisation solution. Capillary 
transfer reaction was employed to blot DNA from the gel onto the membrane, using 20× SSC 
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buffer. This reaction was allowed to proceed for approximately 16-18 h to ensure efficient 
transfer of DNA. 
 
The DNA was cross-linked to the membrane as specified above. The blot was placed in 
pre-hybridisation buffer and incubated for 2 h at 65°C. The labeled probe was diluted in 
standard hybridisation buffer to a concentration of 20 ng of DIG-labeled probe per mL of buffer. 
The probe solution was denatured by heating at 95°C for 10 min before being added to the 
membrane and incubated overnight at 65°C. The membrane was washed twice with 2×SSC 
wash buffer for 5 min each at room temperature, followed by two 15 min washes in 0.5× SSC 
wash buffer at 68°C (0.1× SSC was used when more stringent wash conditions was required). 
After equilibration in maleic acid wash buffer, the membrane was incubated in 1% blocking 
solution for 1 h at room temperature. This was then replaced with anti-DIG antibody solution and 
incubation was continue for another 30 min. Unbound antibody was removed by washing the 
membrane twice in maleic acid wash buffer for 15 min each. The blot was equilibrated in 
detection buffer before finally, being incubated in the dark with substrate solution for colour 
development. 
 
2.3.8 Recombinant DNA Techniques 
2.3.8.1 Synthesis and Cloning of PCR Products with pCR®2.1 
The gene(s) of interest was amplified using Expand PCR system and DNA from S. 
Typhimurium 82/6915 (details of the experiment are outlined in Chapter 5). The PCR product 
was then analysed by electrophoresis and the concentration was estimated. The gene(s) was 
inserted into the plasmid pCR®2.1 according to the manufacturer’s manual. Briefly, the following 
ligation reaction was set up: fresh PCR product (~100-300 ng), 10× Ligation buffer (1×), 
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pCR®2.1 vector (50 ng), T4 DNA ligase (2 Weiss U) and sterile dH2O to a total volume of 10 µL. 
The ligation mix was incubated overnight at 16°C and transformed into competent E. coli cells, 
as outlined below. 
 
2.3.8.2 Restriction Enzyme Digestion 
The appropriate RE digest of vector and/or insert was prepared as stated in Section 2.3.5. 
The digest reaction was incubated at 37°C for at least 2 h before being subjected to gel 
electrophoresis and purified by extraction. 
 
2.3.8.3 Ligation of DNA 
DNA ligation was prepared according to the protocol outlined below: 
  Digested plasmid DNA  100 ng 
  Digested insert DNA   Variable 
  10× Ligation buffer   1× 
  T4 DNA ligase    3 Weiss U 
  Sterile dH2O     to a total volume of 10 µL 
Ligation was carried out overnight (16-18 h) at 16°C and stored at -20°C. The amount of 
insert DNA required for each ligation reaction was estimated by using the formula below:  
 
(ng of vector DNA) (size of insert  in kb) X 3 = ng of insert DNA 
 size of vector (kb)  1 
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2.3.8.4 Competent Cells (E. coli DH5α, S. Typhimurium 9121  
  and S. II Sofia Bt6) 
2.3.8.4.1 Electrocompetent cells 
A 2 mL volume of fresh overnight culture was inoculated into 200 mL of LBB. Cells were 
grown at 37°C with shaking until A600 of 0.4 to 0.6 is reached. Culture was then incubated on ice 
for 1 h and harvested by centrifugation at 5445 × g for 15 min at 4°C. The resulting cell pellet 
was washed twice in 100 mL of chilled sterile dH2O, once in 4 mL of ice cold sterile 10% 
glycerol before being resuspended in 800 µL of 10% glycerol. The cell suspension was divided 
into 100 µL aliquots and stored at -70°C for up to 8 months. 
 
2.3.8.4.2 Chemically competent cells  
Chemically competent cells were prepared according to the Hanahan method described in 
Sambrook and Russell (Sambrook and Russell, 2001). A 2 mL volume of fresh overnight culture 
was inoculated into 200 mL of LBB. Cells were grown at 37°C with shaking until A600 of 0.4 to 
0.6 is reached. Culture was then incubated on ice for 10 min and recovered by centrifugation at 
5445 × g for 15 min at 4°C. Cells were then washed in 20 mL of ice cold FSB solution (see 
Section 2.3.1.13) and allowed to stand in ice for 10 min. After centrifugation at 5445 × g for 15 
min, cell pellet was resuspended in 2 mL of FSB, dispensed into 200 µL aliquots and stored at -
70°C. 
 
2.3.3.1 Transformation of Plasmid into Cells 
2.3.3.1.1 Electroporation 
Frozen cells were gently thawed on ice, mixed with 1-2 µL of ligation mix and allowed to 
sit on ice for 2 min. The suspension was transferred to a pre-chilled electroporation cuvette with 
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a 0.2 cm gap. A charge of 2.5 V, 25 µF and 200 Ω was pulsed through the cuvette. 
Electroporation with time constants greater than or equal to 4.0 were immediately resuspended 
in 1 mL of SOC broth and incubated at 37°C for 1 h to maximise recovery of transformants. 
Cells were then plated out onto X-gal agar (see Section 2.2.1.12) and incubated at 37°C 
wrapped in foil. 
 
2.3.3.1.2 Chemical Transformation 
Frozen aliquots of cells were thawed on ice, mixed with up to 10 µL of ligation mix and 
incubated on ice for 30 min. Cells were transformed by “heat-shocking” the mix at 42°C for 1.5 
min.  Tubes were incubated on ice for 2 min, and then 800µL of SOC broth was added to each 
tube. Transformants were allowed to recover at 37°C for 1 h before 100 µL of each reaction is 
plated onto X-gal agar (see Section 2.2.1.12).   
  
2.4 Tissue Culture Methods 
All tissue culture related work was carried out in a biological safety cabinet class II to 
minimise risk of contamination. Glassware used for storage of media and solutions was washed 
with Pyroneg detergent, rinsed twice in dH2O and then soaked overnight in dH2O. All glassware 
was autoclaved before being used to make and store tissue culture media. Solutions and dH2O 
(for tissue culture media) were made in sterilised bottles before being re-autoclaved.  
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2.4.1 Tissue Culture Cell Lines Used 
A human intestine epithelial cell line (INT407), chicken embryonic fibroblasts (CEF-DF1) 
and a mouse macrophage cell line (J774) were utilised to carry out the assays outlined in 
Sections 2.4.3.4 and 2.4.3.5. 
 
2.4.2 Media and Solutions 
2.4.2.1 1× DMEM (For INT407 and J774) 
The following reagents were filter-sterilised into 372 mL of sterilised dH2O: 100 mL 5× 
DMEM, 13.5 mL of 7.5% of sodium bicarbonate, 10 mL of HEPES Buffer and 4.5 mL of L-
glutamine. Media was stored at 4°C and aliquots were supplemented with heat-inactivated NCS 
(10% v/v) before use (DMEM/NCS). 
 
2.4.2.2 1× DMEM (For CEF-DF1) 
The following reagents were filter-sterilised into 320 mL of sterilised dH2O: 100 mL 5× 
DMEM, 10 mL of 7.5% of sodium bicarbonate, 10 mL of HEPES Buffer, 10 mL of L-glutamine 
and 50 mL of 45 g/L glucose. Media was stored at 4°C and aliquots were supplemented with 
heat-inactivated NCS (10% v/v) before use (DMEM/NCS). 
 
2.4.2.3 1× PBS 
Standard PBS was used when working with INT407 and J774 cells while Dulbecco’s 1× 
PBS (without Mg or Ca) was utilised for all CEF-DF1 related work. 
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2.4.2.4 Trypsin-EDTA Solution 
Trypsin-EDTA stock was mixed with 1× PBS at a ration of 1:1 and stored at -20°C. This 
solution was used to dissociate INT407 cells from the flask. 
 
2.4.2.5 Trypsin/Versene Solution 
Versene (0.1% v/v), trypsin (2.5% v/v) and Dulbecco’s 1× PBS were mixed and stored at -
20°C. This solution was used to dissociate CEF-DF1 cells from the flask. 
 
2.4.2.6 Gentamicin Solution 
The required concentration of gentamicin sulphate in DMEM/NCS. 
 
2.4.2.7 0.25% Triton X-100 
The detergent Triton X-100 was diluted in sterile dH2O to a concentration of 0.25% v/v. 
Solution was incubated at 37°C for 30 min, filter-sterilised and stored at room temperature. 
 
2.4.3 Tissue Culture Techniques 
2.4.3.1 Tissue Culture Growth Conditions 
Frozen tissue culture cells were resuscitated from liquid nitrogen, thawed and grown in 
their respective media in a 37°C CO2 incubator. Cells were grown until an 80-95% confluency 
was reached before being split and transferred to a new flask or used in an assay. Tissue 
culture cells were only passaged between 5-10 times before a new stock of cells were 
resuscitated.  
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2.4.3.2 Splitting, Recovery and Banking of Cells  
Old media was removed from the flask and the cells washed twice with 1× PBS. To 
dissociate INT407 and CEF-DF1 cells, an appropriate amount of trypsin-EDTA solution was 
added and the flask was incubated at 37°C for 10-15 min. J774 cells were dissociated by gently 
scrapping the flask interior with a cell scraper.  The dissociated cells were washed twice in the 
appropriate media and collected each time by centrifugation at 2000 × g for 5 min. Cells were 
resuspended in 1 mL of DMEM/NCS and an appropriate amount was used to seed a new tissue 
culture flask.  
 
Cells were banked down for storage as outlined above but resuspended in media 
supplemented with 10% DMSO, which acts as a cryoprotectant. The cell suspensions were 
placed into cryovials and stored at -70°C for 2-3 days before being transferred to liquid nitrogen 
for long term storage. 
 
2.4.3.3 Seeding of Tissue Culutre Trays  
Tissue culture cells were prepared according to the protocol for splitting the cells, as 
outlined above. A 10-fold and 100-fold dilution of cells was made with PBS (to a total volume of 
100 µL). A volume of 92 µL of each dilution was mixed with 8 µL of 0.25% trypan blue and 
incubated at room temperature for 5 min to allow dead cells to be stained. Each dilution was 
then transferred (10 µL) to a grid on a cell counting chamber and covered with a cover slip. 
Viable cells were counted (blue cells were excluded) and the number of cells required to seed 
each well was calculated as outlined in Appendix XI. 
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The required amount of cells was mixed with the appropriate DMEM/NCS and 500 µL of 
this suspension was dispensed into each well in a 24-well tissue culture tray. This was then 
incubated at 37°C in 5% CO2 for 16-18 h before being used in an assay (see Section 2.4.3.4 
and 2.4.3.5). 
 
 
2.4.3.4 Adhesion/Invasion Assay 
Adhesion and invasion of Salmonella strains in INT407 and CEF-DF1 cells was carried 
out based on the method previously described by Elsinghorst (Elsinghorst, 1994) and modified 
by Jason Chang, RMIT University (Chang, 2002). Briefly, cells were cultured, harvested and 
counted as stated in Section 2.4.3.2. Both cell lines were seeded at a concentration of 3 × 105 
cells per well and incubated overnight. Before commencing the assay, media was aspirated 
from each well and the cells washed 3 times with PBS. To each well, 100 µL of ~ 109 bacterial 
cells (MOI~ 50-100 bacteria per tissue culture cell) along with 400 µL of DMEM/NCS was added 
and the culture trays were incubated at 37°C in 5% CO2. Each assay was done in triplicates and 
repeated three times on different days. 
 
For the adherence assay, tissue culture trays were incubated for 1 h as described above. 
Wells were then washed 3 times with PBS. tissue culture cells were lysed by the addition of 100 
µL of 0.25% Triton X-100 into each well and incubation at 37°C for 15 min. After pipetting 800 
µL of PBS into each well, 100 µL was subjected to a serial 10-fold dilution before being plated 
out on LBA plates (supplemented with Amp where appropriate). Plates were incubated 
overnight at 37°C and bacteria enumerated. 
 
For the invasion assay, tissue culture trays were incubated for 2 h instead of 1 h. Contents 
of each well was washed 3 times with PBS before 500 µL of 400 µg/mL of gentamicin solution 
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(see Section 2.4.2.6) was added. Culture trays were incubated at 37°C in 5% CO2 for 1 h to kill 
any extracellular bacteria. Wells were again washed thrice with PBS and intracellular bacteria 
released with Triton X-100 as mentioned above. Dilutions were plated and counted as outlined 
above. 
 
2.4.3.5 Intracellular Survival Assay 
The ability of Salmonella isolates to survive intracellularly within macrophages was 
measured based on the method outlined by Buchmeier and Heffron (Buchmeier and Heffron, 
1989) with some modifications. Briefly, 4 × 105 macrophages were seeded into each well in a 
24-well tissue culture tray and incubated overnight. Bacterial cells were opsonised in 10% 
mouse serum at 37°C for 30 min before being added to the wells at a ratio of 10 to 20 bacteria 
per macrophage. Culture trays were centrifuged at 250 × g for 5 min to allow the enhancement 
and synchronisation of infection. Phagocytosis was allowed to proceed for 20 min and wells 
were washed thrice with PBS before 100 µg/mL of gentamicin solution (see Section 2.4.2.6) 
was added. To measure the adherence of bacteria to the macrophages, tissue culture cells 
were lysed in 0.25% Triton X-100 after the washing step (without the addition of any antibiotics) 
and plated out.  
 
After the addition of gentamicin, incubation was continued for another hour. Wells were 
once again rinsed 3 times with PBS and 10 µg/mL of gentamicin solution was added (time point 
0 h). Wells sampled at 0 h were lysed without any further addition of antibiotics. The other wells 
were sampled at 1, 4 and 24 h after infection by removing the media, washing the wells with 
PBS and then lysing the macrophages.  Dilutions were plated out and counted as outlined in 
Section 2.4.3.4. All samples were carried out in triplicates and repeated 3 times. 
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2.5 RNA Methods 
All RNA related work was performed in a biological safety cabinet class II to minimise 
contamination from environmental RNAses. A 20 min. UV sterilisation was applied in the 
biohazard cabinet prior to any RNA work. Glassware to be used was treated with 
diethylpyrocarbonate (DEPC) before sterilisation. All solutions were prepared using RNAse-free 
water and stored in DEPC-treated glassware and sterile RNAse-free plastic ware. Only sterile 
barrier pipette tips and RNAse-free plasticware were used for the RNA work. 
 
 
 
2.5.1 Reagents and Buffers 
2.5.1.1 RNAse-free water 
Ultrapure™ water was used for work involving volumes less than 100 mL. For larger 
volumes (e.g. see Section 2.5.1.3), DEPC-treated water was used. This was prepared by 
incubating dH2O in 0.1% DEPC at 37°C overnight and autoclaving the solution under standard 
conditions (which removes residual DEPC). 
 
2.5.1.2 RNAse-free 75 % Ethanol 
100% ethanol (AR grade) from a new unopened bottle was opened, decanted into a 
DEPC treated bottle and diluted to 75% with DEPC treated water in a biohazard cabinet class II. 
Solution was stored at -20°C. 
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2.5.1.3 10× Formaldehyde Gel Running Buffer  
MOPS (0.2 M), sodium acetate (0.05 M) and EDTA (0.01 M) was dissolved in RNase-free 
water and adjusted to pH 7.0 with NaOH. Buffer stock was diluted to 1× with DEPC-treated 
water and mixed with formaldehyde (0.74% v/v) before use.  
 
 
2.5.1.4 5× RNA Loading Buffer 
The following reagents were mixed together: 16 µL saturated Orange G, 80 µL of 500 mM 
EDTA (pH 8.0), 720 µL of 37% formaldehyde, 2 mL of 100% glycerol, 3.038 mL of formamide 
and 4 mL of 10 x Formaldehyde Gel Running Buffer. Dye was stored in aliquots at 4°C. 
 
 
2.5.2 RNA Techniques 
2.5.2.1 RNA Isolation 
Salmonella spp. RNA was extracted using the RNAgents® Total RNA Isolation System kit 
as per the manufacturer’s instructions with some modifications. After incubating bacteria at the 
required conditions, the cell suspensions were immediately mixed with RNAprotect reagent at a 
ratio of 1:1. This was incubated for 10 min at room temperature to stabilise mRNA expression. 
Cells were then pelleted by centrifugation at 16 000 × g for 5 min. Stabilised cell pellets may 
now be stored frozen at -70°C for a later extraction. 
 
 Cell pellets were resuspended in 300 µL of chilled RNAgents® denaturing solution and 
mixed well to break up any cell clumps. After the addition of 30 µL of sodium acetate, the 
mixture was extracted with 300 µL of room temperature PCI by shaking the tube vigorously for 
10 s. After incubating on ice for 15 min, phase separation was achieved by centrifugation at 16 
000 × g for 20 min. The upper aqueous phase was retained and RNA was precipitated by 
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adding an equal volume of isopropanol and incubating the sample at -20°c for 30 min. 
Precipitated RNA was recovered by centrifugation at 10 000 × g for 10 min. RNA pellet was 
then washed in 1 mL of 75% ethanol, air dried and resuspended in 10-20 µL of RNase-free 
water. All isolated RNA samples were stored at -70°C. 
 
2.5.2.2 Estimation of RNA concentration 
A 250-fold dilution of RNA samples were made with RNase-free water. Concentration of 
isolated RNA was determined using spectrophotometer to measure absorbance at 260 and 280 
nm. The RNA concentration was calculated by using the ratio of 1 O.D. to 40 µg/mL of ssRNA 
and taking the dilution factor into account. 
 
2.5.2.3 Formaldehyde Gel Electrophoresis 
All RNA samples were subjected to electrophoresis to check the integrity and purity of the 
isolation and to ensure that the RNA was in linear form. All gel apparatus (tank, tray and comb) 
were first cleaned with 0.5% SDS, rinsed with water, then dried with 70% ethanol and treated 
with 3% H2O2 for 10 min at room temperature to remove contaminating RNases. After this 
treatment, the apparatus was rinsed thoroughly with DEPC-treated water and placed in a fume 
hood.  
 
Prior to running the gel, a 1/5 volume of 5× RNA loading dye was added to the samples. 
Samples were heated at 65°C for 5 min to further denature the RNA. The samples were then 
loaded with barrier tips into a pre-equilibrated 1.2% agarose gel prepared with 1× formaldehyde 
running buffer containing 100 µg/mL of ethidium bromide. Electrophoresis was carried out at 90 
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V for about 2 h. Gel was then visualised with the transilluminator and photographed using the 
Gel-Doc system. 
 
2.5.2.4 DNAse Treatment of RNA Samples  
To remove any contaminating genomic DNA, RNA samples were treated with RQ1 
RNase-Free DNase kit according to the manufacturer’s manual outlined below: 
  RNA stocks (420 ng/µL)   43 µL  
  RQ1 DNase buffer (10×)   5 µL 
  RQ1 DNase     2 µL 
  Total volume     50 µL 
 
The reaction was prepared on ice and incubated at 37°c for 30 min to allow DNA 
digestion. After the addition of 1 µL of RQ1 stop solution to each reaction (on ice), the DNase 
was inactivated at 65°C for 10 min. All treated RNA samples (final concentration 400 ng/ µL) 
were stored at -70°C. 
 
2.5.3 RT-PCR 
2.5.3.1 Reverse Transcription (RT) 
The mRNA present in samples was converted to cDNA through RT using the Improm-II™ 
Reverse Transcription kit as per manufacturer’s instructions. Briefly, 1 µg of RNA was mixed 
with 0.6-1.0 µM of primer and RNase-free water to a total volume of 11 µL on an ice water bath. 
The mixture was denatured at 70°C for 5 min and placed on ice. The RT reaction was prepared 
by mixing the reagents below in the following order: 
  5× RT buffer    1× 
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  25 mM MgCl2    2.5 mM 
   dNTP mix    200 µM 
  RNasin RNase inhibitor  20U 
  Reverse transcriptase (RTase) 1U 
  Total volume     9 µL 
 
The production of cDNA was achieved by mixing together the denaturation and RT 
reactions and incubating them at 25°C for 5 min, 42°C for 1 h, followed by a RTase inactivation 
step at 70°C for 15 min. All cDNA samples were stored at -20°C and used as a starting template 
for the PCR step below, where cDNA is converted into dsDNA. 
     
2.5.3.2 Gene-Specific RT-PCR 
The addition of formamide to reduce non-specific bands in a PCR was performed as 
described by Sarkar and colleagues (Sarkar et al., 1990). It was discovered that the addition of 
Q solution to the reaction mix greatly improved the specificity and quality of the PCR compared 
to the addition of formamide (data not shown). 
 
Therefore, PCR amplification was carried out according to the protocol outlined in Section 
2.3.3.2 with the modifications below: 
  Template cDNA   5 µL 
  5× Q solution (QIAGEN)  5 µL 
The PCR reactions were subjected to the following cycling conditions: 1 cycle of 94°C for 
3 min followed by 40 cycles of 94°C for 30 s, annealing temperature for 1 min and 72°C for 1 
min, with a final extension time of 72°C for 10 min. All PCR products were stored at -20°C.
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CHAPTER 3: MOLECULAR TYPING OF SALMONELLA 
II SOFIA 
 
3.1 Introduction 
Molecular fingerprinting methods are commonly employed to characterise and study the 
genetic relatedness of various bacterial isolates, including Salmonella spp. PFGE is one such 
method that uses the separation of infrequently digested genomic DNA to subtype bacterial 
isolates (Olive and Bean, 1999; Olsen, 2000). Considered by some to be the “gold standard” of 
molecular typing methods, PFGE is accurate, reliable, reproducible, highly discriminatory and 
relatively easy to perform (Olive and Bean, 1999; Olsen, 2000). PFGE typing is one of the most 
commonly used methods to characterise and group Salmonella isolates from various sources 
(Bakeri et al., 2003, Bessa et al., 2007; Cardinale et al., 2005; Ethelberg et al., 2004; Langvad 
et al., 2006; Matsumoto et al., 2006; Old et al., 1999; Olsen et al., 1994; Pang et al., 2005; Seo 
et al., 2006; Tsen et al., 2000; Tsen and Lin, 2001; Uesugi et al., 2007; Usera et al., 1998; Ward 
et al., 2005).  
 
On the other hand, amplification fingerprinting utilises PCR to identify and subtype 
bacterial isolates (Olive and Bean, 1999). One such method makes use of short repetitive DNA 
sequences to generate banding patterns for analysis. An example of this fingerprinting method 
is rep-PCR, which uses REP elements present in bacterial genomes to characterise and 
subtype bacterial isolates (Gilson et al., 1984; 1990; Stern et al., 1984; Versalovic et al., 1991; 
1994). Rep-PCR is frequently used to subtype and analyse Salmonella isolates as the method 
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is easy to perform, reproducible, sensitive and discriminatory (Beyer et al., 1998; Foley et al., 
2006; Johnson et al., 2001; Maré et al., 2001; Millemann et al., 2000; Mills-Robertson et al., 
2003; Rasschaert et al., 2005; Saxena et al., 2002; Weigel et al., 2004; Woo and Lee, 2006).  
 
Although Salmonella serovar II Sofia has consistently been isolated from Australian 
poultry since the 1970s, surprisingly few studies of these isolates using genotyping methods 
have been carried out. So far, only two papers regarding the molecular fingerprinting of S. II 
Sofia isolates have been published (Harrington et al., 1991; Ross et al., 2003). Harrington and 
her colleagues (Harrington et al., 1991) compared S. II Sofia isolates from Australian and Israeli 
chickens and humans through SDS-PAGE of the OMPs, plasmid profile and RFLP analysis. 
Although plasmid profiling identified a 6.4 kB plasmid of unknown function, this method was not 
sufficiently discriminatory to characterise the isolates (Harrington et al., 1991). No reproducible 
differences could be obtained from the analysis of the OMPs from strains from either location 
(Harrington et al., 1991). However, RFLP analysis was able to successfully group S. II Sofia and 
divided the isolates into 7 groups and showed that significant differences exist between the 
Australian and Israeli S. II Sofia strains (Harrington et al., 1991). However, only a limited 
number of strains were used in the RFLP analysis and this result should be treated with caution 
– perhaps more samples should have been analysed.  
 
Fluorescent AFLP has also been shown to be a useful method in the molecular 
fingerprinting of S. II Sofia isolates (Ross et al., 2003). The typing of 68 Australian S. II Sofia 
strains has revealed that most isolates were clustered into 4 groups (70-90% similarity) and that 
S. II Sofia is genetically variable with certain clonal groupings persisting over time (Ross et al., 
2003). However, no relationship could be established between a particular group and their 
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geographical location, source or host (Ross et al., 2003). No major differences were reported 
between the Australian and Israeli S. II Sofia isolates tested - no specific clonal group 
corresponding to Israeli isolates (Ross et al., 2003). In addition, Ross and his colleagues (Ross 
et al., 2003) reported that S. II Sofia cannot be typed with PFGE due to DNase activity, despite 
the application of anti-DNase treatments such as formaldehyde (Gibson et al., 1994) and 
thiourea (Leisegang and Tschäpe, 2002).  
  
A total of 84 S. II Sofia isolates from various locations around Australia were subtyped 
using PFGE (XbaI and SpeI) and Rep-PCR (with REP DNA sequence). All resulting 
electrophoretic banding patterns were analysed both through visual analysis and with computer 
software - GelCompar® II (Applied Maths, Belgium).  
The aims of the experimental methods carried out in this chapter were to: 
(i) minimise DNA degradation in isolates by devising a DNase inactivation step,  
(ii) investigate the genetic and clonal relationship of Australian S. II Sofia isolates 
 using Rep-PCR, the modified PFGE protocol and GelCompar® II, 
(iii) compare the discriminatory ability of each typing system using Simpson’s Index 
 of Diversity (D). 
 
3.2 Methods and Results 
3.2.1 Inactivation of DNase Activity in S. II Sofia 
S. II Sofia DNA was prepared as described previously in Chapter 2 (see Section 2.3.6.1). 
Attempts to analyse S. II Sofia samples through PFGE were unsuccessful, resulting in smears 
on the gel (data not shown). Neither the formaldehyde treatment of cells (see Section 2.3.6.2) 
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nor modifications to the PFGE running buffer (see Section 2.3.6.3) could protect the DNA of S. II 
Sofia isolates from degradation. Modification of protocol conditions such as variation in 
incubation time (during cell lysis and RE digestion), varying the concentration of Proteinase K 
and sarkosyl in ESP solution (see Section 2.3.1.12) and preincubation with lysozyme prior to 
cell lysis did not improve the generation of banding patterns of the DNase-sensitive isolates 
(data not shown). 
 
Further modifications were carried out on the ingredients of the ESP lysis solution. It was 
discovered that the addition of the detergent SDS had the potential to stop DNA degradation of 
isolates. A series of ESP solutions (ESP1 to 36) were created by varying the concentrations of 
EDTA, pH 9 (0.5, 0.9 and 1.2 M), sarkosyl (1%, 3% and 5% w/v), Proteinase K (100, 200 and 
500 µg/mL) and SDS (1%, 3% and 5% w/v). Each ESP solution was used to lyse S. II Sofia 
cells and PFGE was conducted to assess the efficiency of each combination in protecting DNA 
from degradation. The lysis solutions ESP31, 34 and 35 were found to stop DNA degradation, 
resulting in the production of visible banding patterns (data not shown). ESP34 (0.5 M EDTA, 
5% sarkosyl, 200 µg/mL Proteinase K and 5% SDS) was chosen as the PFGE lysis solution for 
processing S. II Sofia isolates.    
 
DNA degradation observed after PFGE is due to the presence of DNase in the S. II Sofia 
isolates. To observe the effect of DNase activity on PFGE of digested DNA fragments, the 
following Salmonella strains were used: S. Typhimurium 82/6915, S. II Sofia strains Bt8 and 
786CL. Bacterial plugs were made with each of these isolates and by combining 82/6915 with 
Bt8 and 82/6915 with 786CL (bacterial suspensions were mixed at a ratio of 1:1 before being 
set in low-melt agarose). PFGE patterns of each sample were compared after treatment with  
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Figure 3.1 PFGE patterns showing a comparison between normal (N) and modified (S) ESP 
lysis treatment. Lane M, PFGE λ ladder; Lane 1, S. Typhimurium 82/6915 (N); Lane 2a, S. II 
Sofia Bt8 (N); Lane 2b, S. II Sofia 786CL (N); Lane 3a, 82/6915 and Bt8 (N); Lane 3b, 82/6915 
and 768CL (N); Lane 4, 82/6915 (S); Lane 5a, Bt8 (S); Lane 5b, 786CL (S); Lane 6a, 82/6915 
and Bt8 (S); Lane 6b, 82/6915 and 768CL (S). 
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Figure 3.2 PFGE patterns showing a comparison between Treatment 1, 2 and 3. Lane M, 
PFGE λ ladder; Lane 1a-1c, Treatment 1 of S. Typhimurium 9, S. Enteritidis 446302 and S. II 
Sofia Bt1 respectively; Lane 2a-2c, Treatment 2 of Bt1, 446302 and 9 respectively; Lane 3a-3c, 
Treatment 3 of 9, 446302 and Bt1 respectively.  
1a M 1c 2b2a 2c 3a 3b 3c 1b 
48.5 
97.0 
(kB) 
145.5 
194.0 
291.0 
824.5 
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normal and modified lysis solution (Figure 3.1). S. Typhimurium 82/6915 was not affected by 
either of the lysis solutions, producing identical PFGE patterns after both treatments. Normal 
treatment of the S. II Sofia and mixed plugs resulted in total degradation and partial smearing of  
DNA bands, respectively (Figure 3.1).  In contrast, PFGE bands produced after incubation with 
ESP34 lysis solution were visible and undegraded.     
 
The PFGE protocol used to type S. II Sofia can be hazardous and labour-intensive (see 
Section 2.3.6.1), limiting the number of samples that can be processed simultaneously. 
Therefore, a series of treatments involving modifications to the lysis incubation time and 
washing steps were devised: 
(i) Treatment 1 – as described by Nayak and his colleagues (Nayak et al., 2004) with  
     modifications (1% SDS in plugs, overnight incubation in ESP34, wash once with  
     preheated [50°C] dH2O and 4× with preheated TE buffer, 20 min for each wash), 
(ii) Treatment 2 – as described by Nayak and his colleagues (Nayak et al., 2004) (1%  
      SDS in plugs, 2 h incubation in ESP34, washes as outlined in Treatment 1),  
(iii) Treatment 3 – PFGE protocol with ESP34 lysis solution (see Section 2.3.6.1).  
All 3 treatment systems were applied individually to S. Typhimurium 9, S. Enteritidis 446302 and 
S. II Sofia Bt1. Each experiment was repeated 3 times on different days. The addition of 1% 
SDS into bacterial plugs was also assessed for improvement to banding patterns.  
 
All resulting PFGE patterns from the different treatments were compared (Figure 3.2).  No 
differences in quality of the PFGE bands were observed with the serovars Typhimurium and 
Enteritidis between each treatment. Generation of clear S. II Sofia bands were uneven with 
Treatment 1 and 2, producing visible bands once (Treatment 1) and twice (Treatment 2) out of 
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the 3 repeats. PFGE patterns that were produced were observed to have partial smearing (data 
not shown). Only Treatment 3 was able to protect Bt1 DNA from degradation, producing visible 
patterns for each repeat (Figure 3.2). Addition of SDS to bacterial plugs did not improve the 
quality of PFGE patterns of any of the Salmonella isolates.         
 
 
3.2.2 PFGE Profile 
Bacterial plugs of all 84 S. II Sofia isolates were prepared using the modified PFGE 
protocol, containing ESP34 lysis solution. PFGE was carried out as described previously (see 
Section 2.3.6.1), with the restriction enzymes XbaI and SpeI. Preparation of plugs and PFGE 
was repeated 3 times with the same conditions on different occasions. Commercial PFGE λ 
ladder was loaded onto all gels. PFGE profiles of all isolates were compared visually and DNA 
patterns differing by one or more bands were assigned a profile type: X(n) for XbaI and S(n) for 
SpeI, with n = profile/group number. Several isolates representing each profile were selected 
and subjected to PFGE on 1% SeaKem® Gold agarose for 18 h (XbaI) and 22 h (SpeI). This 
high-strength agarose is routinely utilised in methods that require the separation of large DNA 
fragments (PFGE). Gels were stained, visualised and the final images used during computer 
analysis of isolates (see Section 3.2.5).  
 
Each PFGE profile obtained was compared to a specific PFGE profile, which is arbitrarily 
assigned as the reference profile. In this case, all patterns obtained were compared to X1 and 
S1 for XbaI- and SpeI-digested DNA, respectively. In addition, the Dice coefficient, F, for each 
PFGE profile was calculated as described by Tsen and his coworkers (Tsen et al., 2000). This 
value expresses the proportion of shared DNA bands in 2 patterns and is calculated using the 
formula: F = 2nxy/(nx +ny), where nx and ny is the total number of bands in pattern X and Y, 
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respectively and nxy is the number of bands shared by both patterns. When F = 1.0, both PFGE 
patterns are identical and when F = 0, the two patterns are completely dissimilar (Tsen et al., 
2000).  
 
3.2.2.1 XbaI  
The PFGE analysis of XbaI-digested DNA from 84 S. II Sofia isolates gave 13 to 22 
visible, stable and reproducible DNA fragments in the size range of 40 to 825 kB (Figure 3.3). 
Based on the PFGE patterns, all isolates can be divided into 8 distinct groups – X1 to X8. A 
representative of these 8 PFGE profiles is shown in Figure 3.3 and is summarised in Table 3.2. 
The most common PFGE profile obtained was X1 (Figure 3.3), with 73.8% of S. II Sofia isolates 
showing this profile (62 strains). This was then followed by X6 (9 isolates), X3 (4 isolates), X4 
and X5 (3 isolates each), and X2, X7 and X8 (1 isolate each). XbaI PFGE profiles are related, 
differing from one another by 1-7 bands with F values ranging from 0.44 to 0.96 (Table 3.1). 
 
Distributions of each XbaI profile (X1 to X8) across the various locations around Australia 
were compared. Pattern X1 was observed to be the most common PFGE profile amongst the 
isolates from each location (Victoria, New South Wales, South Australia, Queensland and 
Tasmania). S. II Sofia isolates from Victoria were found to exhibit the most variation, with 5 
different patterns (X1, X3, X4, X5 and X6) obtained from the typing of 34 isolates. Four different 
patterns were present among the 13 and 15 isolates from New South Wales (X1, X2, X3 and 
X6) and Queensland (X1, X3, X6 and X7), respectively. While only profile X1 and X2 were found 
among the 11 South Australian isolates, all 10 Tasmanian S. II Sofia strains were shown to 
have only one XbaI pattern, X1. It was also observed that S. II Sofia 131 was the only isolate to 
show profile X8 (origin of this isolate is unknown).  
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Figure 3.3 Representations of XbaI-digested PFGE pattern profiles X1 to X8 from S. II Sofia 
isolates (PFGE pattern of each individual isolate is listed and summarised in Table 3.2). 
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3.2.2.2 SpeI 
Digestion of all 84 S. II Sofia isolates with SpeI yielded 16 to 24 stable and reproducible 
DNA fragments of 40 to 1000 kB in size (Figure 3.4). Six distinct PFGE profiles were seen 
among the isolates (S1 to S6) and a representative of these profiles is shown in Figure 3.4 and 
summarised in Table 3.2. S1 was the most common pattern observed, representing 88.1% (74 
isolates) of the 84 isolates typed (Figure 3.4). This was then followed by pattern S3 (3 isolates), 
S4 (2 isolates) and S5 and S6 (1 isolate each). For SpeI, PFGE patterns obtained were closely 
related, differing from one another by only 1-3 bands and exhibiting F values in the range of 
0.72 to 0.98 (Table 3.1).  
 
The PFGE patterns between the Victorian, South Australian, New South Wales, 
Queensland and Tasmanian S. II Sofia isolates were compared. SpeI pattern S1 was observed 
to be the major profile at each location. Three different profiles were found among the 34 
Victoria (S1, S4 and S5), 15 Queensland (S1, S3 and S4) and 13 New South Wales (S1, S2 
and S3) isolates. South Australian isolates were found to have 2 different profiles, either S1 or 
S2 (11 isolates). Only one SpeI profile was seen among all 10 isolates from Tasmania (pattern 
S1). The isolate S. II Sofia 131 (the origin of isolate is unknown), was observed to be the only 
strain to exhibit pattern S6. 
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Figure 3.4 Representations of SpeI-digested PFGE pattern profiles S1 to S6 from S. II Sofia 
isolates (PFGE pattern of each individual isolate is listed and summarised in Table 3.2). 
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Table 3.1 Coefficient, F values of each typing profile for the 84 S. II Sofia isolates 
PFGE pattern 
XbaI SpeI 
Rep-PCR pattern 
X1 (1.0) S1 (1.0) R1 (1.0) 
X2 (0.78) S2 (0.72) R2 (0.97) 
X3 (0.89) S3 (0.98) R3 (0.79) 
X4 (0.89) S4 (0.95) R4 (0.65) 
X5 (0.92) S5 (0.90) R5 (0.79) 
X6 (0.96) S6 (0.72)  
X7 (0.71)   
X8 (0.44)   
F values are shown in parentheses.  
Definition and calculation of F values is as described in Section 3.2.2. 
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3.2.3 Rep-PCR Profile 
Genomic DNA was extracted from all 84 S. II Sofia isolates using the CTAB method as 
described previously in Chapter 2 (see Section 2.3.2.1). The extracted DNA was subjected to 
repetitive PCR using BoxA1R (Koeuth et al., 1995), ERIC2, REP1R-I and REP2-I (Versalovic et 
al., 1991) primers. PCR ribotyping with the combination of P1 and P2 primers (see Appendix V) 
was also performed according to the method by Lagatolla and her coworkers (Lagatolla et al., 
1996). PCR amplification with each primer set was carried out on a selected number of S. II 
Sofia isolates (for primer sequence and PCR conditions, see Appendix VI). All PCR 
amplification products were subjected to electrophoresis (1.5% agarose gels) and gels were 
stained and visualised. The ability of each PCR typing method to differentiate the S. II Sofia 
isolates was evaluated.  
 
Molecular patterns generated from PCR carried out using either the ERIC2 and BoxA1R 
primers were not discriminatory enough to differentiate the isolates – amplification resulted in 
either a single DNA pattern or patterns that differ by only one band (data not shown). The same 
observation was also seen with the PCR ribotyping method using the primers P1 and P2. 
Amplification with REP1R-I yielded PCR patterns that were more varied and complex (but still 
distinct enough for analysis) compared to the patterns obtained with REP2-I (data not shown). 
The use of both REP primers together for typing was also evaluated and it was found that the 
PCR patterns generated were too numerous and complex, making analysis difficult (data not 
shown). Therefore, rep-PCR typing of S. II Sofia isolates was carried out using REP1R-I. All 
PCR products were loaded on 1.5% maxigels (see Section 2.3.4) for electrophoresis (50V for 
16-18 h) and gels were stained and visualised. 
.           
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Figure 3.5 Representations of REP1 pattern profiles R1 to R5 from S. II Sofia isolates 
(REP1 pattern of each individual isolate is listed and summarised in Table 3.2). 
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Visual comparison of all REP1 profiles was conducted and profile types were assigned 
based on differing DNA banding patterns: R(n), with n = profile/group number. Each REP1 
profile obtained was compared to a specific REP1 profile, in this case, all patterns obtained 
were compared to R1. The F value for each REP1 pattern was also calculated (for the 
calculation formula, see Section 3.2.2). REP1 amplification of the 84 S. II Sofia isolates yielded 
5 different profile patterns (R1 to R5), consisting of about 13 to 22 visible, stable and 
reproducible DNA fragments (0.5 to 4.5 kB in size). A summary of these profiles is listed in 
Figure 3.5 and Table 3.2.  
 
Profile R1 was observed to be the major pattern among the isolates, with 73.8% (62 
isolates) of isolates exhibiting this pattern (Figure 3.5). The next most predominant profile is 
pattern R3 (12 isolates) and this was followed by R2 (8 isolates), R4 and R5 (1 isolate each). 
REP1 patterns were found to differ from one another by 1-7 bands with F values in the range of 
0.65 to 0.97 (Table 3.1). R1 is the dominant S. II Sofia pattern obtained at each location (34 
Victorian, 13 New South Wales, 11 South Australian, 15 Queensland and 10 Tasmanian 
isolates). Victorian isolates showed the most variation, with 4 different REP1 profiles (R1, R2, 
R3 and R5) and S. II Sofia isolates from New South Wales and South Australia exhibited 3 (R1, 
R2 and R4) and 2 patterns (R1 and R5), respectively. On the other hand, Queensland and 
Tasmanian isolates were found to have only one REP1 pattern, R1. In contrast to its PFGE 
profiles, S. II Sofia 131 did not have a unique REP1 pattern (R2).  
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Table 3.2 Summary of molecular fingerprinting data for the 84 S. II Sofia isolates 
 
Profile pattern 
PFGE PCR S. II Sofia isolates XbaI 
(X) 
SpeI 
(S) 
REP1 
(R) 
Number of 
isolates showing 
this pattern 
combination 
Bt1, 2, 3, 6, 7, 8, 12, 13, 14, 15, 16, 18 1 1 3 12 
3451, 3453, 3454, 3455, 140TCA, 
537NCA, 538NCA, 541NCA, 561NCA, 
567NCA, 627MSC, 629MSC, 633MSC, 
659SCA, 655SCA, 665SCA, 146TC, 
147TC, 148TC, 150TC, 146TCA, 
147TCA, 148TCA, 150TCA, 242T, 
561NC, 566NC, 336QC, 339QC, 
348QC, 360QC, 362QC, 365QC, 
391QCA, 404QCA, 985Q, 986Q, 965Q, 
826V, 842V, 846V, 847V 
1 1 1 42 
644SC, 569NCA, 636SC, 656SC, 
656SCA 
1 1 2 5 
786CL, 768XTA 1 3 1 2 
642SC 1 3 2 1 
554NCA 2 2 4 1 
403QCA, 539NC, 566NCA 3 1 1 3 
630MSC 3 1 5 1 
987VCA, 10VCA 4 1 1 2 
858V 4 5 1 1 
3452 5 1 2 1 
620MSC, 838V 5 5 1 2 
985VCA, 992VCA, 664SCA, 671SC, 
671SCA, 9VCA, 568NC, 963Q 
6 1 1 8 
856V 6 4 1 1 
988Q 7 4 1 1 
131 8 6 2 1 
Total number of isolates: 84 
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3.2.4 Combination of PFGE and Rep-PCR Profiles 
When all three molecular fingerprinting profiles (PFGE and REP1 patterns) were 
combined, a total of 16 pattern combinations were obtained (Table 3.2). Pattern combination 
X1S1R1 was found to be the most common profile among S. II Sofia isolates, with 50% (42 
isolates) of all strains showing this pattern combination. It was shown that 42 of the 62 X1 
strains (the predominant XbaI profile) belong to this profile (X1S1R1; Table 3.2). The other 
combinations observed in X1 strains include X1S1R3 (12 isolates), X1S1R2 (5 isolates), 
X1S3R1 (2 isolates) and X1S3R2 (1 isolate). Distribution of different profiles between the 
different locations: Victoria (9 combinations), New South Wales (5 combinations), South 
Australia and Queensland (4 combinations). All Tasmanian isolates were found to exhibit only 
one profile, which is the major pattern combination X1S1R1 (Table 3.2). 
     
3.2.5 Analysis of Banding Patterns with GelCompar® II  
After manual analysis of both PFGE and REP profiles, the computer software 
GelCompar® II was used to analyse the banding patterns and to generate dendograms. All 
analysis using this software was done at the Department of Microbiology at Austin Health, 
Melbourne, Victoria. S. Braenderup H9812 was used as the reference strain in PFGE for the 
determination of size standards (see Appendix III) and for the normalisation of gel images for 
analysis (Hunter et al., 2005).  This was accomplished by placing this strain in certain positions 
on each gel - on the gel, S. Braenderup H9812 was inserted between every 3 isolates of S. II 
Sofia. For REP1 analysis, the λDNA (PstI) marker was used as a reference. Using the software, 
genetic similarity was calculated with Dice coefficient and DNA profiles clustered using the 
Unweighed Paired Group Arithmetic Average (UPGMA) method, creating dendograms for the 
isolates (Figures 3.6 to 3.8). The UPGMA method assumes a constant evolutionary rate occurs 
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between the different lineages and identifies patterns in order of similarity, allowing the tree to 
be constructed in a step-wise manner (Opperdoes, 1997). A position tolerance of 1.0% was 
chosen for generation of all dendograms as the analysis of multiple runs of S. Braenderup 
H9812 (PFGE) and λDNA (PstI) marker (REP1) with GelCompar® II showed similarity of 100%. 
This parameter indicates the extent of positional deviation between 2 identical bands run in 
different lanes and on different gels (Gerner-Smidt et al.¸1998). As GelCompar® II was able to 
accurately align the reference strain, which was run in different lanes and gels, the default 
position tolerance of 1.0% was chosen.     
 
Using the fingerprint patterns from selected S. II Sofia isolates representing each profile 
type, three separate dendograms were constructed (XbaI, SpeI and REP1; Figure 3.6, 3.7 and 
3.8, respectively). Software analysis of the fingerprint patterns have matched and confirmed 
with the visual comparison of patterns. The dendogram for XbaI showed an overall similarity of 
between 44 to 100% and was divided to 4 clusters (I to IV; Figure 3.6) with the first cluster 
(73.8% of the isolates) containing 5 profiles (X1 and X3 to X6) and cluster II, III and IV 
consisting of only 1 profile each. The genetic relatedness of SpeI PFGE patterns ranged from 
66 to 100%, with the patterns being catergorised into 3 clusters (I to III; Figure 3.7). While the 
first cluster (96.4% of isolates) consisted of 4 profiles (S1 and S3 to S5), the second and third 
cluster contained only one profile. REP1 patterns were divided into 2 major clusters (I and II) 
that showed an overall similarity of 70 to 100% on the dendogram (Figure 3.8): the first (98.8% 
of the isolates) comprised of 4 profiles (R1 to R3 and R5); and the second of only one profile, 
R4. 
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Figure 3.6 Dendogram showing cluster analysis of selected S. II Sofia isolates representing the different XbaI 
patterns. Eight profiles were obtained (see Table 3.2) and divided into 4 major clusters (I, II, III and IV). Similarity was 
determined using Dice coefficient and profiles clustered with the UPGMA method.  
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Figure 3.7 Dendogram showing cluster analysis of selected S. II Sofia isolates representing the different SpeI patterns. 
Six profiles (see Table 3.2) were observed and catergorised into 3 major clusters (I, II and III). Similarity was calculated using 
Dice coefficient and profiles clustered with the UPGMA method.  
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Figure 3.8 Dendogram showing cluster analysis of selected S. II Sofia isolates representing the different REP1 patterns. 
Five profiles (see Table 3.2) were obtained and divided into 2 major clusters (I and II). Similarity was determined using Dice 
coefficient and dendograms generated with the UPGMA method.  
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3.2.6 Simpson’s Index of Diversity (D) 
The discriminatory ability of the molecular typing systems (used individually or in 
combination) was evaluated by calculating the Simpson’s Index of Diversity as described by 
Hunter and Gaston (Hunter and Gaston, 1988). This discrimination index calculates the 
probability of two unrelated strains being characterized into different typing groups and formula 
is as listed below: 
 
         1 
D = 1 –                                        
 
 
where N is total number of strains in sample population, S is total number of types described 
and no is the number of isolates belonging to jth type. All D values were evaluated as indicated - 
the higher the index value (the closer the D value gets to 1.0), the better the discriminatory 
ability of the typing method. 
 
A summary of the discrimination indices and the number of profiles generated by each 
molecular typing method(s) is listed in Table 3.3. Restriction analysis with XbaI was shown to be 
better at discriminating S. II Sofia isolates compared to SpeI. The REP1 typing system has 
better discrimination than PFGE with SpeI, despite the latter being able to differentiate more 
profile types and containing a higher proportion of isolates in the predominant profile type (Table 
3.2). The various combinations of typing systems were found to have higher discriminatory 
power compared to the individual typing methods. Overall, the 2 most discriminatory molecular 
typing methods for the analysis of S. II Sofia are the XbaI/SpeI/REP1 and XbaI/REP1 systems, 
with index values of 0.721 and 0.693, respectively (Table 3.2). 
 
Σ nj (nj - 1) N(N – 1) 
S 
j = 1
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Table 3.3 Discrimination indices for S. II Sofia molecular fingerprinting methods 
 
 
Molecular typing 
method 
Number of 
profiles 
Size (%) in the 
dominant profile type 
Simpson’s index of 
discrimination (D) 
XbaI 8 73.8 0.444 
SpeI 6 89.3 0.225 
REP1 5 73.8 0.431 
XbaI/SpeI 12 70.2 0.498 
XbaI/REP1 12 52.4 0.693 
SpeI/REP1 10 65.5 0.548 
XbaI/SpeI/REP1 16 50.0 0.721 
D values were calculated as described in Section 3.2.5 
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3.3 Discussion  
All previous attempts to subtype S. II Sofia strains through PFGE have been unsuccessful, 
resulting in smears indicative of DNA degradation (Ross et al., 2003). Ross and his coworkers 
(Ross et al., 2003) have reported that about 60% of the S. II Sofia isolates used in their study 
were non-typeable by PFGE. DNA degradation can occur for various reasons and some 
bacterial strains appear more sensitive to DNA degradation than others. DNase-positive 
bacterial strains (e.g. Campylobacter jejuni Lior biotype II) have been shown to degrade their 
genomic DNA during the preparation stage before PFGE (Gibson et al., 1994). However, 
formalin fixation of cells was sufficient to inactivate DNase produced by these strains, allowing 
them to be typed by PFGE (Gibson et al., 1994). Other strains appear to be more sensitive to 
the Tris radicals generated during the electrophoresis process (Ray et al., 1995), which are 
capable of breaking down DNA (Corkill et al., 2000; Koort et al., 2002; Liesegang and Tschäpe, 
2002; Lyytikäinen et al., 2000; Zhang et al., 2004). However, the reason for the sensitivity of 
certain strains to Tris radicals over others is unknown. Modifications to the running buffer such 
as addition of thiourea or use of HEPES buffer have been shown to counteract this activity 
(Corkill et al., 2000; Koort et al., 2002; Liesegang and Tschäpe, 2002; Zhang et al., 2004).    
 
However, any efforts to protect S. II Sofia DNA from degradation before and during PFGE 
through modifications to the protocol (see Section 3.2.1) and/or use of established anti-DNase 
treatments (formaldehyde, thiourea and HEPES), in the previous (Ross et al., 2003) and current 
study have been unsuccessful. An evaluation on whether altering contents of the ESP lysis 
solution would improve typeability of S. II Sofia isolates was conducted since DNA degradation 
is most likely to occur at this stage (lysis of cells and release of genomic DNA in the plugs). The 
addition of SDS into bacterial plugs (presumably to improve lysis of cells) has been utilised in 
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several PFGE protocols (Fakhr et al., 2006; Nayak et al., 2004; Ribot et al., 2001). It is included 
in the CDC PulseNet PFGE protocol used in the United States to process food-borne pathogens 
(Hunter et al.¸2005; Swaminathan et al., 2001). By adding SDS into the lysis solution, which 
already contains sarkosyl, the potential of the combined strength of both these detergents in the 
inactivation of S. II Sofia DNase activity was investigated. 
 
It was discovered that addition of 5% SDS (w/v) and the increase of sarkosyl and 
Proteinase K concentration (from 1 to 5%, w/v and 100 to 200 µg/mL, respectively) in the lysis 
solution (ESP34) was sufficient to inactivate nuclease activity in S. II Sofia, leading to the 
generation of visible bands. This observation was confirmed by the normal and modified ESP 
lysis treatment of bacterial plugs (Figure 3.1). The DNase activity of S. II Sofia isolates is 
evident in the S. II Sofia and mixed plugs lysed with normal ESP solution, resulting in partial to 
total smearing on the gel. It is also evident that the presence SDS is able to stop this nuclease 
activity, producing bands that can be used for further analysis (Figure 3.1). Moreover, PFGE 
quality of S. Typhimurium 82/6915 appears to be unaffected by the use of ESP34, which means 
that this lysis solution can be used to process DNase-negative strains, making pattern 
comparison between S. II Sofia and other Salmonella serovars possible. 
      
The conventional PFGE protocol used in this chapter is easy to perform but labour-
intensive, taking 3 days (from preparation of plugs to restriction digest to PFGE) to complete 
(see Section 2.3.6.1). The protocol also requires the use of PMSF during the washing stage, a 
chemical which can be hazardous as it is known to be destructive to the mucous membranes of 
the respiratory tract, skin and eyes (Sambrook and Russell, 2001). Development of newer 
PFGE protocols have removed the use of PMSF, where bacterial plugs were washed several 
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times in preheated (50-55°C) dH2O and/or TE buffer instead (Fakhr et al., 2006; Liebana et al., 
2001; Nayak et al., 2004; Ribot et al., 2001; Swaminathan et al., 2001; Thong et al., 1995). 
Furthermore, reduction of cell lysis incubation time has been carried out without affecting the 
generation of PFGE bands (Fakhr et al., 2006; Nayak et al., 2004; Ribot et al., 2001; 
Swaminathan et al., 2001). This can be observed with the PFGE patterns of the Typhimurium 
and Enteritidis serovars, where application of any one of the 3 treatment systems did not affect 
the generation or quality of DNA bands (Figure 3.2). Neither of these serotypes is known to 
produce DNase, making PFGE typing easy to conduct as both these isolates were not prone to 
DNA degradation. 
 
However, the same cannot be said regarding the S. II Sofia isolate (Figure 3.2), which 
seems only to consistently produce visible bands with no smearing using Treatment 3. 
Overnight incubation with SDS is probably required in order to properly inactivate DNase in S. II 
Sofia, which would explain the inconsistent generation of bands from Treatment 2 (2 h 
incubation with ESP). Since S. II Sofia DNA appear to be more sensitive to degradation 
compared to other Salmonella serovars, it is possible that the change in temperature (from RT 
to 50 °C) during the washing steps could have encouraged the DNA degradation process. 
PMSF can function as a protein inhibitor and thus, is used in the first step of plug washing to 
inactivate Proteinase K and any other bacterial proteins not digested after overnight lysis 
incubation. The omission of PMSF from plug preparation (Treatment 1 and 2) could have 
lowered the effectiveness of the washing step in removing proteins and cell debris after lysis. 
This could increase the chances for DNA breakdown, resulting in the inconsistent production of 
visible patterns. Therefore, Treatment 3 is deemed the best protocol for preparation of S. II 
Sofia DNA for PFGE. 
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A collection of S. II Sofia strains (84 strains) isolated from poultry flocks around Australia 
was studied using 2 different molecular subtyping methods: PFGE (with XbaI and SpeI) and 
rep-PCR (with REP1 element). Restriction analysis of the isolates resulted in generation of 
banding patterns and a number of profile types: 8 XbaI (X1 to X8) and 6 SpeI patterns (S1 to 
S6) (Figures 3.3 and 3.4). The XbaI restriction patterns are more easily discernable compared 
to the SpeI patterns, which are more numerous and closely packed together, making analysis of 
banding pattern more difficult. Molecular fingerprinting through the detection of a number of 
repetitive sequences (BOX, ERIC and REP) was also carried out on the S. II Sofia isolates. 
Only REP elements were varied enough to be used for typing since all the other repetitive 
elements gave a single pattern (indicating that the number and location of BOX and ERIC 
sequences in S. II Sofia strains were constant). There does not seem to be a correlation 
between the typing methods as overlap and diversity can be obtained within each profile (in 
other words, no single pattern type is associated with a specific profile type).  
 
The overall difference between a majority of the PFGE and REP profiles were small, with 
only S. II Sofia 131 and 988Q (PFGE), and 554NCA (PFGE and REP1) displaying greater band 
differences (compared to the rest of the 84 II Sofia isolates). It appears that a majority of the 
patterns are grouped within a single profile type, with the other types encountered consisting of 
a few isolates each (Table 3.2). This limited genetic diversity is confirmed by the Dice coefficient 
(F) values calculated manually and with computer software (Table 3.1 and Figures 3.6 to 3.8). 
Dice coefficient is defined as a correlation coefficient for discrete events and is used to measure 
the genetic similarity in 2 isolates (with the assumption that bands of identical size are, with high 
probability, genetically homologous) (Anon, 2004). Most of the strains are found to be closely 
related (with F values in the range of 0.89 to 0.98), with the exception of isolate 131, 988Q and 
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554NCA (Table 3.1). This genetic relatedness can also be seen from the dendograms 
generated using with GelCompar® II, with a majority of the S. II Sofia strains being grouped into 
Cluster I in each dendogram and showing similarity of 80 to 100% (Figures 3.6 to 3.8).  
 
However, the estimate of genetic relatedness of S. II Sofia isolates varies, depending on 
the typing method used. XbaI restriction digest analysis appears to be the most discriminatory 
method of the three, with 8 different profile types generated (Figure 3.3). Compared to SpeI and 
REP1 patterns, XbaI profiles have a wider diversity range, showing an overall similarity of 
between 44 to 100% (Figure 3.6). Although the discriminatory ability of the typing methods used 
here was comparable to the RFLP typing conducted previously (Harrington et al., 1991), neither 
the previous nor current typing methods were as highly discriminatory as the fluorescent AFLP 
method (Ross et al., 2003) for the study of Australian S. II Sofia isolates. AFLP tends to 
generate a large number of DNA fragments (in comparison to other typing methods such as 
PFGE), which means that subtle changes in the bacterial genome are more likely to be 
detected, contributing to the number of pattern types (Ross et al., 2003). While this typing 
method is highly discriminatory, the high setup cost (for equipment and expertise) is a 
disadvantage, compared to cheaper methods such as PFGE or PCR typing.     
 
The discriminatory ability of XbaI PFGE is also reflected in the Simpson’s Index values 
(Table 3.3). Initially used to evaluate species diversity within an ecological habitat (Hunter and 
Gaston, 1988), the Simpson’s Index of Diversity has been employed to evaluate the typing 
systems used to characterise bacterial strains such as Salmonella spp. (Malorny et al., 2001; 
Pang et al., 2005; Woo and Lee, 2006).  Individually, the different degrees of polymorphism 
generated by each typing system are ranked in the descending order: PFGE (XbaI, 8 types, D = 
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0.444), followed by REP1 (5 types, D = 0.431) and PFGE (SpeI, 6 types, D = 0.225). Overall, 
the discriminatory power of each typing system is rather poor. The close association of a portion 
of the fragments produced from restriction analysis with SpeI (bands were situated close to one 
another and occasionally appear to be “fused” together, see Figure 3.4) could have made 
scoring of bands difficult, lowering the discrimination power of the method. In the case of PCR 
typing, a generated pattern typically consists of dominant intense bands, that are easy to score, 
and faint or less intense bands, which introduces uncertainty during the development of profile 
types (Burr et al., 1998). It is possible that this, along with other factors (slight variation between 
the different PCR amplifications, presence of PCR artifacts, etc) could have decreased the 
ability of REP1 typing to differentiate S. II Sofia isolates. The high genetic similarity shared by 
the S. II Sofia strains could have contributed to the poor discriminatory power of the individual 
typing methods – a limited genetic diversity makes it more difficult to find typing methods that 
are capable of detecting the minor genome changes present in the isolates.           
 
Therefore, a single typing method usually cannot be relied on to properly characterise and 
discriminate strains. It has been shown that a combination of typing methods has been 
employed to successfully study various Salmonella spp. (Gudmundsdottir et al., 2003; Liebana 
et al., 2001; Lindqvist et al., 2002; Malorny et al., 2001; Nayak et al., 2004; Pang et al., 2005; 
Ridley et al., 1998). The use of more than one RE has also been shown to increase the ability of 
PFGE to discriminate Salmonella isolates (Cardinale et al., 2005; Lindqvist et al., 2002; Malorny 
et al., 2001; Murase et al., 1995; Pang et al., 2005; Seo et al., 2006; Thong et al., 1995; Tsen et 
al., 2000; Tsen and Lin, 2001). However, the high genetic similarity exhibited by S. II Sofia 
isolates have made it difficult to type the strains and only 2 fingerprint methods were chosen: 
PFGE (XbaI and SpeI) and rep-PCR (REP1). By combining the typing systems, the 
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discrimination of S. II Sofia isolates could be improved: e.g. the dominant SpeI pattern (S1), 
which comprised of 89.3% of the isolates, can be further divided into 8 pattern combinations 
with XbaI and REP1 analysis – X1S1R1, X1S1R3, X1S1R2, X3S1R1, X3S1R2, X4S1R1, 
X5S1R2 and X6S1R1. When all 3 methods are combined for typing, the 84 isolates could be 
divided into 16 subtypes, increasing the discriminatory index to 0.721 (Tables 3.2 and 3.3). An 
index of 0.721 indicates that if 2 strains were randomly sampled from the population, on 72.1% 
of the occasions, they would fall into different groups. This improvement in differentiation is 
reflected not only in the increase in index value but also in the decrease of sample size in the 
predominant profile type over a single measure (indicating that the capability of the typing 
methods in further dividing the strains) (Table 3.3). 
 
 Although the high pattern similarity exhibited by the Australian S. II Sofia isolates could 
limit the value of typing systems used here as a tool for epidemiological analysis, it can also be 
an indication of the clonal nature of the strains. This limited clonal diversity is reflected in the 
Dice coefficient values and dendograms (Table 3.1 and Figures 3.6 to 3.8), which show that a 
large portion of DNA bands (about 70 to 90%) observed in the patterns from the strains, were 
probably identical. The limited diversity of BOX, ERIC and ribotyping pattern obtained via PCR 
also reflects on the clonal nature of the isolates. Only the REP sequences were varied enough 
to be used for typing. Further, as ribotyping usually results in a small number of bands, this 
tends to hinder differentiation among closely related strains (as is probably the case in S. II 
Sofia). The poor discrimination indices from each individual typing system supports the theory 
regarding the clonal nature of the isolates, making it necessary to combine fingerprinting 
methods to increase discrimination of said isolates.  
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The clonality observed in the current study is also supported by previous epidemiological 
studies of S. II Sofia (Harrington et al., 1991; Ross et al., 2003). Harrington and her colleagues 
(Harrington et al., 1991) found that the Australian S. II Sofia isolates studied belonged to a 
single clonal group. Characterisation of S. II Sofia using fluorescent AFLP have shown that 
isolates share >70% similarity, with certain groups persisting over time (Ross et al., 2003). The 
limited genetic diversity observed here indicates that the isolates were possibly derived from a 
single clone. The spread of S. II Sofia throughout Australia meant that the strains were 
subjected to selective pressure from a variety of sources: different farm management practices, 
different environments and food, use of antibiotics, etc. Such selection is sufficient to cause 
minor genetic changes (gain or loss of restriction site), leading to the variation seen in the 84 
isolates. 
 
There was little correlation between the profile types and geographical location. A majority 
of the S. II Sofia isolates were not geographically restricted: the predominant pattern 
combination (X1S1R1) was found to be spread among the isolates from various locations (Table 
3.2). Victorian S. II Sofia isolates were found to exhibit the most diverse pattern types (9 
combinations) compared to isolates from other states. However, this could be due to the larger 
sample population: 34 Victorian S. II Sofia strains were analysed compared to 10-15 isolates 
from the other states. In addition, all 10 Tasmanian isolates appear to belong to a single pattern 
type, which is the major pattern X1S1R1 (Table 3.2).  
 
Two S. II Sofia strains were observed to show unique profile pattern – 554NCA and 131. 
The XbaI, SpeI and REP1 pattern of isolate 554NCA (New South Wales) was not obtained from 
the typing of the other 83 isolates (all isolates obtained were confirmed as S. II Sofia through 
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malonate and ONPG biochemical tests [see Appendix II] before being subjected to further 
analysis). The reason for the particular pattern combination is unknown and more samples 
would need to be typed to ascertain whether such a pattern is restricted to a certain location 
(New South Wales). On the other hand, while S. II Sofia 131 had unique PFGE profiles (X8 and 
S6), PCR typing has shown it has the second most common REP1 pattern R2. XbaI restriction 
analysis appears to be most efficient at discriminating 131, producing a pattern with an overall 
similarity of 44% (Figure 3.6). The origin of 131 is unknown (the strain has been in the RMIT 
collection) and since no correlation could be found between profile type and location, there is no 
way to determine where the isolate is from. Any conclusion regarding the relationship of profile 
patterns and geographical locations can only be made after more isolates (from Queensland, 
New South Wales, Tasmania and South Australia) are collected and analysed.      
 
A DNAse inactivation step to minimise DNA degradation was successfully devised, 
allowing S. II Sofia to be subtyped using PFGE. A total of 84 Australian S. II Sofia isolates were 
typed using PFGE (XbaI and SpeI) and PCR typing (REP1) – resulting in generation of 8 XbaI, 
6 SpeI and 5 REP1 profile types.  The discriminatory ability of the individual typing systems was 
found to be poor, with low diversity indices. By combining the typing systems, isolates could be 
further discriminated into 16 profile types with an index diversity of 0.721. No link could be 
established between any of the fingerprint typing methods. There was no correlation between a 
majority of the profile types and geographical location – the analysis of more samples is still 
required before any conclusions could be drawn. Molecular fingerprinting of the isolates and its 
subsequent analysis indicates that Australian S. II Sofia strains have limited genetic diversity 
and are probably clonally related. PFGE has potential as an epidemiological tool for the future 
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study of S. II Sofia and further experimental work is needed to develop the method e.g. the use 
of additional restriction enzymes in subtyping. 
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CHAPTER 4: MOLECULAR ANALYSIS OF SPI1 TO 
SPI5 IN SALMONELLA II SOFIA 
 
4.1 Introduction 
Most Salmonella species are capable of invading a host and causing 
gastrointestinal and/or systemic disease (Jones and Falkow, 1996; Marcus et al., 2000; 
Ohl and Miller, 2001). The pathogenic ability of Salmonella spp. is dependent upon the 
presence of virulence determinants that can induce a variety of functions once within the 
host cell, such as cell invasion, cytoskeletal rearrangements, fluid accumulation, 
intracellular survival and replication, etc. A large proportion of virulence factors are found 
clustered together in distinct regions of bacterial chromosomes, which are termed 
pathogenicity islands (Hentschel and Hacker, 2001; Hensel, 2004). Pathogenicity islands 
are found in a wide variety of bacterial pathogens, including Salmonella spp. and an 
example would be the Salmonella Pathogenicity Island (SPI). A number of SPIs can be 
found within the Salmonella spp. genome (depending on the serovar) but the most 
common and best studied are SPI1 to SPI5. 
 
SPI1 is a 40 kB region that encompasses a large number of genes encoding 
components of a TTSS and its effector proteins. This region is responsible for enabling 
Salmonella spp. to colonise and invade intestinal epithelial cells and transport virulence 
effector proteins from the bacteria into the host cell cytosol (Galán, 1999; Hansen-
Wester and Hensel, 2001; Hensel, 2004; Marcus et al., 2000; Ohl and Miller, 2001). 
Several genes in this region (prg, org, spa and inv operons) have been shown to be 
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involved in the formation of the needle complex of the SPI1 TTS system (Eichelberg et 
al., 1994; Kaniga et al., 1994; Kimbrough and Miller, 2000; Klein et al., 2000; Kubori et 
al., 1998; 2000; Sukhan et al., 2001; Watson et al., 1998). This structure acts like a 
needle, piercing the host cell membrane and allowing effector proteins to be delivered 
into the host. Furthermore, SPI1 contains genes encoding effector (sip, sptP and avrA), 
accessory (invB, sicP, sicA and iagB) and regulatory (invF, hilA, hilC and hilD) proteins. 
Once inside the host cells, the virulent effector proteins are involved in a variety of 
functions such as aiding translocation of proteins, cytoskeletal rearrangements, 
membrane ruffling and cell apoptosis, all of which leads to bacterial invasion (Chang et 
al., 2007; Cherayil et al., 2000; Collier-Hyams et al., 2002; Darwin and Miller, 1999b; Fu 
and Galán, 1998b; Hayward and Koronakis, 1999; Ye et al., 2007; Zhang et al., 2003).  
 
Another large virulence region is the 40 kB SPI2, which encodes a second TTS 
system that is structurally and functionally different from the TTSS encoded by SPI1 
(Chakravortty et al., 2005; Hensel et al., 1995; 1997b; Marcus et al., 2000; Ochman et 
al., 1996; Shea et al., 1996). In addition to genes encoding components of the TTSS 
(ssa and sseBCD), this region also consists of ORFs that encode effector proteins, their 
cognate chaperones (sse and ssc) and regulatory proteins (ssr) (Chakravortty et al., 
2005; Hensel et al., 1997a; 2000; Shea et al., 1996). SPI2 effector proteins are 
responsible for virulence functions such as aiding the translocation of effector proteins, 
intracellular trafficking of SCVs (maturation, maintenance and positioning) and 
intracellular survival and replication (Guy et al., 2000; Kuhle and Hensel, 2002; Nikolaus 
et al., 2001; Uchiya et al., 1999; Yu et al., 2004). Through the effects of proteins 
encoded by this region, Salmonella spp. is able to accumulate in the liver and spleen 
cells, leading to the development of systemic disease.  
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Two other pathogenicity islands, SPI3 and SPI4 (a 17 kB and 27 kB region, 
respectively) are present in Salmonella spp. (Blanc-Potard and Groisman, 1997; Wong 
et al., 1998).  Compared to SPI1 and SPI2, these two virulence regions are not as well 
studied and thus, the role of some of the genes is still unknown. SPI3 is comprised of 10 
ORFs organised into 6 transcriptional units and include mgtCB (required for 
intramacrophage survival), misL (a surface adhesin that is required for intestinal 
colonisation) and marT (a transcriptional activator of the misL promoter) (Blanc-Potard 
and Groisman, 1997; Dorsey et al., 2005; Morgan et al., 2004). Further, it has been 
shown that the genes cigR, rhuM, rmbA and fidL could potentially be involved in the 
systemic disease process (Lawley et al.¸2006).However, the exact function played by 
the proteins encode by these genes is not known. Analysis of the SPI4 region have 
revealed that it contains 6 genes (siiABCDEF) that form an operon and are most 
probably co-transcribed together as a large mRNA (Gerlach et al., 2007a; Gerlach et al., 
2007b; Morgan et al., 2004; Morgan et al., 2007). This operon encodes components for 
a T1SS (siiCDF), a large non-fimbrial adhesin protein that mediates contact-dependent 
adhesion of Salmonella to epithelial cell surfaces (siiE) and 2 other proteins of unknown 
function (siiAB) (Gerlach et al., 2007b; Morgan et al., 2004; 2007). 
 
The smallest of the 5 SPIs, SPI5 is a 7.6 kB region found in Salmonella serovars 
such as Dublin and Typhimurium (Hong and Miller, 1998; Wood et al., 1998). Sequence 
analysis revealed that this region contains 6 novel genes – pipD, orfX, sopB, pipC, pipB 
and pipA (Wood et al., 1998). SPI5 is responsible for eliciting intestinal secretory and 
inflammatory responses in the host by mediating chloride secretion in infected epithelial 
cells (leading to fluid influx), accumulation of neutrophils in the gut and intestinal 
inflammation (Galyov et al., 1997; Norris et al., 1998; Pfeifer et al., 1999; Wood et al., 
1998). Unlike the other SPIs, SPI5 does not seem to encode its own secretion system 
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and effector proteins are transported by the TTSS of SPI1 and SPI2. SopB (and its 
chaperone, PipC) has been shown to be translocated in a Sip-dependent pathway, 
indicating that the SPI1 TTS system is responsible for its delivery into host cells (Galyov 
et al., 1997; Hong and Miller, 1998; Zhang et al., 2002). In contrast, the protein PipB is 
translocated by the SPI2 TTS system to the SCVs; however, its exact function in the 
virulence process is still unclear (Knodler et al., 2002).  
 
Although a majority of Salmonella spp. are pathogenic, their virulence (disease 
and host range) seem to vary from serovar to serovar. As pathogenicity of a serovar is 
dependent on the effects of various virulence proteins, this diversity can be attributed to 
genetic polymorphisms in virulence genes encoding such proteins. Salmonella spp. with 
naturally occurring deletions in the SPI regions are less virulent and unable to invade the 
host or cause systemic disease (Boyd et al., 1996; Ginnocchio et al., 1997; Porwollik et 
al., 2002). Analysis of SPI1 to SPI5 regions in various Salmonella serovars have 
revealed that a range of insertions and deletions were found in the strains, which could 
explain the pathogenic diversity of Salmonella spp. (Amavisit et al., 2003; Porwollik et 
al., 2002). Such insertions and deletions are mediated by mobile elements such as 
transposons and IS elements; and by changes in the genetic sequence - base insertion, 
deletion or substitution (Anon, 2008b; Dobrindt et al., 2004; Steinert et al., 2000). 
     
Salmonella II Sofia is an example of Salmonella serovar that exhibits low virulence 
in humans and chickens. It is an efficient coloniser of chickens and therefore, is 
frequently isolated from poultry flocks (Harrington et al., 1991; Heuzenroeder et al., 
2001). Although S. II Sofia is able to adhere to and invade cultured epithelial cells, the 
strain is unable to survive intracellularly (Rickard, 1998). Further, this serovar only 
appears capable of causing systemic disease in hosts with immature or 
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immunocompromised systems (Rickard, 1998). As very few studies have been 
conducted on the pathogenicity of S. II Sofia, little is known about its virulence process. 
However, Heuzenroeder and his colleagues (Heuzenroeder et al., 2001) have shown 
that S. II Sofia is incomplete within the inv region of SPI1. The inv operon is required for 
TTSS of SPI1 (Eichelberg et al., 1994; Kaniga et al., 1994; Kimbrough and Miller, 2000; 
Kubori et al., 2000; Sukhan et al., 2001) and its absence could be one reason for the 
avirulent nature of S. II Sofia. However, more research on SPI1 and the other SPIs 
needs to be carried out before any conclusions can be made.   
      
In this study, investigation into the pathogenicity of S. II Sofia was undertaken 
through molecular analysis of Salmonella Pathogenicity Islands (SPI) 1 to 5. A series of 
Southern hybridisation, PCR and sequencing experiments (using probes and/or primers 
detecting gene(s) of interest) was carried out on the isolate S. II Sofia Bt8.  
The aims of the experimental methods conducted for this chapter were to:  
(i) examine the genetic variation and distribution of genes across the entire length of 
 SPI1 to SPI5 in S. II Sofia using RFLP and sequencing analysis,  
(ii) construct a genetic map of the SPIs in S. II Sofia using all data and compare it to  
 S. Typhimurium 82/6915 (a known virulent strain), 
(iii) investigate whether the distribution of genes in the SPIs is able to explain the  
 avirulent nature of S. II Sofia.  
   
4.2 Methods and Results 
4.2.1 Southern Hybridisation Analysis of SPI Regions 
The majority of the primers used for the amplification of DNA probes were 
designed using the Clone Manager 7 software as described previously (see Section 
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2.3.3.1), with the SPI sequences of S. Typhimurium LT2 as a reference. The GeneBank 
accession numbers of the LT2 SPI sequences are listed in Appendix VI. All primers used 
here were designed from LT2 reference sequence data except for primers in the 
amplification of a part of SPI1 (1C) and the entire SPI3, which were described previously 
(Amavisit et al., 2003). DNA probes used in Southern blot detection were prepared by 
expand amplification (see Section 2.3.3.3) of one or more fragments encompassing the 
entire length of each SPI (see Appendix VI for details on primer sequence, length, 
elongation time and annealing temperature of probes). Probes were produced using 
genomic DNA extracted from S. Typhimurium SL1344 and restriction analysis was 
carried out on each probe (using the REs BglII, EcoRV and HindIII) to verify that the 
probe produced was accurate. Labeling and estimation of probe concentration was 
conducted as outlined in Chapter 2 (see Section 2.3.7.1).  
 
Genomic DNA from selected S. II Sofia isolates, including strain Bt8 (Table 2.1) 
and S. Typhimurium isolates SL1344, LT2 and 82/6915 (Table 2.2) was digested with 
10U of REs BglII, EcoRV or HindIII or with 10U of a combination of the stated REs (BglII 
and EcoRV or HindIII and EcoRV) (Amavisit et al., 2003). All resulting DNA fragments 
were subjected to electrophoresis before being transferred onto nylon membranes for 
Southern hybridisation (see Section 2.3.7.2). S. Typhimurium SL1344 was included in 
every blot as a reference strain. The bands obtained within each SPI region after 
Southern hybridisation were compared for presence/absence and differences in 
restriction pattern (by using SL1344 as a reference). Any differences observed were 
subjected to further analysis through PCR and sequencing experiments.  
 
Two methods of obtaining genomic DNA for Southern blotting were evaluated: 
DNA extraction and DNA agarose plugs. Genomic DNA was extracted from Salmonella 
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strains using the CTAB method as outlined in Chapter 2 (see Section 2.3.2.1). DNA 
plugs were prepared as described previously (see Section 2.3.6.1.1) with a minor 
modifications – doubling the amount of bacterial cells used for making the agarose 
plugs. For DNA extraction, approximately 20-25 µg of DNA was used for restriction 
digest (see Section 2.3.7.2). DNA plugs were digested as described previously (see 
Section 2.3.6.1.2) and plugs were inserted into wells of the gel and sealed with molten 
agarose. Southern blotting was conducted using DNA prepared from both methods and 
the efficiency of each method was evaluated (data not shown). The agarose plug 
method was found to be more efficient compared to DNA extraction. A small portion of 
the plug (~ 2 mm) contained a sufficient amount of DNA for Southern hybridisation. In 
contrast, DNA extraction had to be carried out a number of times in order to obtain an 
equivalent amount (data not shown). Therefore, all subsequent Southern blotting 
experiments were done by detecting digested fragments from DNA plugs. 
    
4.2.2 PCR Analysis of SPI Regions 
After comparing the restriction pattern between S. Typhimurium SL1344 and S. II 
Sofia Bt8, the regions of difference observed in each SPI region was subjected to further 
analysis by PCR and restriction digest. PCR (general and expand amplification) was 
carried out according to the method detailed in Chapter 2 (see Section 2.3.3.2 and 
2.3.3.3). The oligonucleotide sequences of primers (along with the expected product size 
and annealing temperatures) for all PCR amplifications are listed in Appendix VII. 
Restriction cleavage of PCR products was conducted as described previously (see 
Section 2.3.5) using the appropriate REs, which are mentioned in the relevant sections 
(see Section 4.2.5 to 4.2.10). All resulting PCR amplification and restriction digestion 
was analysed by ethidium bromide agarose gel electrophoresis (see Section 2.3.4). 
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4.2.3 RT-PCR Analysis of SPI Regions 
After incubation in appropriate conditions (see Sections 4.2.6 and 4.2.8), RNA from 
S. Typhimurium 82/6915 and S. II Sofia Bt8 was extracted and analysed as described 
previously (see Section 2.5.2). RT-PCR was carried out on selected genes (listed in 
greater detail in the relevant sections) within the SPI1 and SPI3 region in order to study 
the expression of said genes. The reverse transcription of all samples (with different 
primers) was prepared in pairs: with and without RTase (see Section 2.5.3.1) in order to 
verify that the PCR band produced is the result of mRNA transcription and not genomic 
DNA contamination during the extraction process. RT-PCR analysis was conducted as 
outlined previously (see Section 2.5.3) and primers used (along with expected product 
size and annealing temperature) are listed in Appendix VII.  
 
4.2.4 Sequence Analysis of SPI Regions 
DNA sequencing (see Section 2.3.3.4) was carried out on SPI1 to SPI5 of S. II 
Sofia Bt8. Using S. II Sofia Bt8 DNA, the SPI regions were amplified with the primers for 
DNA probes. The PCR products were purified (see Section 2.3.2.5) and used as a 
template for sequencing via the primer walking method. Briefly, each SPI region is 
sequenced with the corresponding primers, which were used to amplify the region. The 
sequence from the end of the fragment is then used to design a primer for sequencing 
the next portion of the long DNA region: in short, the sequence “walks” along the entire 
DNA region. All resulting sequences were assembled together (using the multiple 
alignment function of Clone Manager 7 software) to produce a full length SPI, which was 
further analysed with the same software. The DNA sequence of each S. II Sofia Bt8 SPI 
region was compared to the sequence of the corresponding S. Typhimurium LT2 SPI 
sequence. The restriction and sequencing data was used to construct a map of SPI1 to 
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SPI5 of isolate Bt8. For the construction of the map, fragments smaller than 0.1 kB were 
excluded as they cannot be detected through Southern hybridisation or restriction digest 
of PCR products (even though such fragments were detected in the sequencing data). In 
addition, the putative protein sequence of each SPI gene was obtained (using the 
software to translate DNA sequence) for comparison with LT2 SPI proteins (see relevant 
sections for further details). 
       
4.2.5 Variation of SPI1 to SPI5 within each serovar  
S.Typhimurium strains 1344, LT2 and 82/6915 were shown to share identical 
restriction cleavage patterns with each of the SPI DNA probes and thus, SL1344 was 
used as a reference in all the blots. However, differences were observed with the 
Southern hybridisation patterns (SPI1 to SPI5) between the Typhimurium and II Sofia 
serovars (results not shown). The selected S. II Sofia isolates (Bt8, Bt15, FSAW3452, 
987VCA, 131, 988Q, 786CL, 554NCA, 140TCA and 642SC) shared the same SPI 
pattern with one another (Figure 4.1). This pattern similarity supports the theory that the 
S. II Sofia isolates are clonally related (see Chapter 3) and thus, the SPI regions of 
isolate Bt8 can be used as a reference for sequencing and map construction. An 
example of pattern similarity within each serovar and variation between the serovars can 
be seen in the Southern hybridisation pattern obtained after digestion using HindIII with 
EcoRV and detection with probe 1A and 4A (see Figure 4.1, Sections 4.2.6, 4.2.9 and 
Appendix VI).  
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Figure 4.1 Southern hybridisation pattern of the Salmonella serovars Typhimurium 
and II Sofia digested with HindIII and EcoRV. The fragment sizes of S. Typhimurium 
SL1344 are indicated at the side of each blot. Lane 1a and 2a, S. Typhimurium SL1344; 
Lane 1b and 2b, S. Typhimurium 82/6915; Lane 1c and 2c, S. II Sofia Bt8; Lane 1d and 
2d, S. II Sofia Bt15; Lane 1e and 2e, S. II Sofia 988Q; Lane 1f and 2f, S. II Sofia 642SC; 
Lane 2g, S. II Sofia 554NCA. A) Probe 1A (13.8 kB). B) Probe 4A (15.5 kB). 
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4.2.6 Variation of SPI1 between S. Typhimurium and S. II Sofia 
 The SPI1 region is 40 kB in length, making it difficult to be utilised as a single 
probe. Therefore, amplification of DNA probes for this region was divided into 3 parts: 1A 
(13.8 kB), 1B (15.1 kB) and 1C (10.8 kB) (Figure 4.2 and Appendix VI). All 3 probes 
were used in the Southern blotting of Salmonella strains. Overall, variation in the 
restriction cleavage data can be observed between Salmonella isolates SL1344 and Bt8 
with all 3 probes. However, attempts to amplify 1A and 1B in S. II Sofia isolates, 
including strain Bt8 have been unsuccessful and only amplification of 1C was possible, 
producing a 10 kB fragment (data not shown).  
 
A series of primers amplifying shorter segments of the 1A and 1B region was 
devised in order to amplify the rest of SPI1 (Appendix VII). The following primer pairs 
were able to produce fragments (3.7 to 8.4 kB in size) within the particular SPI1 region: 
fhlA/F and sitD/R, sprB/F and prgH/R, prgH/F and hilA/R, iagB/F and sipB/R, sipB/F and 
spaR/R (see Figures 4.2 to 4.4 and Appendix VII). These products, along with 1C were 
subjected to RFLP and sequencing analysis as outlined (see Sections 4.2.2 and 4.2.4). 
The final map showing restriction sites of the various REs (BgIII, EcoRV and HindIII) and 
genes within SPI1 of S. II Sofia Bt8 can be seen in Figure 4.2. After comparison between 
RFLP and sequencing data, a majority of the differences observed can be attributed to a 
series of base substitutions, resulting in the loss or gain of restriction sites (Figure 4.2). 
However, several segments within SPI1 seem to have accumulated changes that could 
affect gene expression and these areas were subjected to further analysis. 
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Figure 4.2 Variation of SPI1 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Amavisit et al., 2003). DNA probes (size and extent of each probe) used for Southern hybridisation are indicated above the 
schematic diagram. B) BglII, EcoRV and HindIII restriction maps for S. Sofia Bt8. The numbers indicate the sizes of detected 
fragments in kB. The maps are estimation of the sizes of restricted DNA fragments and are not drawn to scale. C) Comparison of 
EcoRV bands between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S. Sofia Bt8; -, absence of  
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Figure 4.2 Variation of SPI1 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Amavisit et al., 2003). The absence of avrA and presence of the ORF (IS) is indicated as an unshaded block and green shaded 
box, respectively. DNA probes (size and extent of each probe) used for Southern hybridisation are indicated above the schematic 
diagram. B) BglII, EcoRV and HindIII restriction maps for S. II Sofia Bt8. The numbers indicate the sizes of detected fragments in kB. 
The maps are estimation of the sizes of the restricted DNA fragments and are not drawn to scale. C) Comparison of EcoRV bands 
between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S. II Sofia Bt8; -, absence of fragment. Blue 
boxes and numbers indicate the extent of and size (in kB) of the EcoRV fragment.      
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Figure 4.3 Comparison of RFLP analysis encompassing the 1A region of SPI1 in S. Typhimurium SL1344 and S. II Sofia Bt8. M, 
λDNA marker digested with PstI. A) fhlA-sitD (3.79 kB). Lane 1a, 1c and 1e, fhlA-sitD amplified using SL1344 DNA and digested with 
BglII, EcoRV and BglII+EcoRV, respectively; Lane 1b, 1d and 1f, fhlA-sitD amplified using Bt8 DNA and digested with BglII, EcoRV 
and BglII+EcoRV, respectively. B) sprB-prgH (6.36 kB). Lane 2a, 2c and 2e, sprB-prgH amplified using SL1344 DNA and digested 
with HindIII, EcoRV and HindIII +EcoRV, respectively; Lane 2b, 2d and 2f, sprB-prgH amplified using Bt8 DNA and digested with 
HindIII, EcoRV and HindIII +EcoRV, respectively.  C) prgH-hilA (4.6 kB).Lane 3a-3c, prgH-hilA amplified using SL1344 DNA and 
digested with BglII, EcoRV and HindIII, respectively; Lane 3d-3f, prgH-hilA amplified using Bt8 DNA and digested with BglII, EcoRV 
and HindIII, respectively.  
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Figure 4.4 Comparison of RFLP analysis encompassing the 1B and 1C region of SPI1 in S. Typhimurium SL1344 and S. II Sofia 
Bt8. M, λDNA marker digested with PstI. A) iagB-sipB (8.27 kB). Lane 1a, 1c and 1e, amplified using SL1344 DNA and digested with 
HindIII, EcoRV and HindIII +EcoRV, respectively; Lane 1b, 1d and 1f, amplified using Bt8 DNA and digested with HindIII, EcoRV and 
HindIII +EcoRV, respectively. B) sipB-spaR (3.72 kB). Lane 2a, 2c and 2e, sipB-spaR amplified using SL1344 DNA and digested with 
HindIII, EcoRV and BglII, respectively; Lane 2b, 2d and 2f, sipB-spaR amplified using Bt8 DNA and digested with HindIII, EcoRV and 
BglII, respectively.  C) 1C (10.8 kB). Note that this image is visualised in a negative background to make visible comparison of bands 
easier. Lane 3a, 3c and 3e, 1C amplified using SL1344 DNA and digested with BglII, EcoRV and HindIII, respectively; Lane 3b, 3d 
and 3f, 1C amplified using Bt8 DNA and digested with BglII, EcoRV and HindIII, respectively.  
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It was observed that all PCR amplifications of S. II Sofia Bt8 involving primer sets 
containing one primer designed to detect avrA e.g. sitD/F and avrA/R, avrA/F and hilC/R, 
etc (Appendix VII) were unable to produce any products (data not shown). The primer 
pair sitD/F and sprB/R (see Appendix VII) was designed to amplify the genes adjacent to 
avrA (see Figure 4.2), producing a fragment encompassing the avrA gene. Amplification 
of the sitD-sprB region was carried out on selected S. II Sofia isolates and other 
Salmonella serovars and the resulting PCR products were subjected to electrophoresis 
(Figure 4.5). The products encompassing sitD to sprB from the Salmonella serovars 
Typhimurium, Enteritidis, Infantis, Virchow and Agona were the expected 2.3 kB 
fragment (Figure 4.5). However, sitD-sprB product obtained from all the S. II Sofia 
isolates, and serovars Kiambu and Ohio were 1.4 kB in size (Figure 4.5).  
 
Sequencing analysis of sitD-sprB from strain Bt8 has revealed the replacement of 
the missing 0.9 kB fragment between this region (that would encode avrA) with a 0.28 
kB fragment bordered by sitD and sprB (results not shown). A BLAST search (from the 
PubMed website) was performed on this sequence in order to identify other DNA 
sequences in the GeneBank database that may share similarity with the fragment. This 
fragment was found to share 98% sequence similarity with the 200 bp genetic element 
located in the sitD-sprB region of SPI1 from S. Typhi and S. Choleraesius (Appendix 
VIII). Further, this fragment harboured an ORF encoding a protein of unknown function 
(results not shown). Although the sequence data shows that avrA is absent from its 
expected location within SPI1, Southern hybridisation and PCR amplification with avrA 
alone showed that this gene is still present in the S. II Sofia genome  - however, 
Southern hybridisation and PCR bands detected/produced were weaker compared to S. 
Typhimurium SL1344 (Figure 4.5).  
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Figure 4.5 PCR and Southern hybridisation analysis of avrA within SPI1. M, λDNA 
marker digested with PstI. A) PCR amplification of sitD-sprB region from various 
Salmonella serovars. Lane 1a, Typhimurium 82/6915; Lane 1b, Kiambu 343W; Lane 1c, 
Enteritidis 446302; Lane 1d, Ohio 213N; Lane 1e, Infantis 999S; Lane 1f, Virchow 845V; 
Lane 1g, Agona FSAW3416; Lane 1h-1m, II Sofia (Bt8, 630MSC, 988Q, 554NCA, 
150TC and 664SCA, respectively). B) Southern blot detection of avrA. Lane 2a, 
Typhimurium SL1344; Lane 2b-2d, II Sofia (Bt8, 404QCA and 131, respectively). C) 
PCR amplification of avrA from various Salmonella serovars. Lane 3a, Typhimurium 
82/6915; Lane 3b, Kiambu 343W; Lane 3c, Enteritidis 446302; Lane 3d, Virchow 845V; 
Lane 3e, Infantis 999S; Lane 3f, Ohio 213N; Lane 3g, Agona FSAW3416; Lane 3h-3k, II 
Sofia (Bt8, 988Q, 554NCA, 671SC, respectively).   
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Sequencing analysis (through primer walking) of the 1B region (iagB-sipB) of SPI1 
revealed the presence of 1.2 kB fragment between iagB and sptP, which is not found in 
S. Typhimurium SL1344 (Figure 4.2). Translation of this putative ORF predicted a 
protein that is 400 amino acids in length (results not shown). A BLAST search was 
performed on this protein in order to identify other polypeptide sequences in the 
GeneBank database that may share similarity with this protein, enabling the elucidation 
of the putative function of the protein. The BLAST results indicate that this protein shares 
sequence similarity with the transposase from the mutator family; with 52%, 55%, 62%, 
68%, 68-74%, 91% and 96% match to the transposase from Bacteroides 
thetaiotaomicron, Rickettsiella grylli, E. coli CTF073, Psychrobacter spp., Shewanella 
spp. (serovars oneidensis, putrefaciens, denitrificans and baltica), Yersinia enterocolitica 
and S. Weltevreden; respectively (see Figure 4.6 for amino acid alignment).  
 
However, this DNA fragment (termed an insertion sequence or IS – see Figure 4.2) 
appears to be restricted to S. II Sofia. PCR amplification using primer pair iagB/F and 
sptP/R, which detects the genes flanking the IS was performed on selected Salmonella 
serovars and 18 S. II Sofia isolates (Figure 4.7). Amplification of all the other Salmonella 
serovars (Typhimurium, Hadar, Heidelberg, Enteritidis, Agona, Ohio, Infantis, Virchow 
and Kiambu) resulted in a 0.69 kB PCR product (Figure 4.7). In contrast, the amplified 
product from S. II Sofia isolates was much larger (1.99 kB), indicating the presence of an 
additional 1.2 kB ORF between iagB and sptP (Figure 4.7).                
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IS (Bt8)     -----MSQPFDF--DKALKALQSGQALTGKDGILTPLIKQLTEAALSAELDSHL--AQDVE----ANRKNGSGKKTIKAPTGSFELTTPRDRNGTFEPQLVKKH     91 
S. Weltevre  -----MSQPFDF--DKALKALQSGQALTGKDGILTPLIKQLTEAALSAELDSHL--ASDVE----ANRKNGSGKKTIKAPTGTFELATPRDRNGTFEPQLVKKH     91 
Y. enterocol -----MSQPFDF--DKALKALQDGQALTGKDGILTPLIKQLTEAALAAELDSHL--AQDIE----ANRKNGSTKKTVKTPTGAFELATPRDRNGSFEPQLVKKH     91 
S. oneidensi -----MTQPFNF--EQALKDLQSGKSLTGKDSILGPLIKQLTEAALQAELEQHL--AHDPQ----ANRKNGKTPKTIKHPSGNFELDAPRDRNGTFEPQLIKKN     91 
S.  baltica  -----MSKAFDF--EAAVKALRDGQGLSGTDGILTPLIKQLTEAALNAELEQHL--ANDDQ----PNRKNGKASKKIKSMAGNFELETPRDRAGSFEPQLVKKN     91 
R. grylli    MKQAILSKEFEA--E-AIARLKSGESLTGKDGILTPLIKQIIEASLEGELESHL--LSESKTPELSNRRNGKTSKVLKTETESFELETPRDRLGTFEPQMVKKR     99 
B. thetaoita MDR--NSEEYQQMRDKALSQLRSGESLTGKDGAFGPLLKEFLEAALDGEMSSHLDDSERLK----GNKRNGRGSKRVKTMAGEIDIVTPQDRHSSFSPEILKKR    100 
Psychrobacte ------MQNFDF--NEALKGIQAGKPITGSDGVLAPLIKQLTEAALNAEIQSHL--EQSST----SNRRNGYSKKTVKSAAGSFELETPRDRNGEYEPVLVKKH     91 
E. coli CFT0 ----------------------------------------------------------------------------------------------------MKKH      4 
 
IS (Bt8)     QTTLSDEIERKIIRLFALGMSYQDISREIEDLYAFSVSTATISTVTDKVIPELKQWQQRPLEKVYPFVWLDAIHYKIREDGHYQSKAVYTVLALNLEGKKEVLG    193 
S. Weltevre  QTTLSDEIERKIIRLFALGMSYQDIGREIEDLYAFSVSTATISAITDKVIPELKQWQQRPLEKVYPFVWLDAIHYKVREDGRYQNKAVYTVLALNLEGKKEVLG    193 
Y. enterocol QTTLSDEIERKIIRMFALGMSYKDISQEIEDLYAFSVSSATITAVTDKVIPELKQWQQRPLEAVYPFVWLDAIHYKIREDGHYQSKAVYTVLALNLEGKKENLG    193 
S. oneidensi QTTLTDEIERKVLSMFSIGMSYRDINQHVEDMYGLNVSNATVSAITDKLIPELKAWQQRPLDSHYPIVWLDAIHYKVKEDGRYVSKAVYTLLALNMKGKKEILG    193 
S.  baltica  QTRLTDDLERKILSMFALGMSYRDMRAHVQEMYDMDISEATISSVTDQLLPKLKEWRQRQLDAIYPIVWLDAIHYKVKDEGRYAHKAIYTLLGVNLEGKKELIG    193 
R. grylli    QTVLNESLDNKILSLYALGMSYEAIQDHLADMYGLEVSAAKISLISDKLMPVITEWRNRPLESVYPIVFLDAMHFKVRIEGKVSSRAFYSVLGVNNQGRKEILG    201 
B. thetaoita ETILADNMSSKIISLYGMGLSLRDISSHIEEMYDVEISHNTLSEIIERIVPKVKEWQSRPLESMYTIVWLDAMHYKVKDGGRTESRAVYNVLAVNKDGHKELIG    200 
Psychrobacte QTKLTAEIDSRILSLFSHGMSYRDIRHHIAEIYQLEVSEATISSITDELIPQLKAWQSRPLDSVYPFVWLDAIHYKVKDEGRYVSKAIYTLLALNTEGKKELIG    193 
E. coli CFT0 QTTLSDELERKIIRLFALGMSYQDISREIEDLYAFSVSTTTISAVTDKVIPELKQWQQRPLEKVYPFVWLDAIHYKIREDGCYQSKAVYTVLALNLEGKKEVLG    106 
 
IS (Bt8)     LYLSESEGANFWLSVLSDLQNRGMEDILIACVDGLTGFPEAINSIYPQTEVQLCVIHQIRNSIKYVASKHHRAFMADLKPVYRAVSKEAAETALDELETKWGQQ    294 
S. Weltevre  QTTLESEIERFILSVFSDVQNRGVEDILIACVDGLTGFPEAINSIYPQTEVQLCVIHQIRNSIKYVASKHHKAFMADLKPVYRAVSKDAAETALDELEEKWGQQ    294 
Y. enterocol LYLSENEGANFWLSVLTDLQNRGVDDILIACVDGLTRFPEAINSIYPDTEVQLCVIHQIRNSIKYVASKHHKAFMADLKPVYRAVSKVAAETALDELEEKWGQQ    294 
S. oneidensi LHLSENEGANYWLSVLTDLNNRGVKDILIACVDGLTGFPEAIASIFPHTETQLCVIHQIRNSMKYVASKNQKAFMADLKPVYRAVSKEAAEMALDELEAKWGDA    294 
S.  baltica  LYLSETEGANHWLTVLTDLHNRGVEDILIACVDGLTGFPEAIAAIYPKTEVQLCIIHQIRSSLKYVASKDQKAFMADLKLVYRASTLEVAAASLDDLEEKWGEQ    294 
R. grylli    LYLSENEGSRFWLSVLNDLRARGVEDILIASIDGLKGFPEAIAEVFPQTEIQLCVIHQIRHSLKYVTSKDQKSFMADLKLVYRASSKDLAEHHLLELDEKWGKK    303 
B. thetaoita MYVSESEGANFWLSVLTDLKARGMKDVLIACIDNLTGFAEAISTIFPEVIIQNCVIHQIRNSLKYIASKDQKEFMADLKTVYQAPNKDLAELNLDKLQDKWGKK    302 
Psychrobacte LYCSESEGANYWLSVLTDLHNRGVQDILIACVDGLKGFPEAINAIFPNTEVQLCVIHQIRNSIRYVASRDQKAFMRDLKPVYKAVNKESAELALDDLEAVWGDQ    294 
E. coli CFT0 LYLSESEGANFWLSVLSDLQNRGVEDILIACVDGLTGFPEAINSIYPQTEVQLCVIHQIRNSIKYVASKHHKAFMADLKPVYRAVSKEAAETALDELEAKRGQQ    208 
 
IS (Bt8)     YPVVLQSWRRKWENLSAYFRYPANIRKVIYTTNAIESVHRQFRKLTKTKGAFPNENSLLKLLYLGLMNAQEKWTMPIQSWNLTLSQLAIYFEGRLNNVMTL       400 
S. Weltevre  YPVVLQSWRRKWENLSAYFRYPANIRKVIYTTNAIESVHRQFRKLTKTKGAFPNENSLLKLLYLGLMNAQEKWTMPIQSWNLTLSQLAIYFEGRLNNVMTL       400 
Y. enterocol YPVVLQSWRRKWENLSHYFRYPATIRKVIYTTNAIESVHRQFRKLTKTKGAFPNENSLLKLLYLRLMNAQEKWAMPIQSWNLTLSQLAIYFEGRLDKVITL       400 
S. oneidensi YPLVINSWRRKWHNLSHYFKYPEHIRKVIYTTNAVEAVHRQFRKLTKTKGAFPNENSLLKLLYAGILNASDKWTMPIHNWSLCLSQLAIYFEGRLDSVLEI       400 
S.  baltica  YPIVIKSWRNKWVNLSAYFKYPHYIRKAIYTTNAIEAVHRQFRKLTKTKGAFPNENSLLKLLYAGILNASKKWTMPIQNWGPTLSQLAIHFDGRLDDALGL       400 
R. grylli    YPAVIKSWQTQWDKLSQYFKYPEELRRIIYTTNIIEGFHRQVRKYTKNKGAFTSENALLKLIYCACQKILEKWCQPLHNWALIASQLQIFFDGRLNLQLR-       407 
B. thetaoita YPVVLESWRRNWDNLSAYFAYDEHIRRLIYTTNAVEGFHRQVRKVTKTKGVFPNDMALMKLIYLAVMNISKKWTQPLQNWALTAGQLRIKFGERMPLAI--       405 
Psychrobacte YPAVIKSWRDKWHLLSAYFKYPEAVRKPIYTTNAVEAVHRQFRKLTKTKGAFPNETSLLKLLYVGMLNASAKWTMPIRNWGQTMMQLSIYFPGRLDSVMRL       399 
E. coli CFT0 YPVVLQSWRRKRENLSAYFRYPANIRKVIYTTNAIESVHRQFRKLTKT-----------------------------------------------------       260 
 
Figure 4.6 Alignment of the transposase from S. II Sofia Bt8 (IS) and other bacteria species (Salmonella Weltevreden, Y. enterocolitica, 
Shewanella spp., R. grylli, B. thetaoitaomicron, Psychrobacter spp. and E. coli CFT073, respectively) using Clone Manager 7 software. 
Identical residues are shaded in pink and non-identical residues are not shaded. Numbering on the right side of the residues refers to the 
position of each amino acid in the polypeptide sequence. A list with both the single- and three-letter amino acid codes is shown in Appendix 
IX. 
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Figure 4.7 PCR amplification of iagB-sptP region from various Salmonella serovars. 
M, λDNA marker digested with PstI. Lane 1 and 15, PCR negative control; Lane 2 and 3, 
Typhimurium (SL1344 and 82/6915, respectively); Lane 4, Hadar P12; Lane 5, 
Enteritidis 446302; Lane 6, Agona FSAW3463; Lane 7, Ohio 213N; Lane 8, Infantis 
999S; Lane 9, Virchow 370QC; Lane 10, Kiambu 345W; Lane 11-14 and 16-29, II Sofia 
(Bt8, 988Q, 554NCA, FSAW3452, 826V, 630MSC, 147TC, 147TCA, 150TC, 150TCA, 
537NCA, 566NC, 664SCA, 659SCA, 642SC, 985Q, 391QCA and 348QC, respectively). 
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Overall, a majority of the proteins encoded by the genes in SPI1 of S. II Sofia Bt8 
were highly similar (in length and amino acid content) to the proteins from the 
corresponding genes in SPI1 of S. Typhimurium LT2, with most S. II Sofia Bt8 SPI1-
associated proteins showing a 87 to 99% match to its LT2 SPI1-encoded counterparts 
(see Appendix VIII for further details). However, a number of SPI1 genes (orgB, prgI, 
sptP, sipD and invJ) from strain Bt8 appear to have accumulated changes in their DNA 
sequence, which in turn alters the sequence of the predicted proteins (Appendix VIII). 
The orgB gene contains an additional 10 bp sequence (ATCGTAAAAT) near the end of 
the gene, which (due to an in-frame stop codon) resulted in a protein missing 3 amino 
acids from the end of the polypeptide sequence when translated with Clone Manager 7 – 
valine, isoleucine and arginine. PrgI from S. II Sofia Bt8 was observed to contain an 
extra threonine residue at position 3 due to the insertion of CCA after the start codon of 
the gene (Appendix VIII). Although the InvJ protein from strain Bt8 was shown to be 
highly similar to InvJ from LT2 (98% match, see Appendix VIII), a single base 
substitution of adenine with guanine (A with G: ATG to GTG) at the start codon of invJ 
from strain Bt8 resulted in first amino acid of the polypeptide being changed from 
methionine to valine.  
 
From the sequencing data, the two SPI1 genes (and thus, their putative proteins) 
observed to have the most changes are sptP and sipD. Multiple changes could be 
observed in the genetic sequence of sptP such as insertion and deletion of sequences 
and base substitutions, with a majority of these changes being base substitutions (data 
not shown). After translation of the DNA sequence, the predicted SptP obtained was 
found to contain 511 amino acids as opposed to the expected 543 amino acids – there 
was an absence of 32 amino acids from the polypeptide sequence (Figure 4.8 and 
Appendix VIII). In addition, an alignment performed between SptP from strains LT2 and 
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Bt8 showed that the multiple alterations in the gene led to changes in the amino acid 
composition of the protein – a 72% similarity was obtained (Figure 4.8). Multiple 
sequence changes could also be observed in the sipD from S. II Sofia Bt8 (Figure 4.9). 
The sipD gene (from LT2) is expected to encode a 343-amino acid protein. However, a 
number of sequence changes (insertion, deletion and substitution events) towards the 
end portion of the gene (from base 790 to 820) seemed to have altered the predicted 
protein sequence of sipD from isolate Bt8 (Figure 4.9). This resulted in the translation of 
a truncated 260-amino acid protein. 
 
    The absence of avrA and the genetic changes observed in sptP and sipD within 
SPI1 from S. II Sofia Bt8 could imply that these genes are not expressed during bacterial 
invasion (when the SPI1 region is most active). All 3 genes were then subjected to 
conditions known to activate SPI1 in order to investigate the expression of the individual 
genes. Induction of SPI1 expression was carried out as described previously with some 
minor modifications (Miao and Miller, 2000). Briefly, overnight cultures of S. 
Typhimurium 82/6915 and S. II Sofia Bt8 were diluted 1:30 in 5 mL of fresh LBB and 
incubated at 37°C for 5 h with aeration before RNA isolation (see Section 4.2.3). RT-
PCR analysis was performed on all RNA samples and the expression of the 3 genes 
between isolates 82/6915 and Bt8 was compared. The expression of avrA, sipD and 
sptP from Typhimurium 82/6915 was detected, producing a single band of 0.67, 0.79 
and 0.95 kB in size, respectively (Figure 4.10). However, no products were obtained 
from S. II Sofia Bt8 after RT-PCR, indicating the possibility that avrA, sptP and sipD are 
not expressed by this strain (Figure 4.10). 
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SptP (LT2)   MLKYEERKLNNLTLSSFSKVGVSNDARLYIAKENTDKAYV     40 
SptP (Bt8)   ---------------------VLFDSWSHRTKEYPHETHI     19 
 
SptP (LT2)   APEKFSSKVLTWLGKMPLFKNTEVVQKHTENIRVQDQKIL     80 
SptP (Bt8)   ASEKFASKILTWLGKVPLFKNIDAVRKYVENTQVQDPKAF     59 
 
SptP (LT2)   QTFLHALTEKYGETAVNDALLMSRINMNKPLTQRLAVQIT    120 
SptP (Bt8)   QQFLQALTEKHGEKAVGRVILMSRIDINKPLTERVAQQIK     99 
 
SptP (LT2)   ECVKAADEGFINLIKSKDNVGVRNAALVIKGGDTKVAEKN    160 
SptP (Bt8)   QCVKAADKGF-------------DASLVKKNGDTKVVEQC    126 
 
SptP (LT2)   NDVGAES--KQPLLDIALKGLKRTLPQLEQMDGNSLRENF    198 
SptP (Bt8)   SAFDTDMVKKQ-LLDIALKGLNDVIPELENIDGNRLRENF    165 
 
SptP (LT2)   QEMASGNGPLRSLMTNLQNLNKIPEAKQLNDYVTTLTNIQ    238 
SptP (Bt8)   PEMASNNGSLRKLMTNLQNLNSVPEAKQLNYYAITLKNIQ    205 
 
SptP (LT2)   VGVARFSQWGTCGGEVERWVDKASTHELTQAVKKIHVIAK    278 
SptP (Bt8)   VGVAPFSQWGTDGGVVARWIDKASNHELNQAAKKIQAITQ    245 
 
SptP (LT2)   ELKNVTAELEKIEAGAPMPQTMSGPTLGLARFAVSSIPIN    318 
SptP (Bt8)   ELKNVAAGLENINAGALMPQMLSGPTLGLARFPASNVPIN    285 
 
SptP (LT2)   QQTQVKLSDGMPVPVNTLTFDGKPVALAGSYPKNTPDALE    358 
SptP (Bt8)   QLTQVKLNDGTPMPVNTLNFDGKAVALAGSYPKDTPDALE    325 
 
SptP (LT2)   AHMKMLLEKECSCLVVLTSEDQMQAKQLPPYFRGSYTFGE    398 
SptP (Bt8)   AHVKMLLEKECSCLVVLTSEEQMQTRSLPDYFKGHHTFGE    365 
 
SptP (LT2)   VHTNSQKVSSASQGEAIDQYNMQLSCGEKRYTIPVLHVKN    438 
SptP (Bt8)   VHTNSQKVNSGNLGEEVDQYKMQLSWGEKQYTIPVLHVKN    405 
 
SptP (LT2)   WPDHQPLPSTDQLEYLADRVK-NSNQNGAPGRSSSDKHLP    477 
SptP (Bt8)   WPDHQPLPSATQLENLADSVKSMVNQNGAPGRSSSDKHLP    445 
 
SptP (LT2)   MIHCLGGVGRTGTMAAALVLKDNPHSNLEQVRADFRDSRN    517 
SptP (Bt8)   MIHCLGGVGRTGTMAAALVLKDDPHSNLEQVRADFRDSRN    485 
 
SptP (LT2)   NRMLEDASQFVQLKAMQAQLLMTTAS          543 
SptP (Bt8)   NRMLEDTSQFVQLKAMQAQLLTKTAS            511 
 
 
 
Figure 4.8 Amino acid alignment of the SptP protein from S. Typhimurium LT2 with 
the putative SptP from S. II Sofia Bt8 using Clone Manager 7 software. Identical 
residues are shaded in pink and non-identical residues are not shaded. Numbering on 
the right side of the residues refers to the position of each amino acid in the polypeptide 
sequence. The SptP proteins share 72% match in amino acid composition. A list with 
both the single- and three-letter amino acid codes is shown in Appendix IX.       
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sipD (LT2)   ATGCTTAATATTCAAAATTATTCCGCTTCTCCTCATCCGGGGATCGTTGCCGAACGGCCGCAGACTCCCTCGGCGAGCGAGCACGTCGAGACTGCCGTGG    100 
sipD (Bt8)   ATGCTTAATATTCAAAATTATTCCGCTTCTCCTCGTCCGGGACTTGCTGCCGAACGGCCACAGACAACCGCGGCGAGCGAGCATGTAGAGACTACCGCTG    100 
 
sipD (LT2)   TACCGTCTACCACAGAACATCGCGGTACAGATATCATTTCATTATCGCAGGCGGCTACTAAAATCCACCAGGCACAGCAGACGCTGCAGTCAACGCCACC    200 
sipD (Bt8)   CGCCGTCCACCACAGAACCTCGCGGTGCGGATATTATTTCATTATCTCAGGCGGCTGCTAAAGCCCAACAGGCGCAGCAGACATTACGATCAACGTTGCC    200 
 
sipD (LT2)   GATCTCTGAAGAGAATAATGACGAGCGCACGCTGGCGCGCCAGCAGTTGACCAGCAGCCTGAATGCGCTGGCGAAGTCCGGCGTGTCATTATCCGCAGAA    300 
sipD (Bt8)   GGTCTCCGAAGAGAATAATGACGAGCGCACTCTGGCGCGCCAACAGTTGACCAGCAGCCTGAATGCTCTGGAAAAATCGGGTGTTTCATTATCTGCAGAA    300 
 
sipD (LT2)   CAAAATGAGAACCTGCGGAGCGCGTTTTCTGCGCCGACGTCGGCCTTATTTAGCGCTTCGCCTATGGCGCAGCCGAGAACAACCATTTCTGATGCTGAGA    400 
sipD (Bt8)   CAACATGAGGGGTTGAGGAACGCGTTTTCTGCGCCTGCGCTGGCTTTATTTAGCACTGCGCCGATGGCGCAACCGAGGGCAACCATTTCCGATGCAGAGA    400 
 
sipD (LT2)   TTTGGGATATGGTTTCCCAAAATATATCGGCGATAGGTGACAGCTATCTGGGCGTTTATGAAAACGTTGTCGCAGTCTATACCGATTTTTATCAGGCCTT    500 
sipD (Bt8)   TTTGGGATATGGTTTCCCAAAATATATCGGCGATTGGCGACAACTATTTGGGTGTTTATGAAAACGTTGTCGCAGTTTACACCGATTTTTATCAGGCATT    500 
 
sipD (LT2)   CAGTGATATTCTTTCCAAAATGGGAGGCTGGTTATTACCAGGTAAGGACGGTAATACCGTTAAGCTAGATGTTACCTCACTCAAAAATGATTTAAACAGT    600 
sipD (Bt8)   CAGTGACATTCTCTCCAAAATGGGAGGCTGGTTATCGCCTGGCAAGGATGGAAATACCGTTAAGCTAAATGTTAATGCGCTTAAAAGTGAAATAAGTAAT    600 
 
sipD (LT2)   TTAGTCAATAAATATAATCAAATAAACAGTAATACCGTTTTATTTCCAGCGCAGTCAGGCAGCGGCGTTAAAGTAGCCACTGAAGCGGAAGCGAGACAGT    700 
sipD (Bt8)   CTGATTAATAAATACAACCAAATCAATAAAAATACGATTTTATTTCCCACGCAGACCGGTAGTGGCGTGACAACAGCGTCGAAAGCGGAAGCTGAGCAGT    700 
 
sipD (LT2)   GGCTCAGTGAATTGAATTTACCGAATAGCTGCCTGAAATCTTATGGATCCGGTTATGTCGTCACCGTTGATCTGACGCCA-TTACAAAAAATGGTTCAGG    798 
sipD (Bt8)   GGATTAAGGAGTTGAATTTACCAGACAGCTGTCTTAAGGCGTCTGGTTCTGGTTATGTCGTACTGGTGGATACGGGGCCACTGAGAAAAAATGGTTAGCG    798 
 
sipD (LT2)   ATATTGATGGTTTAGGCGCGCCGGGAAAAGACTCAAAACTCGAAATGGATAACGCCAAATATCAAGCCTGGCAGTCGGGTTTTAAAGCGCAGGAAGAAAA    897 
sipD (Bt8)   ATCTTAATGGGATA---------GGATCAGGTTCCGCCCTTGAACTGGATAACGCGAAATATCAGGCCTGGCAGTCCGGTTTTAAAGCGCAGGAAGAAAA    889 
 
sipD (LT2)   TATGAAAACCACATTACAGACGCTGACGCAAAAATATAGCAATGCCAATTCATTGTACGACAACCTGGTAAAAGTGCTGAGCAGTACGATAAGTAGCAGC    997 
sipD (Bt8)   TCTAAAAACGACGCTACAGACGCTGACCCAAAAATACAGCAATGCCAATTCATTATACGACAACCTGGTAAAAGTGCTGAGCAGTACGATAAGCAGCAGT    989 
 
sipD (LT2)   CTGGAAACCGCCAAAAGCTTCCTGCAAGGATAA                       1032 
sipD (Bt8)   CTGGAAACCGCCAAAAGCTTCCTGCAAGGATAA                       1024 
 
 
Figure 4.9 DNA sequence alignment of sipD from S. Typhimurium LT2 with sipD from S. II Sofia Bt8 using Clone Manager 7 
software. Identical bases for sipD sequence from LT2 and Bt8 are shaded in green and non-identical bases are unshaded. Numbering 
on the right side of the sequence refers to the position of each base in the DNA sequence. The sipD genes share an 80% sequence 
similarity.  
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Figure 4.10 RT-PCR analysis of avrA, sipD and sptP from S.Typhimurium 82/6915 
and S. II Sofia Bt8. M, λDNA marker digested with PstI. Lane 1, 3, 5, 7, 9 and 11 are 
samples prepared without RTase (negative control) and Lane 2, 4, 6, 8, and 12 are 
samples with added RTase. Lane 1 and 2, avrA from 82/6915; Lane 3 and 4, avrA from 
Bt8; Lane 5 and 6, sptP from 82/6915; Lane 7 and 8, sptP from Bt8; Lane 9 and 10; sipD 
from 82/6915; Lane 11 and 12, sipD from Bt8; Lane 13, no sample. 
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4.2.7 Variation of SPI2 between S. Typhimurium and S. II Sofia 
 The SPI2 region was divided into 3 parts to make detection by Southern 
hybridisation easier to perform. Three individual DNA probes were derived from the SPI2 
of S. Typhimurium SL1344 and used to probe Salmonella spp. genomic DNA after 
restriction digest with the appropriate REs: 2A (13.6 kB), 2B (13.5 kB) and 2C (12.9 kB) 
(Figure 4.10 and Appendix VI). All 3 probes detected variation in the hybridisation 
patterns between strains SL1344 and Bt8 (results not shown). Further, the Southern 
hybridisation data was found to match with both the RFLP and sequencing data – thus, 
all the data were used to construct the restriction maps of SPI2 (Figures 4.11 and 4.12).  
A large proportion of the differences found in the SPI2 from isolate Bt8 were attributable 
to the loss or gain of restriction sites (Figure 4.11) and most possibly did not hinder gene 
expression. These predicted proteins were highly similar to their S. Typhimurium LT2 
counterparts with an 83% to 98% identity between proteins (Appendix VIII).  
 
However, insertion and deletion events were observed in 3 of the S. II Sofia Bt8 
SPI2-associated genes – ssaP, ssaI and ssaE (Appendix VIII). The SsaP is missing one 
amino acid (proline) from its polypeptide sequence due to the deletion of three bases 
from the gene – CCT (Appendix VIII). In contrast, ssaI contains an insertion of AGA, 
making the SsaI protein longer by one amino acid, with arginine being the extra residue 
(Appendix VIII). A deletion of approximately 200 bp was observed at the junction 
between sseA and ssaE of isolate Bt8 (indicated by * in the table of fragments obtained 
from EcoRV digestion in Figure 4.11). A single base substitution of T to C in ssaE 
probably interfered with the stop codon of this protein, resulting in 5 extra residues at the 
end of the polypeptide chain of SsaE: glutamine-lysine-serine-leucine-serine (Appendix 
VIII). 
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B
A
(kB) 
SPI-2
EcoRV 
5.1 2.55 3.61 1.98 3.57 3.73 1.73 2.59 3.60 2.41 
0.83 0.40 
0.49 4.71 1.24 
1.05 
1.73 
HindIII 
14.99 15.48 5.62 1.54 0.96 
0.92 
BglII 
3.61 6.08 0.38 29.4 
Isolate Sizes of EcoRV digested fragments (kB) 
Bt8 5.10 2.55 1.98 3.57 3.61  -* 3.73 2.59 0.83 1.73 0.40 0.49 3.60 2.41 0.52 4.27 1.24 1.05 1.73 
SL1344 + + + + + 0.23 + + + + + + + + + +  + + + 
 
C
4.59 kB 0.89 kB6.53 kB7.18 kB
Figure 4.11 Variation of SPI2 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Amavisit et al., 2003). DNA probes (size and extent of each probe) used for Southern hybridisation are indicated above the 
schematic diagram. B) BglII, EcoRV and HindIII restriction maps for S. II Sofia Bt8. The numbers indicate the sizes of detected 
fragments in kB. The maps are estimation of the sizes of restricted DNA fragments and are not drawn to scale. C) Comparison of 
EcoRV bands between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S. II Sofia Bt8; -, absence of 
fragment. *, shows the missing 230 bp between sseA and ssaE from Bt8. Blue boxes and numbers indicate the extent of and size (in 
kB) of the EcoRV fragment.   
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Figure 4.12 Comparison of RFLP analysis encompassing the 2A, 2B and 2C region of SPI2 in S. Typhimurium SL1344 and S. II 
Sofia Bt8. M, λDNA marker digested with PstI. A) 2A (13.6 kB). Lane 1a, 1c, 1e, 1g and 1i, 2A amplified using SL1344 DNA and 
digested with HindIII, EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, respectively; Lane 1b, 1d, 1f, 1h and 1j, 2A amplified using 
Bt8 DNA and digested with HindIII, EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, respectively. B) 2B (13.5 kB). Lane 2a, 2c, 2e, 
2g and 2i, 2B amplified using SL1344 DNA and digested with HindIII, EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, respectively; 
Lane 2b, 2d, 2f, 2h and 2j, 2B amplified using Bt8 DNA and digested with HindIII, EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, 
respectively. C) 2C (10.9 kB). Lane 3a, 3c, 3e, 3g and 3i, 2C amplified using SL1344 DNA and digested with HindIII, EcoRV, BglII, 
BglII+ EcoRV and HindIII +EcoRV, respectively; Lane 3b, 3d, 3f, 3h and 3j, 2C amplified using Bt8 DNA and digested with HindIII, 
EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, respectively. 
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4.2.8 Variation of SPI3 between S. Typhimurium and S. II Sofia 
A single 17 kB SPI3 probe was derived from the genomic DNA of S. Typhimurium 
SL1344 for use in Southern hybridisation. A comparison of the Southern blotting data 
obtained from strains SL1344 and Bt8 revealed a variation in the SPI3 hybridisation 
pattern (results not shown) and this was confirmed by the restriction digest and 
sequencing of SPI3 (Figures 4.13 and 4.14). Most of the RFLP pattern variation 
observed can be attributed to a series of loss/gain of restriction sites (Figure 4.13). 
However, several genes within SPI3 were observed to carry mutations that could affect 
protein sequences and these areas were subjected to further analysis.  
 
The left hand portion of SPI3, which contains the genes sugR and rhuM, was 
found to be absent in the corresponding region of S. II Sofia Bt8. PCR amplification of 
genomic DNA from Salmonella serovars Typhimurium and II Sofia with the primer pair 
3/F3 and rhuM/R, showed that only the Typhimurium strains (SL1344, LT2 and 82/6915) 
yielded the specific 3.43 kB fragment containing both the genes (Figure 4.15). The 
missing sugR-rhuM region was further confirmed by amplification of another 10 S. II 
Sofia isolates with the same primer pair, by Southern hybridisation and by sequencing of 
SPI3 from isolate Bt8 (results not shown).  Analysis of the sequence located in the 
missing sugR-rhuM region have revealed that it contains a 135 bp nucleotide sequence 
sharing 99% similarity with the putative IS1351 transposase (pseudogene) from S. Typhi 
CT18 (data not shown).  
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rhuM 
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marT IS fidL 
ORF307 
mgtB mgtC 
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A
(kB) 
B
SPI-3
3 (17.0 kB) 
BglII 
6.45 2.02 2.52 3.42 
HindIII 
12.94 1.45 
EcoRV 
0.15 
0.74 4.61 0.51 2.71 2.10 0.98 
0.57 
2.22 
Isolate Sizes of EcoRV digested fragments (kB) 
SL1344 + + 1.70 0.74 1.13 0.15 + + + + - + + + + 
Bt8 0.18 0.34 - (missing sugR and rhuM) 0.40 4.61 0.51 2.11 0.58,  0.73 1.39 0.57 2.22 0.98 
 
C
2.04 kB 3.22 kB
0.74 kB 2.71 kB 2.10 kB
3.50 kB
Figure 4.13 Variation of SPI3 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Amavisit et al., 2003). The absence of sugR-rhuM and presence of the ORF (IS) is indicated as an unshaded block and green 
shaded box, respectively. DNA probes (size and extent of each probe) used for Southern hybridisation are indicated above the 
schematic diagram. B) BglII, EcoRV and HindIII restriction maps for S. II Sofia Bt8. The numbers indicate the sizes of detected 
fragments in kB. The maps are estimation of the sizes of restricted DNA fragments and are not drawn to scale. C) Comparison of 
EcoRV bands between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S. II Sofia Bt8; -, absence 
of fragment. Blue boxes and numbers indicate the extent of and size (in kB) of the EcoRV fragment.      
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Figure 4.14 Comparison of RFLP analysis of the SPI3 region in S. Typhimurium 
SL1344 and S. II Sofia Bt8. M, λDNA marker digested with PstI. Lane 1, 3, 5, 7 and 9, 
probe 3 amplified using SL1344 DNA and digested with HindIII, EcoRV, BglII, BglII+ 
EcoRV and HindIII +EcoRV, respectively; Lane 2, 4, 6, 8 and 10, probe 3 amplified using 
Bt8 DNA and digested with HindIII, EcoRV, BglII, BglII+ EcoRV and HindIII +EcoRV, 
respectively.  
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Figure 4.15 PCR analysis of sugR-rhuM and slsA-cigR regions within SPI3. M, λDNA 
marker digested with PstI. A) PCR amplification of sugR-rhuM region (with primer pair 
3/F3 and rhuM/R) from various Salmonella serovars. Lane 1, Typhimurium SL1344; 
Lane 2, Typhimurium LT2 9121; Lane 3, Typhimurium 82/6915; Lane 4-7, II Sofia (Bt8, 
988Q 664SCA and 554NCA, respectively). B) PCR amplification of slsA-cigR region 
(with primer pair 3/F12 and 3/R8) from various Salmonella serovars. Lane 1, 
Typhimurium 82/6915; Lane 2, Hadar P12; Lane 3, Heidelberg; Lane 4, Enteritidis 
446302; Lane 5, Agona FSAW3416; Lane 6, Ohio 213N; Lane 7, Infantis 999S; Lane 8, 
Virchow 370 QC; Lane 9, Kiambu 343W; Lane 10-29, II Sofia (Bt8, FSAW3452, 826V, 
630MSC, 988Q, 348QC, 404QCA, 985Q, 554NCA, 561NC, 566NC, 537NCA, 140TCA, 
147TC, 150TC, 150TCA, 659SCA, 671SCA, 636SC and 642SC, respectively).   
 
1.7 
1.7 
1 3 2 (kB) 
0.51 
0.80 
4 5 6 
M 
M 7 8 9 10 
11.5 
2.6, 2.5, 2.4 
5.1, 4.7, 4.5 
2.8 
0.51 
0.80 
2.6, 2.5, 2.4 
M M
1 2 3 4 5 6 7
(kB) 
(kB) 
11 
20 
12 13 14 15 16 17 18 19 
21 22 23 24 25 26 27 28 29 
A 
B 
3.43 kB 
0.42 kB 
1.6 kB 
1.6 kB 
CHAPTER 4 
 171
Sequencing analysis has also revealed the presence of a 1.2 kB fragment between 
slsA and cigR, which is not found in S. Typhimurium SL1344 (Figure 4.13). This ORF 
(IS) was found to encode a 400-amino acid protein that is identical to the protein from 
the putative ORF located between iagB and sptP of SPI1 from strain Bt8 (see Section 
4.2.6). Further, this sequence is also restricted to S. II Sofia: using the primer pair 3/F12 
and 3/R8 (Appendix VII), it has been shown that only the amplification of S. II Sofia 
isolates generated PCR products containing this ORF; resulting in a 1.6 kB fragment 
instead of the expected 0.42 kB seen in all the other Salmonella serovars (Figure 4.15).    
 
Sequencing analysis revealed that out of the 8 genes (rmbA, misL, fidL, marT, 
slsA, cigR, mgtC and mgtB) in SPI3 of S. II Sofia Bt8, 3 of these genes (misL, marT and 
slsA) were found to contain changes that affected the translation of its proteins; with the 
rest of the SPI3-associated proteins showing a 95-98% identity when compared with the 
corresponding SPI3 proteins from strain LT2 (Appendix VIII).  A 15 bp deletion 
(TCCCTGACCCTGTCG) from the middle of misL from S. II Sofia resulted in the 
translation of a protein missing 5 amino acid residues from the middle portion 
polypeptide sequence: valine-proline-aspartic acid-proline-valine (Appendix VIII). On the 
other hand, 23 residues were absent from the start of the MarT protein due to the 
insertion of the 10 bp sequence (ACCGGGAGAAA), which caused a frameshift within 
the gene (see Appendix VIII). The presence of the IS sequence in the slsA-cigR region 
of strain Bt8 appeared to have interfered with the expression of slsA. From the 
sequencing data, it was shown that the 1.2 kB IS element was inserted towards the end 
of the slsA gene, causing a frameshift which disrupted the stop codon for this protein 
(data not shown). The predicted SlsA (translated using Clone Manager 7) had an 
additional 25 amino acids at the end of the polypeptide sequence (Appendix VIII). 
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The expression of SPI3 genes marT and slsA were analysed through RT-PCR 
(see Section 4.2.3). Cultures of S. Typhimurium 82/6915 and S. II Sofia Bt8 were 
incubated as described previously (see Section 4.2.6) before being subjected to RNA 
isolation and RT-PCR. No expression of slsA was detected from either S. Typhimurium 
82/6915 or S. II Sofia Bt8: no RT-dependent PCR product could be amplified from RNA 
of either strain (Figure 4.16). However, RT-PCR analysis of marT from strains 82/6915 
and Bt8 yielded the expected 0.42 kB fragment (Figure 4.16).  
 
4.2.9 Variation of SPI4 between S. Typhimurium and S. II Sofia  
Two probes (4A and 4B, see Appendix VI for details) were used to investigate the 
variation between S. Typhimurium SL1344 and S. II Sofia Bt8 in SPI4. The variation in 
the Southern hybridisation pattern obtained was confirmed by restriction digest and 
sequencing analysis and all data was used in the construction of the SPI4 restriction 
maps of Bt8 (Figures 4.17 and 4.18). Analysis of the sequencing data obtained (using 
Clone Manager 7) has revealed that the S. II Sofia Bt8-associated SPI4 proteins were 
highly similar to the S. Typhimurium LT2-associated SPI4 proteins, exhibiting a 91-98% 
match (Appendix VIII). Thus, the differences observed in the restriction pattern between 
the 2 serovars could be attributed to the loss or gain of restriction sites, not to any 
insertions or deletions. 
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Figure 4.16 RT-PCR analysis marT and slsA from S.Typhimurium 82/6915 and S. II 
Sofia Bt8. M, λDNA marker digested with PstI. Lane 1, 3, 5 and 7 are samples prepared 
without RTase (negative control) and Lane 2, 4, 6 and 8 are samples with added RTase. 
Lane 1 and 2, slsA from 82/6915; Lane 3 and 4, slsA from Bt8; Lane 5 and 6, marT from 
82/6915; Lane 7 and 8, marT from Bt8. 
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SL1344 + + + + + + + + + + + + + + + + 
Bt8 0.36 3.83 3.50 0.31 0.16 5.88 1.45 0.88 2.04 1.16 0.59 0.23 1.10 0.60 0.71 0.59, 0.086 
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1.70 kB3.20 kB 8.21 kB 1.38 kB
Figure 4.17 Variation of SPI4 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Gerlach et al., 2007). DNA probes (size and extent of each probe) used for Southern hybridisation are indicated above the 
schematic diagram. B) BglII, EcoRV and HindIII restriction maps for S. II Sofia Bt8. The numbers indicate the sizes of detected 
fragments in kB. The maps are estimation of the sizes of restricted DNA fragments and are not drawn to scale. C) Comparison of 
EcoRV bands between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S .II Sofia Bt8; -, absence 
of fragment. Blue boxes and numbers indicate the extent of and size (in kB) of the EcoRV fragment.      
CHAPTER 4 
 175
 
 
 
 
 
 
 
 
 
Figure 4.18 Comparison of RFLP analysis encompassing the 4A and 4B region of 
SPI4 in S. Typhimurium SL1344 and S. II Sofia Bt8. M, λDNA marker digested with PstI. 
Lane 1, 3 and 5, 4A amplified using SL1344 DNA and digested with BglII, EcoRV and 
HindIII respectively; Lane 2, 4 and 6, 4A amplified using Bt8 DNA and digested with 
BglII, EcoRV and HindIII, respectively; Lane 7, 9 and 11, 4B amplified using SL1344 
DNA and digested with BglII, EcoRV and HindIII, respectively; Lane 8, 10 and 12, 4B 
amplified using Bt8 DNA and digested with BglII, EcoRV and HindIII, respectively. 
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4.2.10 Variation of SPI5 between S. Typhimurium and S. II Sofia 
For the Southern hybridisation of SPI5, chromosomal DNA was digested with 10U 
of DraI or EcoRV or with 10U of a combination of both REs as described previously 
(Amavisit et al., 2003). Southern blotting of digested genomic DNA (serovars 
Typhimurium SL1344 and II Sofia Bt8) was carried out with DNA probe 5 (6.23 kB, see 
Appendix VII). The Southern hybridisation pattern obtained from S. II Sofia Bt8 was 
observed to be different compared to that of Typhimurium SL1344 (results not shown). 
However, all attempts to amplify this region from strain Bt8 (with the primer pair 5/F and 
5/R) were unsuccessful. Therefore, a series of primers encompassing different areas 
within SPI5 were designed in an attempt to amplify this region within S. II Sofia Bt8 
(Appendix VII). Only the region containing copR, copS, pipD and orfX was successfully 
amplified and the SPI5 of isolate Bt8 appeared to be missing the 4.5 kB region 
containing sopB, pipC, pipB and pipA – all PCR amplifications of this particular region 
did not yield any product despite numerous attempts (data not shown).  
 
The total absence of this 4.5 kB region was further confirmed by the Southern 
hybridisation (carried out in low and high stringency conditions) of Salmonella serovars 
Typhimurium and II Sofia with the probe sopB-pipA (Figure 4.19). The map of SPI5 of S. 
II Sofia Bt8 was then constructed based on Southern hybridisation, restriction digest and 
sequencing data (Figures 4.19 and 4.20). Overall, the deduced proteins encoded by the 
SPI5-associated genes of strain Bt8 share 95 to 100% polypeptide match when 
compared to the corresponding SPI5 proteins of strain LT2 (Appendix VIII). However, a 
base substitution (G with T) was observed at the start of the ORF (Appendix VIII) from 
Bt8 and this caused a missense mutation in the start codon of this gene (ATG to ATT) – 
protein encoded by this gene is probably not translated.   
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Figure 4.19 Southern hybridisation and restriction digest analysis of the SPI5 region 
from S. Typhimurium and S. II Sofia serovars. The fragment sizes of S. Typhimurium 
SL1344 were indicated at the side for each blot (A and B). A) Southern blot detection of 
sopB-pipA (4.5 kB) under high stringency conditions (hybridisation temperature 65°C, 
~90% identity between genes). Genomic DNA was digested with XbaI. Lane 1, 
Typhimurium SL1344; Lane 2-4, II Sofia (Bt8, 986Q and 554NCA, respectively). B) 
Southern blot detection of sopB-pipA (4.5 kB) under low stringency conditions 
(hybridisation temperature 50°C, ~65% identity between genes). Genomic DNA was 
digested with EcoRV. Lane 1 and 2, Typhimurium (SL1344 and 82/6915, respectively); 
Lane 3-7, II Sofia (Bt8, 659SCA, 391QCA, 242T and 554NCA, respectively). C) RFLP 
analysis of copR-orfX (4.0 kB) from 1344 and Bt8. M, λDNA marker digested with PstI. 
Lane 1 and 3, SL1344 digested with HindIII and EcoRI, respectively; Lane 2 and 4, Bt8 
digested with HindIII and EcoRI, respectively.  
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Figure 4.20 Variation of SPI5 between S. Typhimurium SL1344 and S. II Sofia Bt8 as detected by Southern hybridisation, PCR 
restriction digest and sequencing analysis. A) Schematic representation of SPI genes and their direction of transcription (adapted 
from Amavisit et al., 2003). The absence of sopB-pipA region is indicated by unshaded block. DNA probes (size and extent of each 
probe) used for Southern hybridisation are indicated above the schematic diagram. B) DraI, EcoRV and HindIII restriction maps for 
S. II Sofia Bt8. The numbers indicate the sizes of detected fragments in kB. The absence of sopB-pipA region is indicated by 
dashed lines on the restriction maps. The maps are estimation of the sizes of restricted DNA fragments and are not drawn to scale. 
C) Comparison of EcoRV bands between SL1344 and Bt8. +, presence of a fragment of the same size as that observed in S. II 
Sofia Bt8; -, absence of fragment. Blue boxes and numbers indicate the extent of and size (in kB) of the EcoRV fragment.      
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4.3 Discussion  
To evaluate the RE digests of S. II Sofia DNA, a relatively large amount of 
genomic DNA (approximately 20-25 µg) was required for the subsequent Southern 
blotting experiments to ensure that all bands were detected after probe hybridisation and 
detection. The intensity of the bands detected (with the ANTI-DIG system, see Section 
2.3.7) was dependent on the amount of digested chromosomal DNA present (higher 
DNA concentration produce more intense bands) and size of the fragment binding to the 
probe (smaller fragments tend to bind less efficiently compared to larger fragments – 
using more DNA increases the intensity of such bands). Therefore, by using 20-25 µg of 
DNA for Southern hybridisation studies, membrane blots with visible and clear bands 
were produced (Figure 4.1).  
 
The preparation of agarose plugs was found to be a more useful method for 
obtaining high concentrations of genomic DNA than the extraction method. DNA 
extraction usually involves a series of steps that extract, purify and concentrate the 
chromosomal DNA from the cells and at every step; a small amount of DNA is lost - e.g. 
after PCI extraction, a small amount of the aqueous phase (which contains the DNA) is 
not removed in order to avoid disturbing the interface where the contaminants are 
precipitated (see Section 2.3.2.1). The loss from each step ultimately affects the final 
yield of DNA, evident as the extraction process had to be carried out a few times in order 
to obtain the amount of DNA required. In contrast, plugs prevent the loss of DNA as the 
bacterial cells are embedded in agarose before being subjected to lysis and washing 
steps (see Section 2.3.6.1.1): a small slice of the plug (~ 2 mm out of 6 mm plug) was 
found to contain sufficient DNA for Southern hybridisation.  
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The Southern hybridisation patterns (SPI1 to SPI5) obtained from S. II Sofia 
isolates was observed to be identical to one another and different from those of S. 
Typhimurium isolates. Amavisit and his colleagues (Amavisit et al., 2003) carried out and 
compared Southern hybridisation patterns across the 5 SPIs from various Salmonella 
serovars and found that all strains within the same serovar shared the same SPI1 to 
SPI5 pattern. While a majority of differences observed in the SPI pattern from various 
Salmonella serovars were attributable to a series of loss and gain of restriction sites, 
insertion and deletions were found in the SPI1, SPI3 and SPI5 regions (Amavisit et al., 
2003). This was also the case with the S. II Sofia isolates. An example of the altered 
restriction sites can be seen from the comparison of EcoRV restriction maps between S. 
Typhimurium LT2 and S. II Sofia Bt8 (see part C in Figures 4.2, 4.11, 4.13, 4.17 and 
4.20). When compared to SPI1 to SPI5 of strain LT2, the SPI regions of isolate Bt8 were 
found to contain point mutations that caused either a gain of a new (creating a 2-3 
smaller fragments) or loss of EcoRV site (creating a larger fragment). The major genetic 
variation in S. II Sofia Bt8 was also found to be contained within SPI1, SPI3 and SPI5. 
 
The point mutations (base substitutions) throughout the SPIs of strain Bt8 not only 
changed the restriction patterns of the strain but also the amino acid composition of the 
predicted proteins (when the base substitution changes the codon encoding an amino 
acid). A majority of the predicted S. II Sofia SPI-associated proteins had such changes in 
their polypeptide sequence, sharing 87% to 99% identity with corresponding SPI 
proteins from S. Typhimurium LT2 (Appendix VII). The assumption that the S. II Sofia 
proteins are functional is reasonable due to the high sequence similarity between a large 
proportion of the SPI proteins from strains LT2 and Bt8. But it is possible that the 
translation of a different amino acid (missense mutation) may have an effect on protein 
function (Anon, 2008b). In addition, base substitution could cause nonsense mutations 
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by mutating start and stop codon or creating a termination codon in the middle of a gene 
(Anon, 2008b) and this has been observed within the SPI regions of S. II Sofia Bt8. A 
number of S. II Sofia SPI genes also appeared to have accumulated changes (other 
than base substitutions) such as insertions and deletions of bases or sequences, which 
have been shown (using computer software) to alter protein translation process 
(Appendix VIII). 
 
Two major insertion and deletion events were found in the SPI1 of S. II Sofia Bt8: 
insertion of a 1.2 kB transposase ORF and deletion of avrA (Figures 4.5 and 4.6). The 
absence of avrA between sitD-sprB in SPI1 is not unique to S. II Sofia isolates – deletion 
of avrA was also detected within the Salmonella serovars Kiambu and Ohio (Figure 4.5) 
and other Salmonella serovars, which was confirmed by previous studies (Amavisit et 
al., 2003; Hardt and Galán, 1997). These previous studies revealed that the 0.9 kB 
fragment from the avrA region was replaced with ~200 bp sequence, which contained an 
ORF encoding a 69-amino acid protein of unknown function (Amavisit et al., 2003; Hardt 
and Galán, 1997). This sequence replacement was also observed in the sitD-sprB SPI1 
region of S. II Sofia Bt8 (Appendix VIII).    
 
Further, avrA may be missing from SPI1 but the gene is still present in the S. II 
Sofia genome, as can be seen from Figure 4.5. This would indicate that at some point, 
an insertion and excision (mediated by genetic elements such as a phage or IS) or 
horizontal transfer event (Amavisit et al., 2003) probably occurred within SPI1 of strain 
Bt8 that resulted in the transfer of avrA to another location in the S. II Sofia genome. It is 
possible that the ORF found in the deleted region was transferred there as a result of 
genetic recombination between avrA and the ORF, leading to the exchange of genetic 
locations. This transfer event could also have altered the sequence of the gene, resulting 
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in the weaker bands detected by Southern blot and PCR (Figure 4.5). Since avrA is no 
longer influenced by SPI1, the resulting protein is probably not expressed because 
secretion of avrA requires a number of SPI1 genes (Hardt and Galán, 1997). RT-PCR 
analysis of the expression of avrA seemed to support this view: while this gene was 
expressed from S. Typhimurium 82/6915, expression of avrA from S. II Sofia Bt8 was 
not detected (Figure 4.9). The AvrA protein has been shown to be involved in the 
initiation and enhancement of cell apoptosis (Collier-Hyams et al., 2002; Ye et al., 2007) 
and thus, its absence in S. II Sofia may affect the virulence of the strain. 
 
The insertion of a 1.2 kB sequence (between iagB and sptP) was observed within 
the SPI1 of S. II Sofia (Figure 4.6). Sequence analysis of this fragment revealed that it 
contains a putative ORF encoding a 400-amino acid protein with sequence similarity to 
transposase proteins from the mutator family. This family of proteins function as mobile 
DNA elements, inserting and excising into various locations in the bacterial genome and 
thereby, causing and promoting mutations (Pacurar et al., 2006). As this ORF is only 1.2 
kB in size and encodes no other function other than the one involved in its mobility, the 
ORF is probably an IS element. Although found in a number of bacterial species (e.g. 
Yersinia enterocolitica, E. coli, Shewanella spp., etc), the transposase was observed to 
be restricted to the Salmonella serovars Welterveden (Figure 4.6) and II Sofia (Figure 
4.7). The presence of this IS element in S. II Sofia could have potential as a marker to 
differentiate this serovar from other Salmonella spp. As S. II Sofia is so prevalent among 
Australian poultry (but is avirulent), the development of a rapid identification method 
would be useful in the screening of S. II Sofia from the other more pathogenic 
Salmonella strains that are present in the poultry flocks. Although S. Weltevreden is 
currently the most common cause of non-typhoidal salmonellosis in the Southeast Asia 
region (e.g. Malaysia and Thailand), it is rarely isolated from Australian poultry (Galanis 
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et al., 2006; Heuzenroeder et al., 2001; Miller et al., 2005; Murray, 1994; Yohannes et 
al., 2004). 
 
Insertions were observed in the sequence of SPI1-associated orgB and prgI from 
strain Bt8, resulting in translation of proteins with changes in the polypeptide chain 
length. While the insertion in orgB appeared to have caused a frameshift (resulting in 
translation of a protein missing 3 residues from the end of the chain), PrgI contained an 
extra amino acid as the insertion of the CCA codon was in frame with the ORF encoding 
this protein (Appendix VIII). The changes to the polypeptide chain could also have 
altered the function of the proteins. PrgI and OrgB have been shown to be involved with 
the TTS apparatus of SPI1 (Kimbrough and Miller, 2000; Klein et al., 2000; Sukhan et 
al., 2001). Therefore, both these proteins are required for invasion and secretion of 
effector proteins and any mutations would affect the virulence.  
 
A point mutation at the start codon of invJ from isolate Bt8 resulted in the first 
amino acid of the polypeptide being changed from methionine to valine, which could 
affect its function. Although the start codon for most proteins is ATG (methionine),  
occasionally GTG (valine) and TTG (leucine) are used by bacteria as a start codon e.g. 
when using the normal ATG would cause the increase in expression and impair normal 
mechanism of gene expression (Masaru, 2008). Examples of SPI genes with alternative 
start codon include orgC, invA, ttrS, siiB (start codon of GTG) and sicP (start codon of 
TTG). It is possible that the change in the start codon could have impaired function of 
invJ - translation may not occur or be reduced due to the change from normal ATG to 
GTG. As this protein controls the length of the needle complex in the SPI1 TTS system, 
a loss of function in invJ would have an effect on the bacterial invasion process – it has 
been shown that invJ mutants are unable to form a functional TTS system (Chen et al., 
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1996; Collazo et al., 1995; Kubori et al., 2000, Sukhan et al., 2001; Zierler and Galán, 
1995).   
  
Another point mutation that altered the protein start codon was observed in the 
sequence of sptP (Appendix VIII). Unlike the mutation in invJ, this base substitution 
caused a nonsense mutation in the codon – the predicted SptP protein is missing 32 
amino acids from the beginning of its polypeptide sequence (Figure 4.8). This gene was 
also observed to contain a number of other mutations including the insertion and 
deletion of DNA sequences, which caused multiple changes observed in the amino acid 
residues (Appendix VIII and Figure 4.8). The SPI1-associated sipD contained multiple 
changes in its DNA sequence (Figure 4.9), resulting in the truncation of SipD protein due 
to the creation of a termination codon in the middle of the gene. Analysis of the 
nucleotide sequence revealed that this protein truncation could not be attributed to a 
single mutation event – the accumulation of a number of genetic mutations (from base 
790 to 820, see Figure 4.9) changes the protein sequence.     
 
Both these genes could be potential pseudogenes. Pseudogenes are defined as 
ORFs of known genes that are truncated or contain a number of mutations that have 
disrupted a sizeable portion of the coding sequence (Lerat and Ochman, 2005; Liu et al., 
2004; Mira and Pushker, 2005). They are a common feature in many genomes, including 
the bacterial species (especially those undergoing processes such as niche changes 
and host specialisation) (Lerat and Ochman, 2005; Liu et al., 2004; Mira and Pushker, 
2005). A nonsense or missense mutation probably occurred in sipD and sptP genes of 
S. II Sofia, disrupting the gene transcription/protein translation. Without selective 
pressure (proper function of the gene) on the gene, mutations are likely to occur more 
frequently within the ORF, as can be observed with both these genes. This accumulation 
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of genetic changes further disrupts transcription/translation process – the gene then 
becomes a pseudogene due to loss of function.   
     
The SipD and SptP proteins have been shown to be required for the invasion 
process of Salmonella spp. (Collazo and Galán, 1997b; Kaniga et al., 1995a; 1996). 
SipD appears to be part of a protein complex (with the SipBC proteins) that delivers 
effector proteins into the host cells (Cherayil et al., 2000; Collazo and Galán, 1997b; 
Darwin and Miller, 1999b; Zhang et al., 2003) and SptP is a SPI1-encoded effector 
protein, which is translocated in a Sip-dependent manner and is involved in disruption of 
the cell cytoskeleton (Fu and Galán, 1998b; Murli et al., 2001). Therefore, mutations 
within these genes would probably alter the function of their encoded proteins.   It is also 
possible that sptP and sipD from S. II Sofia are non-functional (i.e. not expressed) due to 
these mutations (alteration of start codon and creation of an extra stop codon, 
respectively). This observation appears to be supported by the RT-PCR analysis on the 
expression of sptP and sipD: no band was amplified from the samples of strain Bt8, 
indicating the possibility that both these genes are not expressed by the SPI1 of S. II 
Sofia (Figure 4.10). However, the low levels of expression obtained in strain 82/6915 (as 
seen from the faint bands in Figure 4.10) could mean that mRNA from S. II Sofia was 
produced at levels too low to be detected by RT-PCR. This low expression level could 
also be the result of the gene mutations observed, which may have affected the mRNA 
transcription of sptP and sipD and thereby, the translation of sufficient amounts of 
protein to mediate the bacterial invasion process.  
 
Comparison of SPI2 from S. Typhimurium and S. II Sofia has revealed that this 
region is relatively conserved between the 2 strains, with the putative proteins sharing an 
83 to 98% identity (Figure 4.11 and Appendix VIII). However, three S. II Sofia SPI2 
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genes (ssaP, ssaI and ssaE) appeared to have acquired mutations that could affect the 
encoded proteins. An insertion in ssaI and deletion in ssaP (in both cases, the sequence 
in question was a codon) resulted in translation of a protein with an extra or missing 
residue, respectively (Appendix VIII). A point mutation in ssaE removed the original 
termination codon of this ORF: translation of predicted SsaE with 5 additional amino 
acids in its polypeptide sequence (Appendix VIII). The mutation in ssaE may be linked to 
the 200 bp deletion found between sseA and ssaE. It is possible that the deletion of this 
200 bp sequence was mediated by the insertion and excision of an IS element and this 
event could have caused the mutation in the stop codon of ssaE, which was located 
close to the deletion point (Appendix VIII).  
 
All 3 SPI2 genes encode components of the SPI2 TTS system and ssaI mutants 
have been shown to be defective in intracellular replication and in the translocation and 
secretion process (Chakravortty et al., 2005). Therefore, the mutations observed in the 
SPI2 could have had an effect on pathogenicity of S. II Sofia. The SPI4 region of S. II 
Sofia Bt8 was found to contain only minor genetic variation (when compared to S. 
Typhimurium LT2): the loss or gain of restriction sites and translation of predicted 
proteins sharing 91-98% identity with their S. Typhimurium counterparts (Figure 4.17 
and Appendix VIII). This region is probably functional in S. II Sofia – however, research 
on expression of the SPI4 proteins needs to be carried out to confirm the functionality of 
this region.    
 
Major genetic variation was detected within the SPI3 region of S. II Sofia Bt8, 
including the deletion of 2 genes (sugR and rhuM) and insertion of an IS element within 
the slsA-cigR region, which appeared to have affected slsA (Figures 4.13 and 4.15 and 
Appendix VIII).  This deletion was observed in other Salmonella spp., including serovars 
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Ratchaburi, Virchow, Infantis, Bovismorbificans and Zanzibar (Amavisit et al., 2003). The 
selC region, which is next to the left hand portion of the SPI3 region (and contains the 
genes sugR and rhuM) has been shown to be the integration site for pathogenicity 
islands in Salmonella spp. and E. coli (Amavisit et al., 2003; Blanc-Potard et al., 1997; 
1999). Thus, this portion of SPI3 is probably more prone to genetic changes (insertions 
and deletions) and found to be less conserved compared to the central region, which 
contains the genes rmbA, misL, fidL and marT (Amavisit et al., 2003; Blanc-Potard et al., 
1999). The deletion of sugR and rhuM could possibly be related to the detection of an 
ORF with homology with putative IS1351 transposase pseudogene (Appendix VIII). This 
135 bp fragment appears to be a gene remnant of an insertion sequence (it is non-
functional; hence the term pseudogene) (Parkhill et al., 2001), which was probably left 
behind after the insertion and excision of the IS element, leading to the deletion of sugR 
and rhuM as well. The exact function of both these genes is still unknown – however, 
rhuM has been identified as one of the SPI3 genes that could potentially be required for 
systemic disease (Lawley et al.¸2006). Therefore, its absence may affect S. II Sofia 
pathogenicity.  
 
The insertion of a 1.2 kB ORF was detected between SPI3 genes slsA and cigR in 
S. II Sofia (Figures 4.13 and 4.15). This ORF was shown to encode a putative 
transposase of the mutator type that is identical to the transposase encoded by the IS 
element located between SPI1 genes iagB and sptP in strain Bt8 (Appendix VIII). The 
presence of more then one IS element (of the same type) in the bacterial genome is not 
an uncommon occurrence: e.g. IS200, which has been successfully utilised for the 
typing of Salmonella spp. (Baquar et al., 1994; Lam and Roth, 1983; Millemann et al., 
1995; Old et al., 1999; 2000; Threlfall et al., 1993). The insertion of this sequence alters 
the predicted expression of slsA – a frameshift was detected, which disrupted the 
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termination codon of the gene and resulted in the translation of a protein with an 
additional 25 residues (Appendix VIII). This alteration may also have affected 
transcription of the gene, as can be observed in the RT-PCR analysis of slsA (Figure 
4.16). However, the absence of any RT-PCR product could be due to a number of other 
reasons: expression levels were too low to be detected by RT-PCR, isolates were not 
incubated in conditions that induce gene expression, etc. The exact function of slsA is 
unclear but it has been shown to be needed for colonisation in cattle and chickens 
(Morgan et al., 2004).  
 
An insertion and deletion in misL and marT respectively has resulted in predicted 
proteins with altered polypeptide chain length (Appendix VIII). These changes to the 
protein sequence may have an effect on function. While the MarT protein has been 
identified as a transcriptional activator of the misL promoter (Tükel et al., 2007), MisL 
functions as a surface adhesin and is required for intestinal colonisation in mice and 
chickens (Dorsey et al., 2005; Morgan et al., 2004). The mutations within slsA, marT and 
misL could have altered the functionality of the proteins encoded by the genes, which 
may have affected the virulence ability of S. II Sofia. It is also possible that the extra 
residues in SlsA and MarT could have altered their function in a different manner – by 
increasing the colonisation function of these proteins, which would explain the 
persistence of S. II Sofia in poultry flocks.  
 
 A single base substitution in the SPI5 gene ORF (Figure 4.20) appeared to have 
caused a mutation in the start codon of this gene – the putative protein was probably not 
translated. This ORF was predicted to encode a putative cytoplasmic protein (although 
its exact function is unclear) and therefore, a mutation could affect protein function 
(especially when the mutation renders the gene non-functional). However, the biggest 
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change observed in SPI5 of S. II Sofia Bt8 is the deletion of the right half of this region, 
which comprised the genes sopB, pipC, pipB and pipA (Figures 4.19 and 4.20). The 
detection of this major deletion was confirmed by Southern hybridisation experiments 
carried out in both low and high stringency conditions (Figure 4.19). By carrying out the 
blotting experiments under both these conditions, it can be concluded that not only is this 
4.5 kB region absent from SPI5 of S. II Sofia, the possibility that relatively similar regions 
(~65% sequence similarty) could be present (which would bind with the probe at lower 
stringency conditions – e.g. lower hybridisation temperature) was also excluded.  
 
The genes in the deleted region have been shown to be involved in intestinal 
secretory and inflammation responses and mutations in these genes have resulted in 
attenuation and reduced virulence (Galyov et al., 1997; Morgan et al.¸2004; Norris et al., 
1998; Pfeifer et al., 1999; Wood et al., 1998). Further, the proteins encoded by these 
genes are able to interact with other virulence effectors (from outside the SPI5 region) to 
perform a range of virulence-associated functions such as host invasion, 
enteropathogenicity and disruption of tight junction structure and actin cytoskeletal 
rearrangements (Boyle et al., 2006; Jones et al., 1998; Mirold et al.¸2001; Raffatellu et 
al., 2005; Zhang et al., 2002; Zhou et al., 2001). The absence of these genes could be 
one of the reasons that S. II Sofia is unable to cause disease in poultry or humans – S. II 
Sofia isolates are probably unable to induce intestinal inflammation and secretion, which 
is required to cause gastroenteritis. 
 
It would appear the avirulence of S. II Sofia is not due to a single mutation or 
deletion but rather a series of mutations in the genes within the SPI regions. These 
mutations have been observed to consist of base substitutions, insertion and deletion of 
sequences, which have either altered the codons or caused frameshifts within SPI 
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genes, resulting in truncation of encoded proteins or translation of putative proteins with 
extra/missing amino acid residues (Appendix VIII). Genes could become non-functional 
due to the mutations - the gene transcription process does not occur. The mutations 
could have altered the level of gene expression (and thereby, translation of sufficient 
amounts of protein to mediate the bacterial virulence) or interfered with protein 
translation. It is also possible that transcription and translation occurred but the structure 
and function of the protein produced was impaired as a result of the mutations. In 
addition, the deletion of genes from SPI regions has been observed and this would 
definitely affect the pathogenicity of S. II Sofia.  
 
The mutations observed in SPI1 to SPI3, and SPI5 genes (see Figures 4.2, 4.5, 
4.7 to 4.9, 4.13, 4.15, 4.19 and 4.20; along with Appendix VIII) could be the reason for 
the avirulent nature of S. II Sofia.  SPI1 and SPI2 have been shown to be required for 
bacterial invasion and intracellular replication, respectively (Galán, 1999; Hensel et al., 
1998; Marcus et al., 2000; Ohl and Miller, 2001) - mutations of genes within these 
regions would affect virulence ability of a Salmonella strain. This can be seen from the 
pathogenesis studies done by Rickard (Rickard, 1998): although S. II Sofia is still able to 
adhere and invade cultured epithelial cells, the level of adherence and invasion is greatly 
reduced compared to the pathogenic S. Typhimurium 82/6915. S. II Sofia isolates also 
do not replicate intracellularly and can only cause systemic disease in hosts with 
immature or immunocompromised systems (Rickard, 1998).  
 
The SPI1 mutations discovered in the present study differs from the previous 
studies on this pathogenicity island (Heuzenroeder et al., 2001): other than the point 
mutation in invJ, the rest of the inv region appears to be intact (Appendix VIII). It could 
be that the distribution of genes in the inv operon is not the same within all S. II Sofia 
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isolates. In addition, the study done by Heuzenroeder and his coworkers (Heuzenroeder 
et al., 2001) employed PCR amplification to detect inv genes, which is not as sensitive 
as a Southern hybridisation method. Further studies would have to be carried out to 
properly investigate the distribution pattern of this operon amongst S. II Sofia isolates.   
 
The avirulent nature of S. II Sofia could also be caused by the major deletion in 
SPI5 as these genes are necessary for gastroenteritis disease process (Norris et al., 
1998; Pfeifer et al., 1999; Wood et al., 1998). On the other hand, the SPI3 region 
appears1 to contain mainly genes encoding host-specific colonisation factors – the 
genes have been shown to be involved in the colonisation of a variety of animals such 
as cattle, chickens and mice (Dorsey et al., 2005; Lawley et al.¸2006; Morgan et al., 
2004). It is possible that the mutations observed in SPI3 genes of S. II Sofia could have 
increased the colonisation ability of the strain, which would explain its persistence in 
Australian poultry flocks.  
  
The SPI1 to SPI5 regions of S. II Sofia were observed to exhibit variation in the 
RFLP pattern when compared to S. Typhimurium and these differences could be 
attributed to loss or gain of restriction sites within these regions. A number of SPI genes 
in S. II Sofia were found to have accumulated mutations that could have affected gene 
transcription and/or protein translation. Further, the insertion of transposase and deletion 
of genes within the SPI regions of S. II Sofia were observed (particularly in SPI1, SPI3 
and SPI5). The effects of these mutations, insertions and deletions probably contributed 
to the reduced pathogenicity in S. II Sofia and thus, avirulence of this serovar is not the 
result of a single genetic change but rather a series of alterations to a large number of its 
virulence-associated genes. Further studies on the expression of these genes (and the 
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functionality of their encoded proteins) may reveal the extent of the effect the mutations 
might have had on virulence process.    
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CHAPTER 5: MOLECULAR ANALYSIS OF 
VIRULENCE PLASMID AND CHARACTERISATION 
OF spv OPERON IN SALMONELLA II SOFIA 
 
5.1 Introduction 
A majority of Salmonella strains carry plasmids between 2 to 150 kB in size and 
the frequency, size and distribution of plasmids vary from serovar to serovar (Olsen, 
2000). Some of these plasmids have been shown to contain genes that confer virulence 
phenotype to the strain, as can be seen in virulence plasmids harboured by Salmonella 
serovars Typhimurium, Dublin, Enteritidis, Choleraesius, Gallinarum, Pullorum and 
Abortusovis (Akiba et al., 1999; Barrow and Lovell, 1988; Barrow et al., 1987a; 1987b 
Haneda et al., 2001; Rotger and Casadesús, 1999; Rychlik et al., 2006; Woodward et 
al., 1989). These virulence plasmid share a few common properties, including a low 
copy number, large size (50 to 95 kB) and appear to be limited to S. enterica subspecies 
I serovars, which are mentioned above (Chu et al., 1999; Guiney et al., 1994; 
Montenegro et al., 1991; Popoff et al., 1984; Rotger and Casadesús, 1999; Rychlik et 
al., 2006; Woodward et al., 1989). 
 
All virulence plasmid-containing Salmonella isolates share a highly conserved 8 kB 
operon designated spv region (Guiney et al., 1994; Gulig et al., 1993; Rychlik et 
al.¸2006). This operon has been shown to confer virulence phenotype to a strain and the 
insertion of this 8 kB region on a low copy number vector is sufficient to restore wild-type 
virulence to plasmid-cured Salmonella strains (Guiney et al., 1994; Gulig et al., 1992; 
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Krause et al., 1991; Williamson et al., 1988). The spv operon encompasses 5 genes, 
(spvRABCD), which interact with one another and is probably transcribed in the same 
direction as a single operon (Gulig et al., 1993; Valone et al., 1993). spvR functions as a 
transcriptional activator, activating its own expression and that of spvABCD (Coynault et 
al., 1992; Grob and Guiney, 1996; Krause et al., 1992; 1995). Localisation studies on the 
SpvABCD proteins have shown their presence in cytoplasm, supernatant, outer and 
inner membrane, probably indicating the varied roles these proteins have in the 
virulence process (El-Gedaily et al., 1997). The protein encoded by spvB acts as a mono 
(ADP-ribosyl) transferase and such enzymes are responsible for mediating virulence 
functions like actin degradation and apoptotic cell death (Gotoh et al., 2003; Kurita et al., 
2003; Otto et al., 2000; Tezcan-Merdol et al., 2005). The rest of the spv-encoded 
proteins have also been demonstrated to interact with one another and with SpvR and 
SpvB proteins (Matsui et al., 2001; Valone et al., 1993). 
 
The spv region is essential for Salmonella spp. virulence: insertional mutations in 
the individual gene have resulted in reduction of virulence and attenuation (Gulig et 
al.¸1992; Krause et al., 1995; Libby et al., 1997; 2000). Further, it has been shown 
through a series of spv mutations and cloned spv sequences that spvBC was sufficient 
to replace the spv operon, as well as the entire virulence plasmid, of S. Typhimurium 
(Matsui et al., 2001). However, the exact role of these genes in virulence is rather 
contradictory, with some investigators reporting that they promote intracellular survival 
and replication in the host (i.e. macrophage cytopathology, leading to cell detachment 
and apoptosis), thereby leading to development of systemic infection (Guiney et al., 
1994; Gulig et al., 1998; Libby et al., 1997; 2000; Paesold et al., 2002) and others finding 
no such correlation between spv gene expression and intracellular survival (Gulig and 
Curtiss III, 1987; Guilloteau et al., 1996; Rhen et al., 1993; Riikonen et al., 1992; Wilson 
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et al., 1997). Therefore, spv function in pathogenesis of Salmonella spp. appears to be 
more complex than initially thought and requires further study.  
 
A number of conditions have been reported to induce and regulate the expression 
of spv operon, including being induced intracellularly (Fierer et al., 1993; Rhen et al., 
1993; Wilson et al., 1997), during stationary growth phase (Coynault et al., 1992; El-
Gedaily et al.¸1997; Krause et al., 1992; Spink et al., 1994; Valone et al., 1993; Wilson et 
al., 1997; Wilson and Gulig, 1998), in nutrient limited condition like glucose starvation 
and low pH (Valone et al.¸1993) and in low iron concentrations (Gotoh et al., 2003; Spink 
et al., 1994; Valone et al.¸1993). The genes themselves contribute to this regulation 
process as well: SpvR is a positive regulator of spvABCD operon and of its own 
expression (Coynault et al., 1992; Gulig et al., 1993; Krause et al., 1992; Spink et al., 
1994) and SpvA has been shown to regulate SpvR expression, providing a negative 
feedback mechanism for this gene (Heiskanen et al., 1994; Spink et al., 1994).  
 
The spv gene expression is also regulated by regulatory proteins encoded 
elsewhere in the Salmonella genome – e.g. the PhoP/PhoQ regulatory system, 
polynucleotide phosphorylase (PNPase), integration host factor (IHF) and leucine-
responsive regulatory protein (Lrp) (Marshall et al.¸1999; Tu et al.¸2006; Ygberg et al., 
2006).  The rpoS or katF gene, which encodes the alternative sigma factor RpoS, has 
been shown to regulate the stationary phase expression of a wide variety of genes, 
including the spv operon (Chen et al., 1995; Fang et al.¸1992; Heiskanen et al., 1994; 
Kowarz et al., 1994; Nickerson and Curtiss III, 1997; Norel et al., 1992; Wilson et 
al.¸1997). By controlling the transcription of spvR, the RpoS protein is able to mediate 
the expression of the downstream spvABCD (Fang et al., 1992; Kowarz et al., 1994; 
Nickerson and Curtiss III, 1997; Wilson et al.¸1997). This regulatory protein is required 
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for full expression of spv region as rpoS/katF mutants have been shown to be less 
virulent and more susceptible to a range of environmental stresses like nutrient 
limitation, DNA damage, oxidative and acid stress (Fang et al., 1992; Kowarz et al., 
1994; Nickerson and Curtiss III, 1997; Wilson et al.¸1997).  
 
Other virulence-associated genes have also been discovered in the virulence 
plasmid of Salmonella serovars. An example would be the 7 kB pef operon encoding 
components of a fimbriae/pili structure, which has been shown to mediate adhesion to 
small intestine of mice (Bäumler et al., 1996a; Friedrich et al., 1993). Another example 
would be the plasmid-encoded rck, which confers serum resistance to Salmonella 
serovars by interfering with the polymerisation of tubular membrane attack complexes on 
the bacterial surface (Hackett et al., 1987; Heffernan et al., 1992a; 1992b). Rck has also 
been shown to be important in cell adhesion/invasion (Heffernan et al., 1994). The 
plasmid-encoded loci of traT and rsk have also been shown to have a role in serum 
resistance of Salmonella spp. (Rhen and Sukupolvi, 1988; Vandenbosch et al., 1989a; 
1989b).  
 
However, very little is known about plasmids (and their genes) from S. II Sofia, 
despite the amount of research that has been carried out on the large plasmids of 
Salmonella serovars and their virulence factors. Harrington and coworkers (Harrington et 
al., 1991) have identified a small 6.4 kB plasmid in their epidemiological study of 
Australian and Israeli S. II Sofia isolates but have been unable to discern the genes or 
their function within this plasmid. Further, PCR and Southern hybridisation analysis have 
revealed that S. II Sofia strains appear to be missing the plasmid borne spv region 
(Heuzenroeder et al.¸ 2001) - its absence would contribute to the avirulence property of 
this particular Salmonella serovar.   
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This chapter will focus on the detection of the large virulence plasmid (and spv 
cluster of genes) among the S. II Sofia isolates and to investigate the effect the spv 
operon may have on the virulence phenotype of S. II Sofia.  
The aims of the research methods carried out in this study were to:    
(i) examine the distribution of the large virulence plasmid and to confirm the 
 absence of spv genes in the S. II Sofia isolates,  
(ii) create mutants via the insertion of spv operon (cloned on a high-copy and low- 
 copy number vector) into S. II Sofia Bt6,  
(iii) investigate the effect of this insertion on the pathogenicity of S. II Sofia through  
 adhesion, invasion and intracellular survival assays.   
 
5.2 Methods and Results 
5.2.1 Presence of Virulence Plasmids and spv Operon in S. II Sofia 
Isolates 
Isolation of the plasmids was carried out as described by Kado and Liu (Kado and 
Liu, 1981) with some modifications (see Section 2.3.2.4). Plasmid extraction was 
performed on 26 selected S. II Sofia and 2 S. Typhimurium isolates (82/6915 and 
ATCC14028). The presence or absence of any plasmid was then determined by 
subjecting the samples to agarose gel electrophoresis and ethidium bromide staining as 
described in Section 2.3.4 (0.7% gel, 60V for approximately 3 h) (Figure 5.1). Plasmid 
analysis was repeated 3 times on different days in order to confirm accuracy and 
reproducibility of data.    
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Figure 5.1 Plasmid content of S. II Sofia isolates. M, λDNA marker digested with 
HindIII. Lane 1 3, and 15, S. Typhimurium ATCC 14028; Lane 2, S. Typhimurium 
82/6915; Lane 4-14 and 16-24, S. II Sofia isolates (Bt2, Bt8, 131, FSAW3452, 988Q, 
554NCA, 360QC, 365QCA, 665SCA, 242T, 768XTA, 146TCA, 539NC, 566NC, 10VCA, 
838V, 403QCA, 662SCA, 632MSC and 642SC, respectively). White smears (indicated 
by the blue boxes) observed on the gel are from chromosomal DNA contamination.  
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Both the S. Typhimurium strains (82/6915 and ATCC 14028) studied possessed 
the 90 kB large plasmid (Figure 5.1). Multiple extractions of S. Typhimurium ATCC14028 
have shown that only a single band (corresponding to the 90 kB virulence plasmid) was 
produced. Thus, this strain was used as a reference strain in the extraction of the S. II 
Sofia isolates – to verify that the extraction procedure was successfully carried out each 
time. Plasmid analysis of the S. II Sofia isolates showed that almost all the isolates 
carried a plasmid slightly larger than the 90 kB plasmid obtained from S. Typhimurium 
strains (Figure 5.1). Further, a number of S. II Sofia isolates were observed to contain 
plasmids of various sizes: in the range of ~1.0 to 23 kB (Figure 5.1). Only 2 S. II Sofia 
isolates showed a slightly different plasmid profile – 131 (single plasmid of about 90 kB) 
and 242T (absence of any plasmids) (Figure 5.1). The plasmids extracted were not 
subjected to restriction digest analysis due to the presence of chromosomal DNA in the 
samples: smearing was obtained when the samples were digested (results not shown). 
This contamination of the samples could not be removed despite modifications to the 
protocol (increase in lysis temperature, increase of lysis incubation time and additional 
PCI extraction steps, see Section 2.3.2.4) and careful extraction process (data not 
shown). 
 
Two different DNA probes were used in the detection of a virulence plasmid in S. II 
Sofia isolates: one probe to detect the spv region and the other encompassing traY-traE 
region of the S. Typhimurium LT2 virulence plasmid pSLT (GeneBank accession number 
NC_003277). Probes were PCR-amplified (from S. Typhimurium SL1344 genomic DNA) 
and analysed through restriction digest (to verify that the probe produced was accurate) 
before being labeled and estimated for Southern hybridisation experiments (see Section 
2.3.7.1). The following primers were used for the expand amplification (see Section 
2.3.3.3): spvRABCD (6.6 kB), 5’–GGGTTTACAGCGGATCTTGCTA-3’ and 5’–
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CAGGTCACCGCCATCCTGTTTT-3’ (annealing temperature of 55°C and elongation 
time of 5 min); and traY-traE (14.1 kB), 5’–TTCGTCTGAGGGATCATCTG-3’ and 5’–
CCGTAAGCGGCAATAATGAG-3’ (annealing temperature of 55°C and elongation time 
of 13 min). Genomic DNA (in agarose plugs, see Section 2.3.6.1.1 and 4.2.1) from S. 
Typhimurium (SL1344 and 82/6915) and selected S. II Sofia isolates were digested with 
10U of EcoRV, prepared by electrophoresis for capillary transfer onto nylon membranes 
before being subjected to Southern hybridisation (see Section 2.3.7.2). Probe 
hybridisation was carried out under 2 conditions: low (hybridisation temperature 50°C) 
and high stringency (hybridisation temperature 65°C), which identifies genes sharing 
~65% and ~90%.sequence similarity, respectively 
 
Southern blotting of Salmonella isolates revealed that only the S. Typhimurium 
strains hybridised to both the spv (Figure 5.2) and traY-traE (data not shown) DNA 
probes. None of the S. II Sofia isolates tested hybridised to either one of the DNA probes 
in both low and high stringency conditions, indicating the possible absence of large 
virulence plasmid in these isolates (for spv detection, see Figure 5.2). The absence of 
these regions (and thereby, the virulence plasmid) was further confirmed by direct 
expand amplification of these regions from S. II Sofia genomic DNA (results not shown).   
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Figure 5.2 Southern blot detection of spvRABCD (probe hybridisation temperature 
65°C). The fragment sizes of S. Typhimurium SL1344 were indicated at the side of each 
blot. Lane 1 and 9, S. Typhimurium SL1344; Lane 2, S. Typhimurium 82/6915; Lane 3-8 
and 10-17; S. II Sofia isolates (Bt6, Bt16, 985Q, 554NCA, 147TC, FSAW3455, 131, 
664SCA, 636SC, 987VCA, 630MSC, 362QC, 541NCA and 148TCA, respectively). 
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5.2.2 Construction of spv Mutant in S. II Sofia Bt6 
To investigate the effect of the spv operon on the pathogenic ability of S. II Sofia, a 
mutant was constructed by inserting the complete spv cluster of genes into the isolate S. 
II Sofia Bt6. Genomic DNA from the pathogenic S. Typhimurium 82/6915 was isolated 
(see Section 2.3.2.1) and used as a template for the expand amplification of the spv 
operon (see Section 2.3.3.3). The following primer pair was designed for this purpose 
(annealing temperature of 60°C and elongation time of 8 min):  
5’–TTCGCTCGAGAGCCGCTACAAATAGCTTCG-3’ (spvR-XhoI/F)  
5’–CAAGTCTAGAGACGGGCAGATTATCGC-3’ (spvD-XbaI/R)  
Restriction cleavage sites XhoI and XbaI (indicated by the underlined bases above) were 
incorporated into the primers for directional cloning into the plasmid pWSK29 (Wang and 
Kushner, 1991). The expected product of this amplification is an 8.2 kB DNA fragment 
encompassing the entire spv operon, along with the ORFs encoding a putative integrase 
(located next to spvR) and transposase (located next to spvD) protein (Figure 5.3). After 
amplification, PCR product was subjected to restriction digest analysis in order to 
confirm that the DNA fragment produced was accurate (Figure 5.3). The resulting 
fragment was then cloned into 2 different plasmids: the high copy pCR®2.1 (Ampr and 
Kanr) and low copy number pWSK29 (Ampr) (see Appendix X) before being transformed 
into S. II Sofia Bt6.  
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Figure 5.3 Expand PCR amplification of spvRABCD (8.2 kB). A) Schematic diagram 
showing the genetic map of the DNA fragment (containing spv operon) used for mutant 
construction. Map was constructed using Clone Manager 7 software. B) RFLP analysis 
of spvRABCD. M, λDNA marker digested with PstI; Lane 1-3 contains spvRABCD 
digested with a different RE. Lane 1, BamHI; Lane 2, EcoRV; Lane 3, HindIII; Lane 4, 
PstI.       
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After amplification and RFLP analysis, spvRABCD was then ligated to the 
pCR®2.1 plasmid according to the manufacturer’s manual (see Section 2.3.8.1). The 
ligation mix was then transformed into electrocompetent Escherichia coli DH5α cells 
(see Sections 2.3.8.4.1 and 2.3.8.5.1). Potential positive transformants were detected by 
blue/white screening – white colonies were selected from the agar plate and subcultured 
in LBB broth (overnight at 37°C) before being subjected to plasmid miniprep extraction 
(see Section 2.3.2.2). All the miniprep extraction samples were analysed by restriction 
digest to detect and identify the clone containing the insert. The clone was further 
confirmed through sequencing analysis (see Section 2.3.3.4). RFLP analysis of the 
plasmid miniprep samples have identified several positive clones and clone pCspv8 was 
chosen (Figure 5.4). Identity of the positive clone chosen was further confirmed through 
sequencing analysis (data not shown).  
 
   Before inserting pCspv8 into S. II Sofia Bt6, the clone was first inserted into S. 
Typhimurium 9121. This transformation modifies the plasmid and prevents its 
degradation by endogenous enzymes when placed into S. II Sofia Bt6. Electrocompetent 
S. Typhimurium and S. II Sofia cells were prepared as described previously (see Section 
2.3.8.4.1). The pCspv8 was transformed into S. Typhimurium 9121 and positive 
transformants selected by blue/white screening and miniprep assay. The modified 
plasmid was analysed by restriction digest (Figure 5.4) before being inserted into S. II 
Sofia Bt6. Positive clones from S. II Sofia were also confirmed through RFLP analysis 
before in vitro assessment (Figure 5.4). 
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Figure 5.4A Construction of S. II Sofia mutant containing spvRABCD (cloned on high 
copy number plasmid pCR®2.1). A) RFLP analysis of the clone pCspv8. M, λDNA 
marker digested with PstI; Lane 1, miniprep assay of pCspv8; Lane 2-4, pCspv8 
(isolated from E. coli DH5α) digested with different REs (BamHI, EcoRV and a 
combination of XbaI and XhoI, respectively), where blue box indicates the DNA fragment 
containing the spvRABCD insert; Lane 5-6, pCR®2.1 digested with BamHI and EcoRV, 
respectively; Lane 7-8; pCspv8 (isolated from S. Typhimurium 9121) digested with 
BamHI and EcoRV, respectively;  Lane 9-10; pCspv8 (isolated from S. II Sofia Bt6) 
digested with BamHI and EcoRV, respectively; B) Schematic diagram representing the 
genetic map of plasmid pCspv8 (in the same orientation as lacZ) constructed using 
Clone Manager 7. Arrows indicate the position of the genes (red for plasmid genes and 
blue arrows for spv genes).  
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To construct the spv clone in the low copy number plasmid pWSK29, pCspv8 was 
digested with the REs XbaI and XhoI (see Section 2.3.8.2) to obtain the spvRABCD 
insert from the clone. Plasmid pWSK29 was also digested with this enzyme combination 
to generate compatible sticky ends, which will facilitate the ligation of the digested insert 
to the plasmid. After gel purification, an overnight ligation reaction was carried out with 
the 2 samples (see Section 2.3.8.3). It was discovered that electroporation was not as 
efficient compared to chemical transformation (data not shown). Thus, all subsequent 
transformations were carried out chemically (see Section 2.3.8.5.2). Chemically 
competent E. coli DH5α, S. Typhimurium 9121 and S. II Sofia Bt6 cells were prepared as 
described in Chapter 2 (see Section 2.3.8.4.2). Ligation product was then chemically 
transformed in DH5α cells, potential positive clones selected via blue/white screening 
and analysed by midiprep isolation (see Section 2.3.2.3) and RFLP analysis (Figure 5.5). 
Clone pWSPV1 was identified as positive construct containing the spvRABCD insert 
(Figure 5.5). This clone was then transformed into S. Typhimurium 9121 before finally 
being inserted in isolated S. II Sofia Bt6.      
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Figure 5.4B Construction of S. II Sofia mutant containing spvRABCD (cloned on low 
copy number plasmid pWSK29). A) RFLP analysis of the clone pWSPV1 (isolated from 
E. coli DH5α). M, λDNA marker digested with PstI; Lane 1-3, pWSPV1 digested with 
different REs (BglII, EcoRI and EcoRV, respectively); Lane 4-5, pWSPV1 digested with a 
combination of REs (XbaI/XhoI and SpeI/NotI, respectively), where blue box indicates 
the DNA fragment containing the spvRABCD insert. B) Schematic diagram representing 
the genetic map of plasmid pWSPV1 constructed using Clone Manager 7. Arrows 
indicate the position of the genes (red for plasmid genes and blue arrows for spv genes).  
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However, all attempts to analyse midiprep samples isolated after insertion in S. 
Typhimurium 9121 and S. II Sofia Bt6 by restriction digest were unsuccessful. The 
modified pWSPV1 appeared to be extremely sensitive to DNA degradation and all 
attempts at RFLP analysis resulted in smears on the gel, despite variation in the digest 
conditions such as RE concentration, addition of bovine serum albumin (BSA), amount 
of DNA, duration of digestion and incubation temperature (results not shown). As intact 
positive clones could be extracted via midiprep (data not shown), detection and 
confirmation of the mutant was performed by dot blotting. In this method (which is a 
slight variation of the Southern hybridisation technique), samples are spotted directly 
onto the membrane instead of being transferred via capillary action after restriction 
digest. All samples were denatured with NaOH (final concentration of 0.2 M) at 37°C for 
15 min before 1 µL of each sample was spotted on the nylon membrane. Membrane was 
then crosslinked with UV light and subjected to Southern blotting (see Section 2.3.7.2). 
 
The spv DNA probe was prepared for use in the dot blot detection as described 
previously (see Section 5.2.1) with some modifications: probe was digested with EcoRI, 
producing 3 fragments (spvR, spvABC and spvD), which were individually labeled and 
used separately in the Southern hybridisation. The spv insert (used in S. II Sofia mutant 
construction) and clone pCspv8 was used as positive controls and were spotted onto 
each membrane. Dot blot analysis of serovars Typhimurium and II Sofia midiprep 
samples confirmed that spvRABCD was successfully cloned in pWSK29 and inserted in 
isolate S. II Sofia Bt6, indicated by the hybridisation of all 3 probes to the samples 
containing the insert – spvRABCD, midiprep and CTAB isolation (see Section 2.3.2.1) of 
pCspv8 and pWSPV1 clones (Figure 5.5). 
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Figure 5.5 Dot blot analysis of pWSPV1 clones. Each sample was spotted in the 
exact same location on each membrane. Spot 1, spvRABCD insert; Spot 2, Miniprep of 
plasmid pCR®2.1; Spot 3, Midiprep of plasmid pWSK29; Spot 4, pCspv8 clone; Spot 5, 
midiprep of pWSPV1 from S. Typhimurium 9121; Spot 6, CTAB isolation of pWSPV1 
from S. Typhimurium 9121; Spot 7, midiprep of pWSPV1 from S. II Sofia Bt6; Spot 8, 
CTAB isolation of pWSPV1 from S. II Sofia Bt6.   
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5.2.3 In Vitro Assays 
Pathogenic ability of the constructed S. II Sofia mutants was assessed in 3 ways: 
its adherence and invasion of INT407 and CEF-DF1 cells and its ability to survive and 
replicate within murine J774 macrophages. All growth, maintenance and the preparation 
of monolayers (for in vitro assay) was conducted as described in Chapter 2 (see Section 
2.4.3.1 to 2.4.3.3). Along with the S. II Sofia mutants Bt6/pCspv8 and Bt6/pWSPV1, the 
following controls were included in each in vitro assessment: E. coli DH5α (negative 
control), S. Typhimurium 82/6915 (positive control), S. II Sofia Bt6 (isolate in its original 
form), Bt6/pCR®2.1 (S. II Sofia Bt6 containing plasmid pCR®2.1 without any insert) and 
Bt6/pWSK29 (S. II Sofia Bt6 containing plasmid pWSK29 without any insert). Since it 
has been shown that spv genes are expressed at the late-log or early stationary growth 
phase (Valone et al., 1993), incubation of the mutant and control strains were carried out 
as described before being assessed in vitro: overnight cultures of the bacterial strains 
were diluted 1:30 in 5 mL of fresh LBB and incubated at 37°C for 7 h with aeration. 
Adhesion, invasion and intracellular survival assays were performed as described 
previously (see Sections 2.4.3.4 and 2.4.3.5). 
 
5.2.3.1 Statistical Analysis 
The CFU counts were expressed as means ± standard errors of the values. 
Statistical analysis was performed using Microsoft Excel program. All data was analysed 
using one-way analysis of variance or ANOVA, which is used in the comparison of 3 or 
more treatments with the assumption that all treatment of samples have similar variance 
(Deacon, 2006). A post hoc analysis of the experimental data was also conducted (after 
ANOVA analysis) using the Dunnett’s test, which compares the means of all treatments 
against a control (Lane, 2008). Only the CFU value of S. II Sofia Bt6 was compared to 
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that of S. Typhimurium 82/6915 – all other experimental values (pCR®2.1, pWSK29, 
pCspv8 and pWSPV1) were compared to mean CFU of S. II Sofia Bt6, which is 
designated as the control group for the statistical analysis. 
    
5.2.3.2 INT407 and CEF-DF1 Cell Adherence 
The adhesion ability of each bacterial sample was expressed as a percentage of 
the number of adhered bacteria (mean value of CFU count) over the number in the 
inoculum (CFU/mL) and is listed in Table 5.1. All statistically significant results have a p 
value of less than p = 0.01. The isolate S. II Sofia Bt6 was significantly less adherent 
compared to the pathogenic S. Typhimurium 82/6915 in both cell lines (Table 5.1). No 
significant difference was observed in the INT407 adhesion values between S. II Sofia 
Bt6 and the pCspv8 and pWSPV1 mutants (Table 5.1). However, insertion of the 
plasmid pCR®2.1, pWSK29 and pCspv8 in S. II Sofia Bt6 appeared to have significantly 
decreased the adhesion ability of this isolate in CEF-DF1 cells (Table 5.1). Only the 
adherent property of pWSPV1 was not affected by the insertion of spvRABCD (Table 
5.1).  
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Table 5.1 Effect of spvRABCD on the adherence abilities of bacterial strains to 
INT407 and CEF-DF1 cells (compared to S. Typhimurium 82/6915). Data values that are 
significantly altered (ANOVA and Dunnett’s post hoc analysis) compared to that of 
82/6915 (for Bt6) and Bt6 (all other samples) are indicated by * and **, respectively (p < 
0.01). 
Cell line Strain % Adherencea 
DH5α 1.49 ± 0.33 
82/6915 9.73 ± 0.88 
Bt6 0.57 ± 0.09* 
Bt6/pCR®2.1  0.71 ± 0.07 
Bt6/pCspv8 0.33 ± 0.06 
Bt6/pWSK29 0.77 ± 0.14 
INT407 
Bt6/pWSPV1 0.68 ± 0.08 
DH5α 0.72 ± 0.20 
82/6915 12.27 ± 1.48 
Bt6 1.00 ± 0.11* 
Bt6/pCR®2.1   0.48 ± 0.06** 
Bt6/pCspv8  0.27 ± 0.03** 
Bt6/pWSK29  0.58 ± 0.07** 
CEF-DF1 
Bt6/pWSPV1 0.98 ± 0.13 
a Percentage of adherent bacteria expressed as described in Section 5.2.3.2 (mean ± 
standard error, n = 9) 
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5.2.3.3 INT407 and CEF-DF1 Cell Invasion 
The invasive ability of each bacterial sample was expressed as the percentage of 
percentage of invasive bacteria shown relative to that of the pathogenic S. Typhimurium 
82/6915 (set to 100%), which is calculated using the formula below:   
% invasion of sample (number of invasive bacteria over number in inoculum)  
% invasion of 82/6915 (number of invasive 82/6915 over number in inoculum) 
 
All statistically significant results have a p value of less than p = 0.01 and can be seen in 
Figures 5.6 and 5.7. 
 
The isolate S. II Sofia Bt6 was significantly less invasive compared to S. 
Typhimurium 82/6915 in both cell lines (Figure 5.6). When the data was compared 
relative to the invasion of S. Typhimurium 82/6915 (set to 100%), a significant difference 
was observed in the invasion of INT407 by Bt6/pCspv8, Bt6/pWSK29 and Bt6/pWSPV1 
(Figure 5.6). No significant change was seen in the 3 bacterial samples above when 
assessed with CEF-DF1 cells. However, the presence of pCR®2.1 in isolate Bt6 
significantly hindered the invasive ability of S. II Sofia Bt6 in CEF-DF1 (Figure 5.6). 
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b Data values calculated as outlined in formula given in Section 5.2.3.3  
 
 
Figure 5.6 Effect of spvRABCD on the invasive abilities of S. II Sofia in INT407 and 
CEF-DF1 cells (compared to S. Typhimurium 82/6915). Invasion of the plasmid-
containing strains was shown relative to that of S. Typhimurium 82/6915 (set to 100%). 
Data point of S. Typhimurium 82/66915 (100%) was not included here to enable visible 
comparison of other values. Data values that are significantly altered (ANOVA and 
Dunnett’s post hoc analysis) compared to that of parent strain S. II Sofia Bt6 are 
indicated by * (p < 0.01). 
 
*
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5.2.3.4 Intracellular Survival Assay (with J774 Macrophages) 
The viable counts of each bacterial sample over a 24 h period was recorded and 
expressed as the total number of surviving bacteria in CFU/mL (Figure 5.7). Viable 
counts for the virulent S. Typhimurium 82/6915 were observed to decrease initially at 1 h 
post-infection before increasing by 4-fold of the level of 0 h post-infection numbers (data 
not shown). This pattern of initial decline followed by the increase in bacterial CFU was 
also shown in each mutant and the parent strain (from which the mutants were derived): 
however, only a 1- to 1.5-fold increase was observed (Figure 5.7). The insertion of 
plasmid (with and without spv insert) did not appear to have affected the survival and 
replication ability of S. II Sofia Bt6, except for Bt6/pCspv8 – the presence of spvRABCD 
in pCR®2.1 decreased the level of S. II Sofia numbers at 24 h post-infection by 
approximately 1-fold, compared to the 24 h viable counts of the other S. II Sofia strains 
(Figure 5.7). 
 
The adhesion and invasive ability of each strain was also assessed (expressed as 
the percentage of adherent/invasive bacteria over the number in the inoculum) (Figure 
5.8). S. Typhimurium 82/6915 was observed to be the most adherent strain to the 
macrophages (Figure 5.8). Although the presence of the plasmids caused a change in 
the adhesion of the strains (an increase with pCspv8 and pWSK29 and a decrease with 
pWSPV1), only the change in Bt6/pWSK29 was significant (Figure 5.8). Despite the 
different adhesion abilities observed, the amount of each Salmonella isolate in the 
macrophages after initial invasion (uptake or phagocytosis of Salmonella spp.) was 
approximately the same – the only exception was Bt6/pWSK29, which showed a 
significant increase in its invasive ability (Figure 5.8). Neither the parent nor mutant S. II 
Sofia strains showed any significant change in its survival and replication ability in J774 
cells, with a 1.2- to 1.5-fold increase observed for all the strains (Figure 5.9).     
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Figure 5.7 Survival of E. coli DH5α and Salmonella strains in murine J774 
macrophages. Viable CFU per 105 macrophage cells in each well (y axis) and time after 
addition of gentamicin (x axis) are indicated. Data points of S. Typhimurium 82/6915 
were not included here to enable visible comparison of the other values. All values are 
the means ± standard errors of 3 different experiments done in triplicates. 
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c Data values expressed as percentage of the number of adherent/invasive bacteria over 
the total number in the original inoculum (mean ± standard error, n = 9) 
 
 
 
Figure 5.8 Effect of spvRABCD on the adhesion and invasive abilities of S. II Sofia in 
J774 macrophages (compared to S. Typhimurium 82/6915). Data values of mutant 
strains that are significantly altered (ANOVA and Dunnett’s post hoc analysis) compared 
to that of parent strain S. II Sofia Bt6 are indicated by * (p < 0.01). 
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d Data values is shown as the number of CFU at 24 h post-infection over the number of 
CFU at 0 h post-infection (mean ± standard error, n = 9) 
 
 
 
 
 
Figure 5.9 Effect of spvRABCD on the survival and replication of S. II Sofia in J774 
macrophages (compared to S. Typhimurium 82/6915) over 24 h. Data values of mutant 
strains that are significantly altered (ANOVA and Dunnett’s post hoc analysis) compared 
to that of parent strain S. II Sofia Bt6 are indicated by * (p < 0.01). 
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5.2.4 RT-PCR Analysis of spvRABCD expression  
The expression of each individual gene in the spv cluster from the clones pCspv8 
and pWSPV1 was evaluated. Induction of spv expression was carried out as described 
previously (see Section 5.2.3) before RNA isolation of the samples (see Section 2.5.2). 
RNA extraction was performed on all bacterial strains employed in the in vitro assay 
(DH5α, 82/6915, Bt6, Bt6/pCR®2.1, Bt6/pCspv8, Bt6/pWSK29 and pWSPV1). The 
expression of the individual spv was compared through RT-PCR analysis (see Section 
2.5.3). Primers used (along with the annealing temperatures) are listed in Appendix XII. 
Along with each spv gene, the expression of the alternative sigma factor or katF was 
also assessed.  
 
PCR amplification carried out on S. Typhimurium 82/6915 and 15 S. II Sofia 
isolates to detect katF yielded the specific 0.7 kB product, indicating the presence of this 
gene in the S. II Sofia genome (results not shown). katF expression was observed in all 
the bacterial samples evaluated (Figure 5.10). RT-PCR analysis showed that the 
spvRABCD genes were expressed in Bt6/pCspv8, indicating that the clone constructed 
was functional in S. II Sofia Bt6 (Figures 5.10 and 5.11). However, spvA, spvB and spvC 
were not expressed in Bt6/pWSPV1, showing the possibility that these genes were not 
induced during in vitro assay (Figures 5.10 and 5.11). No spv expression was detected 
in any of the control strains, except S. Typhimurium 82/6915, which is designated as the 
positive control (Figures 5.10 and 5.11).  
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Figure 5.10 Expression of katF, spvR and spvA in the control strains and Salmonella 
mutant strains. M, λDNA marker digested with PstI. Lane 1, 3, 5, 7, 9, 11 and 13 are 
samples prepared without RTase (negative control) and Lane 2, 4, 6, 8, 12 and 14 are 
samples with added RTase. Lane 1 and 2, E.coli DH5α; Lane 3 and 4, S. Typhimurium 
82/6915; Lane 5 and 6, Parent stain S. II Sofia Bt6; Lane 7 and 8, Bt6/pCR®2.1; Lane 9 
and 10; Bt6/pCspv8; Lane 11 and 12, Bt6/pWSK29; Lane 13 and 14, Bt6/pWSPV1. 
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Figure 5.11 Expression of spvB, spvC and spvD in the control strains and Salmonella 
mutant strains. M, λDNA marker digested with PstI. Lane 1, 3, 5, 7, 9, 11 and 13 are 
samples prepared without RTase (negative control) and Lane 2, 4, 6, 8, 12 and 14 are 
samples with added RTase. Lane 1 and 2, E.coli DH5α; Lane 3 and 4, S. Typhimurium 
82/6915; Lane 5 and 6, Parent stain S. II Sofia Bt6; Lane 7 and 8, Bt6/pCR®2.1; Lane 9 
and 10; Bt6/pCspv8; Lane 11 and 12, Bt6/pWSK29; Lane 13 and 14, Bt6/pWSPV1. 
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5.3 Discussion 
Plasmid analysis showed that a majority of the S. II Sofia isolates appear to 
contain more than one plasmid, ranging in size from approximately 1 kB to >90kB 
(Figure 5.1). This observation contradicts the previous studies carried out on the plasmid 
content of S. II Sofia strains – identification of a single small 6.4 kB plasmid of unknown 
function (Harrington et al., 1991). A number of S. II Sofia isolates studied here were 
observed to contain a plasmid of approximately 6.4 kB (see Lanes 10, 11, 13 and 14 in 
Figure 5.1). However, no isolate was shown to contain a single plasmid of 6.4 kB (Figure 
5.1). The work of Harrington and colleagues (Harrington et al., 1991) has suggested that 
S. II Sofia isolates of the same clone (probably from the same geographical area) were 
used in the study, resulting in the isolation of the same 6.4 kB plasmid in all the 
Australian strains but not the Israeli strains. It is possible that the distribution of plasmids 
amongst the S. II Sofia strains from various locations is different and more isolates 
would have to be analysed for their plasmid content before any conclusions can be 
drawn.   
 
However, the presence of more than one band in the gel could also be due to the 
plasmid taking more than one conformation. Plasmid DNA can appear in more than one 
form, which will run at different rates during gel electrophoresis; resulting in more than 
one band: supercoiled (conformation with the most compact form as the plasmid DNA is 
wound around proteins and thereby, migrates the fastest on the gel), nicked-circular 
(plasmid with a single strand cut, which releases the supercoiling and migrates the 
slowest on a gel), relaxed circular (intact plasmid with no supercoiling) and linear 
(plasmid with cuts in both strands, which on a gel usually runs between the supercoiled 
and nicked forms) (Dellis, 2008; Rogers, 2008). Further, 2 or more plasmids have been 
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known to fuse together under certain conditions to form dimers or multimers – these 
plasmids are much larger than the individual plasmid and thereby, migrate very slowly 
regardless of their conformation (Dellis, 2008; Rogers, 2008). This could explain the 
presence of the much larger plasmid in a majority of the S. II Sofia samples (Figure 5.1). 
The various bands seen in the agarose gels in Figure 5.1 could be from the different 
conformations of a plasmid.   
 
All non-linear conformations of the same plasmid will disappear once digested with 
a RE that is known to cut once in the plasmid, resulting in a single band corresponding 
to the linear form of the plasmid. However, attempts to analyse the plasmids from S. II 
Sofia through restriction digest (using numerous REs since the genetic content and 
therefore, restriction cleavage sites of this sequence is unknown) have been 
unsuccessful as smearing was obtained after RFLP and electrophoresis analysis (results 
not shown). This is most probably due to contamination of the samples with 
chromosomal DNA, which is also cleaved along with the plasmid DNA during digestion 
(resulting in smearing). Although the plasmid isolation method by Kado and Liu (Kado 
and Liu, 1981) showed successful isolation of plasmids that can be directly used for 
restriction digestion, transformation and nick translation; the removal of chromosomal 
DNA from the samples in this study could not be achieved, despite modifications to the 
protocol. Therefore, the plasmid samples could not be analysed through RFLP. Perhaps 
another plasmid isolation method should be utilised in order to obtain sufficient amounts 
of relatively pure plasmid DNA for analysis - the cesium chloride/ethidium bromide 
density gradient plasmid prep method (Rogers, 2008; Sambrook and Russell, 2001).       
 
Southern hybridisation analysis showed that the S. II Sofia isolates may harbour a 
number of plasmids of various sizes but not the virulence plasmid found in S. 
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Typhimurium. Two DNA probes detecting 2 different regions of the virulence plasmid 
failed to hybridise to any of the 15 S. II Sofia strains tested (for spv detection, see Figure 
5.2). This observation was also confirmed through attempts to amplify these 2 regions 
from S. II Sofia DNA, which were unsuccessful (data not shown). The 14 kB probe 
contains 4 genes (traY, traA, traL and traE) that encode components involved in the 
conjugation of the plasmid (Rotger and Casadesús, 1999; Rychlik et al., 2006). The 
absence of these 4 genes could mean that the virulence plasmid is not present in S. II 
Sofia. However, the absence of the virulence plasmid cannot be assumed from failure to 
detect these tra genes as major deletions in the tra operon have been observed in the 
virulence plasmid of various Salmonella serovars (Rotger and Casadesús, 1999; Rychlik 
et al., 2006).  
 
On the other hand, the spv cluster of genes is highly conserved among the 
Salmonella spp. and its absence could indicate that S. II Sofia does not contain the large 
virulence plasmids common in the other Salmonella serovars (Guiney et al., 1994; Gulig 
et al., 1993; Rychlik et al.¸2006). The absence of spv genes could also be one of the 
many reasons contributing to the avirulence nature of S. II Sofia as this operon is 
involved in the virulence process (Guiney et al., 1994; Gulig et al.¸1992; Krause et al., 
1995; Libby et al., 1997; 2000; Williamson et al., 1988). It is possible that the plasmid(s) 
present in S. II Sofia does encode for functions other than virulence e.g. antibiotic-
resistance or bacteriocins (Anon, 2008a). Further, it has been shown that S. II Sofia is 
missing pefA, a plasmid-encoded fimbriae gene (Heuzenroeder et al.¸ 2001). Another 
explanation would be that the virulence plasmid is present in S. II Sofia genome but has 
undergone major mutations, including the deletion of spv and pef operon and portions of 
the tra region. This is a reasonable assumption as other virulence-associated regions in 
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the S. II Sofia genome such as SPIs have been observed to contain major insertions and 
deletions (see Chapter 4). 
 
The spv operon was successfully cloned with pCR®2.1 and pWSK29 (creating 
pCspv8 and pWSPV1) and inserted into S. II Sofia Bt6 (Figures 5.3, 5.4 and 5.5). The 
effect exerted by the spv operon on S. II Sofia was then evaluated through the strain’s 
ability to adhere, invade and replicate intracellularly in host cells. The ability of each 
mutant to adhere, invade and replicate was compared to the pathogenic S. Typhimurium 
82/6915 and parent strain S. II Sofia Bt6. Two other control strains (containing the empty 
plasmid pCR®2.1 and pWSK29, respectively) was also included in this study to 
differentiate between the effects caused by spv genes and that caused by the presence 
of the plasmid itself. The adherence ability of the S. II Sofia mutant strains was 
dependent on the cell line used to assess its adherence (Table 5.1). While the insertion 
of the plasmid (with and without spv insert) had no effect on the adherence of S. II Sofia 
to INT407 cells, it reduced the adhesion ability of S. II Sofia to CEF-DF1 cells and had a 
mixed effect on the adherence of mutant strains to J774 macrophages – increasing 
adherence in Bt6/pCspv8 and Bt6/pWSK29 and decreasing it in Bt6/pWSPV1 (Table 5.1 
and Figure 5.9).  
 
The adhesion of Bt6/pCR®2.1 and Bt6/pWSK29 in CEF-DF1 was observed to 
decline by approximately 2-fold and the presence of spvRABCD in Bt6/pCspv8 further 
decreased the adherence by another 2-fold (when compared to that of parent strain Bt6) 
(Table 5.1). This decrease in the adhesion could be due to the metabolic burden placed 
by the plasmid on the bacterial strain: the adherent ability of Bt6/pCR®2.1 is more 
affected compared to that of Bt6/pWSK29 since pCR®2.1 is a high-copy number 
plasmid and thus, are present in greater numbers in the cell, increasing its metabolic 
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load (Table 5.1). This can further be observed from Bt6/pCspv8 as the presence of both 
pCR®2.1 and spvRABCD caused a 4-fold decline due to the additional burden placed on 
the strain by the insert (Table 5.1). The decrease in adherence could also be due to the 
interaction of the plasmids with an unknown factor within the S. II Sofia genome, 
resulting in the negative effect observed. Further, it appears that the presence of spv 
insert with low-copy number pWSK29 in S. II Sofia Bt6 was able to restore the adherent 
ability of the strain to the levels of the parent strain, indicating the possibility that 
spvRABCD may be involve in the adherence function of Salmonella spp. (Table 5.1).  
 
On the other hand, the opposite was observed in adherence of Bt6/pCspv8, 
Bt6/pWSK29 and Bt6/pWSPV1 to J774 cells (Figure 5.8). It would seem that the 
adherent ability of the mutant strains (with and without the spv insert) is dependent upon 
the type of mammalian host cells the strains come into contact with. Statistical analysis 
showed that a significant difference exist in the adhesion ability of the Salmonella strains 
between the 3 different cell lines (p < 0.001). The empty plasmid or clones may not only 
have interacted with the S. II Sofia genome but also with the host cells, resulting in the 
different adherence abilities obtained (Table 5.1 and Figure 5.8). While INT407 cells are 
of human origin, CEF-DF1 and J774 cells are of animal origin (chicken and mouse, 
respectively) and this might play a part in the different adherent abilities of the Bt6 
strains. It is possible that spvRABCD could play a role in host-specific virulence – the 
virulence plasmids of Salmonella spp. are also known as serovar-specific plasmids as 
they are frequently isolated from Salmonella strains showing host adaptation (Guiney et 
al., 1994; Rotger and Casadesús, 1999; Rychlik et al., 2006). The effect of spvRABCD 
on the adhesion ability of a strain may be a function that is unique to S. II Sofia and 
should be assessed by inserting this operon into another low-copy plasmid to ascertain if 
the same effect was obtained. 
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The presence of spvRABCD in high-copy pCR®2.1 significantly increased the 
bacterial invasion (compared to the invasion of Bt6 and Bt6/pCR®2.1) in the INT407 cell 
line but had no effect in the CEF-DF1 cells (Figure 5.6). Since the empty plasmid 
pCR®2.1 did not appear to affect the invasive ability of S. II Sofia Bt6 in INT407 cells, 
the 2.7-fold increase observed in Bt6/pCspv8 could be attributed to the presence of the 
spv insert – indicating the possibility that spv operon may be involved in the bacterial 
invasion process (Figure 5.6). However, the presence of the spv insert was not able to 
restore the invasiveness of S. II Sofia Bt6 to wild type levels observed in S. Typhimurium 
82/6915 (data not shown). The results also suggest that the presence of plasmid vectors 
may have had an effect on the invasive ability of the S. II Sofia mutant strains, as evident 
from the invasiveness of Bt6/pWSK29 and Bt6/pWSPV1 in INT407 cells (Figure 5.6).  
 
Bacterial sample Bt6/pWSK29 only contains the empty plasmid and therefore, 
should not show any increase in invasion without the presence of any virulence factors. 
However, a 2-fold increase in invasion was observed in this mutant strain – higher than 
the invasiveness observed in Bt6/pWSPV1, indicating that the increase was not from the 
effect of spv genes but from the plasmid itself (Figure 5.6). It has been shown that 
certain cloning vectors (plasmids and fluorescent protein reporter systems) used in the 
study of bacterial pathogenesis can affect the ability of S. Typhimurium to productively 
infect either cultured mammalian cells or mice (Knodler et al., 2005). One of the vectors 
investigated was pWSK29 and the presence of the vector in S. Typhimurium appeared 
to cause an increase in the invasive ability of the strain in HeLa and RAW264.7 cells 
(although the increase observed was not significant) (Knodler et al., 2005). Insertion of 
the pWSK29 plasmid (with or without insert) could have caused an increase in bacterial 
invasion due to the interaction of the plasmid with an unknown factor in the S. II Sofia 
genome – this could also explain the improved adherent and invasion ability of 
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Bt6/pWSK29 to J774 cells (Figure 5.8). No significant differences were observed in the 
invasiveness of the other strains in either CEF-DF1 cells or J774 macrophages, 
indicating that invasion ability (like adherence) is also dependent on the type of cultured 
mammalian cells the strains come into contact with (Figures 5.6 and 5.8). 
 
Despite starting with approximately equal invasion rates, differences were 
observed in the subsequent survival and replication of the Salmonella strains in the J774 
macrophages (Figures 5.7 and 5.9). A 3- to 4-fold difference was shown in the levels of 
24 h post-infection numbers between S. Typhimurium 82/6915 and S. II Sofia strains 
(with and without insert), indicating that serovar Typhimurium has a survival and 
replication advantage in J774 cells. This observation correlates well with previous 
studies, in which S. Typhimurium strains displayed enhanced survival ability in murine 
macrophage cells (Alpuche-Aranda et al., 1995; Buchmeier and Heffron, 1989; Schwan 
and Kopecko, 1997; Schwan et al., 1997). The poor survival and replication of parent S. 
II Sofia Bt6 in J774 cells could explain why this strain was not able to cause disease in 
humans and chickens – intracellular survival in macrophages has been shown to be 
essential for Salmonella virulence (Alpuche-Aranda et al., 1995; Fields et al., 1986; 
Schwan et al., 1997).  
 
The presence of spvRABCD did not significantly affect the survival and replication 
of S. II Sofia Bt6 in J774 macrophages - except in Bt6/pCspv8, in which the slight 
decrease in 24 h post-infection viable counts could be attributed to the metabolic burden 
placed on the strain by the presence of insert in a high-copy number plasmid (Figures 
5.7 and 5.9). This indicates that it is probable that spv operon is not responsible for 
intracellular survival of Salmonella spp., adding to the contradictory studies regarding the 
role of spv genes in virulence. The exact function of the spv genes has been in 
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contention for some time, with some investigators reporting their involvement in 
intracellular survival and replication (Libby et al., 1997; 2000; Paesold et al., 2002) and 
others finding no such link (Gulig and Curtiss III, 1987; Guilloteau et al., 1996; Rhen et 
al., 1993; Riikonen et al., 1992; Wilson et al., 1997). The contradictory results obtained 
could be due to the different in vitro and/or in vivo models used to study the spv genes.  
 
The research showing no established relationship between spv operon and 
intracellular survival (Gulig and Curtiss III, 1987; Guilloteau et al., 1996; Rhen et al., 
1993; Riikonen et al., 1992; Wilson et al., 1997) were all carried out using murine 
cultured cells or animal model. On the other hand, the assessment of the spv genes by 
Libby and his coworkers (Libby et al., 1997; 2000) and by Paesold and his colleagues 
(Paesold et al., 2002) were done using other host systems – bovine (Libby et al., 1997) 
and cultured mammalian cells of human origin, respectively (Libby et al., 2000; Paesold 
et al., 2002). This difference may indicate the host-specificity of the spv operon and that 
the murine host system is not a suitable model for investigating function of the spv 
genes. The S II Sofia mutant strains should be evaluated again using a different 
macrophage cell line e.g. human monocyte-derived macrophages as employed by Libby 
and his colleagues (Libby et al., 2000). Further, an in vivo assay (using chicken animal 
model) should be conducted to further investigate the effect of spv operon on virulence 
as it is possible that some virulence processes do not manifest unless present in a live 
host (Garmony et al., 2002).         
 
The transcription of the individual spv genes was investigated via RT-PCR to verify 
that the clones constructed were expressed within S. II Sofia Bt6. The expression of the 
alternative sigma factor gene katF was also analysed as it has been shown this protein 
controls and regulates this operon (Chen et al., 1995; Fang et al.¸1992; Heiskanen et al., 
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1994; Kowarz et al., 1994; Nickerson and Curtiss III, 1997; Norel et al., 1992; Wilson et 
al.¸1997). PCR and RT-PCR analysis revealed that not only is katF present in S. II Sofia; 
the gene appears to be functional (Figure 5.10). A number of bands observed in RT-
PCR detection of katF from the E. coli DH5α RNA sample could be attributed to the 
presence of katF in E. coli genome. The katF gene is present in enteric bacteria (such as 
E. coli and Salmonella spp.) and it mediates adaptation of the bacterial strain to stress 
conditions – low temperature, nutrient limitation and growth to stationary phase (Hirsch 
and Elliot, 2005). Sequence comparison between the katF of E. coli and S. Typhimurium 
demonstrate a high degree of conservation (Prince et al., 1994) and this shared 
similarity would enable amplification of product from DH5α sample (Figure 5.10).  
 
The expression of the spv operon from Bt6/pCspv8 (and corresponding non-
expression from samples without spv genes) show that this clone is probably functional 
after insertion into S. II Sofia Bt6 (Figures 5.10 and 5.11). Thus, the increase in invasive 
ability of this mutant (Figure 5.6) could be caused by this operon. On the contrary, only 
the expression of spvR and spvD was detected from Bt6/pWSPV1, which could indicate 
that spvABC was not functional during in vitro assay (Figures 5.10 and 5.11). However, 
there are other factors that could account for this non-expression. pCR®2.1 is a high-
copy number vector (200-500 copies per cell) and the cloning of spvRABCD with this 
vector would lead to high levels of gene expression, making it easy to detect via RT-
PCR (Figures 5.10 and 5.11). In contrast, pWSK29 is only present at 6-8 copies per cell 
(Wang and Kushner, 1991) and the low-copy number of the vector could have resulted 
in spvABC expression levels too low to be detected by RT-PCR – although this was not 
the case for spvR and spvD (Figures 5.10 and 5.11). It is also possible that transcription 
of spvABC was transient or only induced intracellularly, making it difficult to detect when 
grown in LBB broth. However, the most probable reason for this non-expression could 
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be the pWSK29 plasmid is an unsuitable cloning vector in this study – plasmid could 
have interacted with an unknown factor in the S. II Sofia genome, which impaired only 
part of the operon expression, leading to the uneven gene transcription observed 
(Figures 5.10 and 5.11). 
 
Although spvRABCD has been shown to be of importance in Salmonella virulence 
(Guilloteau et al., 1996; Gulig and Curtiss III, 1987; Gulig et al.¸1992; 1998; Krause et 
al., 1995; Libby et al., 1997; 2000; Paesold et al., 2002), so far it has only been 
implicated in intracellular survival and replication (and thereby, the development of 
systemic disease) and not in the bacterial adherence and invasion. The spv insert was 
cloned into 2 different plasmid vectors: the high-copy pCR®2.1 (to ensure maximum 
gene expression) and low-copy pWSK29 (to mimic the low-copy number conditions of 
spv operon in the virulence plasmid). The increase in invasive ability of Bt6/pCspv8 
(Figure 5.6) could be caused by the overexpression of Spv proteins due to the high-copy 
nature of pCR®2.1 cloning vector (200-500 copies per cell). It is possible that at such a 
high level of gene expression, the Spv proteins can play a role in the bacterial invasion 
process.  
 
The uneven adherence and invasion ability as well as gene transcription exhibited 
by some of the other mutant strains appeared to be linked to the presence of pWSK29 
plasmid (Table 5.1 and Figures 5.6, 5.8, 5.10 and 5.11).  This cloning vector has been 
shown to alter the ability of Salmonella spp. to invade and replicate in epithelial and 
macrophage-like cell lines (Knodler et al., 2005) and this property could have influenced 
the in vitro assessment of the mutants. The use of another low-copy number cloning 
vector should be considered such as pACYC177 (Chang and Cohen, 1978), pLG338 
and pLG339 (Stoker et al., 1982). In addition, in vivo studies with animal models e.g. 
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chickens should be carried out with the mutant strains as it has been shown that in vitro 
experiments may not be an accurate representation of in vivo processes (Garmony et 
al., 2002) and therefore, both in vitro and in vivo assessment should be used to 
investigate the effect of the presence of spvRABCD to the pathogenicity of S. II Sofia.  
 
Analysis of the plasmid content of S. II Sofia isolates revealed the presence of a 
large plasmid (> 90 kB) along with several smaller plasmids in the range of 1.0 to 23 kB 
in size. The presence of more than one plasmid could be attributed to either the 
existence of multiple plasmids in S. II Sofia genome or the different conformations 
exhibited by a plasmid. However, attempts to further investigate the plasmids through 
RFLP analysis have been unsuccessful due to contamination of plasmid samples with 
chromosomal DNA, which could not be removed despite protocol modifications and 
careful extraction. Southern blot detection using DNA probes from different regions of 
virulence plasmid (including the virulence-associated spvRABCD) failed to detect the 
presence of both these regions, indicating either the absence of the entire virulence 
plasmid or a virulence plasmid containing major deletions in the S. II Sofia isolates. 
Cloning of the spv genes (into high-copy pCR®2.1 and low-copy pWSK29) and insertion 
of constructs into S. II Sofia Bt6 was performed.   
 
The presence of spv operon in pCR®2.1 (clone pCspv8) appeared to significantly 
increase the invasive ability of S. II Sofia Bt6 – overexpression of Spv proteins may have 
a positive effect on bacterial invasion. The uneven adherence and invasion ability of the 
other mutant strains can be explained by the plasmid compromising bacterial fitness or 
interacting with an unknown factor in bacterial genome, leading to decrease and 
increase of adherence and invasion, respectively. The spv operon does not seem to 
affect the survival and replication of S. II Sofia in macrophages in this study. RT-PCR 
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analysis indicates that while the pCspv8 is fully functional, spvABC is not expressed in 
pWSPV1, which further supports the theory that pWSK29 is able to affect the interaction 
between S. II Sofia and host cells. However, more studies on the function of plasmids 
(native and clones) in S. II Sofia are required before any conclusions can be made.    
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CHAPTER 6: GENERAL DISCUSSION 
 
Although Salmonella spp. is one of the most widespread disease-causing 
organisms worldwide, its pathogenicity appears to vary depending on factors such as 
serotype and host range. An example of this pathogenic variation can be seen from the 
Salmonella spp. isolated from Australian poultry flocks. The most common pathogenic 
Salmonella strains isolated from Australian chickens include the serovars Typhimurium, 
Saintpaul and Virchow (Miller et al., 2005; Murray, 2001; Yohannes, 2004). However, the 
most common and prevalent Salmonella serovar amongst Australian poultry is the 
subspecies group II S. Sofia, accounting for 50-60% of the Salmonella chicken isolates 
(Heuzenroder et al., 2001). This particular serovar is persistent in the chicken flocks but 
is avirulent in nature and thus, is rarely associated with diseases in animals and 
humans. The avirulence of S. II Sofia and its high frequency in chickens is a situation 
that is unique to Australia although the reason for this observation is unknown. 
Surprisingly few studies have been done on S. II Sofia despite the serovar being around 
since the 1970s (Harrington et al., 1991; Heuzenroder et al., 2001).  
 
A major focus of this research is to study the genetic variation of the Australian S. 
II Sofia isolates and this includes investigating the epidemiology and genetic distribution 
of virulence genes within the strains. This work is important as little is known about the 
regarding the molecular pathogenesis of this serovar and its genetic relationship with 
one another. The few studies that have been done by other investigators (Harrington et 
al., 1991; Heuzenroder et al., 2001; Rickard, 1998; Ross et al., 2003) have shown that 
the Australian S. II Sofia isolates may share clonal relationship, is only avirulent within 
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individuals with a mature and healthy immune system and this avirulence may be 
attributed to missing virulence-associated genes such as inv and spv regions. By further 
characterising the clonal relationship of the strains and investigating the virulence factors 
important to pathogenesis (e.g. SPI-associated genes), a greater understanding of the 
virulence and colonisation mechanisms of S. II Sofia may be obtained and its future 
pathogenic potential towards chickens and humans assessed. 
 
So far, S. II Sofia isolates have only been subtyped using RFLP and AFLP 
analysis (Harrington et al., 1991; Ross et al., 2003). This study characterised S. II Sofia 
isolates from various locations around Australia using 2 molecular fingerprinting methods 
commonly used to subtype Salmonella strains: pulsed-field gel electrophoresis (PFGE) 
and repetitive PCR typing. Previous attempts to analyse S. II Sofia isolates through 
PFGE have been unsuccessful due to DNAse activity of the strains (leading to DNA 
degradation), which could not be removed despite protocol modifications and use of 
conventional anti-DNAse treatments (Ross et al., 2003). The addition of detergent SDS 
into the lysis solution (used to break open cells and release genomic DNA in the plugs) 
was found to stop DNAse activity of S. II Sofia, allowing the production of clear and 
visible PFGE banding patterns. The combined strength of the 2 different detergents in 
the lysis solution (sarkosyl and SDS) was probably capable of inactivating nuclease 
activity and thus, protected the S. II Sofia genomic DNA from degradation. Further, the 
use of this modified lysis solution on other Salmonella strains did not affect its PFGE 
quality (visibility of bands and PFGE pattern), which means that this lysis solution can be 
used to process DNase-negative strains - making pattern comparison between S. II 
Sofia and other Salmonella serovars possible. 
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A number of repetitive sequences (BOX, ERIC and REP and PCR ribotyping) were 
evaluated in the typing of S. II Sofia and it was discovered that only the REP sequence 
was discriminatory enough to be used for typing since all the other repetitive elements 
showed very limited pattern diversity. Therefore, PFGE (XbaI and SpeI) and REP-PCR 
(with REP1R primer) was carried out on 84 different S. II Sofia isolates, resulting in the 
generation of 8 XbaI, 6 SpeI and 5 REP1 profile patterns. No correlation was obtained 
between the typing methods as there was overlap and diversity within each profile. A 
majority of the patterns were observed to be grouped within a single profile type, with the 
other types encountered consisting of a few isolates each. This limited genetic diversity 
is reflected by the limited pattern diversity obtained with the other repetitive sequences, 
relatively high Dice coefficient (F) values, dendograms and low Simpson’s discrimination 
indices (< 0.5). Combination of the typing methods was able to improve the 
discrimination of samples, dividing the 84 isolates into 16 subtypes, with a discriminatory 
index of 0.721.  
 
All these factors indicate that the Australian S. II Sofia isolates are probably 
clonally related, supporting previous epidemiological studies of S. II Sofia (Harrington et 
al., 1991; Ross et al., 2003) and the minor genetic variation observed could be caused 
by selective pressure on the strains as they spread throughout Australia. In addition, a 
majority of the S. II Sofia isolates were not geographically restricted with the 
predominant pattern combination spread out among the isolates from various locations. 
Victorian S. II Sofia isolates were found to exhibit the most diverse pattern combinations 
compared to isolates from other states, probably due to the larger sample population: 33 
Victorian S. II Sofia strains were analysed compared to 10-15 isolates from the other 
states. The restriction of all Tasmanian isolates to a single pattern type could also be 
from the small sample size. Two S. II Sofia strains were observed to show unique profile 
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pattern – isolate 554NCA and 131 (although the reason for the particular pattern 
combination is unknown). More S. II Sofia isolates (especially those from stated other 
than Victoria) could have to be collected and analysed before any conclusion regarding 
the relationship of profile patterns and geographical locations can be made. 
 
The clonal nature of the S. II Sofia isolates would probably also be reflected in the 
distribution and variation of SPI-associated virulence genes – the genetic content of 
these pathogenicity islands amongst S. II Sofia isolates should be identical. This is 
further confirmed from the identical Southern hybridisation patterns of the S. II Sofia 
isolates obtained using DNA probes encompassing the entire length of the major SPIs 
(SPI1 to SPI5). The SPI1 to SPI5 regions of S. II Sofia were observed to exhibit variation 
in the RFLP pattern when compared to S. Typhimurium and through Southern 
hybridisation, RFLP and sequencing analysis; a majority of the genetic variation 
detected within the 5 SPIs can be attributed to the loss or gain of restriction cleavage 
sites. While SPI2 and SPI4 were found to be relatively conserved, major insertions and 
deletions were observed in SPI1, SPI3 and SPI5 of S. II Sofia.  
 
The major insertion and deletion events observed in SPI1, SPI3 and SPI5 is most 
likely due to the insertion and excision of IS elements. This is reflected by the deletion of 
avrA, sugR-rhuM and sopB-pipA regions from SPI1, SPI3 and SPI5, respectively and 
also by the presence of 1.2 kB ORF encoding a transposase in SPI1 and SPI3 
(transposase found in both these region were shown to be identical). Although found in a 
number of bacterial species such as Yersinia enterocolitica, this transposase was 
observed to be restricted to S. II Sofia (in this study) – there is potential for the 
development of this IS element as a marker to differentiate this serovar from other 
Salmonella spp. in Australian poultry flocks. In addition, a number of base and sequence 
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alterations (insertion, deletion and substitution events) were shown in SPI1 (orgB, prgI, 
sptP, sipD and invJ), SPI2 (ssaP, ssaI and ssaE), SPI3 (misL, marT and slsA) and SPI5 
(ORF) genes, resulting in the predicted translation of proteins with altered polypeptide 
sequences – altered amino acid start residue, truncated proteins from formation of a 
extra termination codon, proteins with missing or additional residues due to genetic 
frameshifts. 
     
Such mutations are able to affect the transcription and/or translation process of the 
SPI genes, which in turn probably altered protein function. Therefore, the avirulent 
nature of S. II Sofia is not caused by a single mutation or deletion event but rather a 
series of mutations in the genes within the SPI regions. The mutations observed in SPI1 
and SPI2 include genes required for the formation of the needle complex structure, 
which is required to translocate effector proteins into the host cells (Chakravottry et al., 
2005; Chen et al., 1996; Cherayil et al., 2000; Collazo et al., 1995; Darwin and Miller, 
1999b; Kimbrough and Miller, 2000; Klein et al., 2000; Kubori et al., 2000, Sukhan et al., 
2001; Zhang et al., 2003). The mutations also affected the 2 SPI1-encoded effector 
proteins SptP and AvrA, shown to be involved in cell cytoskeleton disruptions and 
apoptosis, respectively (Collier-Hyams et al., 2002; Fu and Galán, 1998b; Murli et al., 
2001; Ye et al., 2007).  
 
On the other hand, the mutations in SPI3 involve genes encoding host-specific 
colonisation factors in mice, cattle and chickens (Dorsey et al., 2005; Lawley et al.¸2006; 
Morgan et al., 2004), indicating the possibility that the mutations may have increased the 
colonisation ability of the strain, which would explain its persistence in Australian poultry 
flocks. The major deletion in SPI5 includes genes necessary for the fluid accumulation 
and inflammation in the intestinal system, which is required for the gastroenteritis 
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disease process (Norris et al., 1998; Pfeifer et al., 1999; Wood et al., 1998). Therefore, 
the reduction in the pathogenicity of S. II Sofia probably resulted from the many changes 
in essential SPI genes. However, further studies targeting actual SPI gene and protein 
expression is required in order to gain more in-depth knowledge on the effect of these 
mutations on S. II Sofia virulence. 
 
Salmonella spp. virulence (for certain serovars such as Typhimurium, Dublin, etc) 
has also been shown to be dependent on the presence of large plasmids containing 
virulence factors (Akiba et al., 1999; Barrow and Lovell, 1988; Barrow et al., 1987a; 
1987b Haneda et al., 2001; Rotger and Casadesús, 1999; Rychlik et al., 2006; 
Woodward et al., 1989). Analysis of plasmid content of S. II Sofia isolates revealed the 
presence of a large plasmid along with several smaller plasmids, all in the range of 
approximately 1 to 100 kB in size. However, failure of the S. II Sofia isolates to hybridise 
to the DNA probes detecting regions of the virulence plasmid (including the highly 
conserved virulence-associated spvRABCD) during Southern hybridisation experiments 
was observed. This could indicate 2 things: the total absence of the virulence plasmid or 
the presence of virulence plasmid containing major deletions, either of which would 
contribute to the avirulence of S. II Sofia.  
 
Investigation on the effect of restoring spvRABCD into S. II Sofia was carried out 
by cloning this operon into high-copy pCR®2.1 and low-copy pWSK29 (producing clones 
pCspv8 and pWSPV1, respectively) and assessing its pathogenicity in vitro. The 
presence of pCspv8 was observed to significantly increase invasiveness of S. II Sofia in 
INT407 cells: the high-copy nature of the cloning vector probably lead to the 
overexpression of Spv proteins, which may have had an effect on the invasion process. 
A number of mutant strains containing empty plasmids were shown to exhibit uneven 
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adherence and invasion ability in the cell lines tested. This observation could reflect the 
ability of the cloning vector to affect the fitness of host bacteria through interaction of the 
vector with an unknown factor in bacterial genome, leading to either increase or 
decrease in adherent and invasion ability. This is clearly seen in the apparent increase in 
invasiveness of S. II Sofia Bt6 containing empty pWSK29 in INT407 and J774 cells. The 
pWSK29 plasmid may not be a suitable cloning vector in this study – perhaps the use of 
another low-copy vector such as pACYC177 should be considered.  
 
Further, this cluster of genes was observed to have no effect on the survival and 
replication ability of S. II Sofia in J774 macrophages. Although a few studies have shown 
a positive link between spv operon and intracellular survival, these were carried out 
using different in vitro and in vivo systems (Libby et al., 1997; 2000; Paesold et al., 
2002). In contrast, all studies showing no established relationship between spv operon 
and intracellular were all carried out using murine cultured cells or animal model (Gulig 
and Curtiss III, 1987; Guilloteau et al., 1996; Rhen et al., 1993; Riikonen et al., 1992; 
Wilson et al., 1997). The in vitro and in vivo evaluation of the constructed clones with a 
non-murine macrophage cell line or animal model should be considered. Animal studies 
should particularly be considered for the analysis of the clones in order to confirm that 
any effects seen in vitro  are valid and to assess any virulence effects that do not 
develop unless present in a live host.  Finally, RT-PCR assessment of the clones 
showed while the pCspv8 is fully functional, spvABC is not expressed in pWSPV1, which 
further supports the theory that pWSK29 is able to affect the interaction of S. II Sofia with 
the host cells.         
 
In conclusion, the Australian S. II Sofia isolates showed limited genetic diversity 
and are probably clonally related. The avirulent nature of S. II Sofia is most likely caused 
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by the accumulative effects of mutations in a number of virulence-associated genes such 
as the genes in SPI1 to SPI5 and virulence plasmid. The final aim of this work was to 
assess the pathogenic potential of S. II Sofia in Australia. Based on the study of SPI- 
and plasmid-associated virulence genes, it is most likely that the wild-type S. II Sofia 
strains are unable to regain full pathogenicity (comparable to the pathogenicity of S. 
Typhimurium 82/6915) due to the mutations observed in a large portion of these genes.  
 
This is evident from the in vitro assessment on the effect of spv operon in S. II 
Sofia Bt6. Although the cloning of spv genes with a high-copy vector was able to 
increase the invasive ability of S. II Sofia, the increase was not enough to restore 
invasiveness to the level of S. Typhimurium 82/6915. Restoration of virulence is likely to 
be a very complex and multifactorial process and thus, insertion of just one virulence 
factor back within S. II Sofia is not sufficient to restore virulence levels to those of wild-
type S. Typhimurium. In other words, the numerous mutations observed in the virulence 
genes of S. II Sofia would probably inhibit this serovar from regaining pathogenicity in 
the future, rendering this serovar harmless to both poultry and humans.     
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APPENDICES 
 
Appendix I: General Chemicals and Equipment 
Reagents      Supplier 
5X DMEM Media Thermo Trace Ltd., Australia 
10X PCR Buffer Invitrogen, USA 
10X PCR Buffer (GeneAmp®) Applied Biosystems, USA 
10X Ligase Buffer Promega, USA 
25 mM MgCl2 Applied Biosystems, USA 
100 bp DNA Ladder Promega, USA 
Acetic Acid, Glacial BDH Chemicals, Australia 
Agarose (DNA Grade) Bioline Pty Ltd., Australia 
Ammonium Sulfate, (NH4)2SO4                                   Ajax Chemicals Ltd, Australia 
Ampicillin CSL, Australia 
Anti DIG-AP (Fab Fragments) Roche Applied Sciences, Germany 
Bacteriological Agar (No. 1) Oxoid Australia Pty. Ltd. 
Bacteriological Peptone Oxoid Australia Pty. Ltd. 
Balance 
 (i) Analytical Balance Sartorius GMBH, Germany 
 (ii)Balance (0.1-500g) U-Lab, Australia 
Barrier micropipette plastic tips  Mirella Research Pty Ltd., Australia 
Biological Safety Cabinet Class II LAF Technologies, Australia 
Blocking Reagent Roche Applied Sciences, Germany 
Boric Acid BDH Chemicals, Australia 
Bovine serum albumin, 10 µg/µL (BSA) Promega, USA 
Bromothymol Blue Chem-Suppy, Australia 
Calcium Chloride, CaCl2 Merck, USA 
Cell Counter (Neubaurer, double ruled) Propper MFG Co., USA 
Cell scrapers (25 cm) Interpath Pty Ltd., Australia 
Centrifuge 
 (i) Microcentrifuge Eppendorf, Germany 
 (ii) Bench Top Centrifuge Beckman, USA 
Centrifuge Tubes 
(i) 1.5 mL Microcentrifuge Tubes  Sarstedt, Germany 
(ii) 10 mL Centrifuge Tubes Greiner Bio-One, Germany 
(iii) 15 mL Centrifuge Tubes Greiner Bio-One, Germany 
         (iv) 50 mL Centrifuge Tubes Greiner Bio-One, Germany 
CHEF-DR II System (PFGE) Bio-Rad Laboratories, USA 
Chloroform Merck, USA 
Coverslips Mediglass, Australia 
Cryovials (1.8 mL) Nalgene Company, USA 
Cryogenic tank (liquid nitrogen tank) Cryo Biological Systems, USA 
Deoxynucleoside triphosphates (dNTPs) Roche Applied Sciences, Germany 
DEPC (97% NMR) Sigma-Aldritch Pty. Ltd., USA 
DIG DNA Labelling and Detection Kit Roche Applied Sciences, Germany 
Dithiothreitol (DTT) Bio-Rad Laboratories, USA 
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Dimethylformamide (DMF) BDH Chemicals, Australia 
Dimethylsulfoxide (DMSO) BDH Chemicals, Australia 
DNase agar       Oxoid Australia Pty. Ltd. 
DNA Ligase (T4) Promega, USA 
DNA Polymerase  
(i) TAQ Polymerase  Invitrogen, USA 
(ii) Platinum  Invitrogen, USA  
(iii) AmpliTAQ Gold® Applied Biosystems, USA 
Dulbecco’s 1× PBS (without Mg or Ca) Invitrogen (Gibco®), USA  
Dye-terminator Sequencing Mix V3.1 Monash University, Australia 
Electrophoresis Power Supply 
(i) EPS 500/400 Pharmacia LKB, Sweden 
(ii) EPS600 Pharmacia LKB, Sweden 
(iii) PAC300 Bio-Rad Laboratories, USA 
(iv) PPBasic Bio-Rad Laboratories, USA 
Electrophoresis Units 
(i)         DNA 
  a) Mini-gel Bio-Rad Laboratories, USA 
  b) Midi-gel Bio-Rad Laboratories, USA 
  c) Maxi-gel Pharmacia LKB, Sweden 
(ii)         RNA 
  a) Mini-gel Bio-Rad Laboratories, USA 
  b) Midi-gel Bio-Rad Laboratories, USA 
Electroporation Cuvettes (0.2 cm) Molecular Bio Products, USA 
ELISA Plate Reader (MR7000) Dynatech 
Ethylenediamine tetra acetic acid (EDTA)  BDH Chemicals, Australia 
Ethanol  BDH Chemicals, Australia 
Ethidium Bromide  Roche Applied Sciences, Germany 
Expand Long Template PCR System Roche Applied Sciences, Germany 
Ficol-400 BDH Chemicals, Australia 
Filter (Acrodisc 0.2 µm, 0.45 µm) Gelman Sciences USA 
Formaldehyde (37%) Sigma-Aldritch Pty. Ltd., USA 
Gel-Doc System Bio-Rad Laboratories, USA 
Gentamicin sulfate Sigma-Aldritch Pty. Ltd., USA  
D-Glucose BDH Chemicals, Australia 
L-glutamine (200 mM) Thermo Trace Ltd., Australia 
Geneclean® Kit Bio101® Systems, USA 
Glycerol BDH Chemicals, Australia  
Glycine BDH Chemicals, Australia 
HEPES  Sigma-Aldritch Pty. Ltd., USA 
HEPES Buffer (1 M) ThermoTrace Ltd., Australia 
Hexamminecobalt Chloride     Sigma-Aldritch Pty. Ltd., USA 
Hexadecyltrimethyl ammonium bromide (CTAB) Sigma-Aldritch Pty. Ltd., USA 
Hexanucleotide mix Roche Applied Sciences, Germany  
Hydrochloric Acid, HCl (32%) Eqicell Products P/L, Australia 
Hydrogen Peroxide, H2O2 (30%) BDH Chemicals, Australia 
ImProm-II™ Reverse Transcriptase Promega, USA 
Incubator, for tissue culture (5% CO2) Forma Scientific, USA 
IPTG Sigma-Aldritch Pty. Ltd., USA 
Isoamyl alcohol BDH Chemicals, Australia 
Isopropanol BDH Chemicals, Australia 
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Kanamycin Sigma-Aldritch Pty. Ltd., USA  
Klenow Enzyme Roche Applied Sciences, Germany 
Kim Wipes Kimberly Clarke 
Lambda DNA, λDNA Promega, USA 
DL-Leucine BDH Chemicals, Australia 
Low Melting Point Agarose  Progen Industries, Australia 
Lysozyme Roche Diagnostics, Germany 
Magnesium Chloride, MgCl2 Perkin Elmer, USA 
Magnesium Sulfate, MgSO4 Merck, USA   
Maleic Acid BDH Chemicals, Australia 
Manganese(II) Chloride, MnCl2.4H2O BDH Chemicals, Australia 
Micropipette plastic tips (Blue and Yellow) Greiner Bio-One, Germany 
Micropipette plastic tips (5 mL and 10 mL) Pathtech Pty Ltd., Australia 
Microscopes  
 (i) Light Microscope Olympus Optical 
 (ii) Phase Contrast Microscope Nikon Kogaku KK, Japan 
Microscope Slides LOMB Scientific Co., Australia 
Microtitre Plate (96-well, flat bottom) Nunc, Denmark 
MOPS Sigma-Aldritch Pty. Ltd., USA 
Mouse Serum Chemicon International Inc., USA 
NBT/BCIP substrate solution Roche Diagnostics, Germany 
Newborn Calf Serum (NCS) Thermo Trace Ltd., Australia 
N-Lauroyl Sarcosine (Sarkosyl) BDH Chemicals, Australia 
Nylon Membrane (Hybond-N) Amersham, USA 
ONPG Sigma-Aldritch Pty. Ltd., USA 
Orange G Dye Sigma-Aldritch Pty. Ltd., USA 
Parafilm Pechiney Plastic Packaging Inc., 
USA 
Petri Dish Nunc, Denmark 
PFGE λ ladder (48.5 to 630.5 kB) Bio-Rad Laboratories, USA 
PFGE Plug Moulds Bio-Rad Laboratories, USA 
pH Meter Radiometer, Denmark 
DL-Phenylalanine BDH Chemicals, Australia 
Phenol, Saturated BDH Chemicals, Australia 
Phenol/Chloroform/Isoamyl Alcohol BDH Chemicals, Australia 
Phenylmethylsulfonylfluoride, PMSF Sigma-Aldritch Pty. Ltd., USA 
Phosphate Buffered Saline, PBS Oxoid Australia Pty. Ltd. 
Plastic Cuvettes Eppendorf, Germany 
Potassium Acetate BDH Chemicals, Australia 
Potassium Chloride, KCl BDH Chemicals, Australia 
Potassium dihydrogen orthophosphate Merck, USA 
di-Potassium hydrogen orthophosphate BDH Chemicals, Australia 
Potassium Sulfate BDH Chemicals, Australia 
Proteinase K Roche Diagnostics, Germany 
QIAGEN TAQ PCR Core Kit QIAGEN, USA 
QIAGEN Miniprep Kit QIAGEN, USA 
Recombinant RNasin® Ribonuclease Promega, USA 
Inhibitor 
Restriction Enzymes (RE) 
 BamHI, BglII, DraI, EcoRV, Promega, USA 
 HindIII, NotI, PstI, SpeI, XhoI, XbaI Promega, USA 
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RNAgents® Total RNA Isolation System Promega, USA 
RNAprotect Bacterial Reagent Qiagen, USA 
RNAse  Roche Diagnostics, Germany 
RQ1 RNase-Free DNase Promega, USA 
Salmonella O Agglutinating Sera, including Remel, Europe 
Polyvalent O (Group A-S) and monosera 
(4-O, 6,7-O, 8-O, 9-O, 3,10,15,19-O) 
SeaKem® Gold Agarose Cambrex BioScience Inc., USA 
Sodium Acetate Amresco, USA 
Sodium Bicarbonate (7.5%) Thermo Trace Ltd., Australia 
Sodium Chloride, NaCl BDH Chemicals, Australia 
Sodium Citrate BDH Chemicals, Australia 
Sodium Dodecyl Sulphate, SDS BDH Chemicals, Australia 
di-Sodium hydrogen orthophosphate BDH Chemicals, Australia 
Sodium Hydroxide, NaOH BDH Chemicals, Australia 
Sodium Malonate Sigma-Aldritch Pty. Ltd., USA 
Spectrophtometer (Biophotometer) Eppendorf, Germany 
Syringe (5 mL, 10 mL, 20 mL, 50 mL) Terumo, Pty. Ltd., Australia 
TA Cloning® Kit Invitrogen, USA 
Thiourea Fluka Chemika, Switzerland 
Tissue Culture Flask (25 cm2 and 75 cm2) Greneir Bio-One, Germany 
Tissue Culture Trays, 24-well Greneir Bio-One, Germany 
Transilluminator (UV) Bio-Rad laboratories, USA 
Tris-Base  Roche Diagnostics, Germany 
Tris-HCl Roche Diagnostics, Germany 
Triton-X 100 Sigma-Aldritch Pty. Ltd., USA 
Trypan Blue Sigma-Aldritch Pty. Ltd., USA 
Trypsin EDTA (1:250) Thermo Trace Ltd., Australia 
Trypsin (4%) Invitrogen (Gibco®), USA 
Tryptone Oxoid Australia Pty. Ltd. 
Tween® 20  Sigma-Aldritch Pty. Ltd., USA 
UltraPure™ Water (RNAse-/DNAse-free) Invitrogen, USA 
Versene (1:5000, 0.53 mM EDTA) Invitrogen (Gibco®), USA 
Vortex mixer Ratek Instruments, Australia 
Whatman paper Whatman, England 
X-Gal Sigma-Aldritch Pty. Ltd., USA 
XLD Medium Oxoid Australia Pty. Ltd. 
Yeast Extract Oxoid Australia Pty. Ltd. 
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Appendix II: Biochemical profiles of Salmonella Sofia and other bacteria isolates used 
in this study 
 
Table II(A) Malonate and ONPG results of Salmonella spp. 
Serotype Strain identification ONPG* Malonate** 
554NCA, 858V + 
(colourless to light yellow) 
+ 
131 - + 
II Sofia 
All others strains listed 
in Table 2.1 in Section 
2.2.2.1 
+ + 
Typhimurium 82/6915 - - 
 
* (ONPG) +: colourless to bright yellow; -: no colour change 
** (Malonate) +: green to blue; -: no colour change 
 
Table II(B) Serogroup profiles of S. II Sofia isolates  
Isolate Strain identification Serogroup 
Typhimurium 82/6915 B 
II Sofia All strains listed in Table 
2.1 in Section 2.2.2.1 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix III: PFGE λ ladder and size standards for S. Braenderup H9812 
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The size of the λ ladder starts at 48.5 kB and increases 48.5 kB with each successively 
larger band to approximately 1018.5 kB.  
 
Approximate band sizes (in kB) of S. Braenderup H9812 digested with XbaI and 
subjected to PFGE (conditions described in Section 2.3.6.1) (Hunter et al., 2005): 
 
 
 
Appendix IV: DNA (PstI and HindIII, respectively) markers 
 
336.5
244.4
101.5
54.7
28.8
452.7
(kB)
668.9
1135
398.4
310.1
216.9
138.9
78.2
33.3
20.5
APPENDICES 
 293
Appendix V: Primer sequences and amplification conditions of PCR typing (see Section 3.2.3) 
 
PCR conditions Primer 
name Primer sequence Reagents Amplification Reference 
P1 
 
TTGTACACACCGCCCGTCA 
 
P2 GGTACTTAGATGTTTCAGTTC 
1× PCR buffer, 3 mM MgCl2, 1× 
Q solution, 200 µM dNTPs, 0.5 
µM primer (each), 100 ng DNA 
and 2.5U Taq 
35 cycles of 94°C (1 min), 55°C (1 
min) and 72°C (1 min) 
Lagatolla et al., 
1996 
BOXA1R CTACGGCAAGGCGACGCTGACG 
1× PCR buffer, 2.5 mM MgCl2, 
1× Q solution, 500 µM dNTPs, 
0.5 µM primer, 50 ng DNA and 
2.5U Taq 
1 cycle of 95°C (7 min), 30 cycles 
of 90°C (30 s), 53°C (1 min) and 
65°C (8 min), final extension of 
65°C (16 min) 
Koeuth et al., 
1995 
ERIC2 AAGTAAGTGACTGGGGTGAGCG 
1× PCR buffer, 3.5 mM MgCl2, 
1× Q solution, 500 µM dNTPs, 
1.0 µM primer, 100 ng DNA and 
2.5U Taq 
Same as above Versalovic et al., 1991 
REP1R* IIIICGICGICATCIGGC 
1× PCR buffer, 3.0 mM MgCl2, 
1× Q solution, 500 µM dNTPs, 
0.5 µM primer, 20 ng DNA and 
2.5U Taq 
1 cycle of 94°C (7 min), 35 cycles 
of 94°C (30 s), 46°C (1 min) and 
68°C (8 min), final extension of 
68°C (15 min) 
Versalovic et al., 
1991 
 
* “I” in the REP1R oligonucletide sequence represent inosine 
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Appendix VI: Primers for amplification of DNA probes for Southern blot detection of SPI1 to SPI5 (see Section 4.2.1) 
Probes Primer sequence* PCR annealing temperature (°C) 
PCR elongation 
time (min) Reference 
1A (13.8 kB) 1A/F – CACGCTTAGCAGCATGGAATGG 1A/R - CAGGAGGGTTATGAGCAGTATC 53.0 
13 This study 
1B (15.1 kB) 1B/F – TCATCCGTTCCCTCTGAGAACT 1B/R – GCGTCGCATTGCTGCTTTCTAT 53.0 
13 This study 
1C (10.8 kB) 1C/F – GTCTCGGTCTCTTCTCCATACTGACG 1C/R – CTTTCATGGGCAGCAAGTAACGTCTG 62.0 
13 Amavisit et al., 2003 
2A (13.6 kB) 2A/F – CGCAGTGGCCTGAAGAAGCATA 2A/R - ATGCCTCATGGAGTGAGATTCG 62.0 
13 This study 
2B (13.5 kB) 2B/F – TACTTGCCGCTGACGGAATA 2B/R – GGGCGAGAAGCTGAAGTTTGTA 60.0 
13 This study 
2C (12.9 kB) 2C/F – GCCTGCACGATCCGGTACTA 2C/R - TCCAGGTCGATGGCGATGTT 63.0 
13 This study 
3 (17 kB) 3/F – ACATCCTTCTCTCATGCCCACCATT 3/R - ACAGAGCTATCGCCGGTATTAAGCA 62.0 
13 Amavisit et al., 2003 
4A (15.5 kB) 4A/F – AGGGCGGTAGCGTTCACTTT 4A/R - ATATCCAGCGGCCATCCCTC 60.0 
13 This study 
4B (8.2 kB) 4B/F – AGCGGTGATAGCGATGTAGA 4B/R - CACCTGATAACAGCGACAAG 56.6 
7 This study 
5 (6.3 kB) 5/F – AATGGCTGGCAGTACGACTT 5/R - AAGTGTGGCCGAGCGGTTGA 60.0 5 This study 
sopB-pipA (4.5 kB) sopB/F – CGGAATGCAGATTCTCTCAG pipA/R – CCCGAAAGGGTTCCAGAGTT 57 4 This study 
Primers for 1A, 1B and 1C were designed from SPI1 (GeneBank accession number NC_003197); 2A, 2B and 2C from SPI2 
(GeneBank accession numbers X99944, Y09357, AJ224892, U51927, Z95891, AJ224978 and X99945); 4A and 4B from SPI4 
(GeneBank accession number AF060869); and 5 and sopB-pipA from SPI5 (GeneBank accession number AE008747) 
 
All DNA probes are amplified as described in Section 2.3.3.3 
 
*Primer name, F: forward primer and R: reverse primer 
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Appendix VII: PCR primers for analysis of SPI regions (see Sections 4.2.2 to 4.2.4) 
 
Table VII(A) Primers for PCR analysis of SPI1 to SPI5 (see Sections 4.2.6 to 4.2.10) 
SPI  PCR product Primer sequence** Primer annealing temperature (°C) 
fhlA-sitD (3.8 kB) fhlA/F – CCCTGCTGTCGCGTATGAAG sitD/R – GGCCATAATGCAGTAGTGTG 55 
sitD-avrA (1.8 kB) sitD/F – ATTCCCTGCGCCTTACTGTC avrA/R –CGGTGCAGGAGCTATCATGT 53 
avrA-hilC (2.7 kB) avrA/F – GTTGTGCGCCTTGAGTATGT hilC/R – GGAGTTCATCGAACGATCTG 55 
avrA (0.7 kB) avrA/F – GTTGTGCGCCTTGAGTATGT avrA/R – CGGTGCAGGAGCTATCATGT 52 
sitD-sprB (2.3 kB) sitD/F – ATTCCCTGCGCCTTACTGTC sprB/R – CCGTGGCTGCTACGTATGCT 60 
sprB-prgH (6.4 kB)* sprB/F – AGCGATAGCGGTGAAGAGTC prgH/R – TTGCTGACAGGCCGAACACT 60 (5 min) 
prgH-hilA (4.6 kB)* prgH/F – AGCCAGAAAACGGGTTTACG hilA/R – GGTAAGGCACGCTCACTATT 56 (4 min) 
hilA-iagB (2.1 kB) hilA/F – GCTCAACCTGACCGTTAGTA iagB/R – ACGGCCTCCCAGCTATAACC 58  
iagB-sipB (8.3 kB)* iagB/F – GATGGTTCAACCGATCTTGG sipB/R – CGAACCGCATTATGGGATGT 60 (7 min) 
iagB-sptP (1.9 kB) iagB/F – GATGGTTCAACCGATCTTGG sptP/R – GAACAAACCCCTTACCCAAC 55 
sipB-spaR (3.7 kB) sipB/F – GGCCACCATTACCGCAAGTC spaR/R – GCCTCCTGGTAGGGTTATTC 58 
spaS-spaO (2.7 kB) spaS/F – ACAGGTACGCCAACCTTCTC spaO/R –  GAGTCTGGTAATGGGGAAT 56 
SPI1 
1C (10.8 kB) See Appendix VI 
2A (13.6 kB) See Appendix VI 
ssaQ-ssaO (1.0 kB) 2A/F6 – AGGTGGGGCAGGATAAATCT 2A/R8 – AATGGCCGGGCTATTCACTC 58 
ssaG-ssaL (3.7 kB) 2A/F13 – TGCGCATCAAGTTGTTGGAG 2A/R3 – AAAAGTGCGCCGGAGTAATC 58 
2B (13.5 kB) See Appendix VI 
sseB-ssaB (3.9 kB) 2B/F6 – CACGTTCAGCGTTCTTCTGG 2B/R8 – GGGATTCATGCTGGCAGTTT 58 
SPI2 
2C (12.9 kB) See Appendix VI 
3 (17 kB) See Appendix VI 
sugR-rhuM (3.9 kB) 3/F3 – ACATCACAGCCATGCTTACC rhuM/R – TAAGCGCCGTTGTTGTTCAG 58 
slsA-cigR (1.6 kB) 3/F12 – TTGCAACGCACCTGGAATCG 3/R8 – GGTGGTCACGGCGATTATTA 58 
SPI3 
rmbA-slsA (7.6 kB) 3/F3 – ACATCACAGCCATGCTTACC 3/R9 – TGGACAATGCCCATCCAGAG 58 
4A (15.5 kB) See Appendix VI SPI4 4B (8.2 kB) See Appendix VI 
copR-orfX (4.0 kB) copR/F – CTCACGGAAGCAGGCTATGT orfX/R – CAAAGCCCCGGACAAGTAAG 58 
orfX-pipB (3.1 kB) orfX/F – TCGTCACGGTCTTACTTGTC pipB/R – ATACCGCGTGGTGAAGTTGC 58 SPI5 
pipC-pipA (2.7 kB) pipC/F – ATGCCATTGCCTGACGACAT pipA/R – CCCGAAAGGGTTCCAGAGTT 59 
All PCR products ≤ 4.0 kB were amplified as described in Section 2.3.3.2 
*The following PCR products were amplified as described in Section 2.3.3.3 (PCR 
elongation times indicated with the annealing temperature in parentheses) 
** Primer name, F: forward primer and R: reverse primer 
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Table VII(B) Primers for sequencing analysis of SPI1 to SPI5 (see Section 4.2.3) 
SPI PCR product Primer sequence* 
fhlA-sitD 
fhlA/F – CCCTGCTGTCGCGTATGAAG 
fhlA/F2 – ACCAGGCATCGTGCTCTCTC 
sitB/F – CCGAGTTTTGCGACTATACG 
sitB/R – CATCCACGCCGGTAAAAGGT 
sitB/R2 – GGAACCATTTACGCCTACCA 
sitD/R – GGCCATAATGCAGTAGTGTG 
sitD-sprB sitD/F – ATTCCCTGCGCCTTACTGTC sprB/R – CCGTGGCTGCTACGTATGCT 
avrA  avrA/F – GTTGTGCGCCTTGAGTATGT avrA/R – CGGTGCAGGAGCTATCATGT 
sprB-prgH 
sprB/F – AGCGATAGCGGTGAAGAGTC 
hilC/F – CGATGAACTCCCCAAATTCG 
hilC/R – GGAGTTCATCGAACGATCTG 
orgC/F – TCTCCTGCATCCAGGAGGTC 
orgC/R – GAGTCAGCCTCTTCTGAAAC 
orgA/F – CCTTGCCAGATCGGCTCTCA 
orgA/R – CGGCATGGCGGCTTAAGAAC 
prgK/F – AGCGGCGAACCTCGTTCATA 
prgK/R – GACCAGGAACAGGCTAATGA 
prgI/R – ACAAACGCAGGTAACAGAGG 
prgJ/F – CCGGTCATCCAGCGAGACAA 
prgH/F – AGCCAGAAAACGGGTTTACG 
prgH/R – TTGCTGACAGGCCGAACACT 
prgH-hilA 
prgH/F – AGCCAGAAAACGGGTTTACG 
hilD/F – TTCCTGCCAGAAGAGAGGTA 
hilD/F2 – ACGCTCAAACGGAAACTTGC 
hilD/F3 – ACCGAAACAGTCACGCTTGT 
hilD/R – TAGCCTCCCATCCTGATAGA 
hilA/R – GGTAAGGCACGCTCACTATT 
hilA/R2 – AGCCCCAGTAATCCTAAAGC 
hilA/R3 – GGCGCATACTGCGATAATCC 
hilA-iagB 
hilA/F – GCTCAACCTGACCGTTAGTA 
hilA/R2 – AGCCCCAGTAATCCTAAAGC 
iagB/R – ACGGCCTCCCAGCTATAACC 
iagB-sipB 
iagB/F – GATGGTTCAACCGATCTTGG 
iagB/F2 – ATGCCGGGACGTCACCGAAA 
iagB/F3 – AGCCAAAAGTTCGCCCCTTC 
sptP/F – CGTACCTGCTCCAGATTACT 
sptP/F2 – AACCGTGCCAGACCCAGTGT 
sptP/R – GAACAAACCCCTTACCCAAC 
sptP/R2 – GCCAGATCACCAGCCGTTAC 
sicP/F – TCGGGCATCATTCGACACAC 
sicP/R – TACCGCTCACTTTTGACGAC 
iacP/F – CAGCGTAAAGATCCTCAACC 
sipA/F – TGGCAAGCGGCTTCACATTC 
sipA/F2 – ATGCAGCCGGCAATATAGGG 
sipA/R – CGGCAGAGATTGTGAATGTG 
sipC/F – CAGGAGCGCGATTAAATCAC 
sipC/F2 – CTGTGGCTTTCAGTGGTCAG 
sipC/R – CGTTCCGAGCAGCAAATTAG 
sipD/F – GTGCGCTCGTCATTATTCTC 
sipB/R – CGAACCGCATTATGGGATGT 
SPI1 
sipB-spaR 
sipB/F – GGCCACCATTACCGCAAGTC 
sipB/F2 – CTCAATCATCGCCTGCCATA  
spaS/F – ACAGGTACGCCAACCTTCTC 
spaS/F2 – TGATGGCGGCAACCACAAAG 
spaS/R – GCCAACCCCACGCATATTAC 
spaR/R – GCCTCCTGGTAGGGTTATTC 
spaR/R2 – AAAACGGTCTGGTCACGATG 
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spaS-spaO 
spaS/F – ACAGGTACGCCAACCTTCTC 
spaS/F – ACAGGTACGCCAACCTTCTC 
spaQ/F – CGCCCGTAAGAGAGTAAAAC 
spaO/R –  GAGTCTGGTAATGGGGAAT 
1C 
1C/F – GTCTCGGTCTCTTCTCCATACTGACG 
1C/F2 – TGCTCAGCCAGTCCCTGGTT 
1C/F3 – GGCCTCCGCAGAGATCAAAC 
1C/F4 – ATTGCCGGGTAATGTCCCTG 
1C/F5 – GCACGTCCAGTGGGATAAAG 
1C/F6 – GAGGAAGGTACTGCCAGAGG 
1C/F7 – GGCGCTACGTTTTGCTTCAC 
1C/R – CTTTCATGGGCAGCAAGTAACGTCTG 
1C/R2 – AGAGCAACAGGCCAACGCAA 
1C/R3 – TACAACTGGGGCTGATTTGG 
1C/R4 – AAGTACCCTCGATGGCAGTC 
1C/R5 – GCTGGCGCAATTTCGTAACC 
2A 
2A/F – CGCAGTGGCCTGAAGAAGCATA 
2A/F2 – ACAGTACGGTAGCGCCCGAA 
2A/F3 – CAACTGTTGTGCCGACCGAT 
2A/F4 – AGGGAACCGCCGCACAAAAC 
2A/F5 – GCTTTACTGTCCCACTCAGA 
2A/F6 – AGGTGGGGCAGGATAAATCT 
2A/F7 – ACCCAAGGCTTCCCTCAACT 
2A/F8 – GCCAACGGCTCATTCATATC 
2A/F9 – CACTCCTCTTCGCTAAGGTC 
2A/F10 – CTGTCACCCACCACACTAGC 
2A/F11 – CGGCAATCGTATCGCCTTTA 
2A/F12 – GAACGCATTGCGACTCCAGA 
2A/F13 – TGCGCATCAAGTTGTTGGAG 
2A/R – ATGCCTCATGGAGTGAGATTCG 
2A/R2 GCCCAAATGCCCAGGTAGGA 
2A/R3 – AAAAGTGCGCCGGAGTAATC 
2A/R4 – TTCTGACGGCATGTGATGTG 
2A/R5 – TCAAACTGCTGGCGTTATGG 
2A/R6 – ATCCGAGACGCCTATCGTTA 
2A/R7 – GAAATAGGAATGGCGCTGAG 
ssaQ-ssaO (1.0 kB) 2A/F6 – AGGTGGGGCAGGATAAATCT 
ssaG-ssaL (3.7 kB) 2A/R3 – AAAAGTGCGCCGGAGTAATC 2A/R5 – TCAAACTGCTGGCGTTATGG 
2B 
2B/F – TACTTGCCGCTGACGGAATA 
2B/F2 – CGCGTAAAAGTCCCAGTAAG 
2B/F3 – GCGCCACCCGCAGTAATCAT 
2B/F4 – CCCGCGCTTCGCGTCATATT 
2B/F5 – CGGCGCTATCGCTATTACTG 
2B/F6 –  CACGTTCAGCGTTCTTCTGG 
2B/F7 – GATATTGCTGCGGATCCTGT 
2B/F8 – ATTGCGCCCGCACATAATGA 
2B/F9 – CCCGTAGTGATGGATTCAAG 
2B/R – GGGCGAGAAGCTGAAGTTTGTA 
2B/R2 – TTCTGCCCGGCAGTGAGCTT 
2B/R3 – TGTAGCTTTTCGCTGATCCC 
2B/R4 – ATTGGGCCAGGGTAATAAGG 
2B/R5 – GCCAGGTCGTAGAGTTTTCC 
2B/R6 – TCGACAAAACGCCATAACGG 
2B/R7 – GGCGTGCAATTTGGAGGACC 
2B/R8 – GGGATTCATGCTGGCAGTTT 
2B/R9 – GCAGATATCCCCGGGTTATT 
sseB-ssaB (3.9 kB) 2B/F6 – CACGTTCAGCGTTCTTCTGG 2B/R8 – GGGATTCATGCTGGCAGTTT 
SPI2 
2C 2C/F – GCCTGCACGATCCGGTACTA 
2C/F2 – CGCGGAATTACGCGAGGTGA 
2C/F3 – CACATCTCGCGGTACAGTTC 
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2C/F4 – GCGTTAGTGACCGCCGTATC 
2C/F5 – CCAGCAGCATGACCCAAATA 
2C/F6 – ACCCGGTAAAACGGAGATGA 
2C/F7 – TCAACAACAAGCCGGGTATG 
2C/F8 – GTACAGGCGTGTCCTTACGA 
2C/F9 – CGCCTTACAGGCATTCTTCG 
2C/F10 – ACCCCTTGTCTCAGGAACAC 
2C/F11 – TTTGCGCTCTTTATGGGCAC 
2C/F12 – CCGCTTAAAGCCTGGATTTC 
2C/R – TCCAGGTCGATGGCGATGTT 
2C/R2 – TGATCGGCGAAATGACATGG 
2C/R3a – CGCCTTCGCTTTCTTCACTT 
2C/R3b – CCACGAGCGTAGGGAACAAA 
2C/R3c – AGAGAGACTGGCGCGATAGG 
2C/R4 – GAACATGAACGGCTTCTTCC 
2C/R5 – ATCAAAGCCGCCAGAAGGGC 
2C/R6 – CCGCCCTCAGCAACATAATC 
2C/R7 – AGCGGAGGCATATTGAATGG 
2C/R8 – GCGTAGATCGGAACGAATAG 
3 
3/F – ACATCCTTCTCTCATGCCCACCATT 
3/F2 – CCTCCGCAAAGAAGGGATAA 
3/F3 – ACATCACAGCCATGCTTACC 
3/F4 – TCATCACATCACCCCGATAG 
3/F5 – TTTGTACGTCGCCGGGTATC 
3/F6 – GGATGGTGACGGTATTAACG 
3/F7 – CAGGTTCTCGGCAATACTTC 
3/F8 – GGTTACAGCTTCAGGTTAGG 
3/F9 – GCGCCGTACATTTCTCTGGA 
3/F10 – GAGATCTGGCCTCGATAATG 
3/F11 – AGCAGCACTCGTTATGTAGG 
3/F12 – TTGCAACGCACCTGGAATCG 
3/F13 – CCAAAAGTTCGCCCCTTCGC 
3/F14 – CAGCTCACGCTGTTGACTCC 
3/R – ACAGAGCTATCGCCGGTATTAAGCA 
3/R2 – TTACTGGCCGCTATGCTGTT 
3/R3 – TGCAGGAAACACCACACCTT 
3/R4 – TTCGGCTCGCTGGCGAAATC 
3/R5 – TTTGTACGTCGCCGGGTATC 
3/R6 – CTCATGGTGCTTGAGGAAGG 
3/R7 – TGGTATCCCACATCAGAAGG 
3/R8 – GGTGGTCACGGCGATTATTA 
SPI3 
rmbA-slsA 
3/F5 – TTTGTACGTCGCCGGGTATC 
3/F7 – CAGGTTCTCGGCAATACTTC 
3/F10 – GAGATCTGGCCTCGATAATG 
misL/F – TCTGCTACCAGTACACTACC 
SPI4 4A 
4A/F – AGGGCGGTAGCGTTCACTTT 
4A/F2 – GTGTCTACCGCCCGTAACAA 
4A/F3 – GCACGACTGGAGGCAATGAG 
4A/F4 – TAGTGTCTCAGGAGGTTGTG 
4A/F5 – GAGCAGGAGTTTCAGTTAGG 
4A/F6 – CTCATGGTGGTGTGATTCAG 
4A/F7 – ACCGGCTCTAAAATTCTGGG 
4A/F8 – AGGGCTTAACGCCGACCTTG 
4A/F9 – CTCCGACGGTTTCTTTGGAG 
4A/F10 – GATGGCTCGCATGACGTAAC 
4A/F11 – ACGCAACAACCTGATGGTTC 
4A/F12 – TGTCGACGCCGGTTATCGTA 
4A/F13 – GACAAAGCGGGGAACACCAG 
4A/R – ATATCCAGCGGCCATCCCTC 
4A/R2 – CAGCGGGAACGTCAATTCTG 
4A/R3 – TGCTGTCCCTCTGGCATATC 
4A/R4 – CGTTATCCGTTACCTCTACC 
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4A/R5 – TAGCCATGCTGTACCTCAAC 
4A/R6 – CCGGCGTCGACAATGTAGTA 
4A/R7 – CTCGTCTTTCACCGTTACCG 
4A/R8 – GAGGGCCGTTAGCCACATTC 
4A/R9 – TCATGCGAGCCATCGGATAA 
4A/R10 – GGCGTCATCGTCAATATGCT 
4A/R11 – CAACCGTCACTCGAAAATGC 
4B 
4B/F – AGCGGTGATAGCGATGTAGA 
4B/F2 – ATAACTCACGCCCCGGATAG 
4B/F3 – ATCCCACGATTCGCCTTTCA 
4B/F4 – CCAAAGATAGCGGAACTTCG 
4B/R – CACCTGATAACAGCGACAAG 
4B/R2 – AAACGGGAAATCCAGCACAC 
4B/R3 – GATTCAGTGGGATGGGAAAG 
4B/R4 – AAAGCGGGCAACAGTCAACA 
4B/R5 – GATCGCCTCGCTTACTCGTC 
4B/R6 – CGATGGCAACTGGAGTGTGA 
SPI5 copR-orfX  
copR/F – CTCACGGAAGCAGGCTATGT 
copR/F2 – ACGGAAAATCTGCCGCTCTA 
copS/F – GTTCGTCTGCCTGATAGTGG 
copS/F2 – TTTGGCGAGGAGATAATGCC 
copS/R – CCACTATCAGGCAGACGAAC 
orfX/F2 – GCGGCACCAGAATTAGCCAG 
orfX/R – CAAAGCCCCGGACAAGTAAG 
All sequencing reaction were performed as described in Section 2.3.3.4 
* Primer name, F: forward primer and R: reverse primer 
 
 
Table VII(C) Primers for RT-PCR analysis of SPI1 and SPI3 (see Section 4.2.4, 4.2.6 
and 4.2.8) 
SPI  PCR product Primer sequence* PCR annealing temperature (°C) 
avrA (0.67 kB) avrA/F – GCCGGATTGGCCTCCACATA avrA/R – ACGTCAGCGGGGAGCTAAAC 61 
sipD (0.79 kB) sipD/F – TGCGTCAGCGTCTGTAATGT sipD/R – ATTATCGCAGGCGGCTACTA 58 SPI1 
sptP (0.95 kB) sptP/F – CGTACCTGCTCCAGATTACT sptP/R – GCGAGAAAACTTCCAGGAGA 56 
marT (0.42kB) marT/F – TGCTGGAAGGGAAATAGACC marT/R – ACGTACCGTTGGCGAAAATG 57 SPI3 
slsA (0.54 kB) slsA/F – ACGCCCTGCCATTGATGCTA slsA/R – AGGTACGTTGCAGCTCAGAG 55 
 
All RT-PCR reactions were carried out as described in Section 2.5 
* Primer name, F: forward primer and R: reverse primer 
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Appendix VIII: Analysis of SPI1 to SPI5 genes of S. II Sofia Bt8 and their predicted 
protein sequences 
SPI Gene 
Analysis of the genes and predicted proteins from S. II Sofia Bt8 
(using Clone Manager 7) in comparison to S. Typhimurium LT2 
SPI genes and proteins 
sitA-invH SPI1 from LT2 (base 1 to 39600) SPI1 from Bt8 (base 1 to 39400) 
sitA 
sitB 
sitC 
sitD 
Translated proteins are the same length as the corresponding proteins 
from LT2 (98-99% sequence similarity) 
avrA 
Missing from this region (confirmed by Southern hybridisation, PCR 
and sequencing analysis). Replaced with a 200 bp sequence 
harbouring an ORF encoding a protein of unknown function; sharing 
98% sequence similarity with the 200 bp genetic element located in 
the sitD-sprB region of SPI1 from S. Typhi (GeneBank accession no. 
AF013575) and S. Choleraesius (GeneBank accession no. AF013574) 
sprB 
hilC 
orgC 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 94%, 95% and 92% sequence similarity, 
respectively) 
orgB 
Addition of ATCGTAAAAT at base 7149 to 7158 (between base 8257 
and 8258 in SPI1 of LT2). Translated protein (98% match to OrgB 
from LT2) is missing 3 amino acids from the end of the protein: V, I 
and R   
orgA 
prgK 
prgJ 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 93%, 99% and 98% sequence similarity, 
respectively) 
prgI 
Addition of CCA at base 9670 to 9672 (between base 11038 and 
11039 in SPI1 of LT2). Translated protein has an extra threonine (T) 
residue at position 3: 
PrgI (LT2): MA_TPW------QNFR 
PrgI (Bt8):  MPTTPW------QNFR 
prgH 
hilD 
hilA 
iagB 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 97%, 93%, 95% and 93% sequence similarity, 
respectively) 
IS 
Gene is 1.2 kB and translated protein is 400-amino acids in length, 
showing sequence similarity to transposase from the mutator family of 
proteins (Figure 4.6). These include transposase from S. Welterveden 
(ZP_02834589), Yersinia enterocolitica (AAO39032), Bacteroides 
thetaiotaomicron (NP_809193), Rickettsiella grylli (ZP_02061857), E. 
coli CTF073 (NP_757024) and Shewanella spp. (NP_717888, 
ZP_01706506, YP_563181 and YP_001557092).  
This ORF is not found in any other Salmonella serovar, including 
Typhimurium (Figure 4.7) 
1 
sptP Multiple changes in the gene sequence. A majority of the changes are 
base substitutions. 
Insertion of TGG at base 17858 to 17860 (between base 17928 and 
17929 in SPI1 of LT2). Deletion of 39 bp sequence between base 
17929 and 17930 (corresponds to base 17997 to 18035 in SPI1 of 
LT2).  
Change of T to C, which altered start codon of sptP (ATG to ACG). If 
translated, predicted protein is missing the first 32 amino acid residues 
(87% sequence similarity) 
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and starts with valine (V) instead of methionine (M) – see Figure 4.8     
sicP 
iacP 
sipA 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 85%, 90% and 79% sequence similarity, 
respectively) 
sipD 
Multiple changes in the gene (Figure 4.9), resulting in nonsense 
mutation and creating a termination codon in the middle of the gene. 
SipD is truncated after translation of 260 amino acids. 
sipC 
sipB 
sicA 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 91%, 97% and 99% sequence similarity, 
respectively) 
spaS 
spaR 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 98% sequence similarity) 
spaQ 
spaP 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 100% sequence similarity) 
spaO Translated protein is the same length as SpaO from LT2 (showing 98% sequence similarity) 
invJ/spaN 
Change of A to G at base 30866 (corresponds to base 30980 in SPI1 
of LT2), which altered the start codon of invJ (ATG to GTG). 
Translated protein starts with valine (V) instead of methionine (M) 
invI/spaM Translated proteins is identical to InvI from LT2  
invC 
invB 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 99% and 97% sequence similarity, respectively) 
invA 
invE 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 99% sequence similarity) 
invG 
invF 
invH 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 98%, 96% and 91% sequence similarity, 
respectively) 
ssaU-orf48 SPI2 from LT2 (base 1 to 41744) SPI2 from Bt8 (base 1 to 39513) 
ssaU 
ssaT 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 95% sequence similarity) 
ssaS 
ssaR 
ssaQ 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 100%, 98% and 91% sequence similarity, 
respectively) 
ssaP 
Deletion of CCT between base 3999 and 4000 (corresponds to base 
5998 to 6000 in SPI2 of LT2). Translated protein is missing proline (P) 
residue at position 46 (SsaP of LT2 is 124 amino acids in length) 
SsaP from LT2 and Bt8 chare 94% sequence similarity   
ssaO Translated protein is the same length as SsaO from LT2 (showing 92% sequence similarity) 
ssaN 
ssaV 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 96% sequence similarity) 
ssaM 
ssaL 
2 
ssaK 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 95%, 96% and 93% sequence similarity, 
respectively) 
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putative 
ssaJ 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 97% and 96% sequence similarity, respectively) 
ssaI 
Addition of ACA at base 11446 and 11448 (between base 13446 and 
13447 in SPI2 of LT2). Translated protein has extra arginine (R) 
residue at position 3 (SsaI of LT2 is 82 amino acids in length) 
SsaI from LT2 and Bt8 chare 75% sequence similarity   
ssaH 
ssaG 
sseG 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 94%, 95% and 91% sequence similarity, 
respectively) 
sseF 
sscB 
sseE 
sseD 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 90%, 96%, 97% and 91% sequence similarity, 
respectively) 
sseC 
sscA 
sseB 
sseA 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 83%, 92%, 94% and 93% sequence similarity, 
respectively) 
ssaE 
Missing approximately 234 bp at the junction between sseA and ssaE 
Change from T to C at base 17939 (corresponds to base 20149 in 
SPI2 of LT2), which altered the stop codon of ssaE (TAA to CAA). 
Translated protein contains 5 extra residues at the end of the 
polypeptide chain (QKSLS) 
ssaD 
ssaC 
ssaB 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 95%, 96%, and 94% sequence similarity, 
respectively) 
ssrA 
ssrB 
orf242 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 91%, 97% and 95% sequence similarity, 
respectively) 
orf319 Translated protein is the same length as Orf319 from LT2 (showing 97% sequence similarity) 
orf70 
ttrR 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 98% sequence similarity) 
ttrS 
ttrB 
ttrC 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 96%, 99% and 98% sequence similarity, 
respectively) 
ttrA Translated protein is the same length as TtrA from LT2 (showing 97% sequence similarity) 
orf408 Translated protein is the same length as Orf408 from LT2 (showing 96% sequence similarity) 
orf245 
orf32 
orf48 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 98% sequence similarity) 
sugR-mgtC SPI3 from LT2 (base 1 to 17039) SPI3 from Bt8 (base 1 to 14387) 
sugR and 
rhuM 
Missing from this region (confirmed by PCR and sequencing analysis). 
Sequence in this region was found to harbour an ORF showing 98% 
homology to gene remnant encoding putative IS1351 transposase 
pseudogene from S. Typhi CT18 (GeneBank accession no. 
AL627280)  
3 
rmbA Translated protein is the same length as RmbA from LT2 (showing 95% sequence similarity) 
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misL 
Deletion of 15 bp sequence between base 4051 and 4052 
(corresponds to base 7829 to 7845 in SPI3 of LT2), causing a 
frameshift in translation of misL 
Translated protein is missing 5 residues (VPVPD) from position 578 
and 582 (MisL of LT2 is 955 amino acids in length) 
MisL from LT2 and Bt8 chare 97% sequence similarity   
fidL Translated protein is the same length as FidL from LT2 (showing 96% sequence similarity) 
marT 
Deletion of 10 bp sequence at base 6585 to 6593 (between base 
10380 and 10381 in SPI3 of LT2), causing a frameshift in translation of 
marT 
Translated protein is missing the first 23 amino acids 
(MSCYAATASDYTQWCLLTLSNYV)  
MarT from LT2 and Bt8 chare 90% sequence similarity   
slsA 
Insertion of IS element from base 8091 to 9392 (between base 11861 
and 11862 in SPI3 of LT2) 
As this ORF is from base 7420 to 9402, insertion of IS causes a 
frameshift in translation of slsA 
Translated protein has 25 extra residues at the end of the polypeptide 
chain. 
IS 
Gene is 1.2 kB and translated protein is 400-amino acids in length and 
identical to the IS protein from SPI1. ORF is not found in any other 
Salmonella serovar, including Typhimurium (Figure 4.15) 
cigR 
mgtB 
mgtC 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 98%, 96% and 97% sequence similarity, 
respectively) 
siiABCDEF SPI4 from LT2 (base 1 to 23411) SPI4 from Bt8 (base 1 to 23460) 
siiA 
siiB 
siiC 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 96%, 95% and 98% sequence similarity, 
respectively) 
siiD 
siiE 
4 
siiF 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 97%, 91% and 98% sequence similarity, 
respectively) 
copR-pipA SPI5 from LT2 (base 1 to 9069) SPI5 from Bt8 (bace 1 to 3941) 
copR 
copS 
Translated proteins are the same length as the corresponding proteins 
from LT2 (showing 97% and 95% sequence similarity, respectively) 
pipD Translated protein is the same length as SipD from LT2 (showing 97% sequence similarity) 
ORF 
Change of G to T at base 3698 (corresponds to base 3864 in SPI5 of 
LT2), which altered the start codon of protein (ATG to ATT). Protein is 
probably not translated 
orfX Translated protein is identical as that from Lt2 
5 
sopB, pipC, 
putative, pipB 
and pipA 
Missing from this region (confirmed by Southern hybridisation)  
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Appendix IX: Single- and three-letter codes for amino acid residues 
Amino acid Three-letter code Single-letter code 
Methionine (ATG) Met M 
Glycine (GGT, GGC, GGA. GGG) Gly G 
Alanine (GCT, GCC, GCA, GCG) Ala A 
Leucine (TTA, TTG, CTT, CTC, CTA, CTG) Leu L 
Phenylalanine (TTT, TTC) Phe F 
Tryptophan (TGG) Trp W 
Lysine (AAA, AAG) Lys K 
Glutamine (CAA, CAG) Gln Q 
Glutamic Acid (GAA, GAG) Glu E 
Serine (TCT, TCC, TCA, TCG) Ser S 
Proline (CCT, CCC, CCA, CCG) Pro P 
Valine (GTT, GTC, GTA, GTG) Val V 
Isoleucine (ATT, ATC, ATA) Ile I 
Cysteine (TGT, TGC) Cys C 
Tyrosine (TAT, TAC) Tyr Y 
Histidine (CAT, CAC) His H 
Arginine (AGA, AGG) Arg R 
Asparagine (AAT, AAC) Asn N 
Aspartic Acid (GAT, GAC) Asp D 
Threonine (ACT, ACC, ACA, ACG) Thr T 
Termination (TAA, TAG, TGA) - - 
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Appendix X: Cloning vectors used in this study (see Chapter 5) 
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Appendix XI: Formula for calculation of the required amount of tissue culture cells per 
well (see Section 2.4.3.3) 
 
 
    Average number of viable cells 
Percentage of viable cells =  
            Total number of cells                        
 
Total cell number per mL = Average number of viable cells × dilution factor × 104 
 
                                               3 × 105 cells   
Volume that contains 3 × 105 cells (A) =  
                       Total number of cells per mL 
 
Total volume required to seed n wells (B) = A × (n + 1) 
 
Make up volume B to a total volume (0.5 mL × [n + 1]) with DMEM media.  
 
 
 
 
 
 
 
 
 
 
 
 
 
× 100 
× 1 mL 
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Appendix XII: Primers for RT-PCR analysis of katF and spvRABCD in clone pCspv8 
and pWSPV1 (see Section 5.2.4) 
 
PCR product Primer sequence* PCR annealing temperature (°C) 
katF (0.7 kB) katF/F – TGATAACGACCTGGCTGAAG katF/R – CATATCCCAGCAGACCGAAA 56 
spvR (0.48 kB) spvR/F – GGACCTACGGGTAAAACGAA spvR/R – TCTGACGGGGATGAGTAACA 55 
spvA (0.6 kB) spvA/F – ATTGTCCGTCAGACCCGTAA spvA/R – CTAACTGTCGGGCAAAGGTA 55 
spvB (0.86 kB) spvB/F – GCGCAATGGCTGGTTGAGGA spvB/R – TCAGGCCCCGGTATACGACT 61 
spvC (0.63kB) spvC/F – GGGGCGGAAATACCATCTAC spvC/R – CCTCACGTAAAGCCTGTCTC 57 
spvD (0.61 kB) spvD/F – TTTCTGGTAGTGCGTCATCC spvD/R – CCCCTGATGATGAGAAGTGT 55 
All RT-PCR reactions were carried out as described in Section 2.5 
* Primer name, F: forward primer and R: reverse prime
 
 
